data_2hgc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hgc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 CA--C 1.527 0.093 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.773 HH11 ' HA ' ' A' ' 36' ' ' ALA . 33.9 mmt180 -67.42 -56.07 11.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -62.57 -40.79 97.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.751 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.96 87.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.326 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.27 -39.17 72.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.784 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.649 ' HG ' HD12 ' A' ' 40' ' ' LEU . 8.0 mt -56.28 -45.02 80.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 6.8 ttpp -62.56 -39.59 94.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HG2' HG12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -64.61 -37.18 86.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.359 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.08 -44.13 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.278 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.35 -50.51 73.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.318 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.83 -18.99 19.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.482 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.17 -27.12 66.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.332 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 74.2 -1.78 2.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.212 0.605 . . . . 0.0 111.449 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 62.0 p 59.55 153.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.664 1.186 . . . . 0.0 113.33 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 2.0 Cg_endo -81.74 167.12 70.87 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.983 -1.257 . . . . 0.0 112.387 0.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 13' ' ' GLU . 1.7 pt? -140.78 149.05 41.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.685 ' HB3' ' HB2' ' A' ' 25' ' ' ASP . 30.3 t -85.2 167.26 15.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.65 0.738 . . . . 0.0 110.938 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -80.63 -48.21 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.545 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.6 -27.88 68.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.585 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 11.1 t70 -72.73 -40.63 65.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.564 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.423 HG12 ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -74.29 -32.91 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.24 20.37 2.22 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.721 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.66 175.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 117.243 0.522 . . . . 0.0 110.786 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.6 p -85.32 172.5 11.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 mt-10 -58.27 -53.2 60.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 110.403 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.78 -29.97 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.113 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.2 -46.74 66.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.347 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 67.9 t80 -62.87 -45.35 92.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.772 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 55' ' ' ARG . 6.3 t70 -54.75 -53.86 49.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.664 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.9 -40.23 92.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.62 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.773 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -61.06 -52.22 65.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.08 -44.73 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.993 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.45 -45.0 95.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.239 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.34 -46.78 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.649 HD12 ' HG ' ' A' ' 11' ' ' LEU . 90.7 mt -63.74 -34.84 78.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.613 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 56.7 tttm -67.31 -41.55 85.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.776 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -67.29 -47.38 70.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.071 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.62 -22.95 58.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.06 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 46.83 1.92 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.062 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.627 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 86.3 m-85 -98.66 -36.29 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 110.356 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.36 155.6 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 pt -131.82 170.82 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 14.32 50.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.8 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 96.7 t -78.41 114.14 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.033 0.444 . . . . 0.0 110.31 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -109.64 131.62 54.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.621 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.502 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 10.2 mtp180 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 25.2 Cg_endo -62.48 134.48 48.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.644 2.229 . . . . 0.0 112.393 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -126.82 132.41 51.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.124 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.462 HD21 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -97.64 138.67 34.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.428 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -110.37 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.578 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.594 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 54.0 mttp -83.59 -5.37 59.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.389 0.614 . . . . 0.0 110.326 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -156.79 120.86 4.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 64' ' ' GLU . . . 157.36 -57.02 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.896 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HG3' HD21 ' A' ' 58' ' ' LEU . 30.5 Cg_exo -62.3 106.36 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.62 2.213 . . . . 0.0 112.55 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 4.3 mm-40 -110.55 140.07 45.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -88.66 144.22 26.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.896 0.379 . . . . 0.0 110.458 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 p -87.21 171.38 10.7 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.46 -38.3 90.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -63.0 -44.53 95.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.643 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.19 -42.72 94.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.704 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.03 -46.57 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -34.52 77.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.674 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.57 -37.68 87.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.558 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 11' ' ' LEU . 82.8 mt -63.4 -33.46 75.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.578 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.491 -177.552 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' HG12 ' A' ' 10' ' ' ILE . 3.6 mm? . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 121.471 0.653 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.75 ' NH1' ' HA ' ' A' ' 36' ' ' ALA . 4.9 tpp180 -57.57 -37.17 72.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.112 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -69.73 -44.47 70.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.011 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -37.77 76.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.628 HD11 HG13 ' A' ' 26' ' ' ILE . 35.2 mm -65.17 -51.63 63.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 110.098 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.18 -40.61 90.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.093 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -68.32 -28.32 67.05 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.307 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.557 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -81.04 -26.41 36.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.118 0.485 . . . . 0.0 110.193 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.45 -26.99 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.754 0.788 . . . . 0.0 109.471 171.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.92 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -100.41 -40.53 7.43 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.43 55.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.724 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.469 ' O ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER 70.25 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER 173.01 164.84 0.27 Allowed Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 124.18 0.992 . . . . 0.0 108.805 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 19' ' ' THR . 64.7 Cg_endo -90.07 175.21 21.27 Favored 'Cis proline' 0 N--CA 1.462 -0.378 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.823 -3.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.11 137.18 28.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -85.27 170.26 12.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.438 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 6.8 pm0 -59.4 -37.16 77.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.055 0.455 . . . . 0.0 110.797 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.413 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t-20 -65.18 -30.94 71.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.047 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.35 -49.76 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.628 HG13 HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.62 -35.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.105 -176.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.86 30.85 2.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.273 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 32.1 m -130.6 169.17 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 32' ' ' GLN . 23.6 p -85.16 169.32 13.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.785 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.65 -52.58 22.48 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.787 0.68 . . . . 0.0 110.832 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.43 -37.44 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.844 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 18.1 mm-40 -79.02 -32.85 45.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -72.24 -36.39 69.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.511 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.89 -46.41 90.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.596 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -52.11 -49.65 63.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.514 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.75 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . . . -59.69 -58.52 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.819 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.51 -47.09 94.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.588 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.55 -39.32 93.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.61 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HD2' ' HD2' ' A' ' 7' ' ' ARG . 77.1 t80 -67.22 -41.04 86.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.322 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.1 mt -64.44 -44.77 90.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -70.53 -37.25 74.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.889 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -58.89 -55.97 28.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -82.78 -3.22 56.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.62 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.75 44.84 9.9 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.106 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.28 -34.14 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.183 0.516 . . . . 0.0 109.743 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 49' ' ' VAL . 1.8 pp -140.1 157.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.473 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 46.1 pt -132.26 165.65 31.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.48 -1.95 73.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.915 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.401 HG23 HD12 ' A' ' 46' ' ' ILE . 57.4 t -76.67 126.96 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.802 0.334 . . . . 0.0 110.53 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -98.56 147.2 25.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.457 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 56' ' ' PRO . 19.1 m-85 . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 13.3 ttm180 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 28.9 Cg_exo -61.19 147.77 94.71 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.448 2.098 . . . . 0.0 111.073 169.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -118.8 115.61 24.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.402 0.62 . . . . 0.0 111.389 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.39 144.98 26.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.346 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.97 168.99 18.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 19' ' ' THR . 29.8 mtpp -55.98 -56.43 20.83 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.724 0.64 . . . . 0.0 112.232 -168.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.06 90.14 3.21 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.936 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.1 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.021 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 Cg_exo -66.07 109.07 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.146 2.564 . . . . 0.0 113.316 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -108.44 155.79 20.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.164 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.56 148.21 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.065 0.459 . . . . 0.0 111.051 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.0 p -104.55 -179.81 4.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.088 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -54.32 -43.91 71.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.079 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -57.12 -51.36 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -38.67 93.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.269 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.53 -46.93 87.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -61.53 -41.24 97.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.02 -40.18 92.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.97 -42.83 90.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.179 0.514 . . . . 0.0 110.484 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.92 -178.495 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' CZ ' ' HA ' ' A' ' 36' ' ' ALA . 59.1 mmt-85 -54.3 -33.31 58.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.179 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.1 -54.25 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.901 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.03 -48.57 75.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -62.07 -43.77 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 73' ' ' LEU . 12.1 tp -65.64 -35.48 80.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.2 ttpp -70.84 -39.95 72.66 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 9.4 mm-40 -62.26 -39.79 94.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.457 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -32.17 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.383 0.611 . . . . 0.0 110.135 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -75.43 -40.13 58.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.443 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 8.9 mt-10 -80.85 -40.31 25.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.34 50.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.919 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 19' ' ' THR . 5.9 t30 68.89 -90.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.453 0.701 . . . . 0.0 109.52 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER 177.19 159.33 0.5 Allowed Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.998 0.919 . . . . 0.0 109.345 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.815 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 Cg_endo -82.09 167.78 67.79 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.321 -1.116 . . . . 0.0 112.199 0.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -150.17 129.51 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.18 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.99 -38.26 72.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.504 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -68.91 -35.8 77.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.947 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.72 -45.21 87.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.187 0.518 . . . . 0.0 110.629 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.571 HG22 HG23 ' A' ' 28' ' ' VAL . 14.9 tt -79.56 -24.72 12.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.936 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.47 11.99 52.39 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.533 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 26' ' ' ILE . 26.3 m -123.15 167.22 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.979 0.389 . . . . 0.0 110.455 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -78.68 166.7 22.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.819 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.99 -40.59 81.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.97 -48.62 77.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.732 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.7 -35.12 67.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.29 -47.65 81.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.81 -53.52 57.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.644 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.44 -53.36 52.49 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.239 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . . . -67.1 -53.53 29.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.291 -174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.18 -40.16 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.78 -39.64 94.74 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.83 0.348 . . . . 0.0 110.513 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -65.89 -46.62 77.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.58 -42.06 91.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.227 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -66.58 -36.58 82.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -66.79 -43.01 85.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.033 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -78.26 -20.82 50.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.647 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.01 38.7 5.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.29 -30.65 20.72 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.63 -0.336 . . . . 0.0 111.038 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 159.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.05 158.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.97 29.04 19.2 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.202 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.53 109.91 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -91.03 130.94 36.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.979 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.363 175.212 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.63 122.56 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.8 2.333 . . . . 0.0 112.176 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -137.25 105.91 5.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB3' HG22 ' A' ' 19' ' ' THR . 70.9 mt -79.74 122.96 27.23 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.031 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.815 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 75.5 m-85 -107.1 -173.41 2.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -57.07 -52.39 65.47 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.52 0.512 . . . . 0.0 112.001 -171.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.62 135.27 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.755 0.312 . . . . 0.0 110.632 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.48 -70.77 0.5 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.502 ' HG2' HG22 ' A' ' 19' ' ' THR . 25.6 Cg_exo -63.9 119.63 6.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.304 2.669 . . . . 0.0 113.439 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.09 156.26 48.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.809 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.03 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -93.13 169.9 10.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -24.68 64.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -59.3 -47.01 87.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.91 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.38 -34.39 50.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.909 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.41 -43.6 93.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.33 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.05 -30.3 67.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -62.75 -36.56 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.784 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 11' ' ' LEU . 82.8 mt -62.9 -19.75 64.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.094 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.5 tttp . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.622 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.237 0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.53 ' HB3' HD21 ' A' ' 40' ' ' LEU . 22.6 mmt180 -67.24 -34.89 78.41 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.73 -41.02 80.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.153 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -61.53 -35.11 76.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.454 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 19.6 mt -73.99 -30.34 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.438 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.22 -36.16 82.32 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.455 -0.778 . . . . 0.0 109.322 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 13.3 tmtt? -61.93 -52.67 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 10' ' ' ILE . 12.8 pt-20 -60.4 -39.08 86.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.029 0.442 . . . . 0.0 111.411 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.431 HG13 ' HG3' ' A' ' 13' ' ' GLU . 88.6 mt -74.38 -43.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.67 -46.2 89.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.442 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 10.4 pt-20 -92.83 -26.5 17.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.398 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 19' ' ' THR . . . -74.46 -24.29 73.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.116 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 29.3 t-20 76.66 -20.2 0.38 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 111.755 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.785 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 70.9 p 61.95 163.41 0.11 Allowed Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 124.413 1.085 . . . . 0.0 112.67 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.785 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 72.1 Cg_endo -79.51 150.68 84.61 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.522 -2.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -132.63 145.74 51.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.469 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 15.4 m -85.82 165.24 17.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.819 0.342 . . . . 0.0 110.585 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -62.72 -28.43 69.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.986 178.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' C ' HD21 ' A' ' 24' ' ' ASN . 0.3 OUTLIER -70.81 -10.12 58.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.781 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.51 ' N ' HD21 ' A' ' 24' ' ' ASN . 8.8 m-20 -85.28 -50.02 7.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.715 0.293 . . . . 0.0 110.509 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.511 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -78.89 -38.52 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.432 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.78 -13.41 10.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.678 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.511 ' H ' HG23 ' A' ' 26' ' ' ILE . 27.2 m -86.22 157.21 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 117.426 0.613 . . . . 0.0 110.197 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 t -85.13 162.21 19.34 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 10.0 mt-10 -51.04 -50.48 58.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.18 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.09 -41.65 71.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.084 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -79.66 -32.16 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 111.046 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.1 t80 -67.41 -52.85 34.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.22 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD2' ' HD2' ' A' ' 56' ' ' PRO . 0.9 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 178.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.95 -42.29 75.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 10' ' ' ILE . . . -64.51 -50.85 65.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 33' ' ' PHE . 65.8 t -58.41 -44.47 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.691 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.544 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 95.5 m-20 -61.33 -48.78 79.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -56.02 -45.65 79.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 7' ' ' ARG . 89.9 mt -65.98 -40.08 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.256 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 41' ' ' LYS . 0.7 OUTLIER -69.57 -31.34 69.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.153 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 99.6 mtt180 -61.76 -58.55 7.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.75 -24.24 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.349 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.93 52.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.716 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.426 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 81.8 m-85 -93.5 -34.76 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.064 0.459 . . . . 0.0 110.081 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 46' ' ' ILE . 2.2 pp -137.38 148.49 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.476 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.403 ' H ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -132.93 176.76 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.009 178.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 86.37 5.18 82.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.475 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.22 135.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -106.79 119.98 40.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 121.02 0.438 . . . . 0.0 111.276 -178.415 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 74.1 mtp180 . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.689 0.28 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 58.4 Cg_endo -72.45 139.91 32.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.939 2.426 . . . . 0.0 111.726 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -129.25 145.58 51.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.19 145.59 29.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.928 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -130.3 174.35 9.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.818 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.08 -40.38 75.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.38 0.61 . . . . 0.0 109.783 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tt -106.74 105.26 15.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.146 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 170.68 -70.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.167 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.09 109.56 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.009 2.473 . . . . 0.0 113.454 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.49 148.85 43.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.678 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.7 133.43 43.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.6 p -79.96 178.82 7.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.65 -39.9 91.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.36 -44.16 92.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.01 -36.0 64.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.287 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.97 -45.23 93.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.831 0.348 . . . . 0.0 110.666 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.28 -31.24 70.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 110.56 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.54 -34.38 76.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 96.0 mt -58.62 -43.01 89.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.229 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 tttm . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.55 -177.443 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 10' ' ' ILE . 4.3 mm? . . . . . 0 CA--C 1.521 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.657 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 18.6 mtm180 -65.62 -21.8 66.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.917 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 77.2 t80 -70.17 -46.47 64.59 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.979 172.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.56 76.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.831 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 7' ' ' ARG . 69.6 mt -58.07 -51.99 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.555 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD21 HD22 ' A' ' 40' ' ' LEU . 96.4 mt -58.4 -45.8 87.64 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.165 0.507 . . . . 0.0 110.835 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 26.3 ttpp -62.16 -48.67 79.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.175 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -31.02 71.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.0 mt -68.58 -43.47 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 110.589 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -75.3 -50.25 16.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.324 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.6 -40.16 66.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.819 0.342 . . . . 0.0 110.885 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 -27.45 70.06 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.502 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.93 26.05 11.03 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.089 0.556 . . . . 0.0 110.916 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.668 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 46.1 p 56.84 163.27 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.434 1.094 . . . . 0.0 113.134 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.668 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 71.5 Cg_endo -76.3 174.39 53.16 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 124.091 -1.212 . . . . 0.0 112.659 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 26' ' ' ILE . 58.2 tp -152.88 118.76 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.55 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 18.2 m -86.75 170.68 11.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.93 -30.82 68.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 177.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -75.31 -39.91 59.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 8.9 p-10 -85.65 -1.46 57.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.8 HD13 HD23 ' A' ' 21' ' ' LEU . 11.1 tt -99.95 -37.45 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.734 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.5 -34.38 3.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.698 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.88 122.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -67.89 173.24 4.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HG2' ' HG3' ' A' ' 23' ' ' GLU . 4.4 mt-10 -48.96 -51.32 31.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.766 -171.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.55 -57.89 8.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.834 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.48 -32.14 69.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.413 ' O ' HG22 ' A' ' 37' ' ' VAL . 80.0 t80 -65.63 -51.81 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.47 -46.14 89.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.725 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.19 -45.93 89.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.251 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 7' ' ' ARG . . . -60.68 -55.57 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.452 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 33' ' ' PHE . 88.2 t -58.23 -44.13 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.646 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.384 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.46 -38.61 65.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 46' ' ' ILE . 67.8 mt -59.86 -43.93 94.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.088 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.95 -45.35 89.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -57.21 -49.2 76.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.26 -0.16 35.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.287 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.94 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.112 -0.566 . . . . 0.0 113.557 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.57 -43.62 12.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 117.028 0.414 . . . . 0.0 110.773 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.513 HG23 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.57 151.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.423 . . . . 0.0 111.126 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.477 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.53 166.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.486 176.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.06 65.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.196 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -72.63 117.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.4 110.05 21.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.232 178.87 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.73 117.06 4.94 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.498 2.132 . . . . 0.0 112.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -102.06 105.13 15.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -84.1 92.02 7.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.198 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -82.92 176.91 8.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.598 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 35.5 pttt -74.4 -0.59 17.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.74 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.75 129.53 17.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.73 -71.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.653 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HG2' HG22 ' A' ' 19' ' ' THR . 30.6 Cg_endo -63.71 118.4 5.34 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.67 2.247 . . . . 0.0 113.284 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.03 150.41 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.872 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HG ' HG23 ' A' ' 46' ' ' ILE . 7.6 mp -93.65 144.44 25.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 p -92.8 170.72 9.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.585 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.14 -35.19 71.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -58.92 -50.6 73.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.116 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.44 -35.71 46.58 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.326 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HA ' HD11 ' A' ' 73' ' ' LEU . 2.7 tm-20 -61.33 -35.2 76.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.439 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -75.07 -34.96 61.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.053 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.51 -32.5 73.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.283 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.917 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.83 -38.25 75.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.816 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.7 mttp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.957 -178.127 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.538 ' O ' HG13 ' A' ' 10' ' ' ILE . 4.2 mm? . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.551 0.215 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.7 ' NH2' ' HA ' ' A' ' 36' ' ' ALA . 11.3 ptm180 -64.69 -16.5 62.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.755 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -77.47 -44.57 28.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.99 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.7 63.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.838 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 7' ' ' ARG . 52.6 mt -50.55 -37.83 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.578 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.519 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.5 mt -57.59 -34.06 68.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 36.7 ttpt -74.23 -48.06 31.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -38.1 75.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 110.724 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.463 HG12 HD21 ' A' ' 21' ' ' LEU . 70.6 mt -66.85 -45.64 87.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.454 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.8 -48.31 77.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.787 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 28.7 mt-10 -65.11 -39.2 92.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.908 0.385 . . . . 0.0 110.758 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.95 -27.17 51.14 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.42 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.77 26.21 14.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.956 0.503 . . . . 0.0 110.11 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 32.2 p 55.09 166.65 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.346 1.058 . . . . 0.0 112.917 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.756 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.8 Cg_endo -87.3 157.31 47.28 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.433 -3.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.514 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -153.08 129.19 10.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -85.11 170.11 13.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -55.43 -38.13 68.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 178.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.52 -38.61 90.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.587 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.6 -39.6 67.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.797 0.332 . . . . 0.0 111.047 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HB ' HD11 ' A' ' 21' ' ' LEU . 12.5 tt -82.79 -32.05 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.305 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.44 34.86 2.38 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.248 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 26' ' ' ILE . 30.9 m -130.29 169.93 20.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -85.34 167.67 15.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.082 0.468 . . . . 0.0 111.322 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 1.5 mp0 -51.7 -60.32 3.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.046 0.927 . . . . 0.0 111.189 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.4 -19.99 59.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.9 -169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.53 -36.79 37.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.998 0.428 . . . . 0.0 110.068 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 63.8 t80 -65.28 -44.82 86.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.881 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.68 -49.4 77.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.43 -40.56 74.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.7 ' HA ' ' NH2' ' A' ' 7' ' ' ARG . . . -61.79 -57.43 11.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.399 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 33' ' ' PHE . 69.3 t -57.48 -47.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.359 0.412 . . . . 0.0 111.734 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.05 -38.99 84.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.645 ' HB3' HH21 ' A' ' 7' ' ' ARG . 33.1 t80 -71.85 -41.62 67.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.821 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -67.29 -38.21 84.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.84 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 41' ' ' LYS . 11.6 tmtt? -69.74 -38.26 76.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 42' ' ' ARG . 8.0 ttm180 -56.82 -60.5 3.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.432 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -30.43 65.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.381 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.35 56.8 0.57 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.332 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.72 -26.01 13.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.733 0.301 . . . . 0.0 110.406 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 65' ' ' LEU . 1.6 pp -142.65 142.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.851 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.25 164.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.57 22.29 40.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.672 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.22 134.72 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -89.15 109.71 20.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.505 . . . . 0.0 110.19 175.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 17.6 mtp180 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 34.3 Cg_endo -66.14 138.34 51.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.629 2.219 . . . . 0.0 112.121 175.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -132.94 148.32 52.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.09 121.62 45.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.362 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.06 -166.44 1.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.771 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 27.2 mtpp -61.81 -51.61 67.59 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.607 0.567 . . . . 0.0 111.432 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.81 133.93 55.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.125 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.46 -69.74 0.37 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.13 107.67 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.889 2.393 . . . . 0.0 112.999 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -115.81 139.97 49.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.227 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD11 ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -75.59 144.17 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -83.46 168.57 16.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.742 0.306 . . . . 0.0 110.48 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.42 -34.68 77.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 23.8 ttmm -60.34 -47.65 85.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.853 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -64.93 -37.7 94.6 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.06 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -58.28 -53.44 58.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.429 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.33 -29.01 65.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 6.2 t80 -66.85 -30.18 70.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 11' ' ' LEU . 21.2 mt -75.65 -19.05 59.44 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.437 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 111.809 -177.528 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.43 0.157 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.499 ' HB2' HD21 ' A' ' 40' ' ' LEU . 7.7 ptp180 -60.89 -45.75 93.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.108 -174.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.448 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -60.98 -42.37 98.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.415 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.75 68.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.18 -40.91 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.673 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 84.3 mt -58.09 -51.27 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.648 0.261 . . . . 0.0 110.938 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 12' ' ' LYS . 5.6 ttpm? -67.34 -41.86 84.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.773 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -29.49 69.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.465 HG21 HG21 ' A' ' 19' ' ' THR . 53.5 mt -73.46 -47.21 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.96 -47.0 87.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.29 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.21 -33.84 49.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.71 -22.51 57.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.105 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.42 1.46 3.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 0.0 111.237 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.1 p 55.48 164.42 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.263 1.025 . . . . 0.0 113.293 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.582 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 73.5 Cg_endo -90.32 118.35 3.41 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.182 -1.174 . . . . 0.0 111.969 -1.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' H ' HD21 ' A' ' 21' ' ' LEU . 2.7 pt? -90.22 134.77 34.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.761 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -80.75 164.84 22.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.164 0.507 . . . . 0.0 110.948 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -51.0 64.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.011 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.27 -14.6 62.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.331 0.586 . . . . 0.0 110.525 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.45 -39.36 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.608 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.2 tt -76.97 -35.11 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 176.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.1 -31.05 3.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.001 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.06 152.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.887 -0.184 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.2 t -68.51 173.31 5.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.368 0.604 . . . . 0.0 110.524 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.37 -41.26 98.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.472 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.92 -40.5 95.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.274 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -73.99 -39.83 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 110.641 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.24 -49.03 78.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.669 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -62.17 -46.33 89.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.279 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.04 -50.56 70.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.445 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.85 72.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.822 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.47 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.557 0.218 . . . . 0.0 111.483 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -65.26 -35.69 81.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.93 -43.4 75.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.2 mt -63.22 -34.23 77.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.053 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -35.09 77.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -67.24 -42.91 83.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.35 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.168 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.75 39.77 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.19 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.05 -30.73 18.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 0.0 110.217 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.8 pp -142.45 152.02 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.46 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 pt -134.84 177.46 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.867 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.33 16.71 79.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.82 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.05 113.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.231 0.538 . . . . 0.0 109.57 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -80.34 113.09 18.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.794 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 79.5 m-85 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.623 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.474 0.178 . . . . 0.0 110.739 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 38.8 Cg_endo -69.93 143.43 50.0 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.312 2.008 . . . . 0.0 111.022 170.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 49.5 m-70 -104.03 -44.46 5.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 79.8 mt 68.2 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.438 0.637 . . . . 0.0 110.641 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -141.19 173.25 11.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.1 1.74 12.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.57 41.84 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.3 -86.55 1.59 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.153 -0.931 . . . . 0.0 114.019 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.47 159.34 14.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.028 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.55 139.99 51.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.585 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.0 mp -91.43 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.784 0.326 . . . . 0.0 110.729 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.8 p -88.44 170.7 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.28 -24.32 67.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.189 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -50.29 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.89 -42.25 53.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.077 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.03 -44.42 96.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.338 . . . . 0.0 110.473 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.87 -20.04 61.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.882 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -75.86 -28.82 58.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 83.1 mt -70.95 -22.65 62.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.129 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -64.64 -42.94 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -59.72 -43.4 94.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.948 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.12 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.377 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.72 -43.54 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.71 -52.45 64.92 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HB3' HD23 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -71.13 -22.77 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.026 -176.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 1.9 tp10 -80.13 -23.71 40.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.248 0.547 . . . . 0.0 109.883 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.02 -47.12 49.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.85 -50.02 75.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.66 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -99.62 -6.15 27.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 19' ' ' THR . . . -90.09 -12.44 61.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.449 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.9 t30 75.38 -17.24 0.52 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.005 0.522 . . . . 0.0 111.435 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.0 p 58.62 156.92 0.09 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.563 1.145 . . . . 0.0 113.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.5 Cg_endo -83.72 176.31 33.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.798 -1.334 . . . . 0.0 113.136 0.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.4 pt? -150.58 133.5 15.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 m -85.28 170.43 12.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.97 -37.93 77.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.093 175.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.42 -16.79 64.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.589 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.04 -49.98 7.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 110.821 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.456 HG22 HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.7 -38.61 58.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.93 22.17 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.189 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 26' ' ' ILE . 33.9 m -127.38 173.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 t -85.01 157.97 20.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 110.928 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.7 pm0 -63.29 -30.24 71.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.046 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -48.3 79.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.422 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 9.7 mm100 -82.44 -19.95 37.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.962 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.81 -55.58 16.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.05 -47.97 76.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.222 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 8.7 t70 -52.34 -49.04 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.315 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -68.06 -51.45 46.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.288 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.01 -42.32 85.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 111.237 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 95.4 m-20 -65.55 -41.48 92.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.526 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.21 -42.94 96.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.39 . . . . 0.0 110.596 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -59.41 -44.74 92.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.724 ' HB3' ' HZ1' ' A' ' 41' ' ' LYS . 6.2 ttpm? -70.92 -34.62 71.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.369 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 15.4 ttt-85 -66.37 -40.49 89.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.609 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.7 -40.1 61.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.817 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.05 2.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.805 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.511 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 60.2 m-85 -78.3 -41.32 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.571 0.224 . . . . 0.0 111.415 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.47 HG21 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -139.94 161.83 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.0 110.961 -177.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -129.24 170.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.204 174.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 90.71 19.87 42.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.699 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.72 114.5 22.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -88.46 141.03 28.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.0 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 . . . . . 0 C--N 1.32 -0.687 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 120.537 0.208 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.3 134.7 23.3 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.577 2.184 . . . . 0.0 112.739 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -126.47 135.26 51.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.393 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.424 HD23 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -98.66 152.8 19.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.838 0.352 . . . . 0.0 110.604 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -134.71 -177.94 4.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.09 -29.45 64.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.965 0.412 . . . . 0.0 110.881 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -128.2 126.72 41.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.489 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 156.62 -64.82 0.31 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HG3' HD23 ' A' ' 58' ' ' LEU . 10.8 Cg_exo -70.45 100.69 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.738 2.292 . . . . 0.0 112.866 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -105.69 140.24 39.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.658 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' HG ' HG21 ' A' ' 46' ' ' ILE . 6.6 mp -90.96 140.04 30.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.674 0.273 . . . . 0.0 110.395 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.0 p -90.03 177.09 6.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -59.46 -33.11 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.673 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.19 -44.57 95.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.91 -41.83 21.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.714 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.66 -41.08 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.823 0.344 . . . . 0.0 110.975 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -79.12 -20.34 48.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.14 -33.58 76.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' A' ' 12' ' ' LYS . 77.8 mt -61.02 -25.97 67.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.944 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 120.703 0.287 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' O ' HD12 ' A' ' 11' ' ' LEU . 98.7 mtt180 -69.52 -11.84 61.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -100.1 -46.03 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.67 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.54 81.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.86 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.99 -47.79 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.467 HD11 HD21 ' A' ' 40' ' ' LEU . 10.5 mp -64.31 -32.67 74.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.948 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -65.14 -44.78 87.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.99 -41.0 97.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.61 -39.14 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.556 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -68.58 -50.12 54.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.86 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.22 -40.89 26.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.657 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.33 -18.55 58.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.5 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 62.31 24.32 14.47 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 110.497 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.839 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.7 p 54.98 171.96 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.987 0.915 . . . . 0.0 113.235 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.839 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.1 Cg_endo -85.06 179.7 21.99 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 123.809 -1.33 . . . . 0.0 112.074 -3.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.79 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -155.24 124.17 6.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -76.34 163.48 26.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.304 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.435 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.94 -16.48 60.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.75 -42.15 22.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.79 ' HB ' HD11 ' A' ' 21' ' ' LEU . 4.2 tt -77.23 -38.71 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.3 35.89 0.98 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.293 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 26' ' ' ILE . 35.9 m -137.06 174.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -84.99 156.46 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.43 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 4.6 mt-10 -55.38 -40.83 71.84 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.65 -60.71 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.598 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.1 -32.42 69.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.947 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.9 t80 -65.08 -59.2 4.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.899 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 55' ' ' ARG . 5.8 m-20 -57.19 -43.89 83.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.714 0.292 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.41 -45.2 94.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.257 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.82 -48.06 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.46 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 33' ' ' PHE . 99.4 t -59.1 -42.32 86.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.245 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.43 -44.85 93.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.429 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.18 -42.52 99.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.797 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.1 mt -59.11 -42.89 91.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.448 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HD3' ' HB ' ' A' ' 49' ' ' VAL . 29.8 ttpt -75.6 -38.31 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.359 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -39.93 94.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.439 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -4.33 56.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.227 0.537 . . . . 0.0 110.48 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 37.04 40.69 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.482 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -83.48 -47.45 11.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.281 0.54 . . . . 0.0 110.238 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -134.82 161.53 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 177.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 64' ' ' GLU . 25.6 pt -129.96 177.23 6.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.934 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.69 11.85 65.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.513 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HB ' ' HD3' ' A' ' 41' ' ' LYS . 39.1 t -77.79 121.75 31.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -101.98 129.75 48.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.19 0.519 . . . . 0.0 111.586 -173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.789 177.205 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 11.2 ptm180 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -66.15 126.08 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.273 1.982 . . . . 0.0 112.059 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -116.91 130.69 56.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.404 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.02 140.27 35.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.611 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.04 178.13 7.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 68.6 mttm -79.77 -18.03 52.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.61 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.59 104.06 14.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.949 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.58 -67.71 0.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.613 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.15 119.01 3.15 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.534 2.822 . . . . 0.0 114.504 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.474 ' HB2' HG13 ' A' ' 47' ' ' ILE . 41.9 mt-10 -130.92 142.41 50.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.032 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.76 140.98 30.54 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.11 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 p -100.7 171.73 7.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.07 -33.02 73.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.359 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -60.99 -52.04 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.44 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.75 73.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.114 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.14 -45.5 91.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.738 0.304 . . . . 0.0 110.465 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -73.4 -20.27 60.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.465 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -70.05 -47.16 63.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 11' ' ' LEU . 96.2 mt -60.27 -32.44 71.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.002 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.713 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 mm? . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.67 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.4 ptt180 -51.09 -34.28 29.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 111.417 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.485 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 20.3 t80 -71.34 -43.49 66.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.147 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.57 60.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.591 HD13 ' HA ' ' A' ' 7' ' ' ARG . 82.4 mt -59.38 -33.66 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.748 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -52.43 -40.97 62.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 24.9 ttpp -69.95 -44.37 69.68 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.071 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.56 -33.83 75.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.94 0.4 . . . . 0.0 110.504 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.44 HG22 HG22 ' A' ' 19' ' ' THR . 82.4 mt -57.7 -46.48 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.988 172.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -67.28 -44.53 79.05 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.148 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 8.1 mm-40 -62.4 -40.53 96.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.431 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.11 -13.43 52.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.267 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.51 25.54 11.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.145 0.498 . . . . 0.0 110.176 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.44 HG22 HG22 ' A' ' 14' ' ' ILE . 20.6 p 57.76 154.14 0.08 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.428 1.091 . . . . 0.0 113.226 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -91.35 -165.96 2.41 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.693 -0.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.78 125.21 6.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.212 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -84.91 170.02 13.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 111.197 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.76 -41.08 96.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.372 -178.262 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.49 -24.74 65.62 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.454 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.4 -46.23 28.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.639 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.563 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -80.4 -38.74 18.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.459 -177.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.7 -14.8 12.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.673 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.563 ' H ' HG23 ' A' ' 26' ' ' ILE . 35.1 m -101.0 144.95 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.986 0.393 . . . . 0.0 111.127 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.53 161.47 22.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.52 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 7.2 mt-10 -58.81 -40.72 84.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.659 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.24 -34.7 78.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.409 HE21 ' HB ' ' A' ' 28' ' ' VAL . 26.1 mt-30 -75.0 -36.15 61.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.5 . . . . 0.0 109.914 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 37' ' ' VAL . 49.4 t80 -65.6 -52.96 48.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.326 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' OD1' ' HD3' ' A' ' 56' ' ' PRO . 9.8 t70 -56.62 -47.59 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.332 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.58 -45.94 90.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.67 ' HB1' ' HB3' ' A' ' 7' ' ' ARG . . . -66.74 -40.46 88.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.357 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 33' ' ' PHE . 59.5 t -61.76 -46.09 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.616 0.246 . . . . 0.0 110.712 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -63.72 -37.35 87.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.827 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -64.99 -48.55 73.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 0.0 110.121 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 7' ' ' ARG . 59.5 mt -60.98 -37.53 82.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -69.9 -31.5 69.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.27 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.91 -38.86 76.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.859 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' OE1' ' HE2' ' A' ' 45' ' ' TYR . 48.1 mt-10 -79.93 -22.25 42.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.858 0.361 . . . . 0.0 110.793 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 45.51 4.5 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.438 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.457 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 57.0 m-85 -92.0 -34.04 14.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.105 0.453 . . . . 0.0 111.249 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.511 HG21 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.45 144.94 32.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.087 177.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 pp -129.98 165.3 30.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.338 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.05 60.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.486 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.93 122.81 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.02 110.15 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.04 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.422 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.468 ' HD3' ' OD1' ' A' ' 34' ' ' ASP . 71.6 Cg_endo -76.22 120.71 5.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.489 2.126 . . . . 0.0 112.447 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -109.06 112.72 25.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.27 141.18 31.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.007 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.5 -177.97 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.477 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -81.45 15.0 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.752 0.31 . . . . 0.0 110.782 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.4 tp -159.63 120.08 3.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.937 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.51 -71.09 0.41 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.028 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 14.6 Cg_exo -69.24 122.05 8.86 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.855 2.37 . . . . 0.0 113.308 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -125.36 152.38 44.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.019 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' HG ' HG21 ' A' ' 46' ' ' ILE . 6.1 mp -88.09 137.72 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -83.19 173.67 11.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.19 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.42 -41.01 79.55 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -55.83 -54.81 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.748 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -66.55 -41.54 94.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.932 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -58.53 -46.87 85.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.57 -27.3 62.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -70.67 -24.92 62.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 80.4 mt -58.84 -19.28 40.04 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 74' ' ' LYS . 23.9 ttpt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.3 mm? . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.637 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 2.2 ttm-85 -70.58 -41.26 72.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -170.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 63.9 t80 -58.95 -41.66 87.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -58.9 -47.37 85.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 74.5 mt -63.47 -40.94 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.728 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HB3' HD23 ' A' ' 73' ' ' LEU . 23.7 mt -55.06 -50.17 69.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.722 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -72.38 -29.69 63.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.988 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 5.6 mm-40 -70.55 -29.8 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' ILE . 79.8 mt -69.89 -36.69 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.168 0.508 . . . . 0.0 109.876 173.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -78.33 -50.23 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.673 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -84.4 -38.63 20.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.945 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -20.08 75.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 65.86 20.47 11.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.841 0.456 . . . . 0.0 110.777 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.659 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.7 p 55.96 165.41 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.858 0.863 . . . . 0.0 113.039 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.659 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 92.2 Cg_endo -79.56 171.03 65.61 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 124.056 -1.227 . . . . 0.0 112.32 0.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -134.55 118.69 17.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -86.1 169.04 13.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.367 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.79 -40.63 95.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -71.11 -19.14 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.399 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.36 -42.55 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.5 HG21 HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -87.94 -36.04 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.609 -177.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.71 -17.6 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.272 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 26' ' ' ILE . 28.7 m -89.53 161.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 O-C-N 122.742 -0.269 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -85.24 179.99 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -59.45 -44.24 92.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.946 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -53.01 62.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.624 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 44.2 mt-30 -63.7 -46.11 86.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -59.57 -44.72 93.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.162 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.56 -55.53 33.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.084 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.68 -41.58 81.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.64 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . . . -64.51 -57.57 8.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.2 -42.31 94.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 O-C-N 123.251 0.344 . . . . 0.0 111.782 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -61.07 -46.49 90.43 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.713 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.2 mt -61.36 -46.75 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.546 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 46' ' ' ILE . 23.1 tptp -69.24 -38.55 78.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 110.027 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -61.66 -41.59 97.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.376 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.899 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.79 39.96 0.74 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.625 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.564 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 67.4 m-85 -91.3 -29.4 17.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.515 ' O ' ' HD2' ' A' ' 41' ' ' LYS . 1.3 pp -143.75 156.75 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.686 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 29.0 pt -133.02 -179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.422 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.11 17.61 79.91 Favored Glycine 0 N--CA 1.454 -0.13 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.611 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.479 HG22 HD13 ' A' ' 46' ' ' ILE . 86.5 t -93.5 119.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.242 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -94.86 110.68 22.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 111.19 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.604 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.5 ptm85 . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.54 144.08 48.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.06 2.507 . . . . 0.0 112.106 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -124.18 121.66 35.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.34 106.78 18.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.275 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -95.62 -173.88 3.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.654 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 41.5 mtpt -63.0 -48.74 77.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.383 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.88 142.58 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.38 -67.07 0.45 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.613 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 51.7 Cg_exo -56.7 125.68 19.81 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.055 2.504 . . . . 0.0 113.821 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.442 ' HB2' HG13 ' A' ' 47' ' ' ILE . 53.3 mm-40 -123.52 142.03 51.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.1 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.07 138.34 31.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.365 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.4 p -82.5 179.91 7.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.85 -47.55 74.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.62 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.893 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.564 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -64.75 -46.12 90.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.778 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.79 -44.7 96.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.543 0.211 . . . . 0.0 111.355 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -73.32 -30.91 63.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.149 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -66.64 -31.53 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 98.4 mt -57.55 -40.1 78.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.794 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.554 179.658 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' O ' HG13 ' A' ' 10' ' ' ILE . 1.3 mm? . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HG2' HD21 ' A' ' 40' ' ' LEU . 79.5 mtt180 -54.8 -46.88 74.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.506 0.594 . . . . 0.0 111.353 -171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 88.3 t80 -55.44 -57.41 11.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.084 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.26 97.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.486 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.3 mt -59.91 -49.03 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.863 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 ' HB3' HD23 ' A' ' 73' ' ' LEU . 7.4 mp -59.81 -47.25 86.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -75.82 -26.92 57.66 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.582 -0.447 . . . . 0.0 112.063 -176.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -77.08 -28.17 54.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.449 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.53 -48.33 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.92 -50.03 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.13 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.12 -30.36 22.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.431 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.95 -24.88 72.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.134 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.6 -4.28 2.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.0 0.52 . . . . 0.0 111.16 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 53.3 p 57.35 156.42 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.117 0.967 . . . . 0.0 112.957 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.688 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 6.2 Cg_exo -76.35 166.88 81.66 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 124.315 -1.119 . . . . 0.0 112.938 0.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -148.2 127.33 12.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -81.91 169.95 16.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.324 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -58.76 -37.33 76.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.795 174.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.53 -27.78 67.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.602 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.99 -49.86 14.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.758 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 HG22 ' A' ' 28' ' ' VAL . 11.0 tt -75.7 -29.58 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 -175.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.37 32.95 4.08 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.083 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 28.4 m -137.64 171.62 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 164.47 17.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 0.0 110.938 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -60.79 -42.05 96.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.94 -53.94 51.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.665 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.57 -24.16 63.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.01 -54.07 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.69 -48.5 72.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.848 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.72 -56.8 12.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.784 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.34 -45.96 65.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.868 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.72 -44.31 98.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.598 0.237 . . . . 0.0 111.104 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -66.55 -35.26 79.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.992 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.72 -42.11 78.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.911 0.386 . . . . 0.0 110.227 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.646 HD21 ' HG2' ' A' ' 7' ' ' ARG . 89.7 mt -62.1 -37.82 86.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.443 176.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 4.7 ttpm? -70.81 -25.68 62.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.37 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -70.12 -54.33 13.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.803 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 34.8 mt-10 -80.24 -20.14 45.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 110.912 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 58.29 1.37 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.841 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 96.5 m-85 -96.12 -33.43 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.249 0.547 . . . . 0.0 109.59 173.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.439 HD11 ' O ' ' A' ' 46' ' ' ILE . 2.1 pp -140.07 150.55 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.33 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.71 -179.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 84.91 4.19 87.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.081 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.74 113.2 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 0.0 109.984 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -79.97 110.18 15.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.336 0.588 . . . . 0.0 109.657 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.398 0.142 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.07 136.21 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.264 2.643 . . . . 0.0 111.521 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -129.69 123.63 31.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.279 0.562 . . . . 0.0 110.285 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 90.4 mt -86.61 87.37 7.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.582 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -71.82 167.4 20.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.268 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.688 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 23.8 mtpp -61.97 -47.12 86.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.76 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.64 112.72 25.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.358 . . . . 0.0 110.135 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 160.42 -62.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.278 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.85 116.94 3.08 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.01 2.473 . . . . 0.0 113.324 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 62' ' ' GLY . 35.6 mt-10 -129.67 160.26 33.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.488 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.2 147.78 28.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -91.97 170.56 9.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -64.87 -29.64 70.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 4.0 ttmp? -62.89 -46.6 87.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.778 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.29 -36.82 55.21 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.566 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.47 -49.39 75.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -70.66 -25.52 63.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 24.9 t80 -62.92 -39.36 94.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.83 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 11' ' ' LEU . 85.5 mt -54.13 -41.57 68.54 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.152 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.69 0.757 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.728 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -62.89 -28.72 70.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.119 174.026 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.973 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 61.6 t80 -69.76 -41.41 75.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.663 175.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.56 -46.45 80.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.584 HD12 HG13 ' A' ' 26' ' ' ILE . 25.0 mm -54.78 -48.88 72.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.808 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB3' HD22 ' A' ' 73' ' ' LEU . 71.9 mt -56.36 -43.74 79.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -65.39 -45.82 82.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.631 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -29.66 69.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.327 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.6 mt -61.96 -46.59 96.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -67.87 -42.88 80.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.702 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.6 -40.09 73.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.877 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.47 -20.79 57.92 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.006 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.52 20.44 12.15 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.703 0.401 . . . . 0.0 110.16 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 41.6 p 58.38 150.69 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 124.517 1.127 . . . . 0.0 113.255 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -87.25 161.03 49.2 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.208 -0.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.498 HD22 HG12 ' A' ' 14' ' ' ILE . 1.6 pt? -131.37 120.96 23.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 m -82.59 164.86 20.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.559 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HG3' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -59.36 -44.73 92.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 176.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.83 -21.39 62.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.047 0.451 . . . . 0.0 111.011 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.04 -46.79 15.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.665 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.584 HG13 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -71.61 -37.08 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.58 35.96 1.81 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.135 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.512 HG22 HG21 ' A' ' 26' ' ' ILE . 35.8 m -140.42 170.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 p -76.8 160.54 29.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.46 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 5.6 mt-10 -57.64 -48.97 77.98 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.255 0.55 . . . . 0.0 109.52 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.76 -45.52 19.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.786 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -74.65 -38.73 62.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.054 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -64.92 -46.95 79.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.631 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -56.66 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.707 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.73 -34.54 77.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.849 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.728 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -60.34 -52.72 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.68 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -41.87 98.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.715 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -64.3 -48.36 75.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.91 -36.07 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.797 ' HZ3' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -75.74 -28.6 58.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -77.66 -43.98 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -76.22 -13.01 60.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.362 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.45 51.77 4.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -98.2 -39.2 8.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.058 0.456 . . . . 0.0 109.822 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' HG ' ' A' ' 65' ' ' LEU . 2.0 pp -138.78 149.4 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.576 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.96 168.83 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.817 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 24.94 34.14 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.1 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.43 128.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 110.321 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -94.89 126.04 39.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.826 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.269 0.557 . . . . 0.0 111.784 -177.498 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.581 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 75.0 mtp180 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.451 0.167 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 153.33 57.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 143.36 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.24 136.64 51.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 19' ' ' THR . 96.6 m-85 -108.01 -168.63 1.4 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.864 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 49.8 mtpt -75.79 -13.67 60.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.941 0.4 . . . . 0.0 111.119 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD21 ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -161.54 161.12 29.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.99 -59.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.143 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.95 141.85 72.61 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.471 2.114 . . . . 0.0 113.756 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -120.52 150.95 40.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.766 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HG ' HG21 ' A' ' 46' ' ' ILE . 6.1 mp -96.96 144.71 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.4 p -83.4 179.59 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.465 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.1 -42.65 99.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.14 -49.03 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.858 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.91 65.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.74 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.409 . . . . 0.0 111.169 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -77.35 -35.28 54.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.985 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -58.93 -39.1 80.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.254 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.973 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.7 -46.96 83.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.919 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.6 mttp . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.742 -175.04 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? . . . . . 0 C--O 1.227 -0.092 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 8.8 mmt180 -59.77 -51.89 67.8 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.598 0.714 . . . . 0.0 109.404 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -51.85 -46.14 64.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.167 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.46 62.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 6' ' ' LEU . 73.2 mt -59.37 -30.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.604 0.24 . . . . 0.0 111.266 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -52.75 -38.65 61.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.598 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.6 ttpp -74.07 -39.15 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.745 -177.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.07 -32.09 73.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.38 . . . . 0.0 110.523 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.58 -43.51 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 110.081 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -64.09 -50.33 68.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.019 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 6.0 mt-10 -77.7 -19.14 55.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 110.677 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.46 -17.11 69.48 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.617 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.98 16.28 9.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.01 0.524 . . . . 0.0 110.436 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.1 p 56.18 151.6 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.521 1.128 . . . . 0.0 112.956 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.582 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -78.85 177.69 37.39 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.451 -1.479 . . . . 0.0 112.457 -2.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.405 HD21 ' HB ' ' A' ' 26' ' ' ILE . 43.5 tp -149.79 119.31 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.981 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.46 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 17.0 m -85.8 164.51 17.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.201 175.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -68.02 -33.78 75.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.55 -36.47 84.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 9.1 m-20 -71.0 -34.55 71.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.396 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.489 HG23 HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -83.95 -35.03 10.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.099 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 HG23 ' A' ' 26' ' ' ILE . 31.5 m -135.39 173.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 110.326 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 p -85.59 166.76 15.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.681 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 24.3 mt-10 -67.03 -33.22 75.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.708 0.766 . . . . 0.0 108.957 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -49.77 -57.2 7.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.959 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -72.43 -33.79 67.36 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.966 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 47.6 t80 -66.28 -50.71 62.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.3 t70 -62.76 -45.6 91.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.19 -41.89 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.712 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.63 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -67.36 -55.9 11.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.837 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.37 -34.97 67.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.159 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.59 -45.59 86.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.607 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.437 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.7 t80 -61.68 -41.43 97.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.088 0.47 . . . . 0.0 110.065 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.0 mt -64.66 -39.85 94.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.134 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -34.81 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -60.9 -52.99 62.68 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.626 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 8.3 mm-40 -74.12 -28.42 61.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.958 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.08 40.9 2.54 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.953 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -89.78 -32.77 16.81 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.676 -0.308 . . . . 0.0 111.295 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' O ' HD11 ' A' ' 46' ' ' ILE . 1.9 pp -137.42 148.41 25.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.8 170.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.251 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.68 90.57 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.256 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.22 128.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -94.71 119.14 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.106 0.479 . . . . 0.0 111.143 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.437 178.309 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 50.4 mtp180 . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 26.8 Cg_exo -60.11 119.55 6.81 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 113.724 -165.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -106.59 112.62 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.527 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.86 145.76 25.91 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.608 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.12 171.92 12.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.582 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 51.8 mttm -78.17 -18.33 55.68 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.612 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 124.15 42.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.47 -65.59 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.734 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.7 121.73 10.17 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.81 2.34 . . . . 0.0 112.812 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -128.23 145.19 51.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 129.85 39.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.35 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.9 p -80.02 166.14 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.104 0.252 . . . . 0.0 110.877 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.6 -38.28 69.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.145 0.498 . . . . 0.0 109.991 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -52.26 -55.39 21.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.726 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -76.42 -36.03 40.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.02 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -63.41 -40.92 98.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.703 0.287 . . . . 0.0 110.873 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.66 -29.4 61.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.437 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.03 -27.01 68.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.294 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 91.8 mt -69.31 -19.1 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.34 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttp . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -56.71 -38.22 72.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.692 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -59.96 -43.95 94.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.192 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.02 82.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.762 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.01 -49.49 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.654 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 ' HB3' HD22 ' A' ' 73' ' ' LEU . 7.8 mp -61.34 -37.31 82.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.254 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -70.43 -24.26 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.982 -178.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 12' ' ' LYS . 5.4 mm-40 -74.89 -39.18 61.62 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.58 -43.67 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.579 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.52 -50.61 29.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.876 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -83.28 -40.08 20.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.777 0.322 . . . . 0.0 110.842 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 -26.86 59.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.491 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.5 25.9 13.32 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.075 0.55 . . . . 0.0 110.64 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.502 HG21 ' HG2' ' A' ' 63' ' ' PRO . 18.0 p 56.65 156.97 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.39 1.076 . . . . 0.0 113.338 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.2 Cg_endo -83.25 172.8 46.35 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.377 -2.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 HD21 HG23 ' A' ' 19' ' ' THR . 0.5 OUTLIER -147.52 136.18 21.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -85.16 166.86 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.692 0.282 . . . . 0.0 110.461 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.557 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 1.4 mp0 -55.25 -42.61 73.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.443 0.639 . . . . 0.0 110.242 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -69.59 -22.95 63.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.263 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.37 -49.87 44.7 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.66 0.267 . . . . 0.0 110.501 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -38.68 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.907 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.57 -2.52 11.17 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.785 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.09 160.97 15.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.234 0.517 . . . . 0.0 110.839 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 159.88 33.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.557 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 10.0 pt-20 -60.31 -29.63 68.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.003 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.85 -52.36 66.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.597 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -74.61 -35.12 62.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.07 -55.77 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.243 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -54.83 -49.71 70.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.778 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -50.27 73.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.804 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -69.86 -44.82 69.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.549 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.65 -37.03 74.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.482 0.182 . . . . 0.0 110.858 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.19 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.564 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.8 -39.13 93.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.996 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.642 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 95.1 mt -62.37 -37.59 86.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 0.0 110.903 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.676 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 51.9 tttm -77.68 -33.6 53.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.45 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.04 -47.6 70.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.11 8.27 16.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.41 49.01 59.43 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.387 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.642 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 64.1 m-85 -95.15 -39.76 9.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.51 HD13 ' O ' ' A' ' 46' ' ' ILE . 1.9 pp -140.47 142.77 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.214 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.483 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.32 175.71 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.068 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.65 6.08 73.73 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 49.8 t -76.24 109.92 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -87.69 111.07 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.071 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.639 173.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.95 101.95 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.194 1.929 . . . . 0.0 110.722 169.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -92.17 108.72 20.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.72 109.42 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.946 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.8 -168.11 1.94 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.449 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -75.86 -45.48 35.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.204 0.525 . . . . 0.0 110.22 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.32 132.0 53.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.608 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.01 -63.14 0.39 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.398 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.502 ' HG2' HG21 ' A' ' 19' ' ' THR . 35.9 Cg_exo -59.01 120.24 7.98 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.792 2.328 . . . . 0.0 112.662 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.85 151.67 46.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.005 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.21 148.45 22.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.23 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -91.72 161.05 15.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -66.35 -26.8 67.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -61.46 -51.75 67.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.256 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.7 71.44 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.37 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -62.67 -41.88 99.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.04 0.447 . . . . 0.0 109.854 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -70.81 -32.04 68.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.9 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.17 -36.64 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 110.083 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' A' ' 11' ' ' LEU . 89.2 mt -58.41 -33.28 69.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.257 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.5 tttp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.267 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.406 ' HG ' ' CG1' ' A' ' 28' ' ' VAL . 2.1 mm? . . . . . 0 C--O 1.227 -0.111 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.655 ' HG3' HD22 ' A' ' 40' ' ' LEU . 39.9 ttm180 -53.31 -41.65 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 0.0 111.233 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.2 -43.72 95.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.56 61.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.957 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.95 -45.73 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.012 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.93 -41.43 91.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.521 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.06 -46.0 72.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.554 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -39.28 80.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.278 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.05 -50.06 50.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.446 . . . . 0.0 110.414 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -62.76 -50.29 71.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.72 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -82.57 -35.15 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.809 0.338 . . . . 0.0 111.47 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.54 -24.16 75.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.56 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 71.42 5.94 5.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.129 0.572 . . . . 0.0 110.73 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.6 p 55.9 164.51 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 113.334 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.613 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 90.0 Cg_endo -83.98 -178.46 19.38 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.623 -1.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.02 143.43 20.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.2 m -85.27 170.23 13.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.717 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HG3' HD21 ' A' ' 24' ' ' ASN . 13.9 pt-20 -61.5 -47.43 85.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.786 0.326 . . . . 0.0 111.35 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.548 HD21 ' HG3' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -72.71 -9.22 58.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -176.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.81 -47.38 30.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -38.49 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.46 -19.28 5.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.516 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 35.1 m -98.14 162.06 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.666 0.27 . . . . 0.0 110.622 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.7 p -81.02 165.73 21.42 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.09 -31.51 30.86 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.629 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.27 -53.72 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.065 0.46 . . . . 0.0 110.797 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.413 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 2.7 mp0 -70.74 -34.49 71.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.01 -52.06 39.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.661 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -57.71 -54.16 49.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.795 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -54.08 -50.72 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.984 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -62.02 -53.16 59.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.75 -177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.55 -44.89 97.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 111.37 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -65.89 -40.77 91.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.334 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 75.5 t80 -61.58 -47.87 83.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.176 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.655 HD22 ' HG3' ' A' ' 7' ' ' ARG . 96.8 mt -56.2 -44.47 79.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.353 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 3.9 ttpm? -67.33 -38.99 85.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -72.72 -39.89 66.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.407 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 14.2 mm-40 -78.24 -27.64 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.95 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.61 32.93 1.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.55 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -90.3 -43.87 10.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 110.673 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 65' ' ' LEU . 2.4 pp -141.0 154.84 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -133.54 173.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 91.52 13.32 58.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.799 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.65 119.1 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.652 0.263 . . . . 0.0 110.425 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -90.85 124.77 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.71 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 61.4 m-85 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.042 0.449 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 94.9 Cg_endo -86.12 160.57 10.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.106 2.538 . . . . 0.0 113.863 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -137.48 126.92 24.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.378 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 86.1 mt -88.25 154.67 20.24 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -133.11 -177.21 4.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.108 0.48 . . . . 0.0 111.278 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 61' ' ' LEU . 4.1 pp -146.69 145.15 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.952 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 134.68 -67.59 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.892 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 28.1 Cg_exo -62.5 123.57 12.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.637 2.225 . . . . 0.0 111.878 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 151.33 46.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.604 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.637 ' HA ' HG23 ' A' ' 46' ' ' ILE . 8.4 mp -91.92 142.2 27.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.599 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.5 p -88.0 179.31 6.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.262 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.53 -39.24 76.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.3 tppt? -65.02 -42.07 94.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.475 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.59 -47.78 88.5 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.52 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.6 -45.08 94.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -73.28 -25.12 60.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 0.0 111.18 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.22 -40.45 77.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.127 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -55.39 -38.32 68.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.765 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.8 tttp . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.248 -177.916 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' HG12 ' A' ' 10' ' ' ILE . 1.5 mm? . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.507 0.194 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.483 HH11 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -56.56 -40.37 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.45 -42.01 65.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.308 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.654 HD13 HG13 ' A' ' 26' ' ' ILE . 42.8 mm -60.48 -52.79 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.388 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.92 -43.64 91.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.402 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.19 -44.61 94.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.675 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.123 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 10' ' ' ILE . 77.6 mt -65.87 -45.21 91.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 110.339 175.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.96 -50.21 71.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.612 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.72 -17.28 32.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.46 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 -27.71 23.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.685 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.411 ' C ' ' HG1' ' A' ' 19' ' ' THR . 63.7 t30 68.53 11.46 8.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.634 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 28.6 p 55.04 162.65 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 124.345 1.058 . . . . 0.0 113.294 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.634 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 95.3 Cg_endo -79.61 156.14 89.29 Favored 'Cis proline' 0 C--N 1.343 0.274 0 C-N-CA 123.717 -1.368 . . . . 0.0 111.88 -3.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.55 132.51 53.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -85.0 162.89 19.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.138 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.815 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.28 -32.94 74.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -65.56 -34.42 78.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.35 -43.7 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.654 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.68 -27.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.95 33.96 5.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.334 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 26' ' ' ILE . 33.7 m -135.11 175.87 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 p -83.89 156.92 22.17 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.815 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.47 -21.2 64.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.04 -44.8 79.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.056 0.455 . . . . 0.0 109.933 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -68.06 -29.82 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -64.6 -48.79 73.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.562 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.67 -53.58 53.02 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.64 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -49.59 53.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.745 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -61.93 -54.41 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.608 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.96 -38.59 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 O-C-N 123.105 0.253 . . . . 0.0 111.522 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 17.0 m-80 -60.78 -49.41 77.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.647 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.66 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 97.0 mt -60.98 -37.73 83.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 5.3 tmmm? -71.37 -40.76 70.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 55.8 mtt180 -60.75 -47.29 86.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.926 0.393 . . . . 0.0 111.141 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -82.29 4.77 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.48 46.24 94.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.119 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.618 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 29.6 m-85 -87.55 -37.36 16.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.406 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.8 pp -138.68 150.34 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.097 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.29 173.71 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.471 175.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.43 9.34 69.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.084 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.75 124.9 38.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -92.42 111.28 22.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.891 0.377 . . . . 0.0 110.424 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.488 178.298 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.19 99.9 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.446 2.097 . . . . 0.0 111.012 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -82.05 109.78 16.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.068 0.461 . . . . 0.0 110.933 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 85.6 mt -89.17 105.72 17.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.652 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.0 173.1 7.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.03 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -67.92 -26.76 66.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.349 0.595 . . . . 0.0 109.891 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.27 117.8 31.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.641 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.18 -72.33 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.51 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.04 120.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.449 2.766 . . . . 0.0 114.206 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -129.84 144.46 51.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.622 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.66 145.64 26.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.39 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.2 p -96.04 173.85 7.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.27 -37.27 86.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -62.93 -40.45 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.357 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -70.87 -41.97 61.45 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.467 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.15 -38.63 88.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.776 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -36.77 85.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.353 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.61 -36.14 79.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.642 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.4 -44.53 89.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.51 . . . . 0.0 110.489 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -178.304 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.626 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.547 0.213 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.557 ' HA ' HD11 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -66.68 -37.47 84.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 109.953 -172.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -55.41 -48.3 74.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.111 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.38 -18.54 54.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.613 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.632 ' HA ' HD13 ' A' ' 26' ' ' ILE . 66.2 mt -58.65 -39.37 75.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.436 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.584 ' CB ' HD21 ' A' ' 73' ' ' LEU . 46.0 mt -62.3 -30.75 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.385 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -62.94 -43.89 97.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 109.992 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.425 ' HG3' HD12 ' A' ' 26' ' ' ILE . 7.8 mm-40 -63.37 -42.8 98.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.384 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.93 -31.87 55.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.876 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.21 -49.92 57.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.469 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.26 -28.58 21.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.755 0.312 . . . . 0.0 111.822 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.62 -14.76 64.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.599 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 19' ' ' THR . 4.2 t-20 70.51 -81.81 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.596 0.759 . . . . 0.0 109.486 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER 173.16 157.26 0.27 Allowed Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 124.199 0.999 . . . . 0.0 109.012 176.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.796 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 66.7 Cg_endo -87.8 -174.82 9.67 Favored 'Cis proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.108 -0.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -157.73 127.8 6.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 m -85.41 170.14 12.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.367 . . . . 0.0 110.63 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.03 -22.12 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.722 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -84.2 -43.93 14.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.498 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 10' ' ' ILE . 5.1 tp -70.02 -38.43 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.92 -20.13 10.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.943 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.24 160.07 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 t -70.38 166.82 19.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.299 0.571 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.44 -29.15 69.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.45 -43.31 90.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.547 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -71.66 -32.25 67.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.873 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.79 -46.7 80.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.86 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -56.71 -53.14 61.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.453 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.9 -37.64 77.07 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.405 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.617 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.14 -59.9 3.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.717 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.14 -43.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.296 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.999 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -68.91 -45.74 70.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.792 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 74.7 mt -63.21 -37.18 86.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.944 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -60.77 -42.35 97.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.99 12.97 18.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.356 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.28 38.33 96.04 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.638 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 34.7 m-85 -88.26 -28.72 20.93 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.487 -0.419 . . . . 0.0 110.488 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.436 HD11 ' O ' ' A' ' 46' ' ' ILE . 1.9 pp -143.68 149.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -131.84 150.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.63 35.45 6.18 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.518 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.6 115.2 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.944 0.402 . . . . 0.0 110.452 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.425 ' NE2' ' HA3' ' A' ' 62' ' ' GLY . 89.4 m-70 -82.19 135.91 35.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.66 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--N 1.317 -0.809 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.567 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.852 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.378 0 N-CA-C 110.37 -0.234 . . . . 0.0 110.37 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.852 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 52.7 Cg_exo -53.62 136.47 64.71 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.553 2.168 . . . . 0.0 111.835 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.22 105.57 3.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.111 0.482 . . . . 0.0 110.027 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.03 134.33 43.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.147 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.796 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.8 m-85 -125.83 -178.34 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -43.15 -55.66 3.81 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.159 0.912 . . . . 0.0 113.289 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 61' ' ' LEU . 3.2 pp -128.1 146.07 50.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.925 0.393 . . . . 0.0 110.955 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 137.19 -64.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.722 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.23 121.57 8.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.537 2.158 . . . . 0.0 113.074 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -114.72 152.37 32.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.621 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' HA ' HG23 ' A' ' 46' ' ' ILE . 5.9 mp -101.17 134.43 44.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.1 p -80.23 160.95 25.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 10.7 pt-20 -69.43 -20.0 63.79 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.48 -48.32 82.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 -35.23 50.51 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.862 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 32.9 tt0 -63.11 -43.26 98.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.56 0.219 . . . . 0.0 110.905 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -67.37 -32.87 74.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.26 -35.71 81.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.236 0.541 . . . . 0.0 109.607 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.584 HD21 ' CB ' ' A' ' 11' ' ' LEU . 73.8 mt -74.59 -19.41 60.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.34 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.987 0.422 . . . . 0.0 110.908 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.458 -0.034 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -60.79 -41.95 96.6 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.869 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.693 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 72.5 t80 -66.44 -42.85 87.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.147 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.98 -47.21 81.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.459 HG12 HD11 ' A' ' 26' ' ' ILE . 54.2 mt -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 HD22 HD23 ' A' ' 40' ' ' LEU . 82.9 mt -56.01 -46.83 78.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.29 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -68.69 -42.45 77.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.64 ' HG3' HG13 ' A' ' 26' ' ' ILE . 9.1 mm-40 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.016 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 19' ' ' THR . 73.0 mt -65.33 -42.31 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 110.115 173.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.94 -50.1 57.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.402 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.1 -33.28 63.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.023 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.17 -31.28 14.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.249 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 71.99 19.12 4.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.167 0.587 . . . . 0.0 110.614 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.78 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 14.2 p 56.16 169.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.075 0.95 . . . . 0.0 113.156 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.78 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 79.6 Cg_endo -90.77 156.54 27.8 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 124.715 -0.952 . . . . 0.0 112.276 -1.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.685 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -149.35 131.46 15.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.118 0.485 . . . . 0.0 110.527 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -85.26 170.32 12.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.987 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.83 -36.71 77.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.765 0.284 . . . . 0.0 111.765 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -68.47 -25.92 65.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.32 -48.78 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.003 0.43 . . . . 0.0 110.509 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HB ' HD11 ' A' ' 21' ' ' LEU . 9.4 tt -76.56 -34.4 24.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.607 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.25 28.18 3.4 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.245 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 34.5 m -126.92 172.14 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 p -85.16 163.8 18.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.862 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 24.5 mt-10 -55.8 -42.5 75.71 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.61 -62.08 1.62 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.56 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.77 -47.56 80.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.639 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.5 t80 -63.63 -52.1 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.71 -45.77 85.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -62.25 -39.92 94.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -50.53 72.04 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.803 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 33' ' ' PHE . 97.7 t -58.18 -41.77 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.703 0.287 . . . . 0.0 110.956 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -62.53 -45.48 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -64.68 -41.0 96.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.709 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.468 HD23 HD22 ' A' ' 11' ' ' LEU . 84.1 mt -63.81 -46.08 86.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.204 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.55 -26.65 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -56.57 -53.67 54.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 26.1 mt-10 -89.6 -8.4 52.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.11 53.76 2.9 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.936 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HD2' ' HA2' ' A' ' 69' ' ' GLY . 73.4 m-85 -85.42 -38.37 18.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.767 0.317 . . . . 0.0 110.681 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -131.92 149.91 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 176.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 64' ' ' GLU . 18.2 pt -126.9 167.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.12 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 9.99 65.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.67 124.96 38.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.789 174.382 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.431 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 2.6 Cg_endo -81.89 146.48 14.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.486 2.791 . . . . 0.0 112.275 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -125.87 116.29 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' A' ' 63' ' ' PRO . 78.0 mt -89.0 120.6 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.923 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -100.64 -174.36 2.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.768 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 97.0 mttt -69.89 -26.3 64.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.417 0.627 . . . . 0.0 110.394 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.72 101.43 5.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.055 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.42 -79.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.777 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.484 ' HG3' HD23 ' A' ' 58' ' ' LEU . 73.9 Cg_endo -76.87 120.39 5.46 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 114.198 -172.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HB2' HG13 ' A' ' 47' ' ' ILE . 37.4 mt-10 -100.18 142.23 31.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.074 172.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -95.26 134.52 37.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.731 0.301 . . . . 0.0 110.361 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.0 p -93.26 178.43 5.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.351 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.9 -40.31 80.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.014 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.75 -41.0 90.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.88 -41.72 27.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.407 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -65.78 -34.6 78.54 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.979 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.72 -36.06 67.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 0.0 110.942 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.62 -26.35 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.261 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.693 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 97.0 mt -59.92 -41.8 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.721 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 -178.577 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.475 ' HG ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 mm? . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.658 0.266 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.584 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.18 -50.7 11.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.659 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 64.6 t80 -62.15 -46.07 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.959 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.42 89.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.332 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.3 mt -55.99 -46.64 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 98.5 mt -56.45 -50.19 72.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.508 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -77.68 -30.32 51.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.836 -175.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.443 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 5.7 mm-40 -73.61 -22.31 60.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.089 0.471 . . . . 0.0 110.074 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' ILE . 58.9 mt -76.41 -50.38 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 170.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -56.12 -41.6 75.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.586 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -97.01 -26.27 15.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.721 0.296 . . . . 0.0 111.694 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -83.49 -16.0 69.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.383 -174.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.3 t30 76.67 -13.52 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.014 0.526 . . . . 0.0 111.546 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 27.5 p 58.93 156.98 0.09 OUTLIER Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.504 1.122 . . . . 0.0 112.648 -174.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 4.4 Cg_exo -75.55 161.85 93.64 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.946 -1.273 . . . . 0.0 111.935 1.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' H ' HD22 ' A' ' 21' ' ' LEU . 2.4 pt? -124.7 119.96 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -72.18 156.09 39.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.315 0.579 . . . . 0.0 111.042 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.549 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -71.17 -40.76 71.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.662 -175.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.55 -45.54 15.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.301 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.55 -36.79 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 33.7 1.52 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.397 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.475 ' CG1' ' HG ' ' A' ' 6' ' ' LEU . 30.6 m -139.01 174.37 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.843 0.322 . . . . 0.0 110.182 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -85.32 154.26 22.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 0.0 110.343 171.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -68.39 -28.55 67.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.131 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.76 -42.62 85.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.197 0.522 . . . . 0.0 110.58 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' HB2' HG22 ' A' ' 29' ' ' THR . 1.5 mp0 -79.78 -21.19 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.381 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' O ' HG21 ' A' ' 37' ' ' VAL . 84.9 t80 -65.82 -55.97 14.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.063 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.506 ' HB2' ' HG2' ' A' ' 56' ' ' PRO . 1.5 p30 -68.47 -33.86 74.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.283 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.64 -50.52 73.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -60.83 -44.91 96.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.226 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 33' ' ' PHE . 93.0 t -57.05 -40.88 75.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.933 0.396 . . . . 0.0 110.903 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -68.37 -38.62 81.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.171 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -66.83 -40.17 87.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.4 mt -60.87 -38.22 84.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.011 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -70.66 -37.49 73.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.101 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -57.03 -53.12 61.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.08 -34.44 71.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.193 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.22 46.25 1.6 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.571 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -94.45 -35.99 12.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 65' ' ' LEU . 2.1 pp -137.94 154.93 29.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.73 163.37 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.729 177.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.82 28.15 14.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.784 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 56' ' ' PRO . 87.1 t -71.46 117.42 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -96.57 121.98 38.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 . . . . . 0 C--N 1.32 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.456 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.411 0.148 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 26.7 Cg_endo -65.47 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.452 2.102 . . . . 0.0 110.799 170.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -105.74 -35.82 7.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.5 mt 69.5 128.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.862 0.726 . . . . 0.0 110.763 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.677 ' HA ' ' HG3' ' A' ' 20' ' ' PRO . 31.6 m-85 -122.06 -175.55 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.605 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 44.5 mtmt -70.02 -5.14 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 tp -160.29 119.07 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.03 -67.99 0.19 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.221 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG3' HD22 ' A' ' 58' ' ' LEU . 57.7 Cg_endo -71.24 137.8 31.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.364 2.043 . . . . 0.0 113.459 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -130.29 166.11 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.584 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.428 ' HA ' HG23 ' A' ' 46' ' ' ILE . 7.8 mp -97.75 145.18 26.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.919 0.39 . . . . 0.0 110.461 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.3 p -80.06 169.56 17.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.01 -38.36 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.94 0.4 . . . . 0.0 110.014 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -69.21 -45.64 69.37 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.989 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.22 97.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.27 -40.49 90.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.221 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.071 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.58 -28.61 69.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 87.3 mt -58.23 -34.48 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.34 175.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.151 0.5 . . . . 0.0 110.051 177.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -100.41 3.1 42.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.773 HH11 ' HA ' ' A' ' 36' ' ' ALA . 33.9 mmt180 -67.42 -56.07 11.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.576 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 13.9 t80 -62.57 -40.79 97.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.751 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.96 87.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.326 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.27 -39.17 72.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.784 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.649 ' HG ' HD12 ' A' ' 40' ' ' LEU . 8.0 mt -56.28 -45.02 80.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 6.8 ttpp -62.56 -39.59 94.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HG2' HG12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -64.61 -37.18 86.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.359 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.08 -44.13 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.278 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.35 -50.51 73.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.318 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.83 -18.99 19.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.482 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.17 -27.12 66.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.332 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 74.2 -1.78 2.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.212 0.605 . . . . 0.0 111.449 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 62.0 p 59.55 153.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.664 1.186 . . . . 0.0 113.33 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 2.0 Cg_endo -81.74 167.12 70.87 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.983 -1.257 . . . . 0.0 112.387 0.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 13' ' ' GLU . 1.7 pt? -140.78 149.05 41.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.685 ' HB3' ' HB2' ' A' ' 25' ' ' ASP . 30.3 t -85.2 167.26 15.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.65 0.738 . . . . 0.0 110.938 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -80.63 -48.21 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.545 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.6 -27.88 68.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.585 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 11.1 t70 -72.73 -40.63 65.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.564 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG12 ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -74.29 -32.91 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.24 20.37 2.22 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.721 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.66 175.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 117.243 0.522 . . . . 0.0 110.786 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.6 p -85.32 172.5 11.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 mt-10 -58.27 -53.2 60.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 110.403 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.78 -29.97 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.113 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.2 -46.74 66.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.347 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 67.9 t80 -62.87 -45.35 92.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.772 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 55' ' ' ARG . 6.3 t70 -54.75 -53.86 49.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.664 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.9 -40.23 92.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.62 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.773 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -61.06 -52.22 65.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.08 -44.73 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.993 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.45 -45.0 95.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.239 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.34 -46.78 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.649 HD12 ' HG ' ' A' ' 11' ' ' LEU . 90.7 mt -63.74 -34.84 78.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.613 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 56.7 tttm -67.31 -41.55 85.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.776 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -67.29 -47.38 70.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.071 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.62 -22.95 58.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.06 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 46.83 1.92 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.062 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.627 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 86.3 m-85 -98.66 -36.29 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 110.356 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.36 155.6 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 pt -131.82 170.82 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 14.32 50.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.8 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 96.7 t -78.41 114.14 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.033 0.444 . . . . 0.0 110.31 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -109.64 131.62 54.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.621 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.44 142.99 27.08 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.5 t -121.8 -88.51 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.879 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -52.61 64.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.868 0.842 . . . . 0.0 110.001 172.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -169.17 -33.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.546 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 10.2 mtp180 -105.8 163.97 15.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.933 -173.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 25.2 Cg_endo -62.48 134.48 48.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.644 2.229 . . . . 0.0 112.393 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -126.82 132.41 51.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.124 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.462 HD21 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -97.64 138.67 34.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.428 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -110.37 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.578 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.594 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 54.0 mttp -83.59 -5.37 59.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.389 0.614 . . . . 0.0 110.326 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -156.79 120.86 4.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 64' ' ' GLU . . . 157.36 -57.02 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.896 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HG3' HD21 ' A' ' 58' ' ' LEU . 30.5 Cg_exo -62.3 106.36 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.62 2.213 . . . . 0.0 112.55 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 4.3 mm-40 -110.55 140.07 45.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -88.66 144.22 26.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.896 0.379 . . . . 0.0 110.458 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 p -87.21 171.38 10.7 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.46 -38.3 90.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -63.0 -44.53 95.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.643 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.19 -42.72 94.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.704 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.03 -46.57 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -34.52 77.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.674 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.57 -37.68 87.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.558 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 11' ' ' LEU . 82.8 mt -63.4 -33.46 75.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.578 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -68.54 -36.3 78.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.491 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -85.25 -45.78 11.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -89.54 5.48 45.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.328 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.576 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -62.77 -15.08 54.03 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.872 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -75.35 67.0 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.116 0.96 . . . . 0.0 110.584 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -143.31 124.59 14.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.194 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 t -68.9 93.25 0.54 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.003 0.43 . . . . 0.0 110.747 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -154.6 112.5 3.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.999 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' HG12 ' A' ' 10' ' ' ILE . 3.6 mm? -67.44 -16.71 64.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 109.508 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.75 ' NH1' ' HA ' ' A' ' 36' ' ' ALA . 4.9 tpp180 -57.57 -37.17 72.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.112 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -69.73 -44.47 70.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.011 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -37.77 76.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.628 HD11 HG13 ' A' ' 26' ' ' ILE . 35.2 mm -65.17 -51.63 63.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 110.098 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.18 -40.61 90.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.093 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -68.32 -28.32 67.05 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.307 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.557 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -81.04 -26.41 36.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.118 0.485 . . . . 0.0 110.193 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.45 -26.99 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.754 0.788 . . . . 0.0 109.471 171.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.92 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -100.41 -40.53 7.43 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.43 55.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.724 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.469 ' O ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER 70.25 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER 173.01 164.84 0.27 Allowed Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 124.18 0.992 . . . . 0.0 108.805 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HA ' HG23 ' A' ' 19' ' ' THR . 64.7 Cg_endo -90.07 175.21 21.27 Favored 'Cis proline' 0 N--CA 1.462 -0.378 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.823 -3.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.11 137.18 28.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -85.27 170.26 12.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.438 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 6.8 pm0 -59.4 -37.16 77.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.055 0.455 . . . . 0.0 110.797 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.413 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t-20 -65.18 -30.94 71.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.047 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.35 -49.76 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.628 HG13 HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.62 -35.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.105 -176.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.86 30.85 2.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.273 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 32.1 m -130.6 169.17 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 32' ' ' GLN . 23.6 p -85.16 169.32 13.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.785 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -48.65 -52.58 22.48 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.787 0.68 . . . . 0.0 110.832 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.43 -37.44 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.844 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 18.1 mm-40 -79.02 -32.85 45.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -72.24 -36.39 69.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.511 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.89 -46.41 90.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.596 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -52.11 -49.65 63.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.514 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.75 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . . . -59.69 -58.52 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.819 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.51 -47.09 94.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.588 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.55 -39.32 93.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.61 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.612 ' HD2' ' HD2' ' A' ' 7' ' ' ARG . 77.1 t80 -67.22 -41.04 86.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.322 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.1 mt -64.44 -44.77 90.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -70.53 -37.25 74.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.889 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -58.89 -55.97 28.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -82.78 -3.22 56.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.62 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.75 44.84 9.9 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.106 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.28 -34.14 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.183 0.516 . . . . 0.0 109.743 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 49' ' ' VAL . 1.8 pp -140.1 157.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.473 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 46.1 pt -132.26 165.65 31.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.48 -1.95 73.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.915 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.401 HG23 HD12 ' A' ' 46' ' ' ILE . 57.4 t -76.67 126.96 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.802 0.334 . . . . 0.0 110.53 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -98.56 147.2 25.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.457 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 56' ' ' PRO . 19.1 m-85 -119.98 143.41 48.05 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -114.0 164.51 13.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.37 -29.34 67.63 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -97.05 -33.65 11.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 13.3 ttm180 -156.04 140.86 12.14 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.986 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 28.9 Cg_exo -61.19 147.77 94.71 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.448 2.098 . . . . 0.0 111.073 169.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -118.8 115.61 24.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.402 0.62 . . . . 0.0 111.389 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.39 144.98 26.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.346 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.97 168.99 18.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 19' ' ' THR . 29.8 mtpp -55.98 -56.43 20.83 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.724 0.64 . . . . 0.0 112.232 -168.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.06 90.14 3.21 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.936 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.1 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.021 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 Cg_exo -66.07 109.07 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.146 2.564 . . . . 0.0 113.316 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -108.44 155.79 20.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.164 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.56 148.21 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.065 0.459 . . . . 0.0 111.051 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.0 p -104.55 -179.81 4.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.088 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -54.32 -43.91 71.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.079 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -57.12 -51.36 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -38.67 93.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.269 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.53 -46.93 87.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -61.53 -41.24 97.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.02 -40.18 92.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.97 -42.83 90.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.179 0.514 . . . . 0.0 110.484 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.06 -39.57 93.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.92 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -77.12 -39.5 49.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.346 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.81 5.83 48.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.238 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.46 -17.18 4.12 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.936 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 79' ' ' TRP . 10.2 t -81.68 -145.04 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.461 ' HB3' ' O ' ' A' ' 78' ' ' THR . 29.7 t90 79.99 146.83 0.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.456 0.702 . . . . 0.0 110.9 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -79.45 82.78 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.364 0.602 . . . . 0.0 110.87 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -90.42 14.61 12.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.477 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -178.653 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.59 -20.43 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.862 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' CZ ' ' HA ' ' A' ' 36' ' ' ALA . 59.1 mmt-85 -54.3 -33.31 58.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.179 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.479 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 85.4 t80 -68.1 -54.25 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.901 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.03 -48.57 75.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -62.07 -43.77 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 73' ' ' LEU . 12.1 tp -65.64 -35.48 80.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.2 ttpp -70.84 -39.95 72.66 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 9.4 mm-40 -62.26 -39.79 94.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.457 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -32.17 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.383 0.611 . . . . 0.0 110.135 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -75.43 -40.13 58.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.443 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 8.9 mt-10 -80.85 -40.31 25.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.34 50.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.919 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 19' ' ' THR . 5.9 t30 68.89 -90.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.453 0.701 . . . . 0.0 109.52 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER 177.19 159.33 0.5 Allowed Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.998 0.919 . . . . 0.0 109.345 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.815 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 Cg_endo -82.09 167.78 67.79 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.321 -1.116 . . . . 0.0 112.199 0.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -150.17 129.51 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.18 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.99 -38.26 72.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.504 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -68.91 -35.8 77.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.947 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.72 -45.21 87.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.187 0.518 . . . . 0.0 110.629 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.571 HG22 HG23 ' A' ' 28' ' ' VAL . 14.9 tt -79.56 -24.72 12.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.936 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.47 11.99 52.39 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.533 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.571 HG23 HG22 ' A' ' 26' ' ' ILE . 26.3 m -123.15 167.22 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.979 0.389 . . . . 0.0 110.455 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -78.68 166.7 22.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.819 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -57.99 -40.59 81.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.97 -48.62 77.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.732 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.7 -35.12 67.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.29 -47.65 81.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.81 -53.52 57.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.644 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.44 -53.36 52.49 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.239 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . . . -67.1 -53.53 29.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.291 -174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.18 -40.16 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.78 -39.64 94.74 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.83 0.348 . . . . 0.0 110.513 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -65.89 -46.62 77.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.58 -42.06 91.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.227 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -66.58 -36.58 82.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -66.79 -43.01 85.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.033 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -78.26 -20.82 50.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.647 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.01 38.7 5.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.29 -30.65 20.72 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.63 -0.336 . . . . 0.0 111.038 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 159.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.05 158.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.97 29.04 19.2 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.202 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.53 109.91 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -91.03 130.94 36.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.979 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.92 145.76 30.88 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.363 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -136.69 -52.99 0.71 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 110.211 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 38.5 p-10 -103.19 23.69 12.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.74 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 34.7 t70 82.15 -10.02 1.14 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.794 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -105.32 161.2 23.49 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 170.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.63 122.56 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.8 2.333 . . . . 0.0 112.176 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -137.25 105.91 5.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HB3' HG22 ' A' ' 19' ' ' THR . 70.9 mt -79.74 122.96 27.23 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.031 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.815 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 75.5 m-85 -107.1 -173.41 2.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -57.07 -52.39 65.47 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.52 0.512 . . . . 0.0 112.001 -171.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.62 135.27 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.755 0.312 . . . . 0.0 110.632 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.48 -70.77 0.5 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.502 ' HG2' HG22 ' A' ' 19' ' ' THR . 25.6 Cg_exo -63.9 119.63 6.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.304 2.669 . . . . 0.0 113.439 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.09 156.26 48.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.809 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.03 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -93.13 169.9 10.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -24.68 64.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -59.3 -47.01 87.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.91 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.38 -34.39 50.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.909 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.41 -43.6 93.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.33 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.05 -30.3 67.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -62.75 -36.56 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.784 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.53 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 82.8 mt -62.9 -19.75 64.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.094 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -60.71 -40.22 91.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.622 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -85.45 -48.0 9.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' OD1' ' HA ' ' A' ' 73' ' ' LEU . 32.4 p-10 -89.03 5.11 45.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.561 -173.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.479 ' HA2' ' CE1' ' A' ' 8' ' ' TYR . . . -57.96 -20.66 42.32 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.082 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -70.71 -62.41 1.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.528 0.664 . . . . 0.0 110.497 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.437 ' CG ' ' N ' ' A' ' 80' ' ' SER . 9.6 t90 44.57 -148.57 0.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.951 0.5 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 28.7 m 51.7 54.35 11.12 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.124 0.57 . . . . 0.0 111.554 174.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.31 79.73 2.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.891 0.853 . . . . 0.0 110.775 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.028 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.2 -20.31 16.0 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.758 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.53 ' HB3' HD21 ' A' ' 40' ' ' LEU . 22.6 mmt180 -67.24 -34.89 78.41 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 37.1 t80 -57.73 -41.02 80.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.153 172.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -61.53 -35.11 76.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.454 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 19.6 mt -73.99 -30.34 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.438 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.22 -36.16 82.32 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.455 -0.778 . . . . 0.0 109.322 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 13.3 tmtt? -61.93 -52.67 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 10' ' ' ILE . 12.8 pt-20 -60.4 -39.08 86.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.029 0.442 . . . . 0.0 111.411 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.431 HG13 ' HG3' ' A' ' 13' ' ' GLU . 88.6 mt -74.38 -43.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.67 -46.2 89.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.442 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 10.4 pt-20 -92.83 -26.5 17.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.398 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 19' ' ' THR . . . -74.46 -24.29 73.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.116 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 29.3 t-20 76.66 -20.2 0.38 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 111.755 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.785 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 70.9 p 61.95 163.41 0.11 Allowed Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 124.413 1.085 . . . . 0.0 112.67 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.785 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 72.1 Cg_endo -79.51 150.68 84.61 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.522 -2.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -132.63 145.74 51.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.469 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 15.4 m -85.82 165.24 17.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.819 0.342 . . . . 0.0 110.585 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -62.72 -28.43 69.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.986 178.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' C ' HD21 ' A' ' 24' ' ' ASN . 0.3 OUTLIER -70.81 -10.12 58.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.781 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.51 ' N ' HD21 ' A' ' 24' ' ' ASN . 8.8 m-20 -85.28 -50.02 7.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.715 0.293 . . . . 0.0 110.509 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.511 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -78.89 -38.52 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.432 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.78 -13.41 10.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.678 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.511 ' H ' HG23 ' A' ' 26' ' ' ILE . 27.2 m -86.22 157.21 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 117.426 0.613 . . . . 0.0 110.197 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 t -85.13 162.21 19.34 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 10.0 mt-10 -51.04 -50.48 58.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.18 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.09 -41.65 71.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.084 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -79.66 -32.16 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 111.046 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.1 t80 -67.41 -52.85 34.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.22 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD2' ' HD2' ' A' ' 56' ' ' PRO . 0.9 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 178.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.95 -42.29 75.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 10' ' ' ILE . . . -64.51 -50.85 65.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 33' ' ' PHE . 65.8 t -58.41 -44.47 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.691 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.544 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 95.5 m-20 -61.33 -48.78 79.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -56.02 -45.65 79.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 7' ' ' ARG . 89.9 mt -65.98 -40.08 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.256 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 41' ' ' LYS . 0.7 OUTLIER -69.57 -31.34 69.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.153 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 99.6 mtt180 -61.76 -58.55 7.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.75 -24.24 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.349 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.93 52.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.716 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 81.8 m-85 -93.5 -34.76 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.064 0.459 . . . . 0.0 110.081 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.467 ' O ' HD13 ' A' ' 46' ' ' ILE . 2.2 pp -137.38 148.49 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.476 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.403 ' H ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -132.93 176.76 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.009 178.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 86.37 5.18 82.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.475 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.22 135.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -106.79 119.98 40.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.61 160.04 15.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.02 0.438 . . . . 0.0 111.276 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.4 m -116.21 51.85 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.452 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 65.03 9.49 5.51 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.354 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -167.07 -69.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.311 . . . . 0.0 110.725 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 74.1 mtp180 -91.66 140.54 25.18 Favored Pre-proline 0 C--O 1.237 0.419 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 58.4 Cg_endo -72.45 139.91 32.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.939 2.426 . . . . 0.0 111.726 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -129.25 145.58 51.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.19 145.59 29.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.928 -175.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -130.3 174.35 9.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.818 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.08 -40.38 75.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.38 0.61 . . . . 0.0 109.783 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tt -106.74 105.26 15.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.146 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 170.68 -70.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.167 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.09 109.56 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.009 2.473 . . . . 0.0 113.454 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.49 148.85 43.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.678 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.7 133.43 43.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.6 p -79.96 178.82 7.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.65 -39.9 91.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.36 -44.16 92.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.01 -36.0 64.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.287 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.97 -45.23 93.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.831 0.348 . . . . 0.0 110.666 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.28 -31.24 70.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 110.56 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.54 -34.38 76.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 96.0 mt -58.62 -43.01 89.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.229 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -65.13 -44.87 87.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.55 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.79 -53.27 42.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.709 -174.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.38 5.56 50.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.155 0.502 . . . . 0.0 110.827 -175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.613 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -60.97 -15.04 41.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 113.751 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 t -91.93 11.94 23.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.448 ' CZ3' ' HA ' ' A' ' 81' ' ' LYS . 59.1 t90 -65.29 139.33 58.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.898 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.5 m -74.41 116.18 14.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.105 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.448 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 58.9 mttp -76.57 -150.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.163 0.506 . . . . 0.0 111.42 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -175.45 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.058 0.456 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.457 HD13 ' HH2' ' A' ' 79' ' ' TRP . 4.3 mm? -100.14 -3.27 32.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.05 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.657 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 18.6 mtm180 -65.62 -21.8 66.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.917 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 77.2 t80 -70.17 -46.47 64.59 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.979 172.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.56 76.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.831 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 7' ' ' ARG . 69.6 mt -58.07 -51.99 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.555 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD21 HD22 ' A' ' 40' ' ' LEU . 96.4 mt -58.4 -45.8 87.64 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.165 0.507 . . . . 0.0 110.835 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 26.3 ttpp -62.16 -48.67 79.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.175 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -31.02 71.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.0 mt -68.58 -43.47 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 110.589 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -75.3 -50.25 16.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.324 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.6 -40.16 66.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.819 0.342 . . . . 0.0 110.885 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 -27.45 70.06 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.502 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.93 26.05 11.03 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.089 0.556 . . . . 0.0 110.916 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.668 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 46.1 p 56.84 163.27 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.434 1.094 . . . . 0.0 113.134 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.668 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 71.5 Cg_endo -76.3 174.39 53.16 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 124.091 -1.212 . . . . 0.0 112.659 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.8 HD23 HD13 ' A' ' 26' ' ' ILE . 58.2 tp -152.88 118.76 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.55 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 18.2 m -86.75 170.68 11.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.93 -30.82 68.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 177.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -75.31 -39.91 59.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 8.9 p-10 -85.65 -1.46 57.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.8 HD13 HD23 ' A' ' 21' ' ' LEU . 11.1 tt -99.95 -37.45 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.734 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.5 -34.38 3.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.698 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.88 122.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -67.89 173.24 4.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' HG2' ' HG3' ' A' ' 23' ' ' GLU . 4.4 mt-10 -48.96 -51.32 31.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.766 -171.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.55 -57.89 8.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.834 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.48 -32.14 69.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.413 ' O ' HG22 ' A' ' 37' ' ' VAL . 80.0 t80 -65.63 -51.81 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.47 -46.14 89.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.725 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.19 -45.93 89.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.251 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 7' ' ' ARG . . . -60.68 -55.57 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.452 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 33' ' ' PHE . 88.2 t -58.23 -44.13 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.646 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.384 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.46 -38.61 65.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 46' ' ' ILE . 67.8 mt -59.86 -43.93 94.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.088 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.95 -45.35 89.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -57.21 -49.2 76.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.26 -0.16 35.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.287 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.94 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.112 -0.566 . . . . 0.0 113.557 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.57 -43.62 12.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 117.028 0.414 . . . . 0.0 110.773 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.513 HG23 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.57 151.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.423 . . . . 0.0 111.126 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.477 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.53 166.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.486 176.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.06 65.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.196 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -72.63 117.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.4 110.05 21.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -95.77 139.92 31.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -93.12 12.76 23.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.94 11.11 6.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.344 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.32 -54.0 1.8 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -151.57 150.09 25.71 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.73 117.06 4.94 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.498 2.132 . . . . 0.0 112.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -102.06 105.13 15.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -84.1 92.02 7.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.198 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -82.92 176.91 8.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.598 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 35.5 pttt -74.4 -0.59 17.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.74 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.75 129.53 17.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.73 -71.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.653 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.441 ' HG2' HG22 ' A' ' 19' ' ' THR . 30.6 Cg_endo -63.71 118.4 5.34 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.67 2.247 . . . . 0.0 113.284 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.03 150.41 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.872 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HG ' HG23 ' A' ' 46' ' ' ILE . 7.6 mp -93.65 144.44 25.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 p -92.8 170.72 9.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.585 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.14 -35.19 71.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -58.92 -50.6 73.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.116 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.44 -35.71 46.58 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.326 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HA ' HD11 ' A' ' 73' ' ' LEU . 2.7 tm-20 -61.33 -35.2 76.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.439 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -75.07 -34.96 61.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.053 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.51 -32.5 73.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.283 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.917 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.83 -38.25 75.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.816 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.37 -42.79 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.957 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.45 -49.24 61.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.255 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -90.31 3.02 54.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.558 -172.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -67.27 0.9 7.42 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.436 -0.411 . . . . 0.0 113.966 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.1 t -90.44 12.08 19.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.087 0.47 . . . . 0.0 110.677 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.457 ' HH2' HD13 ' A' ' 6' ' ' LEU . 24.4 t90 -123.69 131.98 53.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.786 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.8 p 53.4 83.28 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.053 0.941 . . . . 0.0 113.131 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -101.81 179.52 4.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.641 -175.424 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.572 ' HG3' HD23 ' A' ' 6' ' ' LEU . 19.8 ptpt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.572 HD23 ' HG3' ' A' ' 5' ' ' LYS . 4.2 mm? -70.82 -30.63 67.12 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.832 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.7 ' NH2' ' HA ' ' A' ' 36' ' ' ALA . 11.3 ptm180 -64.69 -16.5 62.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.755 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.676 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 8.5 t80 -77.47 -44.57 28.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.99 175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.651 ' HA ' ' ND2' ' A' ' 76' ' ' ASN . . . -71.21 -27.7 63.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.838 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 7' ' ' ARG . 52.6 mt -50.55 -37.83 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.578 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.519 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.5 mt -57.59 -34.06 68.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 36.7 ttpt -74.23 -48.06 31.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -38.1 75.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 110.724 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG12 HD21 ' A' ' 21' ' ' LEU . 70.6 mt -66.85 -45.64 87.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.454 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.8 -48.31 77.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.787 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 28.7 mt-10 -65.11 -39.2 92.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.908 0.385 . . . . 0.0 110.758 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.95 -27.17 51.14 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.42 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.77 26.21 14.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.956 0.503 . . . . 0.0 110.11 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 32.2 p 55.09 166.65 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.346 1.058 . . . . 0.0 112.917 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.756 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.8 Cg_endo -87.3 157.31 47.28 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.433 -3.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.514 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -153.08 129.19 10.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -85.11 170.11 13.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -55.43 -38.13 68.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 178.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.52 -38.61 90.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.587 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.6 -39.6 67.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.797 0.332 . . . . 0.0 111.047 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HB ' HD11 ' A' ' 21' ' ' LEU . 12.5 tt -82.79 -32.05 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.305 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.44 34.86 2.38 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.248 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 26' ' ' ILE . 30.9 m -130.29 169.93 20.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -85.34 167.67 15.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.082 0.468 . . . . 0.0 111.322 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 1.5 mp0 -51.7 -60.32 3.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.046 0.927 . . . . 0.0 111.189 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.4 -19.99 59.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.9 -169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.53 -36.79 37.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.998 0.428 . . . . 0.0 110.068 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 63.8 t80 -65.28 -44.82 86.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.881 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.68 -49.4 77.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.43 -40.56 74.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.7 ' HA ' ' NH2' ' A' ' 7' ' ' ARG . . . -61.79 -57.43 11.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.399 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 33' ' ' PHE . 69.3 t -57.48 -47.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.359 0.412 . . . . 0.0 111.734 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.05 -38.99 84.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.645 ' HB3' HH21 ' A' ' 7' ' ' ARG . 33.1 t80 -71.85 -41.62 67.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.821 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -67.29 -38.21 84.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.84 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 41' ' ' LYS . 11.6 tmtt? -69.74 -38.26 76.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 42' ' ' ARG . 8.0 ttm180 -56.82 -60.5 3.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.432 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -30.43 65.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.381 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.35 56.8 0.57 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.332 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.72 -26.01 13.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.733 0.301 . . . . 0.0 110.406 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 65' ' ' LEU . 1.6 pp -142.65 142.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.851 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.25 164.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.57 22.29 40.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.672 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.22 134.72 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -89.15 109.71 20.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -95.33 120.11 34.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.505 . . . . 0.0 110.19 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.0 t -98.14 30.36 3.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.893 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 72.0 -46.81 0.65 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.025 0.93 . . . . 0.0 110.999 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -66.05 -75.71 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.304 0.573 . . . . 0.0 110.282 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 17.6 mtp180 -141.59 164.12 36.8 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.775 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 34.3 Cg_endo -66.14 138.34 51.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.629 2.219 . . . . 0.0 112.121 175.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -132.94 148.32 52.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.09 121.62 45.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.362 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.06 -166.44 1.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.771 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 27.2 mtpp -61.81 -51.61 67.59 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.607 0.567 . . . . 0.0 111.432 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.81 133.93 55.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.125 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.46 -69.74 0.37 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.13 107.67 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.889 2.393 . . . . 0.0 112.999 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -115.81 139.97 49.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.227 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD11 ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -75.59 144.17 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -83.46 168.57 16.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.742 0.306 . . . . 0.0 110.48 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.42 -34.68 77.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 23.8 ttmm -60.34 -47.65 85.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.853 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -64.93 -37.7 94.6 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.06 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -58.28 -53.44 58.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.429 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.33 -29.01 65.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 6.2 t80 -66.85 -30.18 70.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 11' ' ' LEU . 21.2 mt -75.65 -19.05 59.44 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.437 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -54.91 -29.05 55.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 111.809 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 6.4 mm-40 -85.28 -27.53 25.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 60.0 t30 -85.4 3.33 40.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.318 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -48.7 -41.38 26.82 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.453 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 2.0 t -91.33 -81.96 0.31 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.286 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' C ' ' H ' ' A' ' 81' ' ' LYS . 33.7 t-105 45.59 80.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.877 0.471 . . . . 0.0 111.024 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 t 70.26 -34.84 0.3 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.459 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 79' ' ' TRP . 97.5 mttt -71.38 80.77 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 110.013 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.669 176.018 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.312 0.577 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.63 -9.66 46.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.703 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.499 ' HB2' HD21 ' A' ' 40' ' ' LEU . 7.7 ptp180 -60.89 -45.75 93.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.108 -174.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.479 ' HE2' ' CG ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -60.98 -42.37 98.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.415 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.75 68.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.18 -40.91 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.673 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 84.3 mt -58.09 -51.27 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.648 0.261 . . . . 0.0 110.938 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 12' ' ' LYS . 5.6 ttpm? -67.34 -41.86 84.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.773 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -29.49 69.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.465 HG21 HG21 ' A' ' 19' ' ' THR . 53.5 mt -73.46 -47.21 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.96 -47.0 87.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.29 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.21 -33.84 49.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.71 -22.51 57.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.105 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.42 1.46 3.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 0.0 111.237 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.1 p 55.48 164.42 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.263 1.025 . . . . 0.0 113.293 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.582 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 73.5 Cg_endo -90.32 118.35 3.41 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.182 -1.174 . . . . 0.0 111.969 -1.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' H ' HD21 ' A' ' 21' ' ' LEU . 2.7 pt? -90.22 134.77 34.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.761 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -80.75 164.84 22.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.164 0.507 . . . . 0.0 110.948 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -51.0 64.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.011 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.27 -14.6 62.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.331 0.586 . . . . 0.0 110.525 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.45 -39.36 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.608 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.2 tt -76.97 -35.11 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 176.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.1 -31.05 3.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.001 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.06 152.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.887 -0.184 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.2 t -68.51 173.31 5.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.368 0.604 . . . . 0.0 110.524 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.37 -41.26 98.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.472 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.92 -40.5 95.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.274 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -73.99 -39.83 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 110.641 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.24 -49.03 78.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.669 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -62.17 -46.33 89.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.279 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.04 -50.56 70.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.445 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.85 72.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.822 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.47 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.557 0.218 . . . . 0.0 111.483 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -65.26 -35.69 81.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.93 -43.4 75.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.2 mt -63.22 -34.23 77.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.053 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -35.09 77.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -67.24 -42.91 83.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.35 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.168 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.75 39.77 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.19 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.05 -30.73 18.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 0.0 110.217 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.8 pp -142.45 152.02 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.46 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 pt -134.84 177.46 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.867 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.33 16.71 79.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.82 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.05 113.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.231 0.538 . . . . 0.0 109.57 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -80.34 113.09 18.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.794 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 79.5 m-85 -101.51 143.28 31.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.6 m -129.29 93.12 3.5 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.7 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 64.85 -76.03 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.393 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.12 -44.04 6.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.623 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -137.03 148.46 62.9 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.739 -170.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.623 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 38.8 Cg_endo -69.93 143.43 50.0 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.312 2.008 . . . . 0.0 111.022 170.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 49.5 m-70 -104.03 -44.46 5.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 79.8 mt 68.2 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.438 0.637 . . . . 0.0 110.641 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -141.19 173.25 11.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.1 1.74 12.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.57 41.84 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.3 -86.55 1.59 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.153 -0.931 . . . . 0.0 114.019 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.47 159.34 14.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.028 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.55 139.99 51.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.585 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.0 mp -91.43 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.784 0.326 . . . . 0.0 110.729 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.8 p -88.44 170.7 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.28 -24.32 67.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.189 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -50.29 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.89 -42.25 53.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.077 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.03 -44.42 96.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.338 . . . . 0.0 110.473 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.87 -20.04 61.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.882 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -75.86 -28.82 58.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 83.1 mt -70.95 -22.65 62.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -51.16 -65.12 0.61 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.74 -30.18 56.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.767 -172.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.43 3.28 55.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -48.85 -26.42 5.69 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -84.92 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 117.472 0.636 . . . . 0.0 112.081 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 8' ' ' TYR . 69.9 t-105 66.92 175.2 0.25 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.365 0.602 . . . . 0.0 111.267 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.6 m -146.37 121.24 9.96 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.077 -0.389 . . . . 0.0 110.138 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -79.6 -8.53 59.25 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB3' ' HD2' ' A' ' 81' ' ' LYS . . . . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.533 0.206 . . . . 0.0 111.504 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.839 ' HG3' HD22 ' A' ' 6' ' ' LEU . 12.1 ptmm? . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.66 0.267 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD22 ' HG3' ' A' ' 5' ' ' LYS . 3.3 mm? -81.43 -12.11 59.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -64.64 -42.94 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.418 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 43.8 t80 -59.72 -43.4 94.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.948 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.12 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.377 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.72 -43.54 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.71 -52.45 64.92 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HB3' HD23 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -71.13 -22.77 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.026 -176.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 1.9 tp10 -80.13 -23.71 40.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.248 0.547 . . . . 0.0 109.883 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.02 -47.12 49.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.85 -50.02 75.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.66 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -99.62 -6.15 27.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 19' ' ' THR . . . -90.09 -12.44 61.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.449 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.9 t30 75.38 -17.24 0.52 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.005 0.522 . . . . 0.0 111.435 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.0 p 58.62 156.92 0.09 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.563 1.145 . . . . 0.0 113.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.5 Cg_endo -83.72 176.31 33.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.798 -1.334 . . . . 0.0 113.136 0.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.4 pt? -150.58 133.5 15.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 m -85.28 170.43 12.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.97 -37.93 77.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.093 175.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.42 -16.79 64.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.589 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.04 -49.98 7.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 110.821 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.456 HG22 HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.7 -38.61 58.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.93 22.17 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.189 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 26' ' ' ILE . 33.9 m -127.38 173.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 t -85.01 157.97 20.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 110.928 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.7 pm0 -63.29 -30.24 71.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.046 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -48.3 79.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.422 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 9.7 mm100 -82.44 -19.95 37.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.962 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.81 -55.58 16.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.05 -47.97 76.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.222 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 8.7 t70 -52.34 -49.04 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.315 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.568 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -68.06 -51.45 46.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.288 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.01 -42.32 85.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 111.237 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 95.4 m-20 -65.55 -41.48 92.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.526 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.21 -42.94 96.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.39 . . . . 0.0 110.596 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -59.41 -44.74 92.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.724 ' HB3' ' HZ1' ' A' ' 41' ' ' LYS . 6.2 ttpm? -70.92 -34.62 71.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.369 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 15.4 ttt-85 -66.37 -40.49 89.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.609 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.7 -40.1 61.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.817 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.05 2.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.805 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.511 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 60.2 m-85 -78.3 -41.32 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.571 0.224 . . . . 0.0 111.415 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.47 HG21 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -139.94 161.83 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.0 110.961 -177.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -129.24 170.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.204 174.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 90.71 19.87 42.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.699 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.72 114.5 22.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -88.46 141.03 28.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.0 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -119.99 136.13 54.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.0 m -122.33 -80.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.122 0.487 . . . . 0.0 111.295 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -37.96 84.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 164.32 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.535 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -103.88 158.36 32.05 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.833 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.3 134.7 23.3 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.577 2.184 . . . . 0.0 112.739 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -126.47 135.26 51.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.393 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.424 HD23 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -98.66 152.8 19.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.838 0.352 . . . . 0.0 110.604 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -134.71 -177.94 4.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.09 -29.45 64.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.965 0.412 . . . . 0.0 110.881 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -128.2 126.72 41.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.489 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 156.62 -64.82 0.31 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HG3' HD23 ' A' ' 58' ' ' LEU . 10.8 Cg_exo -70.45 100.69 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.738 2.292 . . . . 0.0 112.866 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -105.69 140.24 39.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.658 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' HG ' HG21 ' A' ' 46' ' ' ILE . 6.6 mp -90.96 140.04 30.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.674 0.273 . . . . 0.0 110.395 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.0 p -90.03 177.09 6.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -59.46 -33.11 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.673 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.19 -44.57 95.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.91 -41.83 21.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.714 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.66 -41.08 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.823 0.344 . . . . 0.0 110.975 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -79.12 -20.34 48.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.14 -33.58 76.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' A' ' 12' ' ' LYS . 77.8 mt -61.02 -25.97 67.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.944 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -74.17 -50.01 21.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -40.3 64.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.822 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -98.95 5.77 47.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.914 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -57.52 -22.08 44.31 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.391 170.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 t -76.32 -22.78 54.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.252 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 4.6 t90 49.83 62.29 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.219 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 p -174.45 92.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.212 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.25 80.93 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.508 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.311 178.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.597 ' HB3' ' HE1' ' A' ' 79' ' ' TRP . 98.2 mttt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 121.052 0.453 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.76 -26.93 61.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.983 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' O ' HD12 ' A' ' 11' ' ' LEU . 98.7 mtt180 -69.52 -11.84 61.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.542 ' HB2' HD21 ' A' ' 76' ' ' ASN . 57.1 t80 -100.1 -46.03 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.67 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.54 81.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.86 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.99 -47.79 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.467 HD11 HD21 ' A' ' 40' ' ' LEU . 10.5 mp -64.31 -32.67 74.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.948 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -65.14 -44.78 87.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.99 -41.0 97.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.61 -39.14 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.556 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -68.58 -50.12 54.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.86 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.22 -40.89 26.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.657 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.33 -18.55 58.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.5 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 62.31 24.32 14.47 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 110.497 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.839 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.7 p 54.98 171.96 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.987 0.915 . . . . 0.0 113.235 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.839 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.1 Cg_endo -85.06 179.7 21.99 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 123.809 -1.33 . . . . 0.0 112.074 -3.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.79 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -155.24 124.17 6.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -76.34 163.48 26.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.304 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.435 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.94 -16.48 60.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.75 -42.15 22.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.79 ' HB ' HD11 ' A' ' 21' ' ' LEU . 4.2 tt -77.23 -38.71 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.3 35.89 0.98 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.293 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 26' ' ' ILE . 35.9 m -137.06 174.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -84.99 156.46 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.43 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 4.6 mt-10 -55.38 -40.83 71.84 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.65 -60.71 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.598 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.1 -32.42 69.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.947 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.9 t80 -65.08 -59.2 4.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.899 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 55' ' ' ARG . 5.8 m-20 -57.19 -43.89 83.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.714 0.292 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.41 -45.2 94.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.257 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.82 -48.06 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.46 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 33' ' ' PHE . 99.4 t -59.1 -42.32 86.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.245 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.43 -44.85 93.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.429 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.18 -42.52 99.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.797 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.1 mt -59.11 -42.89 91.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.448 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HD3' ' HB ' ' A' ' 49' ' ' VAL . 29.8 ttpt -75.6 -38.31 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.359 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -39.93 94.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.439 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -4.33 56.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.227 0.537 . . . . 0.0 110.48 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 37.04 40.69 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.482 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -83.48 -47.45 11.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.281 0.54 . . . . 0.0 110.238 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -134.82 161.53 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 177.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 64' ' ' GLU . 25.6 pt -129.96 177.23 6.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.934 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.69 11.85 65.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.513 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HB ' ' HD3' ' A' ' 41' ' ' LYS . 39.1 t -77.79 121.75 31.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -101.98 129.75 48.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.19 0.519 . . . . 0.0 111.586 -173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -115.65 132.72 56.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.789 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -102.67 34.8 2.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.422 0.629 . . . . 0.0 109.317 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t70 51.32 58.45 5.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.961 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -156.78 -46.66 0.07 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.434 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.505 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 11.2 ptm180 -176.6 163.43 1.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -66.15 126.08 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.273 1.982 . . . . 0.0 112.059 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -116.91 130.69 56.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.404 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.02 140.27 35.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.611 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.04 178.13 7.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 68.6 mttm -79.77 -18.03 52.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.61 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.59 104.06 14.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.949 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.58 -67.71 0.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.613 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.15 119.01 3.15 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.534 2.822 . . . . 0.0 114.504 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' HB2' HG13 ' A' ' 47' ' ' ILE . 41.9 mt-10 -130.92 142.41 50.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.032 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.76 140.98 30.54 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.11 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 p -100.7 171.73 7.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.07 -33.02 73.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.359 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -60.99 -52.04 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.44 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.75 73.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.114 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.14 -45.5 91.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.738 0.304 . . . . 0.0 110.465 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -73.4 -20.27 60.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.465 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -70.05 -47.16 63.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 11' ' ' LEU . 96.2 mt -60.27 -32.44 71.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.002 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.45 -55.83 29.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.713 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.22 -32.45 22.63 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.542 HD21 ' HB2' ' A' ' 8' ' ' TYR . 1.7 t30 -79.97 2.85 21.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA2' ' CE1' ' A' ' 8' ' ' TYR . . . -66.02 -18.95 67.38 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.524 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.07 -47.72 70.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.597 ' HE1' ' HB3' ' A' ' 5' ' ' LYS . 9.2 t90 64.08 -74.04 0.05 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 123.862 0.726 . . . . 0.0 111.591 174.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m -154.15 -54.4 0.1 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 68.44 -77.55 0.05 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.569 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -175.021 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.653 0.263 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 mm? -56.75 -34.4 67.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.095 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.67 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.4 ptt180 -51.09 -34.28 29.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 111.417 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 20.3 t80 -71.34 -43.49 66.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.147 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.57 60.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.591 HD13 ' HA ' ' A' ' 7' ' ' ARG . 82.4 mt -59.38 -33.66 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.748 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -52.43 -40.97 62.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 24.9 ttpp -69.95 -44.37 69.68 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.071 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.56 -33.83 75.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.94 0.4 . . . . 0.0 110.504 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.44 HG22 HG22 ' A' ' 19' ' ' THR . 82.4 mt -57.7 -46.48 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.988 172.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -67.28 -44.53 79.05 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.148 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 8.1 mm-40 -62.4 -40.53 96.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.431 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.11 -13.43 52.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.267 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.51 25.54 11.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.145 0.498 . . . . 0.0 110.176 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.44 HG22 HG22 ' A' ' 14' ' ' ILE . 20.6 p 57.76 154.14 0.08 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.428 1.091 . . . . 0.0 113.226 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -91.35 -165.96 2.41 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.693 -0.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.78 125.21 6.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.212 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -84.91 170.02 13.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 111.197 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.76 -41.08 96.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.372 -178.262 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.49 -24.74 65.62 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.454 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.4 -46.23 28.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.639 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.563 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -80.4 -38.74 18.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.459 -177.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.7 -14.8 12.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.673 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.563 ' H ' HG23 ' A' ' 26' ' ' ILE . 35.1 m -101.0 144.95 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.986 0.393 . . . . 0.0 111.127 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.53 161.47 22.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.52 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 7.2 mt-10 -58.81 -40.72 84.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.659 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.24 -34.7 78.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.409 HE21 ' HB ' ' A' ' 28' ' ' VAL . 26.1 mt-30 -75.0 -36.15 61.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.5 . . . . 0.0 109.914 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 37' ' ' VAL . 49.4 t80 -65.6 -52.96 48.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.326 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' OD1' ' HD3' ' A' ' 56' ' ' PRO . 9.8 t70 -56.62 -47.59 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.332 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.58 -45.94 90.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.67 ' HB1' ' HB3' ' A' ' 7' ' ' ARG . . . -66.74 -40.46 88.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.357 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 33' ' ' PHE . 59.5 t -61.76 -46.09 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.616 0.246 . . . . 0.0 110.712 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -63.72 -37.35 87.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.827 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -64.99 -48.55 73.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 0.0 110.121 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 7' ' ' ARG . 59.5 mt -60.98 -37.53 82.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -69.9 -31.5 69.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.27 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.91 -38.86 76.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.859 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' OE1' ' HE2' ' A' ' 45' ' ' TYR . 48.1 mt-10 -79.93 -22.25 42.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.858 0.361 . . . . 0.0 110.793 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 45.51 4.5 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.438 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 57.0 m-85 -92.0 -34.04 14.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.105 0.453 . . . . 0.0 111.249 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.511 HG21 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.45 144.94 32.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.087 177.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 pp -129.98 165.3 30.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.338 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.05 60.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.486 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.93 122.81 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.02 110.15 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.04 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -93.85 114.52 26.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 m -99.06 -75.56 0.56 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 110.388 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 9.9 p-10 -79.42 -32.0 42.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.095 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 53' ' ' ASP . 32.8 t70 163.47 -25.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.334 -173.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -102.81 157.8 33.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.049 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.468 ' HD3' ' OD1' ' A' ' 34' ' ' ASP . 71.6 Cg_endo -76.22 120.71 5.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.489 2.126 . . . . 0.0 112.447 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -109.06 112.72 25.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.27 141.18 31.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.007 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.5 -177.97 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.477 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -81.45 15.0 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.752 0.31 . . . . 0.0 110.782 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.4 tp -159.63 120.08 3.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.937 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.51 -71.09 0.41 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.028 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 14.6 Cg_exo -69.24 122.05 8.86 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.855 2.37 . . . . 0.0 113.308 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -125.36 152.38 44.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.019 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' HG ' HG21 ' A' ' 46' ' ' ILE . 6.1 mp -88.09 137.72 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -83.19 173.67 11.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.19 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.42 -41.01 79.55 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -55.83 -54.81 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.748 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -66.55 -41.54 94.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.932 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -58.53 -46.87 85.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.57 -27.3 62.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -70.67 -24.92 62.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 80.4 mt -58.84 -19.28 40.04 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 74' ' ' LYS . 23.9 ttpt -43.27 -49.3 6.74 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -73.69 -37.1 65.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.078 0.466 . . . . 0.0 111.19 -174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 58.9 t30 -61.56 -20.96 63.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.496 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.52 -34.29 75.23 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.882 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -100.71 -8.33 22.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.257 0.529 . . . . 0.0 110.838 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -80.93 -39.64 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -84.71 -34.82 22.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.63 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 66.58 -83.68 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.819 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 121.096 0.474 . . . . 0.0 110.54 -176.654 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.76 ' HB2' HD23 ' A' ' 6' ' ' LEU . 48.0 mttp . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.76 HD23 ' HB2' ' A' ' 5' ' ' LYS . 2.3 mm? -100.32 -7.95 23.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -171.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.637 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 2.2 ttm-85 -70.58 -41.26 72.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -170.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 76' ' ' ASN . 63.9 t80 -58.95 -41.66 87.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB3' ' CH2' ' A' ' 79' ' ' TRP . . . -58.9 -47.37 85.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.468 ' O ' HG13 ' A' ' 14' ' ' ILE . 74.5 mt -63.47 -40.94 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.728 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HB3' HD23 ' A' ' 73' ' ' LEU . 23.7 mt -55.06 -50.17 69.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.722 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -72.38 -29.69 63.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.988 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 5.6 mm-40 -70.55 -29.8 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 10' ' ' ILE . 79.8 mt -69.89 -36.69 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.168 0.508 . . . . 0.0 109.876 173.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -78.33 -50.23 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.673 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -84.4 -38.63 20.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.945 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -20.08 75.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 65.86 20.47 11.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.841 0.456 . . . . 0.0 110.777 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.659 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.7 p 55.96 165.41 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.858 0.863 . . . . 0.0 113.039 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.659 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 92.2 Cg_endo -79.56 171.03 65.61 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 124.056 -1.227 . . . . 0.0 112.32 0.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -134.55 118.69 17.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -86.1 169.04 13.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.367 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.79 -40.63 95.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -71.11 -19.14 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.399 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.36 -42.55 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.5 HG21 HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -87.94 -36.04 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.609 -177.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.71 -17.6 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.272 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.5 HG21 HG21 ' A' ' 26' ' ' ILE . 28.7 m -89.53 161.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 O-C-N 122.742 -0.269 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -85.24 179.99 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -59.45 -44.24 92.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.946 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -53.01 62.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.624 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.495 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 44.2 mt-30 -63.7 -46.11 86.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -59.57 -44.72 93.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.162 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.56 -55.53 33.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.084 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.68 -41.58 81.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.64 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . . . -64.51 -57.57 8.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.2 -42.31 94.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 O-C-N 123.251 0.344 . . . . 0.0 111.782 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -61.07 -46.49 90.43 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.713 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.2 mt -61.36 -46.75 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.546 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 46' ' ' ILE . 23.1 tptp -69.24 -38.55 78.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 110.027 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -61.66 -41.59 97.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.376 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.899 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.79 39.96 0.74 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.625 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.564 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 67.4 m-85 -91.3 -29.4 17.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.515 ' O ' ' HD2' ' A' ' 41' ' ' LYS . 1.3 pp -143.75 156.75 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.686 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 29.0 pt -133.02 -179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.422 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.11 17.61 79.91 Favored Glycine 0 N--CA 1.454 -0.13 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.611 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.479 HG22 HD13 ' A' ' 46' ' ' ILE . 86.5 t -93.5 119.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.242 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -94.86 110.68 22.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 111.19 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -79.8 134.98 36.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.3 m -127.86 -80.09 0.59 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.114 0.483 . . . . 0.0 110.621 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 11.2 p-10 -105.14 82.61 1.87 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.926 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 6.4 t70 72.03 -36.19 0.35 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.588 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 53' ' ' ASP . 12.5 ptm85 -118.98 153.81 52.9 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -170.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.54 144.08 48.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.06 2.507 . . . . 0.0 112.106 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -124.18 121.66 35.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.34 106.78 18.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.275 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -95.62 -173.88 3.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.654 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 41.5 mtpt -63.0 -48.74 77.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.383 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.88 142.58 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.38 -67.07 0.45 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.613 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 51.7 Cg_exo -56.7 125.68 19.81 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.055 2.504 . . . . 0.0 113.821 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.442 ' HB2' HG13 ' A' ' 47' ' ' ILE . 53.3 mm-40 -123.52 142.03 51.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.1 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.07 138.34 31.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.365 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.4 p -82.5 179.91 7.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.85 -47.55 74.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.62 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.893 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.564 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -64.75 -46.12 90.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.778 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.79 -44.7 96.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.543 0.211 . . . . 0.0 111.355 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -73.32 -30.91 63.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.149 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -66.64 -31.53 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 98.4 mt -57.55 -40.1 78.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.794 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -66.5 -43.49 85.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.554 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.02 -46.9 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 0.0 111.076 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -88.71 5.22 44.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.446 -177.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' HA2' ' HH ' ' A' ' 8' ' ' TYR . . . -51.3 -34.19 32.81 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.134 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -82.05 89.17 6.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.822 0.82 . . . . 0.0 109.493 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.436 ' CH2' ' HB3' ' A' ' 9' ' ' ALA . 64.5 t90 -141.41 136.25 31.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.797 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.3 p 55.72 -161.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.83 0.852 . . . . 0.0 112.013 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -140.24 -171.39 3.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -173.568 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.764 ' HG3' HD21 ' A' ' 6' ' ' LEU . 49.1 pttt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 120.713 0.292 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.764 HD21 ' HG3' ' A' ' 5' ' ' LYS . 1.3 mm? -100.58 -13.59 18.53 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HG2' HD21 ' A' ' 40' ' ' LEU . 79.5 mtt180 -54.8 -46.88 74.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.506 0.594 . . . . 0.0 111.353 -171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.802 ' HE1' ' HA2' ' A' ' 77' ' ' GLY . 88.3 t80 -55.44 -57.41 11.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.084 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.26 97.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.486 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.3 mt -59.91 -49.03 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.863 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 ' HB3' HD23 ' A' ' 73' ' ' LEU . 7.4 mp -59.81 -47.25 86.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -75.82 -26.92 57.66 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.582 -0.447 . . . . 0.0 112.063 -176.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -77.08 -28.17 54.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.449 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.53 -48.33 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.92 -50.03 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.13 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.12 -30.36 22.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.431 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.95 -24.88 72.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.134 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.6 -4.28 2.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.0 0.52 . . . . 0.0 111.16 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 53.3 p 57.35 156.42 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.117 0.967 . . . . 0.0 112.957 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.688 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 6.2 Cg_exo -76.35 166.88 81.66 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 124.315 -1.119 . . . . 0.0 112.938 0.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.482 HD13 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -148.2 127.33 12.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -81.91 169.95 16.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.324 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -58.76 -37.33 76.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.795 174.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.53 -27.78 67.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.602 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.99 -49.86 14.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.758 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 HG22 ' A' ' 28' ' ' VAL . 11.0 tt -75.7 -29.58 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 -175.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.37 32.95 4.08 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.083 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 28.4 m -137.64 171.62 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 t -85.39 164.47 17.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 0.0 110.938 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -60.79 -42.05 96.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.94 -53.94 51.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.665 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -69.57 -24.16 63.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.01 -54.07 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.69 -48.5 72.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.848 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.72 -56.8 12.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.784 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.34 -45.96 65.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.868 -175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.72 -44.31 98.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.598 0.237 . . . . 0.0 111.104 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -66.55 -35.26 79.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.992 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.72 -42.11 78.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.911 0.386 . . . . 0.0 110.227 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.646 HD21 ' HG2' ' A' ' 7' ' ' ARG . 89.7 mt -62.1 -37.82 86.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.443 176.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 4.7 ttpm? -70.81 -25.68 62.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.37 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -70.12 -54.33 13.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.803 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 34.8 mt-10 -80.24 -20.14 45.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 110.912 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 58.29 1.37 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.841 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 96.5 m-85 -96.12 -33.43 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.249 0.547 . . . . 0.0 109.59 173.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.439 HD11 ' O ' ' A' ' 46' ' ' ILE . 2.1 pp -140.07 150.55 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.33 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.71 -179.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 84.91 4.19 87.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.081 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.74 113.2 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 0.0 109.984 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -79.97 110.18 15.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.336 0.588 . . . . 0.0 109.657 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.37 130.4 39.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 -176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -97.05 23.35 7.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 70.97 -49.55 0.68 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.133 0.973 . . . . 0.0 111.41 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.7 -59.31 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -141.8 164.32 35.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.07 136.21 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.264 2.643 . . . . 0.0 111.521 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -129.69 123.63 31.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.279 0.562 . . . . 0.0 110.285 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 90.4 mt -86.61 87.37 7.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.582 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -71.82 167.4 20.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.268 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.688 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 23.8 mtpp -61.97 -47.12 86.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.76 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.64 112.72 25.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.358 . . . . 0.0 110.135 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.469 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 160.42 -62.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.278 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.85 116.94 3.08 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.01 2.473 . . . . 0.0 113.324 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 62' ' ' GLY . 35.6 mt-10 -129.67 160.26 33.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.488 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.2 147.78 28.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -91.97 170.56 9.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -64.87 -29.64 70.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 4.0 ttmp? -62.89 -46.6 87.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.778 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.29 -36.82 55.21 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.566 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.47 -49.39 75.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -70.66 -25.52 63.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 24.9 t80 -62.92 -39.36 94.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.83 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 11' ' ' LEU . 85.5 mt -54.13 -41.57 68.54 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -66.21 -32.19 73.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.152 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.02 -62.94 1.48 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.128 0.49 . . . . 0.0 110.998 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.72 5.07 16.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.474 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.802 ' HA2' ' HE1' ' A' ' 8' ' ' TYR . . . -62.5 -7.17 13.44 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.921 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -71.92 -53.48 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.819 0.31 . . . . 0.0 110.634 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 29.88 57.15 0.17 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.4 1.08 . . . . 0.0 112.622 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 t 66.65 -86.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.159 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.85 22.59 5.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.144 0.578 . . . . 0.0 112.053 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.172 179.392 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 mttm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.2 -32.97 61.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 109.013 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.728 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -62.89 -28.72 70.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.119 174.026 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.973 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 61.6 t80 -69.76 -41.41 75.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.663 175.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.56 -46.45 80.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.584 HD12 HG13 ' A' ' 26' ' ' ILE . 25.0 mm -54.78 -48.88 72.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.808 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB3' HD22 ' A' ' 73' ' ' LEU . 71.9 mt -56.36 -43.74 79.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -65.39 -45.82 82.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.631 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -29.66 69.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.327 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.6 mt -61.96 -46.59 96.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -67.87 -42.88 80.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.702 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.6 -40.09 73.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.877 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.47 -20.79 57.92 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.006 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.52 20.44 12.15 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.703 0.401 . . . . 0.0 110.16 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 41.6 p 58.38 150.69 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 124.517 1.127 . . . . 0.0 113.255 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -87.25 161.03 49.2 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.208 -0.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD22 HG12 ' A' ' 14' ' ' ILE . 1.6 pt? -131.37 120.96 23.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 m -82.59 164.86 20.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.559 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HG3' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -59.36 -44.73 92.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 176.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.83 -21.39 62.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.047 0.451 . . . . 0.0 111.011 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.04 -46.79 15.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.665 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.584 HG13 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -71.61 -37.08 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.58 35.96 1.81 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.135 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.512 HG22 HG21 ' A' ' 26' ' ' ILE . 35.8 m -140.42 170.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 p -76.8 160.54 29.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.46 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 5.6 mt-10 -57.64 -48.97 77.98 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.255 0.55 . . . . 0.0 109.52 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.76 -45.52 19.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.786 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -74.65 -38.73 62.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.054 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -64.92 -46.95 79.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.631 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -56.66 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.707 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.73 -34.54 77.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.849 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.728 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -60.34 -52.72 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.68 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -41.87 98.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.715 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -64.3 -48.36 75.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.91 -36.07 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.797 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -75.74 -28.6 58.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -77.66 -43.98 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -76.22 -13.01 60.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.362 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.45 51.77 4.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -98.2 -39.2 8.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.058 0.456 . . . . 0.0 109.822 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' HG ' ' A' ' 65' ' ' LEU . 2.0 pp -138.78 149.4 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.576 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.96 168.83 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.817 178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 24.94 34.14 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.1 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.43 128.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 110.321 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -94.89 126.04 39.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.826 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.63 145.75 28.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.269 0.557 . . . . 0.0 111.784 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.2 t -96.23 -149.53 0.31 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.673 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -43.08 -57.0 3.1 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.627 0.579 . . . . 0.0 110.695 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.36 -18.68 0.71 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.074 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.581 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 75.0 mtp180 -105.36 148.4 36.22 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 122.33 -0.231 . . . . 0.0 110.599 -172.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 153.33 57.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 143.36 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.24 136.64 51.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 19' ' ' THR . 96.6 m-85 -108.01 -168.63 1.4 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.864 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 49.8 mtpt -75.79 -13.67 60.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.941 0.4 . . . . 0.0 111.119 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' C ' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -161.54 161.12 29.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.99 -59.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.143 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.95 141.85 72.61 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.471 2.114 . . . . 0.0 113.756 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -120.52 150.95 40.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.766 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HG ' HG21 ' A' ' 46' ' ' ILE . 6.1 mp -96.96 144.71 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.4 p -83.4 179.59 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.465 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.1 -42.65 99.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.14 -49.03 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.858 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.91 65.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.74 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.409 . . . . 0.0 111.169 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -77.35 -35.28 54.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.985 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -58.93 -39.1 80.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.254 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.973 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.7 -46.96 83.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.919 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -71.32 -39.89 71.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.742 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -73.48 -39.02 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.931 0.396 . . . . 0.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -92.74 5.66 50.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -52.94 -12.3 1.7 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.707 0.643 . . . . 0.0 114.707 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -95.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 117.235 0.517 . . . . 0.0 110.154 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.401 ' C ' ' HG ' ' A' ' 80' ' ' SER . 9.7 t90 51.68 -152.27 0.23 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.665 0.386 . . . . 0.0 110.135 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 79' ' ' TRP . 77.3 p 51.18 23.49 1.63 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.703 0.801 . . . . 0.0 112.408 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -81.38 72.38 8.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 173.1 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.617 0.246 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? -91.43 -14.38 30.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.778 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 8.8 mmt180 -59.77 -51.89 67.8 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.598 0.714 . . . . 0.0 109.404 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 18.3 t80 -51.85 -46.14 64.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.167 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.46 62.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 6' ' ' LEU . 73.2 mt -59.37 -30.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.604 0.24 . . . . 0.0 111.266 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -52.75 -38.65 61.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.598 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.525 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.6 ttpp -74.07 -39.15 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.745 -177.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.07 -32.09 73.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.38 . . . . 0.0 110.523 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.58 -43.51 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 110.081 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -64.09 -50.33 68.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.019 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.525 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 6.0 mt-10 -77.7 -19.14 55.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 110.677 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.46 -17.11 69.48 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.617 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.98 16.28 9.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.01 0.524 . . . . 0.0 110.436 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.1 p 56.18 151.6 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.521 1.128 . . . . 0.0 112.956 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.582 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -78.85 177.69 37.39 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.451 -1.479 . . . . 0.0 112.457 -2.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD21 ' HB ' ' A' ' 26' ' ' ILE . 43.5 tp -149.79 119.31 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.981 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.46 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 17.0 m -85.8 164.51 17.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.201 175.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -68.02 -33.78 75.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.55 -36.47 84.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 9.1 m-20 -71.0 -34.55 71.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.396 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.489 HG23 HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -83.95 -35.03 10.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.099 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG21 HG23 ' A' ' 26' ' ' ILE . 31.5 m -135.39 173.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 110.326 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 p -85.59 166.76 15.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.681 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 24.3 mt-10 -67.03 -33.22 75.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.708 0.766 . . . . 0.0 108.957 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -49.77 -57.2 7.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.959 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -72.43 -33.79 67.36 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.966 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 47.6 t80 -66.28 -50.71 62.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.3 t70 -62.76 -45.6 91.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.19 -41.89 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.712 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.63 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -67.36 -55.9 11.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.837 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.37 -34.97 67.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.159 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.59 -45.59 86.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.607 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.437 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.7 t80 -61.68 -41.43 97.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.088 0.47 . . . . 0.0 110.065 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.0 mt -64.66 -39.85 94.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.134 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -34.81 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -60.9 -52.99 62.68 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.626 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 8.3 mm-40 -74.12 -28.42 61.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.958 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.08 40.9 2.54 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.953 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -89.78 -32.77 16.81 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.676 -0.308 . . . . 0.0 111.295 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.434 HD11 ' O ' ' A' ' 46' ' ' ILE . 1.9 pp -137.42 148.41 25.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.8 170.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.251 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.68 90.57 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.256 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.22 128.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -94.71 119.14 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.106 0.479 . . . . 0.0 111.143 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -109.79 143.96 38.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.437 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -145.01 -85.28 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 55' ' ' ARG . 15.6 t70 -65.13 111.91 3.14 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 153.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 4.0 m-20 -52.8 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.657 1.223 . . . . 0.0 113.444 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 50.4 mtp180 -149.05 116.24 3.76 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.076 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 26.8 Cg_exo -60.11 119.55 6.81 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 113.724 -165.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -106.59 112.62 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.527 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.86 145.76 25.91 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.608 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.12 171.92 12.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.582 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 51.8 mttm -78.17 -18.33 55.68 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.612 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 124.15 42.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.47 -65.59 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.734 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.7 121.73 10.17 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.81 2.34 . . . . 0.0 112.812 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -128.23 145.19 51.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 129.85 39.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.35 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.9 p -80.02 166.14 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.104 0.252 . . . . 0.0 110.877 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.6 -38.28 69.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.145 0.498 . . . . 0.0 109.991 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -52.26 -55.39 21.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.726 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -76.42 -36.03 40.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.02 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -63.41 -40.92 98.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.703 0.287 . . . . 0.0 110.873 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.66 -29.4 61.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.437 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.03 -27.01 68.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.294 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 91.8 mt -69.31 -19.1 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.34 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -45.87 -47.51 16.09 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -83.15 -19.64 36.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 111.156 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 65.5 t30 -78.85 -9.26 59.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 -175.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.5 -19.28 57.65 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.432 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 t -103.31 -7.64 20.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.498 ' HZ3' ' HD2' ' A' ' 8' ' ' TYR . 10.7 t90 -104.8 147.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.468 ' HG ' ' C ' ' A' ' 79' ' ' TRP . 46.8 p 51.05 31.75 6.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.496 0.665 . . . . 0.0 111.07 -176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.487 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 52.2 tttp -152.78 167.69 28.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 120.462 0.172 . . . . 0.0 111.184 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 33.8 mttm . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.459 0.647 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.71 -28.43 67.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.897 174.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -56.71 -38.22 72.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.692 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 5' ' ' LYS . 39.3 t80 -59.96 -43.95 94.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.192 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.02 82.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.762 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.01 -49.49 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.654 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 ' HB3' HD22 ' A' ' 73' ' ' LEU . 7.8 mp -61.34 -37.31 82.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.254 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -70.43 -24.26 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.982 -178.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 12' ' ' LYS . 5.4 mm-40 -74.89 -39.18 61.62 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.58 -43.67 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.579 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.52 -50.61 29.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.876 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -83.28 -40.08 20.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.777 0.322 . . . . 0.0 110.842 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 -26.86 59.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.491 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.5 25.9 13.32 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.075 0.55 . . . . 0.0 110.64 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.502 HG21 ' HG2' ' A' ' 63' ' ' PRO . 18.0 p 56.65 156.97 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.39 1.076 . . . . 0.0 113.338 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.2 Cg_endo -83.25 172.8 46.35 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.377 -2.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 HD21 HG23 ' A' ' 19' ' ' THR . 0.5 OUTLIER -147.52 136.18 21.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -85.16 166.86 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.692 0.282 . . . . 0.0 110.461 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.557 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 1.4 mp0 -55.25 -42.61 73.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.443 0.639 . . . . 0.0 110.242 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -69.59 -22.95 63.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.263 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.37 -49.87 44.7 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.66 0.267 . . . . 0.0 110.501 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -38.68 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.907 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.57 -2.52 11.17 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.785 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 m -116.09 160.97 15.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.234 0.517 . . . . 0.0 110.839 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 159.88 33.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 175.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.557 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 10.0 pt-20 -60.31 -29.63 68.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.003 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.85 -52.36 66.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.597 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -74.61 -35.12 62.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -58.07 -55.77 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.243 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -54.83 -49.71 70.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.778 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -50.27 73.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.804 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.509 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -69.86 -44.82 69.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.549 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.65 -37.03 74.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.482 0.182 . . . . 0.0 110.858 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.19 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.564 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.8 -39.13 93.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.996 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.642 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 95.1 mt -62.37 -37.59 86.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 0.0 110.903 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.676 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 51.9 tttm -77.68 -33.6 53.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.45 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.04 -47.6 70.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.11 8.27 16.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.41 49.01 59.43 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.387 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.642 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 64.1 m-85 -95.15 -39.76 9.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.51 ' O ' HD13 ' A' ' 46' ' ' ILE . 1.9 pp -140.47 142.77 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.214 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.32 175.71 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.068 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.65 6.08 73.73 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 49.8 t -76.24 109.92 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -87.69 111.07 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.071 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.39 135.78 37.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.639 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 7.6 t -104.28 32.41 4.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.2 t70 74.75 -47.13 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.257 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD1' ' HB3' ' A' ' 52' ' ' SER . 11.5 p-10 -71.29 -54.22 11.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -147.4 164.33 23.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.13 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.95 101.95 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.194 1.929 . . . . 0.0 110.722 169.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -92.17 108.72 20.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.72 109.42 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.946 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.8 -168.11 1.94 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.449 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -75.86 -45.48 35.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.204 0.525 . . . . 0.0 110.22 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.32 132.0 53.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.608 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.01 -63.14 0.39 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.398 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.502 ' HG2' HG21 ' A' ' 19' ' ' THR . 35.9 Cg_exo -59.01 120.24 7.98 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.792 2.328 . . . . 0.0 112.662 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.85 151.67 46.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.005 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.21 148.45 22.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.23 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -91.72 161.05 15.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -66.35 -26.8 67.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -61.46 -51.75 67.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.256 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.7 71.44 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.37 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -62.67 -41.88 99.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.04 0.447 . . . . 0.0 109.854 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -70.81 -32.04 68.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.9 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.17 -36.64 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 110.083 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.861 ' HA ' HD22 ' A' ' 76' ' ' ASN . 89.2 mt -58.41 -33.28 69.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.257 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -62.01 -34.7 76.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.57 -43.18 14.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.606 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.861 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -91.1 5.62 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.97 -18.88 4.76 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.262 0.351 . . . . 0.0 113.952 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 t -74.15 -118.16 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.578 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 73.1 t90 72.93 120.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.8 m 68.86 -65.5 0.28 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -75.64 80.38 2.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.124 0.964 . . . . 0.0 111.508 -172.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.634 -179.333 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.645 ' HG3' HD23 ' A' ' 6' ' ' LEU . 46.6 pttt . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.645 HD23 ' HG3' ' A' ' 5' ' ' LYS . 2.1 mm? -82.91 -13.03 56.84 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.305 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.655 ' HG3' HD22 ' A' ' 40' ' ' LEU . 39.9 ttm180 -53.31 -41.65 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 0.0 111.233 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.583 ' HB2' HD21 ' A' ' 76' ' ' ASN . 91.0 t80 -60.2 -43.72 95.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.56 61.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.957 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.95 -45.73 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.012 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.93 -41.43 91.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.521 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.06 -46.0 72.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.554 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -39.28 80.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.278 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.05 -50.06 50.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.446 . . . . 0.0 110.414 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -62.76 -50.29 71.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.72 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -82.57 -35.15 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.809 0.338 . . . . 0.0 111.47 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.54 -24.16 75.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.56 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 71.42 5.94 5.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.129 0.572 . . . . 0.0 110.73 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.6 p 55.9 164.51 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 113.334 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.613 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 90.0 Cg_endo -83.98 -178.46 19.38 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.623 -1.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.02 143.43 20.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.2 m -85.27 170.23 13.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.717 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HG3' HD21 ' A' ' 24' ' ' ASN . 13.9 pt-20 -61.5 -47.43 85.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.786 0.326 . . . . 0.0 111.35 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.548 HD21 ' HG3' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -72.71 -9.22 58.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -176.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.81 -47.38 30.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 -38.49 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.46 -19.28 5.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.516 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 35.1 m -98.14 162.06 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.666 0.27 . . . . 0.0 110.622 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.7 p -81.02 165.73 21.42 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.09 -31.51 30.86 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.629 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.27 -53.72 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.065 0.46 . . . . 0.0 110.797 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.413 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 2.7 mp0 -70.74 -34.49 71.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.01 -52.06 39.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.661 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -57.71 -54.16 49.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.795 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -54.08 -50.72 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.984 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.634 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -62.02 -53.16 59.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.75 -177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.55 -44.89 97.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 111.37 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -65.89 -40.77 91.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.334 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 75.5 t80 -61.58 -47.87 83.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.176 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.655 HD22 ' HG3' ' A' ' 7' ' ' ARG . 96.8 mt -56.2 -44.47 79.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.353 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 3.9 ttpm? -67.33 -38.99 85.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -72.72 -39.89 66.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.407 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 14.2 mm-40 -78.24 -27.64 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.95 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.61 32.93 1.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.55 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -90.3 -43.87 10.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 110.673 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 65' ' ' LEU . 2.4 pp -141.0 154.84 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -133.54 173.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 91.52 13.32 58.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.799 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.65 119.1 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.652 0.263 . . . . 0.0 110.425 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -90.85 124.77 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.71 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 61.4 m-85 -102.66 153.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -88.03 -41.0 13.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.439 0.638 . . . . 0.0 109.589 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 t70 178.62 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.53 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.501 ' OD2' ' HG3' ' A' ' 55' ' ' ARG . 5.6 p-10 -135.8 -39.67 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.125 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.501 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 88.9 mtt180 -118.42 146.79 40.42 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 121.042 0.449 . . . . 0.0 111.256 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 94.9 Cg_endo -86.12 160.57 10.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.106 2.538 . . . . 0.0 113.863 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -137.48 126.92 24.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.378 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 86.1 mt -88.25 154.67 20.24 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -133.11 -177.21 4.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.108 0.48 . . . . 0.0 111.278 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 61' ' ' LEU . 4.1 pp -146.69 145.15 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.952 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 134.68 -67.59 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.892 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 28.1 Cg_exo -62.5 123.57 12.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.637 2.225 . . . . 0.0 111.878 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 151.33 46.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.604 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.637 ' HA ' HG23 ' A' ' 46' ' ' ILE . 8.4 mp -91.92 142.2 27.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.599 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.5 p -88.0 179.31 6.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.262 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.53 -39.24 76.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.3 tppt? -65.02 -42.07 94.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.475 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.59 -47.78 88.5 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.52 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.6 -45.08 94.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -73.28 -25.12 60.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 0.0 111.18 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.22 -40.45 77.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.127 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -55.39 -38.32 68.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.765 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -56.23 -48.22 76.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.248 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.413 ' O ' HG22 ' A' ' 78' ' ' THR . 42.3 mt-10 -85.06 -31.87 23.17 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.3 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.583 HD21 ' HB2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -76.26 5.65 6.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.716 0.293 . . . . 0.0 110.75 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.79 -20.28 56.75 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 164.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 75' ' ' GLU . 6.1 t -78.53 -17.81 55.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 72.9 -75.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.313 171.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.5 t -145.44 85.55 1.72 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.914 0.388 . . . . 0.0 110.768 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -175.84 34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 109.074 174.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.871 -177.828 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HB2' HD22 ' A' ' 6' ' ' LEU . 43.5 mttp . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.377 0.608 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' O ' HG12 ' A' ' 10' ' ' ILE . 1.5 mm? -75.99 -30.35 58.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.736 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.483 HH11 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -56.56 -40.37 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.45 -42.01 65.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.308 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.654 HD13 HG13 ' A' ' 26' ' ' ILE . 42.8 mm -60.48 -52.79 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.388 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.92 -43.64 91.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.402 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.19 -44.61 94.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.675 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.123 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 10' ' ' ILE . 77.6 mt -65.87 -45.21 91.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 110.339 175.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.96 -50.21 71.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.612 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.72 -17.28 32.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.46 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 -27.71 23.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.685 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.411 ' C ' ' HG1' ' A' ' 19' ' ' THR . 63.7 t30 68.53 11.46 8.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.634 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 28.6 p 55.04 162.65 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 124.345 1.058 . . . . 0.0 113.294 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.634 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 95.3 Cg_endo -79.61 156.14 89.29 Favored 'Cis proline' 0 C--N 1.343 0.274 0 C-N-CA 123.717 -1.368 . . . . 0.0 111.88 -3.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.55 132.51 53.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -85.0 162.89 19.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.138 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.815 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.28 -32.94 74.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -65.56 -34.42 78.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.35 -43.7 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.654 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.68 -27.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.95 33.96 5.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.334 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 26' ' ' ILE . 33.7 m -135.11 175.87 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 p -83.89 156.92 22.17 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.815 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.47 -21.2 64.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.04 -44.8 79.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.056 0.455 . . . . 0.0 109.933 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -68.06 -29.82 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -64.6 -48.79 73.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.562 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.67 -53.58 53.02 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.64 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -49.59 53.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.745 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -61.93 -54.41 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.608 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.96 -38.59 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 O-C-N 123.105 0.253 . . . . 0.0 111.522 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 17.0 m-80 -60.78 -49.41 77.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.647 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.66 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 97.0 mt -60.98 -37.73 83.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 5.3 tmmm? -71.37 -40.76 70.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 55.8 mtt180 -60.75 -47.29 86.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.926 0.393 . . . . 0.0 111.141 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -82.29 4.77 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.48 46.24 94.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.119 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.618 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 29.6 m-85 -87.55 -37.36 16.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.406 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.8 pp -138.68 150.34 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.097 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.29 173.71 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.471 175.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.43 9.34 69.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.084 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.75 124.9 38.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -92.42 111.28 22.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.891 0.377 . . . . 0.0 110.424 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -89.84 130.54 36.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.488 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -133.12 110.37 10.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.944 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 63.03 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.989 0.806 . . . . 0.0 110.599 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 33.4 t70 -151.72 80.03 1.27 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.807 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 13.3 tpt180 173.46 119.09 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.76 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.19 99.9 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.446 2.097 . . . . 0.0 111.012 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -82.05 109.78 16.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.068 0.461 . . . . 0.0 110.933 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 85.6 mt -89.17 105.72 17.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.652 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.0 173.1 7.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.03 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -67.92 -26.76 66.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.349 0.595 . . . . 0.0 109.891 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.27 117.8 31.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.641 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.18 -72.33 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.51 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.04 120.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.449 2.766 . . . . 0.0 114.206 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -129.84 144.46 51.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.622 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.66 145.64 26.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.39 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.2 p -96.04 173.85 7.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.27 -37.27 86.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -62.93 -40.45 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.357 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -70.87 -41.97 61.45 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.467 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.15 -38.63 88.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.776 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -36.77 85.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.353 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.61 -36.14 79.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.642 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.4 -44.53 89.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.51 . . . . 0.0 110.489 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -71.93 -31.84 66.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.44 -44.66 34.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.075 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.64 3.2 48.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 110.412 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.88 -0.05 12.52 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.352 -0.451 . . . . 0.0 113.102 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -89.8 19.22 4.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.552 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.424 ' O ' ' HB2' ' A' ' 80' ' ' SER . 30.8 t90 -91.6 143.52 26.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.789 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 79' ' ' TRP . 68.1 m 74.7 153.13 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.468 0.707 . . . . 0.0 111.742 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -142.13 -178.67 5.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.876 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.329 0 O-C-N 123.962 0.789 . . . . 0.0 111.409 -179.748 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 mttm . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.626 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? -100.05 -28.05 13.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.505 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.557 ' HA ' HD11 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -66.68 -37.47 84.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 109.953 -172.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -55.41 -48.3 74.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.111 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.38 -18.54 54.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.613 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.632 ' HA ' HD13 ' A' ' 26' ' ' ILE . 66.2 mt -58.65 -39.37 75.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.436 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.584 ' CB ' HD21 ' A' ' 73' ' ' LEU . 46.0 mt -62.3 -30.75 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.385 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.609 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -62.94 -43.89 97.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 109.992 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.425 ' HG3' HD12 ' A' ' 26' ' ' ILE . 7.8 mm-40 -63.37 -42.8 98.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.384 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.93 -31.87 55.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.876 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.21 -49.92 57.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.469 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.26 -28.58 21.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.755 0.312 . . . . 0.0 111.822 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.62 -14.76 64.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.599 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 19' ' ' THR . 4.2 t-20 70.51 -81.81 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.596 0.759 . . . . 0.0 109.486 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER 173.16 157.26 0.27 Allowed Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 124.199 0.999 . . . . 0.0 109.012 176.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.796 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 66.7 Cg_endo -87.8 -174.82 9.67 Favored 'Cis proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.108 -0.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -157.73 127.8 6.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 m -85.41 170.14 12.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.367 . . . . 0.0 110.63 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.03 -22.12 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.722 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -84.2 -43.93 14.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.498 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 10' ' ' ILE . 5.1 tp -70.02 -38.43 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.92 -20.13 10.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.943 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.24 160.07 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 t -70.38 166.82 19.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.299 0.571 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.44 -29.15 69.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.45 -43.31 90.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.547 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -71.66 -32.25 67.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.873 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.79 -46.7 80.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.86 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -56.71 -53.14 61.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.453 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.9 -37.64 77.07 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.405 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.617 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.14 -59.9 3.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.717 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.14 -43.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.296 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.999 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -68.91 -45.74 70.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.792 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 74.7 mt -63.21 -37.18 86.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.944 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -60.77 -42.35 97.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.99 12.97 18.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.356 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.28 38.33 96.04 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.638 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 34.7 m-85 -88.26 -28.72 20.93 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.487 -0.419 . . . . 0.0 110.488 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.436 HD11 ' O ' ' A' ' 46' ' ' ILE . 1.9 pp -143.68 149.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -131.84 150.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.63 35.45 6.18 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.518 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.6 115.2 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.944 0.402 . . . . 0.0 110.452 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.425 ' NE2' ' HA3' ' A' ' 62' ' ' GLY . 89.4 m-70 -82.19 135.91 35.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.66 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -108.01 135.66 49.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 t -67.25 -34.88 78.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.409 0.623 . . . . 0.0 109.853 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 174.22 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.686 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -131.98 -43.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.079 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.852 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -108.18 147.21 35.11 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.37 -173.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.852 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 52.7 Cg_exo -53.62 136.47 64.71 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.553 2.168 . . . . 0.0 111.835 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.22 105.57 3.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.111 0.482 . . . . 0.0 110.027 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.03 134.33 43.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.147 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.796 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.8 m-85 -125.83 -178.34 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -43.15 -55.66 3.81 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.159 0.912 . . . . 0.0 113.289 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 61' ' ' LEU . 3.2 pp -128.1 146.07 50.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.925 0.393 . . . . 0.0 110.955 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 137.19 -64.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.722 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.23 121.57 8.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.537 2.158 . . . . 0.0 113.074 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -114.72 152.37 32.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.621 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' HA ' HG23 ' A' ' 46' ' ' ILE . 5.9 mp -101.17 134.43 44.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.1 p -80.23 160.95 25.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 10.7 pt-20 -69.43 -20.0 63.79 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.48 -48.32 82.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 -35.23 50.51 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.862 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 32.9 tt0 -63.11 -43.26 98.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.56 0.219 . . . . 0.0 110.905 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -67.37 -32.87 74.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.26 -35.71 81.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.236 0.541 . . . . 0.0 109.607 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.584 HD21 ' CB ' ' A' ' 11' ' ' LEU . 73.8 mt -74.59 -19.41 60.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.34 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -53.03 -37.24 61.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.987 0.422 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.08 -19.89 31.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.439 0.638 . . . . 0.0 110.706 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 12' ' ' LYS . 2.7 t-20 -80.01 -9.8 59.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.268 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.33 -20.89 63.72 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.912 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 t -100.72 21.19 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.631 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -105.51 130.76 53.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -118.76 159.56 23.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -94.63 28.82 2.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.268 0.556 . . . . 0.0 110.112 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.358 172.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 9.9 mptt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.24 -29.73 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 175.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -60.79 -41.95 96.6 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.869 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.693 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 72.5 t80 -66.44 -42.85 87.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.147 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.98 -47.21 81.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.459 HG12 HD11 ' A' ' 26' ' ' ILE . 54.2 mt -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 HD22 HD23 ' A' ' 40' ' ' LEU . 82.9 mt -56.01 -46.83 78.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.29 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -68.69 -42.45 77.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.64 ' HG3' HG13 ' A' ' 26' ' ' ILE . 9.1 mm-40 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.016 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 19' ' ' THR . 73.0 mt -65.33 -42.31 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 110.115 173.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.94 -50.1 57.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.402 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.1 -33.28 63.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.023 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.17 -31.28 14.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.249 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 71.99 19.12 4.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.167 0.587 . . . . 0.0 110.614 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.78 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 14.2 p 56.16 169.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.075 0.95 . . . . 0.0 113.156 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.78 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 79.6 Cg_endo -90.77 156.54 27.8 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 124.715 -0.952 . . . . 0.0 112.276 -1.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.685 HD11 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -149.35 131.46 15.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.118 0.485 . . . . 0.0 110.527 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -85.26 170.32 12.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.987 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.83 -36.71 77.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.765 0.284 . . . . 0.0 111.765 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -68.47 -25.92 65.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.32 -48.78 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.003 0.43 . . . . 0.0 110.509 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HB ' HD11 ' A' ' 21' ' ' LEU . 9.4 tt -76.56 -34.4 24.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.607 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.25 28.18 3.4 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.245 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 34.5 m -126.92 172.14 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 p -85.16 163.8 18.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.862 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 24.5 mt-10 -55.8 -42.5 75.71 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.61 -62.08 1.62 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.56 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.77 -47.56 80.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.639 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.5 t80 -63.63 -52.1 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.71 -45.77 85.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -62.25 -39.92 94.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -50.53 72.04 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.803 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 33' ' ' PHE . 97.7 t -58.18 -41.77 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.703 0.287 . . . . 0.0 110.956 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -62.53 -45.48 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -64.68 -41.0 96.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.709 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.468 HD23 HD22 ' A' ' 11' ' ' LEU . 84.1 mt -63.81 -46.08 86.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.204 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.55 -26.65 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -56.57 -53.67 54.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 26.1 mt-10 -89.6 -8.4 52.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.11 53.76 2.9 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.936 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HD2' ' HA2' ' A' ' 69' ' ' GLY . 73.4 m-85 -85.42 -38.37 18.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.767 0.317 . . . . 0.0 110.681 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -131.92 149.91 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 176.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 64' ' ' GLU . 18.2 pt -126.9 167.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.12 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 9.99 65.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.67 124.96 38.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -98.21 137.98 36.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.789 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.9 m -77.23 -75.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -115.69 -21.83 9.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.328 172.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -173.96 -29.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.768 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -86.86 140.52 33.12 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.431 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 2.6 Cg_endo -81.89 146.48 14.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.486 2.791 . . . . 0.0 112.275 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -125.87 116.29 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.484 HD23 ' HG3' ' A' ' 63' ' ' PRO . 78.0 mt -89.0 120.6 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.923 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -100.64 -174.36 2.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.768 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 97.0 mttt -69.89 -26.3 64.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.417 0.627 . . . . 0.0 110.394 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.72 101.43 5.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.055 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.42 -79.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.777 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.484 ' HG3' HD23 ' A' ' 58' ' ' LEU . 73.9 Cg_endo -76.87 120.39 5.46 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 114.198 -172.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HB2' HG13 ' A' ' 47' ' ' ILE . 37.4 mt-10 -100.18 142.23 31.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.074 172.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -95.26 134.52 37.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.731 0.301 . . . . 0.0 110.361 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.0 p -93.26 178.43 5.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.351 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.9 -40.31 80.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.014 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.75 -41.0 90.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.88 -41.72 27.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.407 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -65.78 -34.6 78.54 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.979 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.72 -36.06 67.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 0.0 110.942 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.62 -26.35 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.261 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.693 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 97.0 mt -59.92 -41.8 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.721 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -70.15 -43.08 71.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.02 -44.12 73.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.829 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.14 5.06 43.15 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.125 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 -9.75 29.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.635 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -82.01 -2.87 53.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 110.82 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -70.53 158.08 36.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.076 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 82' ' ' ALA . 60.3 p 62.35 168.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 111.303 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 71.82 -33.06 0.26 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.287 0.635 . . . . 0.0 112.601 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 80' ' ' SER . . . . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -172.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.831 ' HG3' HD22 ' A' ' 6' ' ' LEU . 43.3 pttt . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.831 HD22 ' HG3' ' A' ' 5' ' ' LYS . 3.6 mm? -100.22 5.11 44.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.658 0.266 . . . . 0.0 110.662 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.584 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.18 -50.7 11.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.659 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 64.6 t80 -62.15 -46.07 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.959 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.593 ' HB3' ' CZ2' ' A' ' 79' ' ' TRP . . . -61.67 -46.42 89.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.332 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.3 mt -55.99 -46.64 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 98.5 mt -56.45 -50.19 72.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.508 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -77.68 -30.32 51.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.836 -175.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 5.7 mm-40 -73.61 -22.31 60.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.089 0.471 . . . . 0.0 110.074 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 10' ' ' ILE . 58.9 mt -76.41 -50.38 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 170.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -56.12 -41.6 75.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.586 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -97.01 -26.27 15.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.721 0.296 . . . . 0.0 111.694 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -83.49 -16.0 69.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.383 -174.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.3 t30 76.67 -13.52 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.014 0.526 . . . . 0.0 111.546 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 27.5 p 58.93 156.98 0.09 OUTLIER Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.504 1.122 . . . . 0.0 112.648 -174.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.677 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 4.4 Cg_exo -75.55 161.85 93.64 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.946 -1.273 . . . . 0.0 111.935 1.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' H ' HD22 ' A' ' 21' ' ' LEU . 2.4 pt? -124.7 119.96 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -72.18 156.09 39.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.315 0.579 . . . . 0.0 111.042 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.549 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -71.17 -40.76 71.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.662 -175.159 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.55 -45.54 15.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.301 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.55 -36.79 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 33.7 1.52 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.397 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.475 ' CG1' ' HG ' ' A' ' 6' ' ' LEU . 30.6 m -139.01 174.37 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.843 0.322 . . . . 0.0 110.182 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -85.32 154.26 22.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 0.0 110.343 171.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.515 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -68.39 -28.55 67.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.131 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.76 -42.62 85.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.197 0.522 . . . . 0.0 110.58 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' HB2' HG22 ' A' ' 29' ' ' THR . 1.5 mp0 -79.78 -21.19 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.381 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' O ' HG21 ' A' ' 37' ' ' VAL . 84.9 t80 -65.82 -55.97 14.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.063 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.506 ' HB2' ' HG2' ' A' ' 56' ' ' PRO . 1.5 p30 -68.47 -33.86 74.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.283 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.64 -50.52 73.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -60.83 -44.91 96.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.226 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 33' ' ' PHE . 93.0 t -57.05 -40.88 75.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.933 0.396 . . . . 0.0 110.903 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -68.37 -38.62 81.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.171 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -66.83 -40.17 87.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.4 mt -60.87 -38.22 84.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.011 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -70.66 -37.49 73.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.101 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -57.03 -53.12 61.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.08 -34.44 71.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.193 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.22 46.25 1.6 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.571 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -94.45 -35.99 12.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 65' ' ' LEU . 2.1 pp -137.94 154.93 29.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.73 163.37 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.729 177.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.82 28.15 14.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.784 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 56' ' ' PRO . 87.1 t -71.46 117.42 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -96.57 121.98 38.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 121.55 41.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -69.13 -65.73 0.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.163 0.506 . . . . 0.0 110.157 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.71 -20.68 5.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.05 -34.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.101 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -103.21 142.19 24.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.851 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 26.7 Cg_endo -65.47 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.452 2.102 . . . . 0.0 110.799 170.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -105.74 -35.82 7.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.5 mt 69.5 128.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.862 0.726 . . . . 0.0 110.763 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.677 ' HA ' ' HG3' ' A' ' 20' ' ' PRO . 31.6 m-85 -122.06 -175.55 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.605 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 44.5 mtmt -70.02 -5.14 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 tp -160.29 119.07 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.03 -67.99 0.19 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.221 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG3' HD22 ' A' ' 58' ' ' LEU . 57.7 Cg_endo -71.24 137.8 31.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.364 2.043 . . . . 0.0 113.459 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -130.29 166.11 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.584 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.428 ' HA ' HG23 ' A' ' 46' ' ' ILE . 7.8 mp -97.75 145.18 26.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.919 0.39 . . . . 0.0 110.461 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.3 p -80.06 169.56 17.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.01 -38.36 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.94 0.4 . . . . 0.0 110.014 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -69.21 -45.64 69.37 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.989 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.22 97.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.27 -40.49 90.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.221 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.071 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.58 -28.61 69.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 87.3 mt -58.23 -34.48 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.34 175.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -68.44 -45.56 72.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.151 0.5 . . . . 0.0 110.051 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -64.78 -48.88 72.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.988 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.541 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -91.71 5.28 50.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.696 -175.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.79 -2.34 1.16 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 114.901 0.721 . . . . 0.0 114.901 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -90.54 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 171.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.593 ' CZ2' ' HB3' ' A' ' 9' ' ' ALA . 69.6 t-105 67.11 166.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 165.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -147.0 121.39 9.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.961 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -71.48 152.84 42.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.962 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.449 . . . . 0.0 111.443 -176.715 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 CA--C 1.527 0.093 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.788 HH11 ' HA ' ' A' ' 36' ' ' ALA . 33.9 mmt180 -67.42 -56.07 11.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -62.57 -40.79 97.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.751 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.96 87.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.326 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.27 -39.17 72.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.784 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.633 ' HG ' HD13 ' A' ' 40' ' ' LEU . 8.0 mt -56.28 -45.02 80.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 6.8 ttpp -62.56 -39.59 94.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HG2' HG12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -64.61 -37.18 86.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.359 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.08 -44.13 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.278 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.35 -50.51 73.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.318 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.83 -18.99 19.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.482 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.17 -27.12 66.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.332 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.2 -1.78 2.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.212 0.605 . . . . 0.0 111.449 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 62.0 p 59.55 153.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.664 1.186 . . . . 0.0 113.33 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.626 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 2.0 Cg_endo -81.74 167.12 70.87 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.983 -1.257 . . . . 0.0 112.387 0.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 13' ' ' GLU . 1.7 pt? -140.78 149.05 41.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 25' ' ' ASP . 30.3 t -85.2 167.26 15.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.65 0.738 . . . . 0.0 110.938 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -80.63 -48.21 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.545 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -66.6 -27.88 68.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.585 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 11.1 t70 -72.73 -40.63 65.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.564 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -74.29 -32.91 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.24 20.37 2.22 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.721 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.66 175.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 117.243 0.522 . . . . 0.0 110.786 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.6 p -85.32 172.5 11.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.693 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 mt-10 -58.27 -53.2 60.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 110.403 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.78 -29.97 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.113 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.2 -46.74 66.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.347 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 67.9 t80 -62.87 -45.35 92.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.772 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 55' ' ' ARG . 6.3 t70 -54.75 -53.86 49.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.664 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.9 -40.23 92.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.62 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.788 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -61.06 -52.22 65.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.08 -44.73 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.993 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.45 -45.0 95.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.239 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.34 -46.78 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.633 HD13 ' HG ' ' A' ' 11' ' ' LEU . 90.7 mt -63.74 -34.84 78.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 56.7 tttm -67.31 -41.55 85.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.776 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -67.29 -47.38 70.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.071 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.62 -22.95 58.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.06 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 46.83 1.92 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.062 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.638 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 86.3 m-85 -98.66 -36.29 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 110.356 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.0 pp -142.36 155.6 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 34.8 pt -131.82 170.82 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.908 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 14.32 50.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.8 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.604 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 96.7 t -78.41 114.14 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.033 0.444 . . . . 0.0 110.31 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -109.64 131.62 54.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.621 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.502 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.524 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 10.2 mtp180 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 25.2 Cg_endo -62.48 134.48 48.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.644 2.229 . . . . 0.0 112.393 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -126.82 132.41 51.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.124 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -97.64 138.67 34.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.428 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -110.37 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.578 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.626 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 54.0 mttp -83.59 -5.37 59.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.389 0.614 . . . . 0.0 110.326 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -156.79 120.86 4.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . . . 157.36 -57.02 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.896 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG3' HD22 ' A' ' 58' ' ' LEU . 30.5 Cg_exo -62.3 106.36 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.62 2.213 . . . . 0.0 112.55 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 4.3 mm-40 -110.55 140.07 45.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 46' ' ' ILE . 6.3 mp -88.66 144.22 26.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.896 0.379 . . . . 0.0 110.458 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 p -87.21 171.38 10.7 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.46 -38.3 90.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -63.0 -44.53 95.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.643 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.19 -42.72 94.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.704 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.03 -46.57 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.23 -34.52 77.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.674 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.57 -37.68 87.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.558 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 11' ' ' LEU . 82.8 mt -63.4 -33.46 75.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.578 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.491 -177.552 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' ILE . 3.6 mm? . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 121.471 0.653 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.761 ' NH1' ' HA ' ' A' ' 36' ' ' ALA . 4.9 tpp180 -57.57 -37.17 72.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.112 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -69.73 -44.47 70.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.011 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -37.77 76.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.645 HD13 HG13 ' A' ' 26' ' ' ILE . 35.2 mm -65.17 -51.63 63.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 110.098 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.18 -40.61 90.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.093 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -68.32 -28.32 67.05 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.307 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.56 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -81.04 -26.41 36.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.118 0.485 . . . . 0.0 110.193 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.45 -26.99 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.754 0.788 . . . . 0.0 109.471 171.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.92 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -100.41 -40.53 7.43 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.43 55.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.724 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 19' ' ' THR . 32.5 t-20 70.25 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER 173.01 164.84 0.27 Allowed Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 124.18 0.992 . . . . 0.0 108.805 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 19' ' ' THR . 64.7 Cg_endo -90.07 175.21 21.27 Favored 'Cis proline' 0 N--CA 1.462 -0.378 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.823 -3.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.11 137.18 28.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -85.27 170.26 12.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.438 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 6.8 pm0 -59.4 -37.16 77.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.055 0.455 . . . . 0.0 110.797 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 49.6 t30 -65.18 -30.94 71.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.047 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.35 -49.76 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.645 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.62 -35.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.105 -176.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.86 30.85 2.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.273 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 32.1 m -130.6 169.17 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 32' ' ' GLN . 23.6 p -85.16 169.32 13.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.785 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 2.4 mt-10 -48.65 -52.58 22.48 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.787 0.68 . . . . 0.0 110.832 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.43 -37.44 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.844 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 8.5 mm100 -79.02 -32.85 45.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -72.24 -36.39 69.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.511 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.89 -46.41 90.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.596 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -52.11 -49.65 63.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.514 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . . . -59.69 -58.52 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.819 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.51 -47.09 94.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.588 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.55 -39.32 93.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.61 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.619 ' HD2' ' HD2' ' A' ' 7' ' ' ARG . 77.1 t80 -67.22 -41.04 86.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.322 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.1 mt -64.44 -44.77 90.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -70.53 -37.25 74.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.889 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -58.89 -55.97 28.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 73.4 mm-40 -82.78 -3.22 56.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.62 -174.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.75 44.84 9.9 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.106 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 68.5 m-85 -79.28 -34.14 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.183 0.516 . . . . 0.0 109.743 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 49' ' ' VAL . 1.8 pp -140.1 157.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.473 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 46.1 pt -132.26 165.65 31.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.48 -1.95 73.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.915 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.422 HG21 HD13 ' A' ' 46' ' ' ILE . 57.4 t -76.67 126.96 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.802 0.334 . . . . 0.0 110.53 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -98.56 147.2 25.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.457 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 56' ' ' PRO . 19.1 m-85 . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 13.3 ttm180 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 28.9 Cg_exo -61.19 147.77 94.71 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.448 2.098 . . . . 0.0 111.073 169.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -118.8 115.61 24.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.402 0.62 . . . . 0.0 111.389 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.39 144.98 26.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.346 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.97 168.99 18.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' THR . 29.8 mtpp -55.98 -56.43 20.83 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.724 0.64 . . . . 0.0 112.232 -168.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.06 90.14 3.21 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.936 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.1 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.021 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 Cg_exo -66.07 109.07 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.146 2.564 . . . . 0.0 113.316 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -108.44 155.79 20.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.164 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.56 148.21 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.065 0.459 . . . . 0.0 111.051 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.0 p -104.55 -179.81 4.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.088 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -54.32 -43.91 71.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.079 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -57.12 -51.36 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -38.67 93.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.269 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.53 -46.93 87.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -61.53 -41.24 97.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.02 -40.18 92.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.97 -42.83 90.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.179 0.514 . . . . 0.0 110.484 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.92 -178.495 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 36' ' ' ALA . 59.1 mmt-85 -54.3 -33.31 58.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.179 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.1 -54.25 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.901 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.03 -48.57 75.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -62.07 -43.77 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD21 ' A' ' 73' ' ' LEU . 12.1 tp -65.64 -35.48 80.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.2 ttpp -70.84 -39.95 72.66 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 9.4 mm-40 -62.26 -39.79 94.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.457 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -32.17 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.383 0.611 . . . . 0.0 110.135 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -75.43 -40.13 58.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 8.9 mt-10 -80.85 -40.31 25.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.34 50.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.919 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 19' ' ' THR . 13.8 t-20 68.89 -90.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.453 0.701 . . . . 0.0 109.52 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER 177.19 159.33 0.5 Allowed Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.998 0.919 . . . . 0.0 109.345 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.826 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 Cg_endo -82.09 167.78 67.79 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.321 -1.116 . . . . 0.0 112.199 0.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -150.17 129.51 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.18 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.99 -38.26 72.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.504 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -68.91 -35.8 77.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.947 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.72 -45.21 87.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.187 0.518 . . . . 0.0 110.629 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 28' ' ' VAL . 14.9 tt -79.56 -24.72 12.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.936 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.47 11.99 52.39 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.533 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 26' ' ' ILE . 26.3 m -123.15 167.22 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.979 0.389 . . . . 0.0 110.455 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -78.68 166.7 22.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.819 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 19.9 mt-10 -57.99 -40.59 81.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.97 -48.62 77.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.732 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.7 -35.12 67.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.29 -47.65 81.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.81 -53.52 57.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.644 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.44 -53.36 52.49 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.239 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . . . -67.1 -53.53 29.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.291 -174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.18 -40.16 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.78 -39.64 94.74 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.83 0.348 . . . . 0.0 110.513 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -65.89 -46.62 77.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 46' ' ' ILE . 68.5 mt -59.58 -42.06 91.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.227 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -66.58 -36.58 82.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -66.79 -43.01 85.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.033 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -78.26 -20.82 50.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.647 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.01 38.7 5.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.29 -30.65 20.72 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.63 -0.336 . . . . 0.0 111.038 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -140.82 159.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.05 158.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.97 29.04 19.2 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.202 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.53 109.91 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -91.03 130.94 36.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.979 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.363 175.212 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.63 122.56 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.8 2.333 . . . . 0.0 112.176 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -137.25 105.91 5.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB3' HG21 ' A' ' 19' ' ' THR . 70.9 mt -79.74 122.96 27.23 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.031 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.826 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 75.5 m-85 -107.1 -173.41 2.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -57.07 -52.39 65.47 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.52 0.512 . . . . 0.0 112.001 -171.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.62 135.27 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.755 0.312 . . . . 0.0 110.632 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.48 -70.77 0.5 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.519 ' HG2' HG21 ' A' ' 19' ' ' THR . 25.6 Cg_exo -63.9 119.63 6.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.304 2.669 . . . . 0.0 113.439 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.09 156.26 48.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.809 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.432 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.4 mp -95.03 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -93.13 169.9 10.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -24.68 64.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -59.3 -47.01 87.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.91 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.38 -34.39 50.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.909 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.41 -43.6 93.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.33 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 3.0 m120 -70.05 -30.3 67.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -62.75 -36.56 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.784 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.517 HD21 HD23 ' A' ' 11' ' ' LEU . 82.8 mt -62.9 -19.75 64.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.094 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 47.5 tttp . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.622 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.237 0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HB3' HD21 ' A' ' 40' ' ' LEU . 22.6 mmt180 -67.24 -34.89 78.41 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.73 -41.02 80.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.153 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -61.53 -35.11 76.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.454 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 19.6 mt -73.99 -30.34 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.438 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.22 -36.16 82.32 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.455 -0.778 . . . . 0.0 109.322 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 13.3 tmtt? -61.93 -52.67 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 10' ' ' ILE . 12.8 pt-20 -60.4 -39.08 86.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.029 0.442 . . . . 0.0 111.411 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.462 HG13 ' HG3' ' A' ' 13' ' ' GLU . 88.6 mt -74.38 -43.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.67 -46.2 89.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.442 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 10.4 pt-20 -92.83 -26.5 17.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.398 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -74.46 -24.29 73.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.116 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 29.3 t-20 76.66 -20.2 0.38 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 111.755 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.809 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 70.9 p 61.95 163.41 0.11 Allowed Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 124.413 1.085 . . . . 0.0 112.67 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.809 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 72.1 Cg_endo -79.51 150.68 84.61 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.522 -2.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -132.63 145.74 51.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.4 m -85.82 165.24 17.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.819 0.342 . . . . 0.0 110.585 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -62.72 -28.43 69.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.986 178.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -70.81 -10.12 58.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.781 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.28 -50.02 7.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.715 0.293 . . . . 0.0 110.509 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -78.89 -38.52 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.432 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.78 -13.41 10.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.678 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.555 ' H ' HG23 ' A' ' 26' ' ' ILE . 27.2 m -86.22 157.21 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 117.426 0.613 . . . . 0.0 110.197 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 t -85.13 162.21 19.34 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.571 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 10.0 mt-10 -51.04 -50.48 58.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.18 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.09 -41.65 71.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.084 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -79.66 -32.16 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 111.046 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.1 t80 -67.41 -52.85 34.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.22 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' OD2' ' HD2' ' A' ' 56' ' ' PRO . 0.9 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 178.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.95 -42.29 75.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.49 ' CB ' HD12 ' A' ' 10' ' ' ILE . . . -64.51 -50.85 65.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 33' ' ' PHE . 65.8 t -58.41 -44.47 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.691 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 95.5 m-20 -61.33 -48.78 79.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -56.02 -45.65 79.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 7' ' ' ARG . 89.9 mt -65.98 -40.08 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.256 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 41' ' ' LYS . 0.7 OUTLIER -69.57 -31.34 69.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.153 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 99.6 mtt180 -61.76 -58.55 7.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.75 -24.24 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.349 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.93 52.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.716 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 81.8 m-85 -93.5 -34.76 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.064 0.459 . . . . 0.0 110.081 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 pp -137.38 148.49 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.476 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -132.93 176.76 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.009 178.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 86.37 5.18 82.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.475 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.22 135.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -106.79 119.98 40.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 121.02 0.438 . . . . 0.0 111.276 -178.415 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.571 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 74.1 mtp180 . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.689 0.28 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 58.4 Cg_endo -72.45 139.91 32.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.939 2.426 . . . . 0.0 111.726 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -129.25 145.58 51.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 93.7 mt -104.19 145.59 29.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.928 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -130.3 174.35 9.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.818 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.08 -40.38 75.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.38 0.61 . . . . 0.0 109.783 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tt -106.74 105.26 15.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.146 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.495 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 170.68 -70.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.167 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.09 109.56 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.009 2.473 . . . . 0.0 113.454 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.49 148.85 43.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.678 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.7 133.43 43.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.6 p -79.96 178.82 7.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.65 -39.9 91.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.36 -44.16 92.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.01 -36.0 64.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.287 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.97 -45.23 93.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.831 0.348 . . . . 0.0 110.666 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.28 -31.24 70.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 110.56 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.54 -34.38 76.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 96.0 mt -58.62 -43.01 89.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.229 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 tttm . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.55 -177.443 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 10' ' ' ILE . 4.3 mm? . . . . . 0 CA--C 1.521 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.622 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 18.6 mtm180 -65.62 -21.8 66.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.922 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 77.2 t80 -70.17 -46.47 64.59 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.979 172.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.56 76.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.831 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 7' ' ' ARG . 69.6 mt -58.07 -51.99 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.555 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD21 HD22 ' A' ' 40' ' ' LEU . 96.4 mt -58.4 -45.8 87.64 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.165 0.507 . . . . 0.0 110.835 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 26.3 ttpp -62.16 -48.67 79.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.175 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -31.02 71.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.0 mt -68.58 -43.47 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 110.589 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -75.3 -50.25 16.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.324 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.6 -40.16 66.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.819 0.342 . . . . 0.0 110.885 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 -27.45 70.06 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.502 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.5 t30 65.93 26.05 11.03 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.089 0.556 . . . . 0.0 110.916 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.703 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 46.1 p 56.84 163.27 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.434 1.094 . . . . 0.0 113.134 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 71.5 Cg_endo -76.3 174.39 53.16 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 124.091 -1.212 . . . . 0.0 112.659 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.826 HD21 HD12 ' A' ' 26' ' ' ILE . 58.2 tp -152.88 118.76 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 18.2 m -86.75 170.68 11.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.93 -30.82 68.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 177.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -75.31 -39.91 59.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 8.9 p-10 -85.65 -1.46 57.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.826 HD12 HD21 ' A' ' 21' ' ' LEU . 11.1 tt -99.95 -37.45 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.734 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.5 -34.38 3.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.698 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.88 122.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -67.89 173.24 4.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 23' ' ' GLU . 4.4 mt-10 -48.96 -51.32 31.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.766 -171.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.55 -57.89 8.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.834 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.48 -32.14 69.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 37' ' ' VAL . 80.0 t80 -65.63 -51.81 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.47 -46.14 89.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.725 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.19 -45.93 89.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.251 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 7' ' ' ARG . . . -60.68 -55.57 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.452 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 33' ' ' PHE . 88.2 t -58.23 -44.13 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.646 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.384 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.46 -38.61 65.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 46' ' ' ILE . 67.8 mt -59.86 -43.93 94.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.088 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.95 -45.35 89.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -57.21 -49.2 76.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.26 -0.16 35.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.287 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.94 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.112 -0.566 . . . . 0.0 113.557 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.57 -43.62 12.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 117.028 0.414 . . . . 0.0 110.773 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.546 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.57 151.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.423 . . . . 0.0 111.126 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.53 166.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.486 176.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.06 65.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.196 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -72.63 117.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.4 110.05 21.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.232 178.87 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.73 117.06 4.94 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.498 2.132 . . . . 0.0 112.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -102.06 105.13 15.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -84.1 92.02 7.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.198 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -82.92 176.91 8.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.598 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 35.5 pttt -74.4 -0.59 17.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.74 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.75 129.53 17.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.73 -71.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.653 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HG2' HG21 ' A' ' 19' ' ' THR . 30.6 Cg_endo -63.71 118.4 5.34 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.67 2.247 . . . . 0.0 113.284 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.03 150.41 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.872 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.6 mp -93.65 144.44 25.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 p -92.8 170.72 9.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.585 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.14 -35.19 71.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -58.92 -50.6 73.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.116 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.44 -35.71 46.58 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.326 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 73' ' ' LEU . 2.7 tm-20 -61.33 -35.2 76.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.439 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -75.07 -34.96 61.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.053 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.51 -32.5 73.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.283 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.922 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.83 -38.25 75.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.816 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.7 mttp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.957 -178.127 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 10' ' ' ILE . 4.2 mm? . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.551 0.215 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.714 ' NH2' ' HA ' ' A' ' 36' ' ' ALA . 11.3 ptm180 -64.69 -16.5 62.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.755 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -77.47 -44.57 28.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.99 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.7 63.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.838 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 7' ' ' ARG . 52.6 mt -50.55 -37.83 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.578 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.5 mt -57.59 -34.06 68.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 36.7 ttpt -74.23 -48.06 31.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -38.1 75.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 110.724 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 21' ' ' LEU . 70.6 mt -66.85 -45.64 87.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.454 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.8 -48.31 77.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.787 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 28.7 mt-10 -65.11 -39.2 92.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.908 0.385 . . . . 0.0 110.758 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.95 -27.17 51.14 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.42 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 t30 63.77 26.21 14.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.956 0.503 . . . . 0.0 110.11 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.737 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 32.2 p 55.09 166.65 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.346 1.058 . . . . 0.0 112.917 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.737 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.8 Cg_endo -87.3 157.31 47.28 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.433 -3.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.53 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -153.08 129.19 10.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -85.11 170.11 13.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -55.43 -38.13 68.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 178.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.52 -38.61 90.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.587 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.6 -39.6 67.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.797 0.332 . . . . 0.0 111.047 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.53 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.5 tt -82.79 -32.05 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.305 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.44 34.86 2.38 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.248 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 26' ' ' ILE . 30.9 m -130.29 169.93 20.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -85.34 167.67 15.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.082 0.468 . . . . 0.0 111.322 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 1.5 mp0 -51.7 -60.32 3.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.046 0.927 . . . . 0.0 111.189 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.4 -19.99 59.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.9 -169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.53 -36.79 37.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.998 0.428 . . . . 0.0 110.068 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 63.8 t80 -65.28 -44.82 86.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.881 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.68 -49.4 77.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.43 -40.56 74.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HA ' ' NH2' ' A' ' 7' ' ' ARG . . . -61.79 -57.43 11.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.399 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PHE . 69.3 t -57.48 -47.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.359 0.412 . . . . 0.0 111.734 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.05 -38.99 84.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB3' HH21 ' A' ' 7' ' ' ARG . 33.1 t80 -71.85 -41.62 67.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.821 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -67.29 -38.21 84.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.84 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 41' ' ' LYS . 11.6 tmtt? -69.74 -38.26 76.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HD3' HH11 ' A' ' 42' ' ' ARG . 8.0 ttm180 -56.82 -60.5 3.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.432 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -30.43 65.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.381 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.35 56.8 0.57 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.332 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.72 -26.01 13.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.733 0.301 . . . . 0.0 110.406 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 65' ' ' LEU . 1.6 pp -142.65 142.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.851 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.25 164.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.57 22.29 40.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.672 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.22 134.72 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -89.15 109.71 20.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.505 . . . . 0.0 110.19 175.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 17.6 mtp180 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 34.3 Cg_endo -66.14 138.34 51.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.629 2.219 . . . . 0.0 112.121 175.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -132.94 148.32 52.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.09 121.62 45.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.362 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.06 -166.44 1.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.771 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 27.2 mtpp -61.81 -51.61 67.59 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.607 0.567 . . . . 0.0 111.432 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.81 133.93 55.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.125 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.46 -69.74 0.37 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.13 107.67 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.889 2.393 . . . . 0.0 112.999 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 47' ' ' ILE . 67.2 mm-40 -115.81 139.97 49.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.227 175.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -75.59 144.17 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -83.46 168.57 16.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.742 0.306 . . . . 0.0 110.48 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.42 -34.68 77.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 23.8 ttmm -60.34 -47.65 85.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.853 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -64.93 -37.7 94.6 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.06 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -58.28 -53.44 58.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.429 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.33 -29.01 65.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 6.2 t80 -66.85 -30.18 70.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 11' ' ' LEU . 21.2 mt -75.65 -19.05 59.44 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.437 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 111.809 -177.528 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.43 0.157 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 40' ' ' LEU . 7.7 ptp180 -60.89 -45.75 93.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.108 -174.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.46 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -60.98 -42.37 98.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.415 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.75 68.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.18 -40.91 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.673 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 84.3 mt -58.09 -51.27 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.648 0.261 . . . . 0.0 110.938 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 5.6 ttpm? -67.34 -41.86 84.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.773 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -29.49 69.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 19' ' ' THR . 53.5 mt -73.46 -47.21 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.96 -47.0 87.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.29 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.21 -33.84 49.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.71 -22.51 57.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.105 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.42 1.46 3.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 0.0 111.237 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.1 p 55.48 164.42 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.263 1.025 . . . . 0.0 113.293 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 73.5 Cg_endo -90.32 118.35 3.41 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.182 -1.174 . . . . 0.0 111.969 -1.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.7 pt? -90.22 134.77 34.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.761 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -80.75 164.84 22.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.164 0.507 . . . . 0.0 110.948 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -51.0 64.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.011 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.27 -14.6 62.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.331 0.586 . . . . 0.0 110.525 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.45 -39.36 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.608 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.505 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.2 tt -76.97 -35.11 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.1 -31.05 3.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.001 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.06 152.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.887 -0.184 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.2 t -68.51 173.31 5.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.368 0.604 . . . . 0.0 110.524 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.37 -41.26 98.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.472 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.92 -40.5 95.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.274 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -73.99 -39.83 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 110.641 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.24 -49.03 78.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.669 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -62.17 -46.33 89.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.279 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.04 -50.56 70.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.445 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.85 72.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.822 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.47 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.557 0.218 . . . . 0.0 111.483 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -65.26 -35.69 81.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.93 -43.4 75.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.2 mt -63.22 -34.23 77.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.053 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -35.09 77.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -67.24 -42.91 83.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.35 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.168 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.75 39.77 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.19 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.05 -30.73 18.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 0.0 110.217 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.8 pp -142.45 152.02 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.46 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 pt -134.84 177.46 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.867 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.33 16.71 79.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.82 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.05 113.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.231 0.538 . . . . 0.0 109.57 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -80.34 113.09 18.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.794 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 79.5 m-85 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.611 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.474 0.178 . . . . 0.0 110.739 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 38.8 Cg_endo -69.93 143.43 50.0 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.312 2.008 . . . . 0.0 111.022 170.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 49.5 m-70 -104.03 -44.46 5.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 79.8 mt 68.2 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.438 0.637 . . . . 0.0 110.641 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -141.19 173.25 11.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 87.7 mttt -75.1 1.74 12.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.57 41.84 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.3 -86.55 1.59 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.153 -0.931 . . . . 0.0 114.019 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.47 159.34 14.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.028 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.55 139.99 51.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.585 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.0 mp -91.43 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.784 0.326 . . . . 0.0 110.729 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.8 p -88.44 170.7 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.28 -24.32 67.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.189 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -50.29 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.89 -42.25 53.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.077 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.03 -44.42 96.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.338 . . . . 0.0 110.473 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.419 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 3.2 m120 -72.87 -20.04 61.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.882 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -75.86 -28.82 58.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 83.1 mt -70.95 -22.65 62.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 70.6 mmtt . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 6' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -64.64 -42.94 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -59.72 -43.4 94.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.948 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.12 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.377 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.72 -43.54 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.71 -52.45 64.92 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -71.13 -22.77 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.026 -176.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 1.9 tp10 -80.13 -23.71 40.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.248 0.547 . . . . 0.0 109.883 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.02 -47.12 49.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.85 -50.02 75.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.66 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -99.62 -6.15 27.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -90.09 -12.44 61.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.449 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.9 t30 75.38 -17.24 0.52 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.005 0.522 . . . . 0.0 111.435 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.0 p 58.62 156.92 0.09 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.563 1.145 . . . . 0.0 113.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.5 Cg_endo -83.72 176.31 33.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.798 -1.334 . . . . 0.0 113.136 0.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.4 pt? -150.58 133.5 15.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 m -85.28 170.43 12.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.97 -37.93 77.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.093 175.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.42 -16.79 64.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.589 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.04 -49.98 7.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 110.821 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.7 -38.61 58.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.93 22.17 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.189 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 26' ' ' ILE . 33.9 m -127.38 173.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 t -85.01 157.97 20.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 110.928 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.7 pm0 -63.29 -30.24 71.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.046 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -48.3 79.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.422 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 9.7 mm100 -82.44 -19.95 37.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.962 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.81 -55.58 16.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.05 -47.97 76.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.222 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.602 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 8.7 t70 -52.34 -49.04 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.315 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -68.06 -51.45 46.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.288 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.01 -42.32 85.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 111.237 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 95.4 m-20 -65.55 -41.48 92.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.526 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.21 -42.94 96.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.39 . . . . 0.0 110.596 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -59.41 -44.74 92.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.2 ttpm? -70.92 -34.62 71.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.369 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 15.4 ttt-85 -66.37 -40.49 89.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.609 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.7 -40.1 61.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.817 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.05 2.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.805 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.526 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 60.2 m-85 -78.3 -41.32 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.571 0.224 . . . . 0.0 111.415 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.535 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -139.94 161.83 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.0 110.961 -177.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -129.24 170.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.204 174.019 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 90.71 19.87 42.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.699 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.72 114.5 22.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -88.46 141.03 28.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.0 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 . . . . . 0 C--N 1.32 -0.687 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.719 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 120.537 0.208 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.3 134.7 23.3 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.577 2.184 . . . . 0.0 112.739 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -126.47 135.26 51.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.393 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -98.66 152.8 19.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.838 0.352 . . . . 0.0 110.604 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -134.71 -177.94 4.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.09 -29.45 64.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.965 0.412 . . . . 0.0 110.881 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -128.2 126.72 41.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 156.62 -64.82 0.31 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 58' ' ' LEU . 10.8 Cg_exo -70.45 100.69 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.738 2.292 . . . . 0.0 112.866 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -105.69 140.24 39.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.658 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.6 mp -90.96 140.04 30.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.674 0.273 . . . . 0.0 110.395 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.0 p -90.03 177.09 6.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -59.46 -33.11 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.673 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.19 -44.57 95.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.91 -41.83 21.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.714 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.66 -41.08 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.823 0.344 . . . . 0.0 110.975 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -79.12 -20.34 48.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.14 -33.58 76.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 12' ' ' LYS . 77.8 mt -61.02 -25.97 67.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.944 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 120.703 0.287 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.467 ' O ' HD13 ' A' ' 11' ' ' LEU . 98.7 mtt180 -69.52 -11.84 61.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -100.1 -46.03 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.67 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.54 81.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.86 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.99 -47.79 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 73' ' ' LEU . 10.5 mp -64.31 -32.67 74.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.948 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -65.14 -44.78 87.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.99 -41.0 97.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.61 -39.14 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.556 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' HD2' HD22 ' A' ' 65' ' ' LEU . 15.8 t80 -68.58 -50.12 54.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.86 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.22 -40.89 26.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.657 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.33 -18.55 58.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.5 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 62.31 24.32 14.47 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 110.497 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.7 p 54.98 171.96 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.987 0.915 . . . . 0.0 113.235 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.1 Cg_endo -85.06 179.7 21.99 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 123.809 -1.33 . . . . 0.0 112.074 -3.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -155.24 124.17 6.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -76.34 163.48 26.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.304 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.435 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.94 -16.48 60.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.75 -42.15 22.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 21' ' ' LEU . 4.2 tt -77.23 -38.71 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.3 35.89 0.98 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.293 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 26' ' ' ILE . 35.9 m -137.06 174.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -84.99 156.46 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.43 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 4.6 mt-10 -55.38 -40.83 71.84 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.65 -60.71 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.598 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.1 -32.42 69.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.947 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.9 t80 -65.08 -59.2 4.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.899 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 55' ' ' ARG . 5.8 m-20 -57.19 -43.89 83.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.714 0.292 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.41 -45.2 94.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.257 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.82 -48.06 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.46 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 33' ' ' PHE . 99.4 t -59.1 -42.32 86.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.245 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.43 -44.85 93.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.429 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.18 -42.52 99.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.797 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.1 mt -59.11 -42.89 91.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.448 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.509 ' HD3' ' HB ' ' A' ' 49' ' ' VAL . 29.8 ttpt -75.6 -38.31 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.359 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -39.93 94.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.439 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -4.33 56.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.227 0.537 . . . . 0.0 110.48 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 37.04 40.69 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.482 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -83.48 -47.45 11.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.281 0.54 . . . . 0.0 110.238 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -134.82 161.53 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 177.58 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 64' ' ' GLU . 25.6 pt -129.96 177.23 6.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.934 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.69 11.85 65.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.513 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' ' HD3' ' A' ' 41' ' ' LYS . 39.1 t -77.79 121.75 31.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -101.98 129.75 48.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.19 0.519 . . . . 0.0 111.586 -173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.789 177.205 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 11.2 ptm180 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -66.15 126.08 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.273 1.982 . . . . 0.0 112.059 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -116.91 130.69 56.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.404 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.02 140.27 35.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.611 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.04 178.13 7.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.535 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 68.6 mttm -79.77 -18.03 52.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.61 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.59 104.06 14.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.949 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.58 -67.71 0.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.613 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.15 119.01 3.15 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.534 2.822 . . . . 0.0 114.504 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 47' ' ' ILE . 41.9 mt-10 -130.92 142.41 50.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.032 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD22 ' HD2' ' A' ' 15' ' ' PHE . 6.3 mp -96.76 140.98 30.54 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.11 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 p -100.7 171.73 7.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.07 -33.02 73.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.359 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -60.99 -52.04 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.44 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.75 73.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.114 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.14 -45.5 91.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.738 0.304 . . . . 0.0 110.465 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -73.4 -20.27 60.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.465 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -70.05 -47.16 63.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 11' ' ' LEU . 96.2 mt -60.27 -32.44 71.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.002 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.713 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 mm? . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.4 ptt180 -51.09 -34.28 29.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 111.417 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.491 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 20.3 t80 -71.34 -43.49 66.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.147 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.57 60.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 7' ' ' ARG . 82.4 mt -59.38 -33.66 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.748 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -52.43 -40.97 62.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 24.9 ttpp -69.95 -44.37 69.68 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.071 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.56 -33.83 75.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.94 0.4 . . . . 0.0 110.504 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 19' ' ' THR . 82.4 mt -57.7 -46.48 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.988 172.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -67.28 -44.53 79.05 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.148 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 8.1 mm-40 -62.4 -40.53 96.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.431 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.11 -13.43 52.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.267 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.51 25.54 11.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.145 0.498 . . . . 0.0 110.176 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.534 HG23 HG23 ' A' ' 14' ' ' ILE . 20.6 p 57.76 154.14 0.08 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.428 1.091 . . . . 0.0 113.226 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -91.35 -165.96 2.41 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.693 -0.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.78 125.21 6.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.212 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -84.91 170.02 13.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 111.197 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.76 -41.08 96.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.372 -178.262 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.49 -24.74 65.62 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.454 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.4 -46.23 28.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.639 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.608 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -80.4 -38.74 18.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.459 -177.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.7 -14.8 12.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.673 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.608 ' H ' HG23 ' A' ' 26' ' ' ILE . 35.1 m -101.0 144.95 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.986 0.393 . . . . 0.0 111.127 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -66.53 161.47 22.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 177.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 7.2 mt-10 -58.81 -40.72 84.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.659 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.24 -34.7 78.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.0 -36.15 61.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.5 . . . . 0.0 109.914 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 49.4 t80 -65.6 -52.96 48.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.326 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' ' HD3' ' A' ' 56' ' ' PRO . 9.8 t70 -56.62 -47.59 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.332 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.58 -45.94 90.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 7' ' ' ARG . . . -66.74 -40.46 88.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.357 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' PHE . 59.5 t -61.76 -46.09 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.616 0.246 . . . . 0.0 110.712 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -63.72 -37.35 87.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.827 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -64.99 -48.55 73.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 0.0 110.121 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 7' ' ' ARG . 59.5 mt -60.98 -37.53 82.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -69.9 -31.5 69.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.27 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.91 -38.86 76.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.859 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 45' ' ' TYR . 48.1 mt-10 -79.93 -22.25 42.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.858 0.361 . . . . 0.0 110.793 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 45.51 4.5 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.438 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.456 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 57.0 m-85 -92.0 -34.04 14.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.105 0.453 . . . . 0.0 111.249 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.45 144.94 32.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.087 177.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 pp -129.98 165.3 30.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.338 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.05 60.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.486 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.93 122.81 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.02 110.15 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.04 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.422 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' OD1' ' A' ' 34' ' ' ASP . 71.6 Cg_endo -76.22 120.71 5.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.489 2.126 . . . . 0.0 112.447 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -109.06 112.72 25.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.27 141.18 31.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.007 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.5 -177.97 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.477 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -81.45 15.0 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.752 0.31 . . . . 0.0 110.782 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.4 tp -159.63 120.08 3.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.937 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.51 -71.09 0.41 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.028 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 14.6 Cg_exo -69.24 122.05 8.86 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.855 2.37 . . . . 0.0 113.308 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -125.36 152.38 44.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.019 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -88.09 137.72 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -83.19 173.67 11.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.19 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.42 -41.01 79.55 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -55.83 -54.81 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.748 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -66.55 -41.54 94.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.932 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -58.53 -46.87 85.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.57 -27.3 62.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -70.67 -24.92 62.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 80.4 mt -58.84 -19.28 40.04 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 74' ' ' LYS . 23.9 ttpt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' HG ' HG11 ' A' ' 28' ' ' VAL . 2.3 mm? . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.66 HH11 ' HA ' ' A' ' 36' ' ' ALA . 2.2 ttm-85 -70.58 -41.26 72.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -170.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 63.9 t80 -58.95 -41.66 87.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -58.9 -47.37 85.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 74.5 mt -63.47 -40.94 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.728 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 73' ' ' LEU . 23.7 mt -55.06 -50.17 69.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.722 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -72.38 -29.69 63.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.988 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 5.6 mm-40 -70.55 -29.8 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' ILE . 79.8 mt -69.89 -36.69 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.168 0.508 . . . . 0.0 109.876 173.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -78.33 -50.23 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.673 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -84.4 -38.63 20.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.945 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -20.08 75.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 t30 65.86 20.47 11.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.841 0.456 . . . . 0.0 110.777 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.641 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.7 p 55.96 165.41 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.858 0.863 . . . . 0.0 113.039 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 92.2 Cg_endo -79.56 171.03 65.61 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 124.056 -1.227 . . . . 0.0 112.32 0.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -134.55 118.69 17.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -86.1 169.04 13.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.367 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.79 -40.63 95.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -71.11 -19.14 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.399 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.36 -42.55 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.519 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -87.94 -36.04 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.609 -177.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.71 -17.6 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.272 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 28.7 m -89.53 161.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 O-C-N 122.742 -0.269 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -85.24 179.99 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 10.9 mt-10 -59.45 -44.24 92.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.946 -173.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -53.01 62.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.624 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 44.2 mt-30 -63.7 -46.11 86.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -59.57 -44.72 93.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.162 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.56 -55.53 33.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.084 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.68 -41.58 81.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.64 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.66 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -64.51 -57.57 8.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.2 -42.31 94.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 O-C-N 123.251 0.344 . . . . 0.0 111.782 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -61.07 -46.49 90.43 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.713 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.2 mt -61.36 -46.75 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.546 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HD2' ' O ' ' A' ' 46' ' ' ILE . 23.1 tptp -69.24 -38.55 78.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 110.027 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -61.66 -41.59 97.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.376 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.899 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.79 39.96 0.74 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.625 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.576 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 67.4 m-85 -91.3 -29.4 17.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 49' ' ' VAL . 1.3 pp -143.75 156.75 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.686 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 29.0 pt -133.02 -179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.422 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.11 17.61 79.91 Favored Glycine 0 N--CA 1.454 -0.13 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.611 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 HD13 ' A' ' 46' ' ' ILE . 86.5 t -93.5 119.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.242 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -94.86 110.68 22.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 111.19 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.604 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.5 ptm85 . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.54 144.08 48.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.06 2.507 . . . . 0.0 112.106 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -124.18 121.66 35.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.34 106.78 18.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.275 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 19' ' ' THR . 44.6 m-85 -95.62 -173.88 3.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 41.5 mtpt -63.0 -48.74 77.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.383 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.88 142.58 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.38 -67.07 0.45 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.613 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 51.7 Cg_exo -56.7 125.68 19.81 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.055 2.504 . . . . 0.0 113.821 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 47' ' ' ILE . 53.3 mm-40 -123.52 142.03 51.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.1 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.4 ' HG ' ' CG2' ' A' ' 46' ' ' ILE . 7.0 mp -90.07 138.34 31.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.365 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.4 p -82.5 179.91 7.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.85 -47.55 74.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.62 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.893 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -64.75 -46.12 90.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.778 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.79 -44.7 96.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.543 0.211 . . . . 0.0 111.355 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -73.32 -30.91 63.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.149 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -66.64 -31.53 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 98.4 mt -57.55 -40.1 78.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.794 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.554 179.658 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' O ' HG13 ' A' ' 10' ' ' ILE . 1.3 mm? . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HG2' HD21 ' A' ' 40' ' ' LEU . 79.5 mtt180 -54.8 -46.88 74.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.506 0.594 . . . . 0.0 111.353 -171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.518 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 88.3 t80 -55.44 -57.41 11.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.084 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.26 97.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.486 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.3 mt -59.91 -49.03 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.863 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.4 mp -59.81 -47.25 86.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -75.82 -26.92 57.66 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.582 -0.447 . . . . 0.0 112.063 -176.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -77.08 -28.17 54.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.449 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.53 -48.33 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.92 -50.03 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.13 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.12 -30.36 22.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.431 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.95 -24.88 72.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.134 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.6 -4.28 2.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.0 0.52 . . . . 0.0 111.16 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 53.3 p 57.35 156.42 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.117 0.967 . . . . 0.0 112.957 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 6.2 Cg_exo -76.35 166.88 81.66 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 124.315 -1.119 . . . . 0.0 112.938 0.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -148.2 127.33 12.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -81.91 169.95 16.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.324 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -58.76 -37.33 76.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.795 174.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.53 -27.78 67.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.602 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.99 -49.86 14.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.758 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 28' ' ' VAL . 11.0 tt -75.7 -29.58 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 -175.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.37 32.95 4.08 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.083 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 26' ' ' ILE . 28.4 m -137.64 171.62 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' GLN . 2.3 t -85.39 164.47 17.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 0.0 110.938 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -60.79 -42.05 96.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.94 -53.94 51.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.665 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' H ' HG23 ' A' ' 29' ' ' THR . 30.6 mm-40 -69.57 -24.16 63.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.01 -54.07 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.69 -48.5 72.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.848 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.72 -56.8 12.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.784 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -70.34 -45.96 65.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.868 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.72 -44.31 98.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.598 0.237 . . . . 0.0 111.104 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -66.55 -35.26 79.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.992 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.72 -42.11 78.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.911 0.386 . . . . 0.0 110.227 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 7' ' ' ARG . 89.7 mt -62.1 -37.82 86.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.443 176.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 4.7 ttpm? -70.81 -25.68 62.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.37 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -70.12 -54.33 13.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.803 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 34.8 mt-10 -80.24 -20.14 45.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 110.912 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 58.29 1.37 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.841 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 96.5 m-85 -96.12 -33.43 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.249 0.547 . . . . 0.0 109.59 173.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.441 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -140.07 150.55 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.33 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.71 -179.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 84.91 4.19 87.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.081 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.74 113.2 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 0.0 109.984 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -79.97 110.18 15.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.336 0.588 . . . . 0.0 109.657 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.398 0.142 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.07 136.21 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.264 2.643 . . . . 0.0 111.521 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -129.69 123.63 31.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.279 0.562 . . . . 0.0 110.285 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 90.4 mt -86.61 87.37 7.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.582 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -71.82 167.4 20.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.268 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 23.8 mtpp -61.97 -47.12 86.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.76 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.64 112.72 25.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.358 . . . . 0.0 110.135 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 160.42 -62.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.278 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.85 116.94 3.08 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.01 2.473 . . . . 0.0 113.324 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 62' ' ' GLY . 35.6 mt-10 -129.67 160.26 33.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.488 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.2 147.78 28.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -91.97 170.56 9.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -64.87 -29.64 70.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 4.0 ttmp? -62.89 -46.6 87.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.778 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -73.29 -36.82 55.21 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.566 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.47 -49.39 75.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -70.66 -25.52 63.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 24.9 t80 -62.92 -39.36 94.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.83 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 11' ' ' LEU . 85.5 mt -54.13 -41.57 68.54 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.152 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.69 0.757 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.751 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -62.89 -28.72 70.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.119 174.026 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.981 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 61.6 t80 -69.76 -41.41 75.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.663 175.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.56 -46.45 80.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 26' ' ' ILE . 25.0 mm -54.78 -48.88 72.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.808 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 73' ' ' LEU . 71.9 mt -56.36 -43.74 79.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -65.39 -45.82 82.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.631 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -29.66 69.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.327 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 21' ' ' LEU . 80.6 mt -61.96 -46.59 96.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -67.87 -42.88 80.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.702 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.6 -40.09 73.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.877 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.47 -20.79 57.92 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.006 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.7 t30 64.52 20.44 12.15 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.703 0.401 . . . . 0.0 110.16 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 41.6 p 58.38 150.69 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 124.517 1.127 . . . . 0.0 113.255 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -87.25 161.03 49.2 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.208 -0.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 14' ' ' ILE . 1.6 pt? -131.37 120.96 23.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 m -82.59 164.86 20.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.559 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -59.36 -44.73 92.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 176.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.83 -21.39 62.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.047 0.451 . . . . 0.0 111.011 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.04 -46.79 15.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.665 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -71.61 -37.08 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.001 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.58 35.96 1.81 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.135 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 26' ' ' ILE . 35.8 m -140.42 170.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 p -76.8 160.54 29.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.46 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 5.6 mt-10 -57.64 -48.97 77.98 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.255 0.55 . . . . 0.0 109.52 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.76 -45.52 19.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.786 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -74.65 -38.73 62.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.054 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -64.92 -46.95 79.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.631 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -56.66 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.707 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.73 -34.54 77.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.849 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.751 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -60.34 -52.72 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.68 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -41.87 98.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.715 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -64.3 -48.36 75.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.91 -36.07 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.734 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -75.74 -28.6 58.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -77.66 -43.98 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -76.22 -13.01 60.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.362 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.45 51.77 4.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 73.3 m-85 -98.2 -39.2 8.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.058 0.456 . . . . 0.0 109.822 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 ' HG ' ' A' ' 65' ' ' LEU . 2.0 pp -138.78 149.4 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.576 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.96 168.83 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.817 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 24.94 34.14 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.1 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.43 128.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 110.321 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -94.89 126.04 39.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.826 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.269 0.557 . . . . 0.0 111.784 -177.498 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.593 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 75.0 mtp180 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.451 0.167 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 153.33 57.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 143.36 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.24 136.64 51.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' THR . 96.6 m-85 -108.01 -168.63 1.4 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.864 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 49.8 mtpt -75.79 -13.67 60.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.941 0.4 . . . . 0.0 111.119 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -161.54 161.12 29.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.99 -59.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.143 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.95 141.85 72.61 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.471 2.114 . . . . 0.0 113.756 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -120.52 150.95 40.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.766 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -96.96 144.71 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.4 p -83.4 179.59 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.465 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.1 -42.65 99.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.14 -49.03 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.858 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.65 -47.91 65.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.74 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.409 . . . . 0.0 111.169 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -77.35 -35.28 54.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.985 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -58.93 -39.1 80.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.254 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.981 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.7 -46.96 83.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.919 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.6 mttp . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.742 -175.04 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? . . . . . 0 C--O 1.227 -0.092 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 8.8 mmt180 -59.77 -51.89 67.8 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.598 0.714 . . . . 0.0 109.404 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -51.85 -46.14 64.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.167 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.46 62.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 6' ' ' LEU . 73.2 mt -59.37 -30.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.604 0.24 . . . . 0.0 111.266 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -52.75 -38.65 61.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.598 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.553 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.6 ttpp -74.07 -39.15 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.745 -177.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.07 -32.09 73.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.38 . . . . 0.0 110.523 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.58 -43.51 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 110.081 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -64.09 -50.33 68.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.019 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 6.0 mt-10 -77.7 -19.14 55.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 110.677 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.46 -17.11 69.48 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.617 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.98 16.28 9.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.01 0.524 . . . . 0.0 110.436 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.1 p 56.18 151.6 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.521 1.128 . . . . 0.0 112.956 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -78.85 177.69 37.39 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.451 -1.479 . . . . 0.0 112.457 -2.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 26' ' ' ILE . 43.5 tp -149.79 119.31 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.981 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 17.0 m -85.8 164.51 17.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.201 175.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -68.02 -33.78 75.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.55 -36.47 84.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 9.1 m-20 -71.0 -34.55 71.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.396 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -83.95 -35.03 10.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.099 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 26' ' ' ILE . 31.5 m -135.39 173.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 110.326 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 p -85.59 166.76 15.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.681 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 24.3 mt-10 -67.03 -33.22 75.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.708 0.766 . . . . 0.0 108.957 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -49.77 -57.2 7.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.959 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -72.43 -33.79 67.36 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.966 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 47.6 t80 -66.28 -50.71 62.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.3 t70 -62.76 -45.6 91.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.19 -41.89 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.712 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -67.36 -55.9 11.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.837 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.37 -34.97 67.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.159 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.59 -45.59 86.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.607 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.7 t80 -61.68 -41.43 97.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.088 0.47 . . . . 0.0 110.065 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.0 mt -64.66 -39.85 94.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.134 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -34.81 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -60.9 -52.99 62.68 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.626 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 8.3 mm-40 -74.12 -28.42 61.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.958 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.08 40.9 2.54 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.953 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -89.78 -32.77 16.81 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.676 -0.308 . . . . 0.0 111.295 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -137.42 148.41 25.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 27.6 pt -133.8 170.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.251 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.68 90.57 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.256 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG21 HD13 ' A' ' 46' ' ' ILE . 44.2 t -70.22 128.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -94.71 119.14 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.106 0.479 . . . . 0.0 111.143 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.437 178.309 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 50.4 mtp180 . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 26.8 Cg_exo -60.11 119.55 6.81 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 113.724 -165.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -106.59 112.62 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.527 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.86 145.76 25.91 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.608 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.12 171.92 12.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 51.8 mttm -78.17 -18.33 55.68 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.612 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 124.15 42.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.47 -65.59 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.734 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 33.5 Cg_exo -60.7 121.73 10.17 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.81 2.34 . . . . 0.0 112.812 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -128.23 145.19 51.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 129.85 39.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.35 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.9 p -80.02 166.14 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.104 0.252 . . . . 0.0 110.877 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.6 -38.28 69.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.145 0.498 . . . . 0.0 109.991 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -52.26 -55.39 21.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.726 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -76.42 -36.03 40.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.02 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -63.41 -40.92 98.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.703 0.287 . . . . 0.0 110.873 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.66 -29.4 61.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.437 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.03 -27.01 68.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.294 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 91.8 mt -69.31 -19.1 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.34 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttp . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.885 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -56.71 -38.22 72.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.692 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -59.96 -43.95 94.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.192 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.02 82.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.762 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.01 -49.49 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.654 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.8 mp -61.34 -37.31 82.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.254 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -24.26 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.982 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.89 -39.18 61.62 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.58 -43.67 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.579 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.52 -50.61 29.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.876 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -83.28 -40.08 20.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.777 0.322 . . . . 0.0 110.842 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 -26.86 59.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.491 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 67.1 t30 64.5 25.9 13.32 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.075 0.55 . . . . 0.0 110.64 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.521 HG21 ' HG2' ' A' ' 63' ' ' PRO . 18.0 p 56.65 156.97 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.39 1.076 . . . . 0.0 113.338 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.2 Cg_endo -83.25 172.8 46.35 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.377 -2.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.52 136.18 21.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -85.16 166.86 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.692 0.282 . . . . 0.0 110.461 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 1.4 mp0 -55.25 -42.61 73.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.443 0.639 . . . . 0.0 110.242 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -69.59 -22.95 63.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.263 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.37 -49.87 44.7 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.66 0.267 . . . . 0.0 110.501 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.4 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -70.19 -38.68 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.907 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.57 -2.52 11.17 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.785 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 26' ' ' ILE . 34.1 m -116.09 160.97 15.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.234 0.517 . . . . 0.0 110.839 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -70.12 159.88 33.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 10.0 pt-20 -60.31 -29.63 68.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.003 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.85 -52.36 66.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.597 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -74.61 -35.12 62.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 74.5 t80 -58.07 -55.77 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.243 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -54.83 -49.71 70.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.778 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -50.27 73.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.804 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -69.86 -44.82 69.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.549 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.65 -37.03 74.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.482 0.182 . . . . 0.0 110.858 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.19 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.564 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.8 -39.13 93.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.996 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 95.1 mt -62.37 -37.59 86.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 0.0 110.903 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 51.9 tttm -77.68 -33.6 53.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.45 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.04 -47.6 70.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.11 8.27 16.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.41 49.01 59.43 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.387 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 64.1 m-85 -95.15 -39.76 9.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -140.47 142.77 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.214 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.32 175.71 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.068 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.65 6.08 73.73 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 49.8 t -76.24 109.92 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -87.69 111.07 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.071 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.639 173.846 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.95 101.95 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.194 1.929 . . . . 0.0 110.722 169.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -92.17 108.72 20.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.72 109.42 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.946 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.8 -168.11 1.94 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.449 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -75.86 -45.48 35.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.204 0.525 . . . . 0.0 110.22 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.32 132.0 53.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.608 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.01 -63.14 0.39 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.398 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HG2' HG21 ' A' ' 19' ' ' THR . 35.9 Cg_exo -59.01 120.24 7.98 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.792 2.328 . . . . 0.0 112.662 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.85 151.67 46.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.005 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.21 148.45 22.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.23 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -91.72 161.05 15.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -66.35 -26.8 67.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -61.46 -51.75 67.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.256 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.7 71.44 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.37 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -62.67 -41.88 99.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.04 0.447 . . . . 0.0 109.854 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -70.81 -32.04 68.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.9 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.17 -36.64 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 110.083 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 11' ' ' LEU . 89.2 mt -58.41 -33.28 69.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.257 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.5 tttp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.267 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.415 ' HG ' ' CG1' ' A' ' 28' ' ' VAL . 2.1 mm? . . . . . 0 C--O 1.227 -0.111 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 40' ' ' LEU . 39.9 ttm180 -53.31 -41.65 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 0.0 111.233 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.2 -43.72 95.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.56 61.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.957 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.95 -45.73 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.012 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.93 -41.43 91.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.521 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.06 -46.0 72.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.554 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HB3' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -58.84 -39.28 80.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.278 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.05 -50.06 50.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.446 . . . . 0.0 110.414 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -62.76 -50.29 71.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.72 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -82.57 -35.15 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.809 0.338 . . . . 0.0 111.47 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.54 -24.16 75.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.56 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.42 5.94 5.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.129 0.572 . . . . 0.0 110.73 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.6 p 55.9 164.51 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 113.334 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 90.0 Cg_endo -83.98 -178.46 19.38 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.623 -1.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 13' ' ' GLU . 2.6 pt? -155.02 143.43 20.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.2 m -85.27 170.23 13.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.717 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -61.5 -47.43 85.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.786 0.326 . . . . 0.0 111.35 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.71 -9.22 58.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.81 -47.38 30.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -75.13 -38.49 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.085 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.46 -19.28 5.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.516 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 35.1 m -98.14 162.06 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.666 0.27 . . . . 0.0 110.622 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.7 p -81.02 165.73 21.42 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.09 -31.51 30.86 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.629 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.27 -53.72 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.065 0.46 . . . . 0.0 110.797 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 2.7 mp0 -70.74 -34.49 71.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.01 -52.06 39.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.661 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -57.71 -54.16 49.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.795 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -54.08 -50.72 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.984 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.647 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -62.02 -53.16 59.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.75 -177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.55 -44.89 97.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 111.37 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -65.89 -40.77 91.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.334 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 75.5 t80 -61.58 -47.87 83.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.176 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 7' ' ' ARG . 96.8 mt -56.2 -44.47 79.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.353 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 3.9 ttpm? -67.33 -38.99 85.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -72.72 -39.89 66.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.407 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 14.2 mm-40 -78.24 -27.64 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.95 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.61 32.93 1.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.55 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 95.8 m-85 -90.3 -43.87 10.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 110.673 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.4 pp -141.0 154.84 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -133.54 173.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 91.52 13.32 58.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.799 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.65 119.1 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.652 0.263 . . . . 0.0 110.425 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -90.85 124.77 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.71 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 61.4 m-85 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.042 0.449 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 94.9 Cg_endo -86.12 160.57 10.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.106 2.538 . . . . 0.0 113.863 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -137.48 126.92 24.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.378 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 86.1 mt -88.25 154.67 20.24 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -133.11 -177.21 4.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.108 0.48 . . . . 0.0 111.278 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp -146.69 145.15 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.952 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 134.68 -67.59 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.892 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 28.1 Cg_exo -62.5 123.57 12.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.637 2.225 . . . . 0.0 111.878 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 151.33 46.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.604 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.662 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 mp -91.92 142.2 27.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.599 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.5 p -88.0 179.31 6.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.262 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.53 -39.24 76.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.3 tppt? -65.02 -42.07 94.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.475 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.59 -47.78 88.5 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.52 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.6 -45.08 94.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -73.28 -25.12 60.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 0.0 111.18 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.22 -40.45 77.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.127 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -55.39 -38.32 68.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.765 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.8 tttp . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.248 -177.916 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 10' ' ' ILE . 1.5 mm? . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.507 0.194 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.518 HH11 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -56.56 -40.37 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.45 -42.01 65.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.308 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 26' ' ' ILE . 42.8 mm -60.48 -52.79 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.388 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.92 -43.64 91.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.402 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.19 -44.61 94.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.675 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.123 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ILE . 77.6 mt -65.87 -45.21 91.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 110.339 175.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.96 -50.21 71.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.612 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.72 -17.28 32.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.46 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 -27.71 23.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.685 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.7 t30 68.53 11.46 8.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 28.6 p 55.04 162.65 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 124.345 1.058 . . . . 0.0 113.294 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 95.3 Cg_endo -79.61 156.14 89.29 Favored 'Cis proline' 0 C--N 1.343 0.274 0 C-N-CA 123.717 -1.368 . . . . 0.0 111.88 -3.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.1 pt? -124.55 132.51 53.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -85.0 162.89 19.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.138 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.836 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.28 -32.94 74.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -65.56 -34.42 78.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.35 -43.7 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.68 -27.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.95 33.96 5.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.334 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 26' ' ' ILE . 33.7 m -135.11 175.87 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 p -83.89 156.92 22.17 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.836 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.47 -21.2 64.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.04 -44.8 79.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.056 0.455 . . . . 0.0 109.933 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.06 -29.82 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -64.6 -48.79 73.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.562 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.67 -53.58 53.02 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.64 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -49.59 53.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.745 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -61.93 -54.41 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.608 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.96 -38.59 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 O-C-N 123.105 0.253 . . . . 0.0 111.522 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 17.0 m-80 -60.78 -49.41 77.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.647 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.66 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.629 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 97.0 mt -60.98 -37.73 83.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 5.3 tmmm? -71.37 -40.76 70.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 55.8 mtt180 -60.75 -47.29 86.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.926 0.393 . . . . 0.0 111.141 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -82.29 4.77 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.48 46.24 94.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.119 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 29.6 m-85 -87.55 -37.36 16.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.406 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.8 pp -138.68 150.34 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.097 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.29 173.71 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.471 175.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.43 9.34 69.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.084 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.75 124.9 38.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -92.42 111.28 22.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.891 0.377 . . . . 0.0 110.424 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.488 178.298 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.19 99.9 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.446 2.097 . . . . 0.0 111.012 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -82.05 109.78 16.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.068 0.461 . . . . 0.0 110.933 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 85.6 mt -89.17 105.72 17.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.652 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.0 173.1 7.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.03 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -67.92 -26.76 66.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.349 0.595 . . . . 0.0 109.891 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.27 117.8 31.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.641 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.18 -72.33 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.51 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.04 120.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.449 2.766 . . . . 0.0 114.206 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -129.84 144.46 51.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.622 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.66 145.64 26.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.39 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.2 p -96.04 173.85 7.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.27 -37.27 86.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -62.93 -40.45 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.357 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.511 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -70.87 -41.97 61.45 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.467 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.15 -38.63 88.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.776 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -65.08 -36.77 85.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.353 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.61 -36.14 79.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.642 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.4 -44.53 89.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.51 . . . . 0.0 110.489 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -178.304 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.547 0.213 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -66.68 -37.47 84.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 109.953 -172.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -55.41 -48.3 74.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.111 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.38 -18.54 54.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.613 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 26' ' ' ILE . 66.2 mt -58.65 -39.37 75.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.436 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' CB ' HD21 ' A' ' 73' ' ' LEU . 46.0 mt -62.3 -30.75 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.385 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -62.94 -43.89 97.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 109.992 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 26' ' ' ILE . 7.8 mm-40 -63.37 -42.8 98.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.384 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 65' ' ' LEU . 74.9 mt -65.93 -31.87 55.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.876 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.21 -49.92 57.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.469 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.26 -28.58 21.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.755 0.312 . . . . 0.0 111.822 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.62 -14.76 64.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.599 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 19' ' ' THR . 57.0 t30 70.51 -81.81 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.596 0.759 . . . . 0.0 109.486 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER 173.16 157.26 0.27 Allowed Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 124.199 0.999 . . . . 0.0 109.012 176.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 66.7 Cg_endo -87.8 -174.82 9.67 Favored 'Cis proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.108 -0.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -157.73 127.8 6.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 m -85.41 170.14 12.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.367 . . . . 0.0 110.63 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.03 -22.12 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.722 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -84.2 -43.93 14.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.498 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 10' ' ' ILE . 5.1 tp -70.02 -38.43 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.92 -20.13 10.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.943 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.24 160.07 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 t -70.38 166.82 19.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.299 0.571 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.44 -29.15 69.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.45 -43.31 90.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.547 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -71.66 -32.25 67.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.873 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.79 -46.7 80.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.86 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -56.71 -53.14 61.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.453 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.9 -37.64 77.07 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.405 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.14 -59.9 3.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.717 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.14 -43.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.296 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.999 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -68.91 -45.74 70.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.792 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 74.7 mt -63.21 -37.18 86.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.944 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -60.77 -42.35 97.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.99 12.97 18.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.356 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.28 38.33 96.04 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.638 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 34.7 m-85 -88.26 -28.72 20.93 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.487 -0.419 . . . . 0.0 110.488 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.9 pp -143.68 149.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -131.84 150.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.63 35.45 6.18 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.518 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.6 115.2 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.944 0.402 . . . . 0.0 110.452 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.436 ' NE2' ' HA3' ' A' ' 62' ' ' GLY . 89.4 m-70 -82.19 135.91 35.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.66 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--N 1.317 -0.809 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.567 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.867 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.378 0 N-CA-C 110.37 -0.234 . . . . 0.0 110.37 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.867 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 52.7 Cg_exo -53.62 136.47 64.71 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.553 2.168 . . . . 0.0 111.835 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.22 105.57 3.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.111 0.482 . . . . 0.0 110.027 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB3' HG21 ' A' ' 19' ' ' THR . 86.8 mt -74.03 134.33 43.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.147 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.824 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.8 m-85 -125.83 -178.34 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -43.15 -55.66 3.81 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.159 0.912 . . . . 0.0 113.289 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 61' ' ' LEU . 3.2 pp -128.1 146.07 50.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.925 0.393 . . . . 0.0 110.955 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 137.19 -64.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.722 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.23 121.57 8.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.537 2.158 . . . . 0.0 113.074 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -114.72 152.37 32.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.621 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.9 mp -101.17 134.43 44.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.1 p -80.23 160.95 25.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 10.7 pt-20 -69.43 -20.0 63.79 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.48 -48.32 82.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 -35.23 50.51 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.862 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 32.9 tt0 -63.11 -43.26 98.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.56 0.219 . . . . 0.0 110.905 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -67.37 -32.87 74.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.26 -35.71 81.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.236 0.541 . . . . 0.0 109.607 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.594 HD21 ' CB ' ' A' ' 11' ' ' LEU . 73.8 mt -74.59 -19.41 60.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.34 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.987 0.422 . . . . 0.0 110.908 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.458 -0.034 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -60.79 -41.95 96.6 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.869 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.695 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 72.5 t80 -66.44 -42.85 87.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.147 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.98 -47.21 81.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 26' ' ' ILE . 54.2 mt -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 40' ' ' LEU . 82.9 mt -56.01 -46.83 78.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.29 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 26.3 ttpp -68.69 -42.45 77.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 -177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG3' HG13 ' A' ' 26' ' ' ILE . 9.1 mm-40 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.016 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 19' ' ' THR . 73.0 mt -65.33 -42.31 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 110.115 173.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.94 -50.1 57.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.402 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 10.7 mt-10 -74.1 -33.28 63.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.023 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.17 -31.28 14.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.249 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.99 19.12 4.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.167 0.587 . . . . 0.0 110.614 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.744 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 14.2 p 56.16 169.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.075 0.95 . . . . 0.0 113.156 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.791 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 79.6 Cg_endo -90.77 156.54 27.8 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 124.715 -0.952 . . . . 0.0 112.276 -1.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -149.35 131.46 15.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.118 0.485 . . . . 0.0 110.527 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -85.26 170.32 12.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.987 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.83 -36.71 77.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.765 0.284 . . . . 0.0 111.765 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -68.47 -25.92 65.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.32 -48.78 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.003 0.43 . . . . 0.0 110.509 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 21' ' ' LEU . 9.4 tt -76.56 -34.4 24.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.607 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.25 28.18 3.4 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.245 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 34.5 m -126.92 172.14 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 p -85.16 163.8 18.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.862 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 24.5 mt-10 -55.8 -42.5 75.71 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.61 -62.08 1.62 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.56 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.77 -47.56 80.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.639 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.5 t80 -63.63 -52.1 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.71 -45.77 85.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -62.25 -39.92 94.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -50.53 72.04 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.803 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' PHE . 97.7 t -58.18 -41.77 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.703 0.287 . . . . 0.0 110.956 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -62.53 -45.48 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -64.68 -41.0 96.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.709 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 11' ' ' LEU . 84.1 mt -63.81 -46.08 86.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.204 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.55 -26.65 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -56.57 -53.67 54.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 26.1 mt-10 -89.6 -8.4 52.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.11 53.76 2.9 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.936 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' HD2' ' HA2' ' A' ' 69' ' ' GLY . 73.4 m-85 -85.42 -38.37 18.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.767 0.317 . . . . 0.0 110.681 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -131.92 149.91 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 176.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 pt -126.9 167.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.12 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 9.99 65.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.67 124.96 38.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.789 174.382 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.431 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 2.6 Cg_endo -81.89 146.48 14.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.486 2.791 . . . . 0.0 112.275 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -125.87 116.29 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 63' ' ' PRO . 78.0 mt -89.0 120.6 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.923 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -100.64 -174.36 2.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.791 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 97.0 mttt -69.89 -26.3 64.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.417 0.627 . . . . 0.0 110.394 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.72 101.43 5.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.055 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.42 -79.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.777 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 73.9 Cg_endo -76.87 120.39 5.46 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 114.198 -172.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HB2' HG13 ' A' ' 47' ' ' ILE . 37.4 mt-10 -100.18 142.23 31.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.074 172.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -95.26 134.52 37.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.731 0.301 . . . . 0.0 110.361 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.0 p -93.26 178.43 5.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.351 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.9 -40.31 80.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.014 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.75 -41.0 90.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.88 -41.72 27.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.407 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -65.78 -34.6 78.54 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.979 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.72 -36.06 67.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 0.0 110.942 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.62 -26.35 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.261 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.695 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 97.0 mt -59.92 -41.8 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.721 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 -178.577 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.484 ' HG ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 mm? . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.658 0.266 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.18 -50.7 11.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 64.6 t80 -62.15 -46.07 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.959 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.42 89.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.332 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.3 mt -55.99 -46.64 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 98.5 mt -56.45 -50.19 72.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.508 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -77.68 -30.32 51.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.836 -175.046 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.442 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 5.7 mm-40 -73.61 -22.31 60.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.089 0.471 . . . . 0.0 110.074 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 10' ' ' ILE . 58.9 mt -76.41 -50.38 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 170.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -56.12 -41.6 75.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.586 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -97.01 -26.27 15.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.721 0.296 . . . . 0.0 111.694 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -83.49 -16.0 69.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.383 -174.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.3 t30 76.67 -13.52 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.014 0.526 . . . . 0.0 111.546 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 27.5 p 58.93 156.98 0.09 OUTLIER Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.504 1.122 . . . . 0.0 112.648 -174.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 4.4 Cg_exo -75.55 161.85 93.64 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.946 -1.273 . . . . 0.0 111.935 1.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.4 pt? -124.7 119.96 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -72.18 156.09 39.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.315 0.579 . . . . 0.0 111.042 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.625 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -71.17 -40.76 71.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.662 -175.159 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.55 -45.54 15.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.301 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.55 -36.79 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 33.7 1.52 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.397 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 26' ' ' ILE . 30.6 m -139.01 174.37 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.843 0.322 . . . . 0.0 110.182 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -85.32 154.26 22.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 0.0 110.343 171.623 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -68.39 -28.55 67.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.131 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.76 -42.62 85.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.197 0.522 . . . . 0.0 110.58 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HB2' HG23 ' A' ' 29' ' ' THR . 1.5 mp0 -79.78 -21.19 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.381 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 37' ' ' VAL . 84.9 t80 -65.82 -55.97 14.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.063 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' HB2' ' HG2' ' A' ' 56' ' ' PRO . 1.5 p30 -68.47 -33.86 74.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.283 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.64 -50.52 73.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -60.83 -44.91 96.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.226 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 33' ' ' PHE . 93.0 t -57.05 -40.88 75.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.933 0.396 . . . . 0.0 110.903 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -68.37 -38.62 81.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.171 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -66.83 -40.17 87.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.4 mt -60.87 -38.22 84.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.011 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -70.66 -37.49 73.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.101 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -57.03 -53.12 61.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.08 -34.44 71.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.193 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.22 46.25 1.6 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.571 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -94.45 -35.99 12.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.1 pp -137.94 154.93 29.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.73 163.37 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.729 177.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.82 28.15 14.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.784 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 56' ' ' PRO . 87.1 t -71.46 117.42 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 4.2 t60 -96.57 121.98 38.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 -176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 . . . . . 0 C--N 1.32 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.456 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.411 0.148 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 26.7 Cg_endo -65.47 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.452 2.102 . . . . 0.0 110.799 170.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -105.74 -35.82 7.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.5 mt 69.5 128.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.862 0.726 . . . . 0.0 110.763 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 20' ' ' PRO . 31.6 m-85 -122.06 -175.55 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 44.5 mtmt -70.02 -5.14 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 tp -160.29 119.07 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.03 -67.99 0.19 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.221 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 58' ' ' LEU . 57.7 Cg_endo -71.24 137.8 31.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.364 2.043 . . . . 0.0 113.459 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -130.29 166.11 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.584 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.8 mp -97.75 145.18 26.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.919 0.39 . . . . 0.0 110.461 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.3 p -80.06 169.56 17.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.01 -38.36 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.94 0.4 . . . . 0.0 110.014 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -69.21 -45.64 69.37 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.989 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.22 97.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.27 -40.49 90.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.221 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.071 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.58 -28.61 69.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.669 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 87.3 mt -58.23 -34.48 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.34 175.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.151 0.5 . . . . 0.0 110.051 177.936 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -100.41 3.1 42.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.788 HH11 ' HA ' ' A' ' 36' ' ' ALA . 33.9 mmt180 -67.42 -56.07 11.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 13.9 t80 -62.57 -40.79 97.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.751 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.96 87.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.326 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.27 -39.17 72.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.784 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.633 ' HG ' HD13 ' A' ' 40' ' ' LEU . 8.0 mt -56.28 -45.02 80.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 6.8 ttpp -62.56 -39.59 94.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HG2' HG12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -64.61 -37.18 86.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.359 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.08 -44.13 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.278 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.35 -50.51 73.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.318 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.83 -18.99 19.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.482 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.17 -27.12 66.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.332 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.2 -1.78 2.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.212 0.605 . . . . 0.0 111.449 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 62.0 p 59.55 153.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.664 1.186 . . . . 0.0 113.33 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.626 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 2.0 Cg_endo -81.74 167.12 70.87 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.983 -1.257 . . . . 0.0 112.387 0.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 13' ' ' GLU . 1.7 pt? -140.78 149.05 41.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 25' ' ' ASP . 30.3 t -85.2 167.26 15.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.65 0.738 . . . . 0.0 110.938 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -80.63 -48.21 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.545 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -66.6 -27.88 68.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.585 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 11.1 t70 -72.73 -40.63 65.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.564 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -74.29 -32.91 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.24 20.37 2.22 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.721 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.66 175.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 117.243 0.522 . . . . 0.0 110.786 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.6 p -85.32 172.5 11.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.693 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 mt-10 -58.27 -53.2 60.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 110.403 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.78 -29.97 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.113 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.2 -46.74 66.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.347 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 67.9 t80 -62.87 -45.35 92.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.772 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 55' ' ' ARG . 6.3 t70 -54.75 -53.86 49.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.664 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.9 -40.23 92.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.62 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.788 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -61.06 -52.22 65.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.08 -44.73 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.993 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.45 -45.0 95.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.239 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.34 -46.78 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.633 HD13 ' HG ' ' A' ' 11' ' ' LEU . 90.7 mt -63.74 -34.84 78.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 56.7 tttm -67.31 -41.55 85.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.776 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -67.29 -47.38 70.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.071 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.62 -22.95 58.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.06 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 46.83 1.92 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.062 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.638 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 86.3 m-85 -98.66 -36.29 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 110.356 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.0 pp -142.36 155.6 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 34.8 pt -131.82 170.82 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.908 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 14.32 50.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.8 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.604 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 96.7 t -78.41 114.14 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.033 0.444 . . . . 0.0 110.31 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -109.64 131.62 54.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.621 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.44 142.99 27.08 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.5 t -121.8 -88.51 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.879 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -52.61 64.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.868 0.842 . . . . 0.0 110.001 172.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -169.17 -33.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.546 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.524 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 10.2 mtp180 -105.8 163.97 15.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.933 -173.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 25.2 Cg_endo -62.48 134.48 48.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.644 2.229 . . . . 0.0 112.393 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -126.82 132.41 51.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.124 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -97.64 138.67 34.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.428 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -110.37 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.578 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.626 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 54.0 mttp -83.59 -5.37 59.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.389 0.614 . . . . 0.0 110.326 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -156.79 120.86 4.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . . . 157.36 -57.02 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.896 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG3' HD22 ' A' ' 58' ' ' LEU . 30.5 Cg_exo -62.3 106.36 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.62 2.213 . . . . 0.0 112.55 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 4.3 mm-40 -110.55 140.07 45.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 46' ' ' ILE . 6.3 mp -88.66 144.22 26.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.896 0.379 . . . . 0.0 110.458 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 p -87.21 171.38 10.7 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.46 -38.3 90.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -63.0 -44.53 95.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.643 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.19 -42.72 94.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.704 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.03 -46.57 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -63.23 -34.52 77.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.674 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.57 -37.68 87.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.558 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 11' ' ' LEU . 82.8 mt -63.4 -33.46 75.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.578 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -68.54 -36.3 78.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.491 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -85.25 -45.78 11.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -89.54 5.48 45.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.328 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -62.77 -15.08 54.03 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.872 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -75.35 67.0 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.116 0.96 . . . . 0.0 110.584 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -143.31 124.59 14.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.194 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 t -68.9 93.25 0.54 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.003 0.43 . . . . 0.0 110.747 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -154.6 112.5 3.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.999 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.126 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' ILE . 3.6 mm? -67.44 -16.71 64.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 109.508 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.761 ' NH1' ' HA ' ' A' ' 36' ' ' ALA . 4.9 tpp180 -57.57 -37.17 72.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.112 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -69.73 -44.47 70.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.011 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -37.77 76.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.645 HD13 HG13 ' A' ' 26' ' ' ILE . 35.2 mm -65.17 -51.63 63.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 110.098 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.18 -40.61 90.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.093 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -68.32 -28.32 67.05 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.307 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.56 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -81.04 -26.41 36.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.118 0.485 . . . . 0.0 110.193 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.45 -26.99 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.754 0.788 . . . . 0.0 109.471 171.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.92 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -100.41 -40.53 7.43 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.43 55.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.724 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 19' ' ' THR . 32.5 t-20 70.25 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER 173.01 164.84 0.27 Allowed Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 124.18 0.992 . . . . 0.0 108.805 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 19' ' ' THR . 64.7 Cg_endo -90.07 175.21 21.27 Favored 'Cis proline' 0 N--CA 1.462 -0.378 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.823 -3.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.11 137.18 28.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -85.27 170.26 12.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.438 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 6.8 pm0 -59.4 -37.16 77.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.055 0.455 . . . . 0.0 110.797 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 49.6 t30 -65.18 -30.94 71.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.047 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.35 -49.76 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.645 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.62 -35.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.105 -176.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.86 30.85 2.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.273 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 32.1 m -130.6 169.17 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 32' ' ' GLN . 23.6 p -85.16 169.32 13.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.785 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 2.4 mt-10 -48.65 -52.58 22.48 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.787 0.68 . . . . 0.0 110.832 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.43 -37.44 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.844 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 8.5 mm100 -79.02 -32.85 45.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -72.24 -36.39 69.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.511 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.89 -46.41 90.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.596 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -52.11 -49.65 63.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.514 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . . . -59.69 -58.52 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.819 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.51 -47.09 94.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.588 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.55 -39.32 93.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.61 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.619 ' HD2' ' HD2' ' A' ' 7' ' ' ARG . 77.1 t80 -67.22 -41.04 86.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.322 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.1 mt -64.44 -44.77 90.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -70.53 -37.25 74.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.889 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -58.89 -55.97 28.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 73.4 mm-40 -82.78 -3.22 56.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.62 -174.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.75 44.84 9.9 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.106 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 68.5 m-85 -79.28 -34.14 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.183 0.516 . . . . 0.0 109.743 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 49' ' ' VAL . 1.8 pp -140.1 157.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.473 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 46.1 pt -132.26 165.65 31.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.48 -1.95 73.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.915 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.422 HG21 HD13 ' A' ' 46' ' ' ILE . 57.4 t -76.67 126.96 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.802 0.334 . . . . 0.0 110.53 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -98.56 147.2 25.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.457 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 56' ' ' PRO . 19.1 m-85 -119.98 143.41 48.05 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -114.0 164.51 13.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.37 -29.34 67.63 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -97.05 -33.65 11.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 13.3 ttm180 -156.04 140.86 12.14 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.986 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 28.9 Cg_exo -61.19 147.77 94.71 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.448 2.098 . . . . 0.0 111.073 169.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -118.8 115.61 24.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.402 0.62 . . . . 0.0 111.389 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.39 144.98 26.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.346 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.97 168.99 18.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' THR . 29.8 mtpp -55.98 -56.43 20.83 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.724 0.64 . . . . 0.0 112.232 -168.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.06 90.14 3.21 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.936 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.1 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.021 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 Cg_exo -66.07 109.07 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.146 2.564 . . . . 0.0 113.316 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -108.44 155.79 20.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.164 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.56 148.21 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.065 0.459 . . . . 0.0 111.051 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.0 p -104.55 -179.81 4.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.088 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -54.32 -43.91 71.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.079 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -57.12 -51.36 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -38.67 93.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.269 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.53 -46.93 87.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -61.53 -41.24 97.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.02 -40.18 92.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.97 -42.83 90.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.179 0.514 . . . . 0.0 110.484 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.06 -39.57 93.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.92 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -77.12 -39.5 49.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.346 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.81 5.83 48.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.238 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.46 -17.18 4.12 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.936 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.476 ' O ' ' HB3' ' A' ' 79' ' ' TRP . 10.2 t -81.68 -145.04 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 78' ' ' THR . 29.7 t90 79.99 146.83 0.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.456 0.702 . . . . 0.0 110.9 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -79.45 82.78 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.364 0.602 . . . . 0.0 110.87 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -90.42 14.61 12.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.477 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -178.653 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.59 -20.43 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.862 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 36' ' ' ALA . 59.1 mmt-85 -54.3 -33.31 58.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.179 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 85.4 t80 -68.1 -54.25 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.901 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.03 -48.57 75.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -62.07 -43.77 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD21 ' A' ' 73' ' ' LEU . 12.1 tp -65.64 -35.48 80.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.2 ttpp -70.84 -39.95 72.66 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 9.4 mm-40 -62.26 -39.79 94.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.457 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -32.17 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.383 0.611 . . . . 0.0 110.135 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -75.43 -40.13 58.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 8.9 mt-10 -80.85 -40.31 25.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.34 50.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.919 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 19' ' ' THR . 13.8 t-20 68.89 -90.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.453 0.701 . . . . 0.0 109.52 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER 177.19 159.33 0.5 Allowed Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.998 0.919 . . . . 0.0 109.345 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.826 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 Cg_endo -82.09 167.78 67.79 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.321 -1.116 . . . . 0.0 112.199 0.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -150.17 129.51 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.18 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.99 -38.26 72.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.504 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -68.91 -35.8 77.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.947 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.72 -45.21 87.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.187 0.518 . . . . 0.0 110.629 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 28' ' ' VAL . 14.9 tt -79.56 -24.72 12.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.936 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.47 11.99 52.39 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.533 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 26' ' ' ILE . 26.3 m -123.15 167.22 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.979 0.389 . . . . 0.0 110.455 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -78.68 166.7 22.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.819 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 19.9 mt-10 -57.99 -40.59 81.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.97 -48.62 77.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.732 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.7 -35.12 67.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.29 -47.65 81.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.81 -53.52 57.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.644 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.44 -53.36 52.49 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.239 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . . . -67.1 -53.53 29.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.291 -174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.18 -40.16 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.78 -39.64 94.74 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.83 0.348 . . . . 0.0 110.513 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -65.89 -46.62 77.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 46' ' ' ILE . 68.5 mt -59.58 -42.06 91.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.227 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -66.58 -36.58 82.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -66.79 -43.01 85.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.033 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -78.26 -20.82 50.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.647 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.01 38.7 5.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.29 -30.65 20.72 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.63 -0.336 . . . . 0.0 111.038 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -140.82 159.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.05 158.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.97 29.04 19.2 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.202 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.53 109.91 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -91.03 130.94 36.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.979 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.92 145.76 30.88 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.363 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -136.69 -52.99 0.71 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 110.211 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 38.5 p-10 -103.19 23.69 12.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.74 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 34.7 t70 82.15 -10.02 1.14 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.794 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -105.32 161.2 23.49 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 170.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.63 122.56 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.8 2.333 . . . . 0.0 112.176 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -137.25 105.91 5.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB3' HG21 ' A' ' 19' ' ' THR . 70.9 mt -79.74 122.96 27.23 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.031 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.826 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 75.5 m-85 -107.1 -173.41 2.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -57.07 -52.39 65.47 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.52 0.512 . . . . 0.0 112.001 -171.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.62 135.27 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.755 0.312 . . . . 0.0 110.632 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.48 -70.77 0.5 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.519 ' HG2' HG21 ' A' ' 19' ' ' THR . 25.6 Cg_exo -63.9 119.63 6.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.304 2.669 . . . . 0.0 113.439 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.09 156.26 48.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.809 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.432 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.4 mp -95.03 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -93.13 169.9 10.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -24.68 64.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -59.3 -47.01 87.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.91 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.38 -34.39 50.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.909 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.41 -43.6 93.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.33 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 3.0 m120 -70.05 -30.3 67.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -62.75 -36.56 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.784 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 82.8 mt -62.9 -19.75 64.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.094 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 47.5 tttp -60.71 -40.22 91.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.622 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -85.45 -48.0 9.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 73' ' ' LEU . 32.4 p-10 -89.03 5.11 45.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.561 -173.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.485 ' HA2' ' CE1' ' A' ' 8' ' ' TYR . . . -57.96 -20.66 42.32 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.082 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 79' ' ' TRP . 1.4 t -70.71 -62.41 1.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.528 0.664 . . . . 0.0 110.497 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.513 ' H ' HG23 ' A' ' 78' ' ' THR . 9.6 t90 44.57 -148.57 0.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.951 0.5 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 28.7 m 51.7 54.35 11.12 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.124 0.57 . . . . 0.0 111.554 174.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.31 79.73 2.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.891 0.853 . . . . 0.0 110.775 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.028 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 5' ' ' LYS . 35.1 mtpt . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.2 -20.31 16.0 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.758 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HB3' HD21 ' A' ' 40' ' ' LEU . 22.6 mmt180 -67.24 -34.89 78.41 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 37.1 t80 -57.73 -41.02 80.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.153 172.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -61.53 -35.11 76.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.454 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 19.6 mt -73.99 -30.34 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.438 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.22 -36.16 82.32 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.455 -0.778 . . . . 0.0 109.322 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 13.3 tmtt? -61.93 -52.67 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 10' ' ' ILE . 12.8 pt-20 -60.4 -39.08 86.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.029 0.442 . . . . 0.0 111.411 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.462 HG13 ' HG3' ' A' ' 13' ' ' GLU . 88.6 mt -74.38 -43.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.67 -46.2 89.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.442 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 10.4 pt-20 -92.83 -26.5 17.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.398 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -74.46 -24.29 73.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.116 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 29.3 t-20 76.66 -20.2 0.38 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 111.755 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.809 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 70.9 p 61.95 163.41 0.11 Allowed Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 124.413 1.085 . . . . 0.0 112.67 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.809 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 72.1 Cg_endo -79.51 150.68 84.61 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.522 -2.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -132.63 145.74 51.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.4 m -85.82 165.24 17.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.819 0.342 . . . . 0.0 110.585 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -62.72 -28.43 69.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.986 178.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -70.81 -10.12 58.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.781 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -85.28 -50.02 7.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.715 0.293 . . . . 0.0 110.509 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -78.89 -38.52 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.432 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.78 -13.41 10.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.678 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.555 ' H ' HG23 ' A' ' 26' ' ' ILE . 27.2 m -86.22 157.21 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 117.426 0.613 . . . . 0.0 110.197 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 t -85.13 162.21 19.34 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.571 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 10.0 mt-10 -51.04 -50.48 58.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.18 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.09 -41.65 71.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.084 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -79.66 -32.16 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 111.046 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.1 t80 -67.41 -52.85 34.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.22 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' OD2' ' HD2' ' A' ' 56' ' ' PRO . 0.9 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 178.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.95 -42.29 75.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.49 ' CB ' HD12 ' A' ' 10' ' ' ILE . . . -64.51 -50.85 65.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 33' ' ' PHE . 65.8 t -58.41 -44.47 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.691 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 95.5 m-20 -61.33 -48.78 79.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -56.02 -45.65 79.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 7' ' ' ARG . 89.9 mt -65.98 -40.08 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.256 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 41' ' ' LYS . 0.7 OUTLIER -69.57 -31.34 69.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.153 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 99.6 mtt180 -61.76 -58.55 7.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.75 -24.24 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.349 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.93 52.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.716 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 81.8 m-85 -93.5 -34.76 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.064 0.459 . . . . 0.0 110.081 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 pp -137.38 148.49 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.476 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -132.93 176.76 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.009 178.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 86.37 5.18 82.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.475 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.22 135.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -106.79 119.98 40.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.61 160.04 15.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.02 0.438 . . . . 0.0 111.276 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.4 m -116.21 51.85 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.452 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 65.03 9.49 5.51 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.354 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -167.07 -69.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.311 . . . . 0.0 110.725 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.571 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 74.1 mtp180 -91.66 140.54 25.18 Favored Pre-proline 0 C--O 1.237 0.419 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 58.4 Cg_endo -72.45 139.91 32.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.939 2.426 . . . . 0.0 111.726 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -129.25 145.58 51.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 93.7 mt -104.19 145.59 29.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.928 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -130.3 174.35 9.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.818 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.08 -40.38 75.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.38 0.61 . . . . 0.0 109.783 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tt -106.74 105.26 15.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.146 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 170.68 -70.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.167 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.09 109.56 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.009 2.473 . . . . 0.0 113.454 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.49 148.85 43.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.678 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.7 133.43 43.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.6 p -79.96 178.82 7.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.65 -39.9 91.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.36 -44.16 92.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.01 -36.0 64.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.287 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.97 -45.23 93.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.831 0.348 . . . . 0.0 110.666 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.28 -31.24 70.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 110.56 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.54 -34.38 76.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 96.0 mt -58.62 -43.01 89.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.229 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -65.13 -44.87 87.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.55 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.79 -53.27 42.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.709 -174.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -92.38 5.56 50.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.155 0.502 . . . . 0.0 110.827 -175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -60.97 -15.04 41.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 113.751 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 t -91.93 11.94 23.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.457 ' CZ3' ' HA ' ' A' ' 81' ' ' LYS . 59.1 t90 -65.29 139.33 58.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.898 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.5 m -74.41 116.18 14.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.105 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 58.9 mttp -76.57 -150.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.163 0.506 . . . . 0.0 111.42 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -175.45 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.058 0.456 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD13 ' HH2' ' A' ' 79' ' ' TRP . 4.3 mm? -100.14 -3.27 32.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.05 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.622 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 18.6 mtm180 -65.62 -21.8 66.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.922 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 77.2 t80 -70.17 -46.47 64.59 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.979 172.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.56 76.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.831 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 7' ' ' ARG . 69.6 mt -58.07 -51.99 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.555 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD21 HD22 ' A' ' 40' ' ' LEU . 96.4 mt -58.4 -45.8 87.64 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.165 0.507 . . . . 0.0 110.835 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 26.3 ttpp -62.16 -48.67 79.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.175 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -31.02 71.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.0 mt -68.58 -43.47 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 110.589 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -75.3 -50.25 16.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.324 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.6 -40.16 66.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.819 0.342 . . . . 0.0 110.885 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 -27.45 70.06 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.502 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.5 t30 65.93 26.05 11.03 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.089 0.556 . . . . 0.0 110.916 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.703 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 46.1 p 56.84 163.27 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.434 1.094 . . . . 0.0 113.134 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 71.5 Cg_endo -76.3 174.39 53.16 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 124.091 -1.212 . . . . 0.0 112.659 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.826 HD21 HD12 ' A' ' 26' ' ' ILE . 58.2 tp -152.88 118.76 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 18.2 m -86.75 170.68 11.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.93 -30.82 68.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 177.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -75.31 -39.91 59.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 8.9 p-10 -85.65 -1.46 57.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.826 HD12 HD21 ' A' ' 21' ' ' LEU . 11.1 tt -99.95 -37.45 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.734 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.5 -34.38 3.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.698 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.88 122.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -67.89 173.24 4.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 23' ' ' GLU . 4.4 mt-10 -48.96 -51.32 31.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.766 -171.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.55 -57.89 8.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.834 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.48 -32.14 69.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 37' ' ' VAL . 80.0 t80 -65.63 -51.81 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.47 -46.14 89.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.725 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.19 -45.93 89.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.251 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 7' ' ' ARG . . . -60.68 -55.57 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.452 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 33' ' ' PHE . 88.2 t -58.23 -44.13 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.646 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.384 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.46 -38.61 65.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 46' ' ' ILE . 67.8 mt -59.86 -43.93 94.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.088 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.95 -45.35 89.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -57.21 -49.2 76.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.26 -0.16 35.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.287 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.94 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.112 -0.566 . . . . 0.0 113.557 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.57 -43.62 12.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 117.028 0.414 . . . . 0.0 110.773 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.546 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.57 151.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.423 . . . . 0.0 111.126 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.53 166.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.486 176.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.06 65.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.196 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -72.63 117.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.4 110.05 21.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -95.77 139.92 31.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -93.12 12.76 23.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.94 11.11 6.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.344 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.32 -54.0 1.8 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -151.57 150.09 25.71 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.73 117.06 4.94 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.498 2.132 . . . . 0.0 112.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -102.06 105.13 15.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -84.1 92.02 7.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.198 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -82.92 176.91 8.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.598 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 35.5 pttt -74.4 -0.59 17.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.74 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.75 129.53 17.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.73 -71.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.653 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HG2' HG21 ' A' ' 19' ' ' THR . 30.6 Cg_endo -63.71 118.4 5.34 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.67 2.247 . . . . 0.0 113.284 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.03 150.41 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.872 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.6 mp -93.65 144.44 25.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 p -92.8 170.72 9.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.585 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.14 -35.19 71.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -58.92 -50.6 73.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.116 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.44 -35.71 46.58 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.326 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 73' ' ' LEU . 2.7 tm-20 -61.33 -35.2 76.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.439 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -75.07 -34.96 61.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.053 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.51 -32.5 73.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.283 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.922 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.83 -38.25 75.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.816 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.37 -42.79 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.957 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.45 -49.24 61.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.255 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -90.31 3.02 54.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.558 -172.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -67.27 0.9 7.42 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.436 -0.411 . . . . 0.0 113.966 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.1 t -90.44 12.08 19.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.087 0.47 . . . . 0.0 110.677 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.471 ' HH2' HD13 ' A' ' 6' ' ' LEU . 24.4 t90 -123.69 131.98 53.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.786 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.8 p 53.4 83.28 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.053 0.941 . . . . 0.0 113.131 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -101.81 179.52 4.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.641 -175.424 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.606 ' HG3' HD22 ' A' ' 6' ' ' LEU . 19.8 ptpt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD22 ' HG3' ' A' ' 5' ' ' LYS . 4.2 mm? -70.82 -30.63 67.12 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.832 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.714 ' NH2' ' HA ' ' A' ' 36' ' ' ALA . 11.3 ptm180 -64.69 -16.5 62.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.755 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 8.5 t80 -77.47 -44.57 28.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.99 175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.515 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . . . -71.21 -27.7 63.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.838 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 7' ' ' ARG . 52.6 mt -50.55 -37.83 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.578 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.5 mt -57.59 -34.06 68.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 36.7 ttpt -74.23 -48.06 31.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -38.1 75.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 110.724 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 21' ' ' LEU . 70.6 mt -66.85 -45.64 87.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.454 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.8 -48.31 77.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.787 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 28.7 mt-10 -65.11 -39.2 92.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.908 0.385 . . . . 0.0 110.758 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.95 -27.17 51.14 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.42 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 t30 63.77 26.21 14.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.956 0.503 . . . . 0.0 110.11 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.737 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 32.2 p 55.09 166.65 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.346 1.058 . . . . 0.0 112.917 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.737 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.8 Cg_endo -87.3 157.31 47.28 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.433 -3.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.53 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -153.08 129.19 10.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -85.11 170.11 13.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -55.43 -38.13 68.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 178.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.52 -38.61 90.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.587 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.6 -39.6 67.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.797 0.332 . . . . 0.0 111.047 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.53 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.5 tt -82.79 -32.05 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.305 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.44 34.86 2.38 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.248 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 26' ' ' ILE . 30.9 m -130.29 169.93 20.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -85.34 167.67 15.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.082 0.468 . . . . 0.0 111.322 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 1.5 mp0 -51.7 -60.32 3.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.046 0.927 . . . . 0.0 111.189 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.4 -19.99 59.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.9 -169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.53 -36.79 37.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.998 0.428 . . . . 0.0 110.068 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 63.8 t80 -65.28 -44.82 86.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.881 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.68 -49.4 77.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.43 -40.56 74.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HA ' ' NH2' ' A' ' 7' ' ' ARG . . . -61.79 -57.43 11.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.399 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PHE . 69.3 t -57.48 -47.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.359 0.412 . . . . 0.0 111.734 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.05 -38.99 84.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB3' HH21 ' A' ' 7' ' ' ARG . 33.1 t80 -71.85 -41.62 67.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.821 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -67.29 -38.21 84.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.84 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 41' ' ' LYS . 11.6 tmtt? -69.74 -38.26 76.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HD3' HH11 ' A' ' 42' ' ' ARG . 8.0 ttm180 -56.82 -60.5 3.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.432 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -30.43 65.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.381 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.35 56.8 0.57 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.332 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.72 -26.01 13.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.733 0.301 . . . . 0.0 110.406 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 65' ' ' LEU . 1.6 pp -142.65 142.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.851 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.25 164.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.57 22.29 40.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.672 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.22 134.72 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -89.15 109.71 20.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -95.33 120.11 34.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.505 . . . . 0.0 110.19 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.0 t -98.14 30.36 3.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.893 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 72.0 -46.81 0.65 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.025 0.93 . . . . 0.0 110.999 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -66.05 -75.71 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.304 0.573 . . . . 0.0 110.282 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 17.6 mtp180 -141.59 164.12 36.8 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.775 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 34.3 Cg_endo -66.14 138.34 51.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.629 2.219 . . . . 0.0 112.121 175.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -132.94 148.32 52.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.09 121.62 45.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.362 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.06 -166.44 1.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.771 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 27.2 mtpp -61.81 -51.61 67.59 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.607 0.567 . . . . 0.0 111.432 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.81 133.93 55.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.125 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.46 -69.74 0.37 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.13 107.67 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.889 2.393 . . . . 0.0 112.999 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 47' ' ' ILE . 67.2 mm-40 -115.81 139.97 49.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.227 175.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -75.59 144.17 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -83.46 168.57 16.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.742 0.306 . . . . 0.0 110.48 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.42 -34.68 77.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 23.8 ttmm -60.34 -47.65 85.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.853 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -64.93 -37.7 94.6 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.06 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -58.28 -53.44 58.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.429 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.33 -29.01 65.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 6.2 t80 -66.85 -30.18 70.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 11' ' ' LEU . 21.2 mt -75.65 -19.05 59.44 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.437 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -54.91 -29.05 55.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 111.809 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 6.4 mm-40 -85.28 -27.53 25.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 2.8 t-20 -85.4 3.33 40.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.318 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -48.7 -41.38 26.82 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.453 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.712 HG23 ' H ' ' A' ' 79' ' ' TRP . 2.0 t -91.33 -81.96 0.31 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.286 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.712 ' H ' HG23 ' A' ' 78' ' ' THR . 33.7 t-105 45.59 80.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.877 0.471 . . . . 0.0 111.024 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 t 70.26 -34.84 0.3 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.459 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 78' ' ' THR . 97.5 mttt -71.38 80.77 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 110.013 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.669 176.018 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.312 0.577 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.63 -9.66 46.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.703 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 40' ' ' LEU . 7.7 ptp180 -60.89 -45.75 93.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.108 -174.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.478 ' HE2' ' CG ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -60.98 -42.37 98.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.415 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.75 68.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.18 -40.91 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.673 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 84.3 mt -58.09 -51.27 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.648 0.261 . . . . 0.0 110.938 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 5.6 ttpm? -67.34 -41.86 84.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.773 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -29.49 69.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 19' ' ' THR . 53.5 mt -73.46 -47.21 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.96 -47.0 87.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.29 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.21 -33.84 49.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.71 -22.51 57.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.105 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.42 1.46 3.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 0.0 111.237 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.1 p 55.48 164.42 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.263 1.025 . . . . 0.0 113.293 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 73.5 Cg_endo -90.32 118.35 3.41 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.182 -1.174 . . . . 0.0 111.969 -1.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.7 pt? -90.22 134.77 34.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.761 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -80.75 164.84 22.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.164 0.507 . . . . 0.0 110.948 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -51.0 64.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.011 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.27 -14.6 62.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.331 0.586 . . . . 0.0 110.525 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.45 -39.36 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.608 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.505 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.2 tt -76.97 -35.11 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.1 -31.05 3.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.001 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.06 152.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.887 -0.184 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.2 t -68.51 173.31 5.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.368 0.604 . . . . 0.0 110.524 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.37 -41.26 98.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.472 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.92 -40.5 95.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.274 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -73.99 -39.83 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 110.641 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.24 -49.03 78.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.669 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -62.17 -46.33 89.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.279 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.04 -50.56 70.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.445 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.85 72.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.822 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.47 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.557 0.218 . . . . 0.0 111.483 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -65.26 -35.69 81.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.93 -43.4 75.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.2 mt -63.22 -34.23 77.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.053 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -35.09 77.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -67.24 -42.91 83.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.35 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.168 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.75 39.77 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.19 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.05 -30.73 18.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 0.0 110.217 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.8 pp -142.45 152.02 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.46 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 pt -134.84 177.46 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.867 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.33 16.71 79.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.82 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.05 113.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.231 0.538 . . . . 0.0 109.57 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -80.34 113.09 18.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.794 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 79.5 m-85 -101.51 143.28 31.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.6 m -129.29 93.12 3.5 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.7 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 64.85 -76.03 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.393 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.12 -44.04 6.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.611 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -137.03 148.46 62.9 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.739 -170.01 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 38.8 Cg_endo -69.93 143.43 50.0 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.312 2.008 . . . . 0.0 111.022 170.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 21.6 m80 -104.03 -44.46 5.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 79.8 mt 68.2 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.438 0.637 . . . . 0.0 110.641 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -141.19 173.25 11.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 87.7 mttt -75.1 1.74 12.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.57 41.84 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.3 -86.55 1.59 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.153 -0.931 . . . . 0.0 114.019 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.47 159.34 14.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.028 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.55 139.99 51.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.585 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.0 mp -91.43 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.784 0.326 . . . . 0.0 110.729 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.8 p -88.44 170.7 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.28 -24.32 67.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.189 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -50.29 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.89 -42.25 53.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.077 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.03 -44.42 96.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.338 . . . . 0.0 110.473 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.419 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 3.2 m120 -72.87 -20.04 61.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.882 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -75.86 -28.82 58.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 83.1 mt -70.95 -22.65 62.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 70.6 mmtt -51.16 -65.12 0.61 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.74 -30.18 56.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.767 -172.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.43 3.28 55.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -48.85 -26.42 5.69 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -64.96 -84.92 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 117.472 0.636 . . . . 0.0 112.081 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.478 ' CG ' ' HE2' ' A' ' 8' ' ' TYR . 69.9 t-105 66.92 175.2 0.25 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.365 0.602 . . . . 0.0 111.267 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.6 m -146.37 121.24 9.96 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.077 -0.389 . . . . 0.0 110.138 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -8.53 59.25 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.533 0.206 . . . . 0.0 111.504 -176.808 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.863 ' HG3' HD22 ' A' ' 6' ' ' LEU . 12.1 ptmm? . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.66 0.267 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.863 HD22 ' HG3' ' A' ' 5' ' ' LYS . 3.3 mm? -81.43 -12.11 59.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -64.64 -42.94 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 43.8 t80 -59.72 -43.4 94.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.948 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.12 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.377 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.72 -43.54 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.71 -52.45 64.92 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -71.13 -22.77 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.026 -176.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 1.9 tp10 -80.13 -23.71 40.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.248 0.547 . . . . 0.0 109.883 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.02 -47.12 49.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.85 -50.02 75.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.66 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -99.62 -6.15 27.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -90.09 -12.44 61.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.449 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.9 t30 75.38 -17.24 0.52 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.005 0.522 . . . . 0.0 111.435 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.0 p 58.62 156.92 0.09 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.563 1.145 . . . . 0.0 113.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.5 Cg_endo -83.72 176.31 33.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.798 -1.334 . . . . 0.0 113.136 0.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.4 pt? -150.58 133.5 15.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 m -85.28 170.43 12.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.97 -37.93 77.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.093 175.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.42 -16.79 64.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.589 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.04 -49.98 7.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 110.821 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.7 -38.61 58.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.93 22.17 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.189 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 26' ' ' ILE . 33.9 m -127.38 173.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 t -85.01 157.97 20.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 110.928 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.7 pm0 -63.29 -30.24 71.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.046 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -48.3 79.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.422 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 9.7 mm100 -82.44 -19.95 37.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.962 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.81 -55.58 16.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.05 -47.97 76.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.222 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.602 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 8.7 t70 -52.34 -49.04 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.315 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -68.06 -51.45 46.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.288 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.01 -42.32 85.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 111.237 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 95.4 m-20 -65.55 -41.48 92.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.526 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.21 -42.94 96.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.39 . . . . 0.0 110.596 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -59.41 -44.74 92.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.2 ttpm? -70.92 -34.62 71.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.369 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 15.4 ttt-85 -66.37 -40.49 89.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.609 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.7 -40.1 61.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.817 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.05 2.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.805 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.526 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 60.2 m-85 -78.3 -41.32 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.571 0.224 . . . . 0.0 111.415 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.535 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -139.94 161.83 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.0 110.961 -177.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -129.24 170.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.204 174.019 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 90.71 19.87 42.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.699 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.72 114.5 22.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -88.46 141.03 28.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.0 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -119.99 136.13 54.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.0 m -122.33 -80.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.122 0.487 . . . . 0.0 111.295 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -37.96 84.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 164.32 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.535 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -103.88 158.36 32.05 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.833 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.3 134.7 23.3 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.577 2.184 . . . . 0.0 112.739 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -126.47 135.26 51.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.393 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -98.66 152.8 19.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.838 0.352 . . . . 0.0 110.604 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -134.71 -177.94 4.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.09 -29.45 64.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.965 0.412 . . . . 0.0 110.881 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -128.2 126.72 41.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 156.62 -64.82 0.31 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 58' ' ' LEU . 10.8 Cg_exo -70.45 100.69 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.738 2.292 . . . . 0.0 112.866 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -105.69 140.24 39.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.658 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.6 mp -90.96 140.04 30.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.674 0.273 . . . . 0.0 110.395 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.0 p -90.03 177.09 6.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -59.46 -33.11 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.673 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.19 -44.57 95.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.91 -41.83 21.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.714 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.66 -41.08 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.823 0.344 . . . . 0.0 110.975 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -79.12 -20.34 48.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 72.5 t80 -65.14 -33.58 76.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 12' ' ' LYS . 77.8 mt -61.02 -25.97 67.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.944 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -74.17 -50.01 21.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -73.31 -40.3 64.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.822 -174.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -98.95 5.77 47.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.914 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -57.52 -22.08 44.31 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.391 170.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 t -76.32 -22.78 54.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.252 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 4.6 t90 49.83 62.29 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.219 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 p -174.45 92.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.212 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.25 80.93 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.508 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.311 178.36 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.607 ' HB3' ' HE1' ' A' ' 79' ' ' TRP . 98.2 mttt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 121.052 0.453 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.76 -26.93 61.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.983 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' O ' HD13 ' A' ' 11' ' ' LEU . 98.7 mtt180 -69.52 -11.84 61.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.465 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 57.1 t80 -100.1 -46.03 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.67 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.54 81.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.86 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.99 -47.79 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 73' ' ' LEU . 10.5 mp -64.31 -32.67 74.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.948 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -65.14 -44.78 87.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.99 -41.0 97.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.61 -39.14 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.556 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' HD2' HD22 ' A' ' 65' ' ' LEU . 15.8 t80 -68.58 -50.12 54.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.86 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.22 -40.89 26.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.657 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.33 -18.55 58.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.5 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 62.31 24.32 14.47 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 110.497 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.7 p 54.98 171.96 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.987 0.915 . . . . 0.0 113.235 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.1 Cg_endo -85.06 179.7 21.99 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 123.809 -1.33 . . . . 0.0 112.074 -3.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -155.24 124.17 6.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -76.34 163.48 26.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.304 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.435 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.94 -16.48 60.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.75 -42.15 22.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 21' ' ' LEU . 4.2 tt -77.23 -38.71 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.3 35.89 0.98 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.293 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 26' ' ' ILE . 35.9 m -137.06 174.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -84.99 156.46 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.43 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 4.6 mt-10 -55.38 -40.83 71.84 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.65 -60.71 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.598 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.1 -32.42 69.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.947 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.9 t80 -65.08 -59.2 4.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.899 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 55' ' ' ARG . 5.8 m-20 -57.19 -43.89 83.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.714 0.292 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.41 -45.2 94.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.257 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.82 -48.06 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.46 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 33' ' ' PHE . 99.4 t -59.1 -42.32 86.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.245 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.43 -44.85 93.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.429 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.18 -42.52 99.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.797 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.1 mt -59.11 -42.89 91.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.448 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.509 ' HD3' ' HB ' ' A' ' 49' ' ' VAL . 29.8 ttpt -75.6 -38.31 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.359 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -39.93 94.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.439 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -4.33 56.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.227 0.537 . . . . 0.0 110.48 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 37.04 40.69 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.482 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -83.48 -47.45 11.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.281 0.54 . . . . 0.0 110.238 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -134.82 161.53 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 177.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 64' ' ' GLU . 25.6 pt -129.96 177.23 6.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.934 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.69 11.85 65.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.513 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' ' HD3' ' A' ' 41' ' ' LYS . 39.1 t -77.79 121.75 31.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -101.98 129.75 48.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.19 0.519 . . . . 0.0 111.586 -173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -115.65 132.72 56.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.789 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -102.67 34.8 2.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.422 0.629 . . . . 0.0 109.317 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t70 51.32 58.45 5.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.961 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -156.78 -46.66 0.07 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.434 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 11.2 ptm180 -176.6 163.43 1.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -66.15 126.08 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.273 1.982 . . . . 0.0 112.059 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -116.91 130.69 56.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.404 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.02 140.27 35.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.611 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.04 178.13 7.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.535 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 68.6 mttm -79.77 -18.03 52.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.61 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.59 104.06 14.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.949 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.58 -67.71 0.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.613 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.15 119.01 3.15 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.534 2.822 . . . . 0.0 114.504 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 47' ' ' ILE . 41.9 mt-10 -130.92 142.41 50.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.032 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD22 ' HD2' ' A' ' 15' ' ' PHE . 6.3 mp -96.76 140.98 30.54 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.11 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 p -100.7 171.73 7.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.07 -33.02 73.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.359 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -60.99 -52.04 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.44 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.75 73.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.114 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.14 -45.5 91.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.738 0.304 . . . . 0.0 110.465 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -73.4 -20.27 60.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.465 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -70.05 -47.16 63.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 11' ' ' LEU . 96.2 mt -60.27 -32.44 71.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.002 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.45 -55.83 29.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.713 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.22 -32.45 22.63 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.97 2.85 21.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.465 ' HA2' ' CE1' ' A' ' 8' ' ' TYR . . . -66.02 -18.95 67.38 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.524 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.07 -47.72 70.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.607 ' HE1' ' HB3' ' A' ' 5' ' ' LYS . 9.2 t90 64.08 -74.04 0.05 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 123.862 0.726 . . . . 0.0 111.591 174.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m -154.15 -54.4 0.1 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 68.44 -77.55 0.05 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.569 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -175.021 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.653 0.263 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 mm? -56.75 -34.4 67.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.095 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.4 ptt180 -51.09 -34.28 29.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 111.417 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 20.3 t80 -71.34 -43.49 66.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.147 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.57 60.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 7' ' ' ARG . 82.4 mt -59.38 -33.66 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.748 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -52.43 -40.97 62.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 24.9 ttpp -69.95 -44.37 69.68 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.071 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.56 -33.83 75.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.94 0.4 . . . . 0.0 110.504 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 19' ' ' THR . 82.4 mt -57.7 -46.48 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.988 172.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -67.28 -44.53 79.05 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.148 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 8.1 mm-40 -62.4 -40.53 96.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.431 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.11 -13.43 52.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.267 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.51 25.54 11.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.145 0.498 . . . . 0.0 110.176 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.534 HG23 HG23 ' A' ' 14' ' ' ILE . 20.6 p 57.76 154.14 0.08 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.428 1.091 . . . . 0.0 113.226 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -91.35 -165.96 2.41 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.693 -0.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.78 125.21 6.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.212 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -84.91 170.02 13.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 111.197 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.76 -41.08 96.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.372 -178.262 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.49 -24.74 65.62 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.454 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.4 -46.23 28.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.639 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.608 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -80.4 -38.74 18.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.459 -177.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.7 -14.8 12.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.673 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.608 ' H ' HG23 ' A' ' 26' ' ' ILE . 35.1 m -101.0 144.95 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.986 0.393 . . . . 0.0 111.127 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -66.53 161.47 22.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 177.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 7.2 mt-10 -58.81 -40.72 84.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.659 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.24 -34.7 78.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -75.0 -36.15 61.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.5 . . . . 0.0 109.914 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 49.4 t80 -65.6 -52.96 48.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.326 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' ' HD3' ' A' ' 56' ' ' PRO . 9.8 t70 -56.62 -47.59 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.332 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.58 -45.94 90.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 7' ' ' ARG . . . -66.74 -40.46 88.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.357 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' PHE . 59.5 t -61.76 -46.09 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.616 0.246 . . . . 0.0 110.712 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -63.72 -37.35 87.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.827 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -64.99 -48.55 73.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 0.0 110.121 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 7' ' ' ARG . 59.5 mt -60.98 -37.53 82.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -69.9 -31.5 69.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.27 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.91 -38.86 76.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.859 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 45' ' ' TYR . 48.1 mt-10 -79.93 -22.25 42.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.858 0.361 . . . . 0.0 110.793 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 45.51 4.5 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.438 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.456 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 57.0 m-85 -92.0 -34.04 14.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.105 0.453 . . . . 0.0 111.249 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.45 144.94 32.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.087 177.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 pp -129.98 165.3 30.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.338 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.05 60.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.486 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.93 122.81 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.02 110.15 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.04 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -93.85 114.52 26.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 m -99.06 -75.56 0.56 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 110.388 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 9.9 p-10 -79.42 -32.0 42.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.095 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 53' ' ' ASP . 32.8 t70 163.47 -25.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.334 -173.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -102.81 157.8 33.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.049 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' OD1' ' A' ' 34' ' ' ASP . 71.6 Cg_endo -76.22 120.71 5.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.489 2.126 . . . . 0.0 112.447 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -109.06 112.72 25.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.27 141.18 31.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.007 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.5 -177.97 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.477 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -81.45 15.0 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.752 0.31 . . . . 0.0 110.782 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.4 tp -159.63 120.08 3.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.937 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.51 -71.09 0.41 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.028 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 14.6 Cg_exo -69.24 122.05 8.86 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.855 2.37 . . . . 0.0 113.308 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -125.36 152.38 44.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.019 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -88.09 137.72 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -83.19 173.67 11.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.19 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.42 -41.01 79.55 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -55.83 -54.81 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.748 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -66.55 -41.54 94.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.932 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -58.53 -46.87 85.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.57 -27.3 62.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -70.67 -24.92 62.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 80.4 mt -58.84 -19.28 40.04 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 74' ' ' LYS . 23.9 ttpt -43.27 -49.3 6.74 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -73.69 -37.1 65.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.078 0.466 . . . . 0.0 111.19 -174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 58.9 t30 -61.56 -20.96 63.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.496 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.52 -34.29 75.23 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.882 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -100.71 -8.33 22.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.257 0.529 . . . . 0.0 110.838 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -80.93 -39.64 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -84.71 -34.82 22.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.63 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 66.58 -83.68 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.819 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 121.096 0.474 . . . . 0.0 110.54 -176.654 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.79 ' HB2' HD22 ' A' ' 6' ' ' LEU . 48.0 mttp . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.79 HD22 ' HB2' ' A' ' 5' ' ' LYS . 2.3 mm? -100.32 -7.95 23.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -171.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.66 HH11 ' HA ' ' A' ' 36' ' ' ALA . 2.2 ttm-85 -70.58 -41.26 72.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -170.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CD1' ' HB3' ' A' ' 76' ' ' ASN . 63.9 t80 -58.95 -41.66 87.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HB2' ' CH2' ' A' ' 79' ' ' TRP . . . -58.9 -47.37 85.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 74.5 mt -63.47 -40.94 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.728 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 73' ' ' LEU . 23.7 mt -55.06 -50.17 69.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.722 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -72.38 -29.69 63.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.988 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 5.6 mm-40 -70.55 -29.8 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' ILE . 79.8 mt -69.89 -36.69 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.168 0.508 . . . . 0.0 109.876 173.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -78.33 -50.23 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.673 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -84.4 -38.63 20.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.945 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -20.08 75.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.5 t30 65.86 20.47 11.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.841 0.456 . . . . 0.0 110.777 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.641 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.7 p 55.96 165.41 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.858 0.863 . . . . 0.0 113.039 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 92.2 Cg_endo -79.56 171.03 65.61 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 124.056 -1.227 . . . . 0.0 112.32 0.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -134.55 118.69 17.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -86.1 169.04 13.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.367 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.79 -40.63 95.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -71.11 -19.14 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.399 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.36 -42.55 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.519 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -87.94 -36.04 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.609 -177.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.71 -17.6 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.272 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 28.7 m -89.53 161.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 O-C-N 122.742 -0.269 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -85.24 179.99 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 10.9 mt-10 -59.45 -44.24 92.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.946 -173.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -53.01 62.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.624 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 44.2 mt-30 -63.7 -46.11 86.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -59.57 -44.72 93.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.162 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.56 -55.53 33.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.084 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.68 -41.58 81.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.64 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.66 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -64.51 -57.57 8.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.2 -42.31 94.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 O-C-N 123.251 0.344 . . . . 0.0 111.782 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -61.07 -46.49 90.43 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.713 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.2 mt -61.36 -46.75 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.546 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HD2' ' O ' ' A' ' 46' ' ' ILE . 23.1 tptp -69.24 -38.55 78.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 110.027 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -61.66 -41.59 97.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.376 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.899 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.79 39.96 0.74 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.625 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.576 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 67.4 m-85 -91.3 -29.4 17.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 49' ' ' VAL . 1.3 pp -143.75 156.75 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.686 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 29.0 pt -133.02 -179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.422 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.11 17.61 79.91 Favored Glycine 0 N--CA 1.454 -0.13 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.611 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 HD13 ' A' ' 46' ' ' ILE . 86.5 t -93.5 119.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.242 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -94.86 110.68 22.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 111.19 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -79.8 134.98 36.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.3 m -127.86 -80.09 0.59 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.114 0.483 . . . . 0.0 110.621 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 11.2 p-10 -105.14 82.61 1.87 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.926 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 6.4 t70 72.03 -36.19 0.35 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.588 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.5 ptm85 -118.98 153.81 52.9 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -170.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.54 144.08 48.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.06 2.507 . . . . 0.0 112.106 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -124.18 121.66 35.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.34 106.78 18.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.275 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 19' ' ' THR . 44.6 m-85 -95.62 -173.88 3.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 41.5 mtpt -63.0 -48.74 77.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.383 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.88 142.58 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.38 -67.07 0.45 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.613 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 51.7 Cg_exo -56.7 125.68 19.81 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.055 2.504 . . . . 0.0 113.821 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 47' ' ' ILE . 53.3 mm-40 -123.52 142.03 51.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.1 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.4 ' HG ' ' CG2' ' A' ' 46' ' ' ILE . 7.0 mp -90.07 138.34 31.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.365 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.4 p -82.5 179.91 7.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.85 -47.55 74.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.62 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.893 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -64.75 -46.12 90.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.778 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.79 -44.7 96.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.543 0.211 . . . . 0.0 111.355 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -73.32 -30.91 63.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.149 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -66.64 -31.53 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 98.4 mt -57.55 -40.1 78.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.794 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -66.5 -43.49 85.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.554 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.02 -46.9 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 0.0 111.076 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -88.71 5.22 44.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.446 -177.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -51.3 -34.19 32.81 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.134 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -82.05 89.17 6.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.822 0.82 . . . . 0.0 109.493 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 9' ' ' ALA . 64.5 t90 -141.41 136.25 31.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.797 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.3 p 55.72 -161.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.83 0.852 . . . . 0.0 112.013 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -140.24 -171.39 3.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -173.568 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.8 ' HG3' HD22 ' A' ' 6' ' ' LEU . 49.1 pttt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 120.713 0.292 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.8 HD22 ' HG3' ' A' ' 5' ' ' LYS . 1.3 mm? -100.58 -13.59 18.53 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HG2' HD21 ' A' ' 40' ' ' LEU . 79.5 mtt180 -54.8 -46.88 74.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.506 0.594 . . . . 0.0 111.353 -171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.812 ' HE1' ' HA2' ' A' ' 77' ' ' GLY . 88.3 t80 -55.44 -57.41 11.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.084 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.26 97.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.486 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.3 mt -59.91 -49.03 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.863 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.4 mp -59.81 -47.25 86.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -75.82 -26.92 57.66 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.582 -0.447 . . . . 0.0 112.063 -176.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -77.08 -28.17 54.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.449 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.53 -48.33 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.92 -50.03 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.13 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.12 -30.36 22.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.431 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.95 -24.88 72.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.134 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.6 -4.28 2.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.0 0.52 . . . . 0.0 111.16 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 53.3 p 57.35 156.42 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.117 0.967 . . . . 0.0 112.957 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 6.2 Cg_exo -76.35 166.88 81.66 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 124.315 -1.119 . . . . 0.0 112.938 0.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -148.2 127.33 12.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -81.91 169.95 16.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.324 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -58.76 -37.33 76.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.795 174.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.53 -27.78 67.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.602 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.99 -49.86 14.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.758 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 28' ' ' VAL . 11.0 tt -75.7 -29.58 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 -175.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.37 32.95 4.08 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.083 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 26' ' ' ILE . 28.4 m -137.64 171.62 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' GLN . 2.3 t -85.39 164.47 17.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 0.0 110.938 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -60.79 -42.05 96.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.94 -53.94 51.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.665 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' H ' HG23 ' A' ' 29' ' ' THR . 30.6 mm-40 -69.57 -24.16 63.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.01 -54.07 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.69 -48.5 72.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.848 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.72 -56.8 12.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.784 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -70.34 -45.96 65.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.868 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.72 -44.31 98.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.598 0.237 . . . . 0.0 111.104 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -66.55 -35.26 79.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.992 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.72 -42.11 78.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.911 0.386 . . . . 0.0 110.227 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 7' ' ' ARG . 89.7 mt -62.1 -37.82 86.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.443 176.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 4.7 ttpm? -70.81 -25.68 62.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.37 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -70.12 -54.33 13.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.803 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 34.8 mt-10 -80.24 -20.14 45.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 110.912 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 58.29 1.37 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.841 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 96.5 m-85 -96.12 -33.43 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.249 0.547 . . . . 0.0 109.59 173.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.441 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -140.07 150.55 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.33 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.71 -179.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 84.91 4.19 87.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.081 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.74 113.2 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 0.0 109.984 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -79.97 110.18 15.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.336 0.588 . . . . 0.0 109.657 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.37 130.4 39.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 -176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -97.05 23.35 7.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 70.97 -49.55 0.68 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.133 0.973 . . . . 0.0 111.41 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.7 -59.31 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -141.8 164.32 35.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.07 136.21 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.264 2.643 . . . . 0.0 111.521 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -129.69 123.63 31.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.279 0.562 . . . . 0.0 110.285 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 90.4 mt -86.61 87.37 7.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.582 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -71.82 167.4 20.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.268 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 23.8 mtpp -61.97 -47.12 86.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.76 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.64 112.72 25.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.358 . . . . 0.0 110.135 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 160.42 -62.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.278 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.85 116.94 3.08 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.01 2.473 . . . . 0.0 113.324 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 62' ' ' GLY . 35.6 mt-10 -129.67 160.26 33.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.488 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.2 147.78 28.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -91.97 170.56 9.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -64.87 -29.64 70.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 4.0 ttmp? -62.89 -46.6 87.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.778 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -73.29 -36.82 55.21 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.566 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.47 -49.39 75.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -70.66 -25.52 63.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 24.9 t80 -62.92 -39.36 94.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.83 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 11' ' ' LEU . 85.5 mt -54.13 -41.57 68.54 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -66.21 -32.19 73.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.152 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.02 -62.94 1.48 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.128 0.49 . . . . 0.0 110.998 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 8' ' ' TYR . 20.5 p-10 -80.72 5.07 16.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.474 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.812 ' HA2' ' HE1' ' A' ' 8' ' ' TYR . . . -62.5 -7.17 13.44 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.921 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -71.92 -53.48 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.819 0.31 . . . . 0.0 110.634 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 29.88 57.15 0.17 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.4 1.08 . . . . 0.0 112.622 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 t 66.65 -86.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.159 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.85 22.59 5.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.144 0.578 . . . . 0.0 112.053 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.172 179.392 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 mttm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.2 -32.97 61.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 109.013 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.751 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -62.89 -28.72 70.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.119 174.026 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.981 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 61.6 t80 -69.76 -41.41 75.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.663 175.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.56 -46.45 80.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 26' ' ' ILE . 25.0 mm -54.78 -48.88 72.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.808 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 73' ' ' LEU . 71.9 mt -56.36 -43.74 79.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -65.39 -45.82 82.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.631 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -29.66 69.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.327 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 21' ' ' LEU . 80.6 mt -61.96 -46.59 96.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -67.87 -42.88 80.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.702 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.6 -40.09 73.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.877 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.47 -20.79 57.92 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.006 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.7 t30 64.52 20.44 12.15 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.703 0.401 . . . . 0.0 110.16 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 41.6 p 58.38 150.69 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 124.517 1.127 . . . . 0.0 113.255 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -87.25 161.03 49.2 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.208 -0.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 14' ' ' ILE . 1.6 pt? -131.37 120.96 23.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 m -82.59 164.86 20.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.559 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -59.36 -44.73 92.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 176.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.83 -21.39 62.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.047 0.451 . . . . 0.0 111.011 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.04 -46.79 15.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.665 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -71.61 -37.08 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.001 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.58 35.96 1.81 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.135 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 26' ' ' ILE . 35.8 m -140.42 170.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 p -76.8 160.54 29.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.46 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 5.6 mt-10 -57.64 -48.97 77.98 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.255 0.55 . . . . 0.0 109.52 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.76 -45.52 19.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.786 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -74.65 -38.73 62.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.054 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -64.92 -46.95 79.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.631 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -56.66 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.707 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.73 -34.54 77.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.849 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.751 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -60.34 -52.72 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.68 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -41.87 98.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.715 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -64.3 -48.36 75.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.91 -36.07 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.734 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -75.74 -28.6 58.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -77.66 -43.98 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -76.22 -13.01 60.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.362 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.45 51.77 4.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 73.3 m-85 -98.2 -39.2 8.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.058 0.456 . . . . 0.0 109.822 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 ' HG ' ' A' ' 65' ' ' LEU . 2.0 pp -138.78 149.4 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.576 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.96 168.83 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.817 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 24.94 34.14 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.1 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.43 128.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 110.321 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -94.89 126.04 39.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.826 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.63 145.75 28.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.269 0.557 . . . . 0.0 111.784 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.2 t -96.23 -149.53 0.31 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.673 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -43.08 -57.0 3.1 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.627 0.579 . . . . 0.0 110.695 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.36 -18.68 0.71 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.074 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.593 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 75.0 mtp180 -105.36 148.4 36.22 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 122.33 -0.231 . . . . 0.0 110.599 -172.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 153.33 57.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 143.36 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.24 136.64 51.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' THR . 96.6 m-85 -108.01 -168.63 1.4 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.864 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 49.8 mtpt -75.79 -13.67 60.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.941 0.4 . . . . 0.0 111.119 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -161.54 161.12 29.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.99 -59.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.143 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.95 141.85 72.61 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.471 2.114 . . . . 0.0 113.756 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -120.52 150.95 40.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.766 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -96.96 144.71 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.4 p -83.4 179.59 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.465 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.1 -42.65 99.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.14 -49.03 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.858 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.65 -47.91 65.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.74 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.409 . . . . 0.0 111.169 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -77.35 -35.28 54.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.985 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -58.93 -39.1 80.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.254 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.981 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.7 -46.96 83.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.919 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -71.32 -39.89 71.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.742 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -73.48 -39.02 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.931 0.396 . . . . 0.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -92.74 5.66 50.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -52.94 -12.3 1.7 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.707 0.643 . . . . 0.0 114.707 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -95.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 117.235 0.517 . . . . 0.0 110.154 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.4 ' CG ' ' N ' ' A' ' 80' ' ' SER . 9.7 t90 51.68 -152.27 0.23 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.665 0.386 . . . . 0.0 110.135 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 77.3 p 51.18 23.49 1.63 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.703 0.801 . . . . 0.0 112.408 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -81.38 72.38 8.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 173.1 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.617 0.246 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? -91.43 -14.38 30.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.778 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 8.8 mmt180 -59.77 -51.89 67.8 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.598 0.714 . . . . 0.0 109.404 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 18.3 t80 -51.85 -46.14 64.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.167 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.46 62.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 6' ' ' LEU . 73.2 mt -59.37 -30.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.604 0.24 . . . . 0.0 111.266 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -52.75 -38.65 61.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.598 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.6 ttpp -74.07 -39.15 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.745 -177.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.07 -32.09 73.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.38 . . . . 0.0 110.523 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.58 -43.51 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 110.081 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -64.09 -50.33 68.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.019 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 6.0 mt-10 -77.7 -19.14 55.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 110.677 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.46 -17.11 69.48 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.617 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.98 16.28 9.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.01 0.524 . . . . 0.0 110.436 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.1 p 56.18 151.6 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.521 1.128 . . . . 0.0 112.956 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -78.85 177.69 37.39 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.451 -1.479 . . . . 0.0 112.457 -2.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 26' ' ' ILE . 43.5 tp -149.79 119.31 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.981 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 17.0 m -85.8 164.51 17.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.201 175.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -68.02 -33.78 75.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.55 -36.47 84.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 9.1 m-20 -71.0 -34.55 71.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.396 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -83.95 -35.03 10.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.099 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 26' ' ' ILE . 31.5 m -135.39 173.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 110.326 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 p -85.59 166.76 15.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.681 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 24.3 mt-10 -67.03 -33.22 75.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.708 0.766 . . . . 0.0 108.957 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -49.77 -57.2 7.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.959 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -72.43 -33.79 67.36 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.966 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 47.6 t80 -66.28 -50.71 62.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.3 t70 -62.76 -45.6 91.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.19 -41.89 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.712 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -67.36 -55.9 11.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.837 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.37 -34.97 67.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.159 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.59 -45.59 86.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.607 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.7 t80 -61.68 -41.43 97.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.088 0.47 . . . . 0.0 110.065 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.0 mt -64.66 -39.85 94.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.134 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -34.81 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -60.9 -52.99 62.68 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.626 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 8.3 mm-40 -74.12 -28.42 61.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.958 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.08 40.9 2.54 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.953 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -89.78 -32.77 16.81 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.676 -0.308 . . . . 0.0 111.295 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -137.42 148.41 25.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 27.6 pt -133.8 170.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.251 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.68 90.57 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.256 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG21 HD13 ' A' ' 46' ' ' ILE . 44.2 t -70.22 128.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -94.71 119.14 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.106 0.479 . . . . 0.0 111.143 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -109.79 143.96 38.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.437 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -145.01 -85.28 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 55' ' ' ARG . 15.6 t70 -65.13 111.91 3.14 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 153.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 4.0 m-20 -52.8 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.657 1.223 . . . . 0.0 113.444 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 50.4 mtp180 -149.05 116.24 3.76 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.076 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 26.8 Cg_exo -60.11 119.55 6.81 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 113.724 -165.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -106.59 112.62 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.527 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.86 145.76 25.91 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.608 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.12 171.92 12.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 51.8 mttm -78.17 -18.33 55.68 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.612 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 124.15 42.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.47 -65.59 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.734 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 33.5 Cg_exo -60.7 121.73 10.17 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.81 2.34 . . . . 0.0 112.812 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -128.23 145.19 51.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 129.85 39.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.35 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.9 p -80.02 166.14 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.104 0.252 . . . . 0.0 110.877 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.6 -38.28 69.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.145 0.498 . . . . 0.0 109.991 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -52.26 -55.39 21.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.726 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -76.42 -36.03 40.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.02 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -63.41 -40.92 98.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.703 0.287 . . . . 0.0 110.873 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.66 -29.4 61.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.437 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.03 -27.01 68.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.294 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 91.8 mt -69.31 -19.1 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.34 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -45.87 -47.51 16.09 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -83.15 -19.64 36.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 111.156 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 65.5 t30 -78.85 -9.26 59.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 -175.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.5 -19.28 57.65 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.432 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 t -103.31 -7.64 20.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.507 ' HZ3' ' HD2' ' A' ' 8' ' ' TYR . 10.7 t90 -104.8 147.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.8 p 51.05 31.75 6.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.496 0.665 . . . . 0.0 111.07 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 52.2 tttp -152.78 167.69 28.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 120.462 0.172 . . . . 0.0 111.184 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 33.8 mttm . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.459 0.647 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.71 -28.43 67.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.897 174.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -56.71 -38.22 72.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.692 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 5' ' ' LYS . 39.3 t80 -59.96 -43.95 94.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.192 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.02 82.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.762 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.01 -49.49 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.654 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.8 mp -61.34 -37.31 82.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.254 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -24.26 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.982 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.89 -39.18 61.62 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.58 -43.67 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.579 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.52 -50.61 29.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.876 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -83.28 -40.08 20.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.777 0.322 . . . . 0.0 110.842 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 -26.86 59.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.491 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 67.1 t30 64.5 25.9 13.32 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.075 0.55 . . . . 0.0 110.64 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.521 HG21 ' HG2' ' A' ' 63' ' ' PRO . 18.0 p 56.65 156.97 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.39 1.076 . . . . 0.0 113.338 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.2 Cg_endo -83.25 172.8 46.35 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.377 -2.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.52 136.18 21.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -85.16 166.86 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.692 0.282 . . . . 0.0 110.461 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 1.4 mp0 -55.25 -42.61 73.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.443 0.639 . . . . 0.0 110.242 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -69.59 -22.95 63.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.263 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.37 -49.87 44.7 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.66 0.267 . . . . 0.0 110.501 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.4 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -70.19 -38.68 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.907 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.57 -2.52 11.17 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.785 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 26' ' ' ILE . 34.1 m -116.09 160.97 15.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.234 0.517 . . . . 0.0 110.839 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -70.12 159.88 33.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 10.0 pt-20 -60.31 -29.63 68.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.003 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.85 -52.36 66.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.597 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -74.61 -35.12 62.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 74.5 t80 -58.07 -55.77 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.243 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -54.83 -49.71 70.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.778 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -50.27 73.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.804 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -69.86 -44.82 69.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.549 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.65 -37.03 74.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.482 0.182 . . . . 0.0 110.858 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.19 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.564 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.8 -39.13 93.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.996 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 95.1 mt -62.37 -37.59 86.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 0.0 110.903 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 51.9 tttm -77.68 -33.6 53.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.45 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.04 -47.6 70.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.11 8.27 16.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.41 49.01 59.43 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.387 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 64.1 m-85 -95.15 -39.76 9.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -140.47 142.77 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.214 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.32 175.71 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.068 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.65 6.08 73.73 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 49.8 t -76.24 109.92 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -87.69 111.07 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.071 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.39 135.78 37.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.639 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 7.6 t -104.28 32.41 4.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.2 t70 74.75 -47.13 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.257 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD1' ' HB3' ' A' ' 52' ' ' SER . 11.5 p-10 -71.29 -54.22 11.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -147.4 164.33 23.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.13 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.95 101.95 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.194 1.929 . . . . 0.0 110.722 169.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -92.17 108.72 20.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.72 109.42 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.946 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.8 -168.11 1.94 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.449 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -75.86 -45.48 35.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.204 0.525 . . . . 0.0 110.22 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.32 132.0 53.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.608 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.01 -63.14 0.39 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.398 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HG2' HG21 ' A' ' 19' ' ' THR . 35.9 Cg_exo -59.01 120.24 7.98 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.792 2.328 . . . . 0.0 112.662 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.85 151.67 46.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.005 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.21 148.45 22.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.23 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -91.72 161.05 15.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -66.35 -26.8 67.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -61.46 -51.75 67.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.256 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.7 71.44 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.37 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -62.67 -41.88 99.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.04 0.447 . . . . 0.0 109.854 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -70.81 -32.04 68.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.9 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.17 -36.64 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 110.083 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 11' ' ' LEU . 89.2 mt -58.41 -33.28 69.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.257 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -62.01 -34.7 76.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.57 -43.18 14.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.606 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 73' ' ' LEU . 23.0 p30 -91.1 5.62 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.97 -18.88 4.76 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.262 0.351 . . . . 0.0 113.952 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 79' ' ' TRP . 3.1 t -74.15 -118.16 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.589 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 73.1 t90 72.93 120.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.8 m 68.86 -65.5 0.28 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HD3' ' O ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -75.64 80.38 2.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.124 0.964 . . . . 0.0 111.508 -172.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.634 -179.333 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.689 ' HG3' HD22 ' A' ' 6' ' ' LEU . 46.6 pttt . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.689 HD22 ' HG3' ' A' ' 5' ' ' LYS . 2.1 mm? -82.91 -13.03 56.84 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.305 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 40' ' ' LEU . 39.9 ttm180 -53.31 -41.65 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 0.0 111.233 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.2 -43.72 95.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.56 61.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.957 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.95 -45.73 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.012 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.93 -41.43 91.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.521 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.06 -46.0 72.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.554 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HB3' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -58.84 -39.28 80.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.278 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.05 -50.06 50.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.446 . . . . 0.0 110.414 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -62.76 -50.29 71.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.72 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -82.57 -35.15 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.809 0.338 . . . . 0.0 111.47 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.54 -24.16 75.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.56 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.42 5.94 5.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.129 0.572 . . . . 0.0 110.73 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.6 p 55.9 164.51 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 113.334 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 90.0 Cg_endo -83.98 -178.46 19.38 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.623 -1.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 13' ' ' GLU . 2.6 pt? -155.02 143.43 20.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.2 m -85.27 170.23 13.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.717 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -61.5 -47.43 85.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.786 0.326 . . . . 0.0 111.35 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -72.71 -9.22 58.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.81 -47.38 30.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -75.13 -38.49 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.46 -19.28 5.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.516 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 35.1 m -98.14 162.06 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.666 0.27 . . . . 0.0 110.622 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.7 p -81.02 165.73 21.42 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.09 -31.51 30.86 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.629 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.27 -53.72 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.065 0.46 . . . . 0.0 110.797 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 2.7 mp0 -70.74 -34.49 71.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.01 -52.06 39.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.661 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -57.71 -54.16 49.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.795 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -54.08 -50.72 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.984 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.647 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -62.02 -53.16 59.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.75 -177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.55 -44.89 97.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 111.37 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -65.89 -40.77 91.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.334 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 75.5 t80 -61.58 -47.87 83.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.176 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 7' ' ' ARG . 96.8 mt -56.2 -44.47 79.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.353 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 3.9 ttpm? -67.33 -38.99 85.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -72.72 -39.89 66.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.407 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 14.2 mm-40 -78.24 -27.64 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.95 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.61 32.93 1.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.55 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 95.8 m-85 -90.3 -43.87 10.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 110.673 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.4 pp -141.0 154.84 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -133.54 173.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 91.52 13.32 58.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.799 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.65 119.1 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.652 0.263 . . . . 0.0 110.425 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -90.85 124.77 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.71 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 61.4 m-85 -102.66 153.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -88.03 -41.0 13.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.439 0.638 . . . . 0.0 109.589 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 t70 178.62 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.53 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' OD2' ' HG3' ' A' ' 55' ' ' ARG . 5.6 p-10 -135.8 -39.67 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.125 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 88.9 mtt180 -118.42 146.79 40.42 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 121.042 0.449 . . . . 0.0 111.256 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 94.9 Cg_endo -86.12 160.57 10.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.106 2.538 . . . . 0.0 113.863 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -137.48 126.92 24.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.378 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 86.1 mt -88.25 154.67 20.24 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -133.11 -177.21 4.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.108 0.48 . . . . 0.0 111.278 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp -146.69 145.15 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.952 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 134.68 -67.59 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.892 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 28.1 Cg_exo -62.5 123.57 12.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.637 2.225 . . . . 0.0 111.878 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 151.33 46.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.604 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.662 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 mp -91.92 142.2 27.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.599 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.5 p -88.0 179.31 6.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.262 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.53 -39.24 76.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.3 tppt? -65.02 -42.07 94.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.475 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.59 -47.78 88.5 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.52 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.6 -45.08 94.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -73.28 -25.12 60.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 0.0 111.18 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.22 -40.45 77.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.127 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -55.39 -38.32 68.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.765 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -56.23 -48.22 76.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.248 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 78' ' ' THR . 42.3 mt-10 -85.06 -31.87 23.17 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.3 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.26 5.65 6.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.716 0.293 . . . . 0.0 110.75 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.79 -20.28 56.75 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 164.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 75' ' ' GLU . 6.1 t -78.53 -17.81 55.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 72.9 -75.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.313 171.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.5 t -145.44 85.55 1.72 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.914 0.388 . . . . 0.0 110.768 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -175.84 34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 109.074 174.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.871 -177.828 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HB2' HD22 ' A' ' 6' ' ' LEU . 43.5 mttp . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.377 0.608 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 10' ' ' ILE . 1.5 mm? -75.99 -30.35 58.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.736 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.518 HH11 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -56.56 -40.37 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.45 -42.01 65.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.308 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 26' ' ' ILE . 42.8 mm -60.48 -52.79 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.388 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.92 -43.64 91.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.402 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.19 -44.61 94.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.675 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.123 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ILE . 77.6 mt -65.87 -45.21 91.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 110.339 175.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.96 -50.21 71.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.612 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.72 -17.28 32.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.46 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 -27.71 23.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.685 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.7 t30 68.53 11.46 8.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 28.6 p 55.04 162.65 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 124.345 1.058 . . . . 0.0 113.294 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 95.3 Cg_endo -79.61 156.14 89.29 Favored 'Cis proline' 0 C--N 1.343 0.274 0 C-N-CA 123.717 -1.368 . . . . 0.0 111.88 -3.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.1 pt? -124.55 132.51 53.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -85.0 162.89 19.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.138 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.836 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.28 -32.94 74.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -65.56 -34.42 78.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.35 -43.7 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.68 -27.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.95 33.96 5.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.334 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 26' ' ' ILE . 33.7 m -135.11 175.87 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 p -83.89 156.92 22.17 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.836 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.47 -21.2 64.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.04 -44.8 79.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.056 0.455 . . . . 0.0 109.933 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.06 -29.82 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -64.6 -48.79 73.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.562 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.67 -53.58 53.02 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.64 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -49.59 53.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.745 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -61.93 -54.41 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.608 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.96 -38.59 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 O-C-N 123.105 0.253 . . . . 0.0 111.522 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 17.0 m-80 -60.78 -49.41 77.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.647 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.66 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.629 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 97.0 mt -60.98 -37.73 83.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 5.3 tmmm? -71.37 -40.76 70.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 55.8 mtt180 -60.75 -47.29 86.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.926 0.393 . . . . 0.0 111.141 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -82.29 4.77 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.48 46.24 94.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.119 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 29.6 m-85 -87.55 -37.36 16.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.406 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.8 pp -138.68 150.34 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.097 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.29 173.71 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.471 175.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.43 9.34 69.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.084 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.75 124.9 38.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -92.42 111.28 22.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.891 0.377 . . . . 0.0 110.424 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -89.84 130.54 36.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.488 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -133.12 110.37 10.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.944 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 63.03 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.989 0.806 . . . . 0.0 110.599 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 33.4 t70 -151.72 80.03 1.27 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.807 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 13.3 tpt180 173.46 119.09 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.76 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.19 99.9 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.446 2.097 . . . . 0.0 111.012 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -82.05 109.78 16.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.068 0.461 . . . . 0.0 110.933 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 85.6 mt -89.17 105.72 17.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.652 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.0 173.1 7.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.03 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -67.92 -26.76 66.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.349 0.595 . . . . 0.0 109.891 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.27 117.8 31.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.641 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.18 -72.33 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.51 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.04 120.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.449 2.766 . . . . 0.0 114.206 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -129.84 144.46 51.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.622 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.66 145.64 26.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.39 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.2 p -96.04 173.85 7.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.27 -37.27 86.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -62.93 -40.45 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.357 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.511 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -70.87 -41.97 61.45 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.467 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.15 -38.63 88.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.776 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -65.08 -36.77 85.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.353 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.61 -36.14 79.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.642 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.4 -44.53 89.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.51 . . . . 0.0 110.489 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -71.93 -31.84 66.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.44 -44.66 34.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.075 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.64 3.2 48.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 110.412 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.88 -0.05 12.52 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.352 -0.451 . . . . 0.0 113.102 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -89.8 19.22 4.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.552 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' SER . 30.8 t90 -91.6 143.52 26.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.789 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' TRP . 68.1 m 74.7 153.13 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.468 0.707 . . . . 0.0 111.742 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -142.13 -178.67 5.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.876 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.329 0 O-C-N 123.962 0.789 . . . . 0.0 111.409 -179.748 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 mttm . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? -100.05 -28.05 13.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.505 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -66.68 -37.47 84.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 109.953 -172.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -55.41 -48.3 74.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.111 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.38 -18.54 54.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.613 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 26' ' ' ILE . 66.2 mt -58.65 -39.37 75.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.436 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' CB ' HD21 ' A' ' 73' ' ' LEU . 46.0 mt -62.3 -30.75 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.385 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.62 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -62.94 -43.89 97.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 109.992 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 26' ' ' ILE . 7.8 mm-40 -63.37 -42.8 98.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.384 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 65' ' ' LEU . 74.9 mt -65.93 -31.87 55.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.876 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.21 -49.92 57.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.469 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.26 -28.58 21.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.755 0.312 . . . . 0.0 111.822 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.62 -14.76 64.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.599 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 19' ' ' THR . 57.0 t30 70.51 -81.81 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.596 0.759 . . . . 0.0 109.486 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER 173.16 157.26 0.27 Allowed Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 124.199 0.999 . . . . 0.0 109.012 176.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 66.7 Cg_endo -87.8 -174.82 9.67 Favored 'Cis proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.108 -0.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -157.73 127.8 6.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 m -85.41 170.14 12.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.367 . . . . 0.0 110.63 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.03 -22.12 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.722 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -84.2 -43.93 14.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.498 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 10' ' ' ILE . 5.1 tp -70.02 -38.43 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.92 -20.13 10.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.943 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.24 160.07 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 t -70.38 166.82 19.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.299 0.571 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.44 -29.15 69.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.45 -43.31 90.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.547 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -71.66 -32.25 67.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.873 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.79 -46.7 80.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.86 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -56.71 -53.14 61.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.453 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.9 -37.64 77.07 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.405 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.14 -59.9 3.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.717 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.14 -43.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.296 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.999 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -68.91 -45.74 70.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.792 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 74.7 mt -63.21 -37.18 86.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.944 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -60.77 -42.35 97.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.99 12.97 18.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.356 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.28 38.33 96.04 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.638 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 34.7 m-85 -88.26 -28.72 20.93 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.487 -0.419 . . . . 0.0 110.488 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.9 pp -143.68 149.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -131.84 150.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.63 35.45 6.18 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.518 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.6 115.2 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.944 0.402 . . . . 0.0 110.452 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.436 ' NE2' ' HA3' ' A' ' 62' ' ' GLY . 89.4 m-70 -82.19 135.91 35.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.66 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -108.01 135.66 49.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 t -67.25 -34.88 78.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.409 0.623 . . . . 0.0 109.853 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 174.22 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.686 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -131.98 -43.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.079 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.867 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -108.18 147.21 35.11 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.37 -173.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.867 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 52.7 Cg_exo -53.62 136.47 64.71 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.553 2.168 . . . . 0.0 111.835 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.22 105.57 3.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.111 0.482 . . . . 0.0 110.027 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB3' HG21 ' A' ' 19' ' ' THR . 86.8 mt -74.03 134.33 43.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.147 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.824 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.8 m-85 -125.83 -178.34 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -43.15 -55.66 3.81 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.159 0.912 . . . . 0.0 113.289 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 61' ' ' LEU . 3.2 pp -128.1 146.07 50.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.925 0.393 . . . . 0.0 110.955 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 137.19 -64.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.722 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.23 121.57 8.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.537 2.158 . . . . 0.0 113.074 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -114.72 152.37 32.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.621 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.9 mp -101.17 134.43 44.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.1 p -80.23 160.95 25.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 10.7 pt-20 -69.43 -20.0 63.79 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.48 -48.32 82.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 -35.23 50.51 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.862 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 32.9 tt0 -63.11 -43.26 98.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.56 0.219 . . . . 0.0 110.905 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -67.37 -32.87 74.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.26 -35.71 81.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.236 0.541 . . . . 0.0 109.607 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.594 HD21 ' CB ' ' A' ' 11' ' ' LEU . 73.8 mt -74.59 -19.41 60.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.34 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -53.03 -37.24 61.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.987 0.422 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.08 -19.89 31.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.439 0.638 . . . . 0.0 110.706 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 12' ' ' LYS . 2.7 t-20 -80.01 -9.8 59.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.268 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.33 -20.89 63.72 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.912 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 t -100.72 21.19 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.631 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -105.51 130.76 53.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -118.76 159.56 23.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -94.63 28.82 2.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.268 0.556 . . . . 0.0 110.112 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.358 172.969 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 9.9 mptt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.24 -29.73 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 175.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -60.79 -41.95 96.6 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.869 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.695 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 72.5 t80 -66.44 -42.85 87.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.147 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.98 -47.21 81.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 26' ' ' ILE . 54.2 mt -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 40' ' ' LEU . 82.9 mt -56.01 -46.83 78.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.29 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 26.3 ttpp -68.69 -42.45 77.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 -177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG3' HG13 ' A' ' 26' ' ' ILE . 9.1 mm-40 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.016 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 19' ' ' THR . 73.0 mt -65.33 -42.31 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 110.115 173.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.94 -50.1 57.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.402 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 10.7 mt-10 -74.1 -33.28 63.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.023 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.17 -31.28 14.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.249 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.99 19.12 4.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.167 0.587 . . . . 0.0 110.614 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.744 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 14.2 p 56.16 169.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.075 0.95 . . . . 0.0 113.156 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.791 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 79.6 Cg_endo -90.77 156.54 27.8 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 124.715 -0.952 . . . . 0.0 112.276 -1.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -149.35 131.46 15.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.118 0.485 . . . . 0.0 110.527 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -85.26 170.32 12.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.987 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.83 -36.71 77.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.765 0.284 . . . . 0.0 111.765 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -68.47 -25.92 65.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.32 -48.78 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.003 0.43 . . . . 0.0 110.509 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 21' ' ' LEU . 9.4 tt -76.56 -34.4 24.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.607 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.25 28.18 3.4 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.245 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 34.5 m -126.92 172.14 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 p -85.16 163.8 18.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.862 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 24.5 mt-10 -55.8 -42.5 75.71 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.61 -62.08 1.62 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.56 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.77 -47.56 80.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.639 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.5 t80 -63.63 -52.1 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.71 -45.77 85.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -62.25 -39.92 94.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -50.53 72.04 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.803 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' PHE . 97.7 t -58.18 -41.77 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.703 0.287 . . . . 0.0 110.956 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -62.53 -45.48 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -64.68 -41.0 96.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.709 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 11' ' ' LEU . 84.1 mt -63.81 -46.08 86.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.204 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.55 -26.65 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -56.57 -53.67 54.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 26.1 mt-10 -89.6 -8.4 52.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.11 53.76 2.9 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.936 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' HD2' ' HA2' ' A' ' 69' ' ' GLY . 73.4 m-85 -85.42 -38.37 18.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.767 0.317 . . . . 0.0 110.681 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -131.92 149.91 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 176.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 pt -126.9 167.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.12 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 9.99 65.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.67 124.96 38.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -98.21 137.98 36.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.789 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.9 m -77.23 -75.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -115.69 -21.83 9.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.328 172.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -173.96 -29.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.768 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -86.86 140.52 33.12 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.431 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 2.6 Cg_endo -81.89 146.48 14.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.486 2.791 . . . . 0.0 112.275 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -125.87 116.29 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 63' ' ' PRO . 78.0 mt -89.0 120.6 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.923 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -100.64 -174.36 2.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.791 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 97.0 mttt -69.89 -26.3 64.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.417 0.627 . . . . 0.0 110.394 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.72 101.43 5.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.055 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.42 -79.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.777 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 73.9 Cg_endo -76.87 120.39 5.46 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 114.198 -172.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HB2' HG13 ' A' ' 47' ' ' ILE . 37.4 mt-10 -100.18 142.23 31.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.074 172.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -95.26 134.52 37.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.731 0.301 . . . . 0.0 110.361 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.0 p -93.26 178.43 5.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.351 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.9 -40.31 80.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.014 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.75 -41.0 90.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.88 -41.72 27.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.407 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -65.78 -34.6 78.54 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.979 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.72 -36.06 67.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 0.0 110.942 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.62 -26.35 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.261 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.695 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 97.0 mt -59.92 -41.8 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.721 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -70.15 -43.08 71.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.02 -44.12 73.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.829 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.14 5.06 43.15 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.125 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 -9.75 29.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.635 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -82.01 -2.87 53.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 110.82 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -70.53 158.08 36.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.076 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.3 p 62.35 168.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 111.303 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 71.82 -33.06 0.26 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.287 0.635 . . . . 0.0 112.601 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -172.996 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.827 ' HG3' HD22 ' A' ' 6' ' ' LEU . 43.3 pttt . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.827 HD22 ' HG3' ' A' ' 5' ' ' LYS . 3.6 mm? -100.22 5.11 44.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.658 0.266 . . . . 0.0 110.662 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.18 -50.7 11.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 64.6 t80 -62.15 -46.07 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.959 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 79' ' ' TRP . . . -61.67 -46.42 89.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.332 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.3 mt -55.99 -46.64 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 98.5 mt -56.45 -50.19 72.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.508 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -77.68 -30.32 51.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.836 -175.046 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 5.7 mm-40 -73.61 -22.31 60.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.089 0.471 . . . . 0.0 110.074 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 10' ' ' ILE . 58.9 mt -76.41 -50.38 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 170.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -56.12 -41.6 75.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.586 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -97.01 -26.27 15.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.721 0.296 . . . . 0.0 111.694 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -83.49 -16.0 69.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.383 -174.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.3 t30 76.67 -13.52 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.014 0.526 . . . . 0.0 111.546 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 27.5 p 58.93 156.98 0.09 OUTLIER Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.504 1.122 . . . . 0.0 112.648 -174.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 4.4 Cg_exo -75.55 161.85 93.64 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.946 -1.273 . . . . 0.0 111.935 1.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.4 pt? -124.7 119.96 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -72.18 156.09 39.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.315 0.579 . . . . 0.0 111.042 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.625 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -71.17 -40.76 71.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.662 -175.159 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.55 -45.54 15.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.301 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.55 -36.79 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 33.7 1.52 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.397 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 26' ' ' ILE . 30.6 m -139.01 174.37 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.843 0.322 . . . . 0.0 110.182 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -85.32 154.26 22.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 0.0 110.343 171.623 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -68.39 -28.55 67.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.131 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.76 -42.62 85.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.197 0.522 . . . . 0.0 110.58 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HB2' HG23 ' A' ' 29' ' ' THR . 1.5 mp0 -79.78 -21.19 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.381 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 37' ' ' VAL . 84.9 t80 -65.82 -55.97 14.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.063 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' HB2' ' HG2' ' A' ' 56' ' ' PRO . 1.5 p30 -68.47 -33.86 74.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.283 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.64 -50.52 73.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -60.83 -44.91 96.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.226 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 33' ' ' PHE . 93.0 t -57.05 -40.88 75.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.933 0.396 . . . . 0.0 110.903 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -68.37 -38.62 81.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.171 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -66.83 -40.17 87.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.4 mt -60.87 -38.22 84.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.011 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -70.66 -37.49 73.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.101 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -57.03 -53.12 61.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.08 -34.44 71.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.193 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.22 46.25 1.6 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.571 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -94.45 -35.99 12.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.1 pp -137.94 154.93 29.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.73 163.37 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.729 177.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.82 28.15 14.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.784 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 56' ' ' PRO . 87.1 t -71.46 117.42 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 4.2 t60 -96.57 121.98 38.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 -176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 121.55 41.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -69.13 -65.73 0.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.163 0.506 . . . . 0.0 110.157 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.71 -20.68 5.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.05 -34.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.101 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -103.21 142.19 24.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.851 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 26.7 Cg_endo -65.47 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.452 2.102 . . . . 0.0 110.799 170.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -105.74 -35.82 7.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.5 mt 69.5 128.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.862 0.726 . . . . 0.0 110.763 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 20' ' ' PRO . 31.6 m-85 -122.06 -175.55 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 44.5 mtmt -70.02 -5.14 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 tp -160.29 119.07 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.03 -67.99 0.19 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.221 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 58' ' ' LEU . 57.7 Cg_endo -71.24 137.8 31.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.364 2.043 . . . . 0.0 113.459 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -130.29 166.11 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.584 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.8 mp -97.75 145.18 26.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.919 0.39 . . . . 0.0 110.461 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.3 p -80.06 169.56 17.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.01 -38.36 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.94 0.4 . . . . 0.0 110.014 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -69.21 -45.64 69.37 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.989 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.22 97.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.27 -40.49 90.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.221 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.071 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.58 -28.61 69.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.669 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 87.3 mt -58.23 -34.48 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.34 175.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -68.44 -45.56 72.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.151 0.5 . . . . 0.0 110.051 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -64.78 -48.88 72.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.988 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -91.71 5.28 50.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.696 -175.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.79 -2.34 1.16 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 114.901 0.721 . . . . 0.0 114.901 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -90.54 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 171.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.556 ' CZ2' ' HB2' ' A' ' 9' ' ' ALA . 69.6 t-105 67.11 166.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 165.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -147.0 121.39 9.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.961 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -71.48 152.84 42.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.962 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.449 . . . . 0.0 111.443 -176.715 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 CA--C 1.527 0.093 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.788 HH11 ' HA ' ' A' ' 36' ' ' ALA . 33.9 mmt180 -67.42 -56.07 11.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -62.57 -40.79 97.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.751 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.96 87.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.326 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.27 -39.17 72.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.784 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.633 ' HG ' HD13 ' A' ' 40' ' ' LEU . 8.0 mt -56.28 -45.02 80.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 6.8 ttpp -62.56 -39.59 94.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HG2' HG12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -64.61 -37.18 86.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.359 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.08 -44.13 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.278 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.35 -50.51 73.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.318 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.83 -18.99 19.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.482 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.17 -27.12 66.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.332 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 74.2 -1.78 2.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.212 0.605 . . . . 0.0 111.449 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 62.0 p 59.55 153.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.664 1.186 . . . . 0.0 113.33 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.626 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 2.0 Cg_endo -81.74 167.12 70.87 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.983 -1.257 . . . . 0.0 112.387 0.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 13' ' ' GLU . 1.7 pt? -140.78 149.05 41.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 25' ' ' ASP . 30.3 t -85.2 167.26 15.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.65 0.738 . . . . 0.0 110.938 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -80.63 -48.21 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.545 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.6 -27.88 68.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.585 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 11.1 t70 -72.73 -40.63 65.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.564 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -74.29 -32.91 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.24 20.37 2.22 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.721 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.66 175.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 117.243 0.522 . . . . 0.0 110.786 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.6 p -85.32 172.5 11.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.693 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 mt-10 -58.27 -53.2 60.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 110.403 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.78 -29.97 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.113 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.2 -46.74 66.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.347 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 67.9 t80 -62.87 -45.35 92.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.772 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 55' ' ' ARG . 6.3 t70 -54.75 -53.86 49.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.664 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.9 -40.23 92.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.62 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.788 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -61.06 -52.22 65.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.08 -44.73 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.993 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.45 -45.0 95.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.239 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.34 -46.78 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.633 HD13 ' HG ' ' A' ' 11' ' ' LEU . 90.7 mt -63.74 -34.84 78.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 56.7 tttm -67.31 -41.55 85.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.776 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -67.29 -47.38 70.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.071 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.62 -22.95 58.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.06 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 46.83 1.92 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.062 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.638 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 86.3 m-85 -98.66 -36.29 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 110.356 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.0 pp -142.36 155.6 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 34.8 pt -131.82 170.82 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.908 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 14.32 50.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.8 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.604 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 96.7 t -78.41 114.14 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.033 0.444 . . . . 0.0 110.31 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -109.64 131.62 54.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.621 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.502 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.524 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 10.2 mtp180 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 25.2 Cg_endo -62.48 134.48 48.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.644 2.229 . . . . 0.0 112.393 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -126.82 132.41 51.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.124 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -97.64 138.67 34.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.428 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -110.37 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.578 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.626 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 54.0 mttp -83.59 -5.37 59.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.389 0.614 . . . . 0.0 110.326 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -156.79 120.86 4.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . . . 157.36 -57.02 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.896 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG3' HD22 ' A' ' 58' ' ' LEU . 30.5 Cg_exo -62.3 106.36 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.62 2.213 . . . . 0.0 112.55 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 4.3 mm-40 -110.55 140.07 45.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 46' ' ' ILE . 6.3 mp -88.66 144.22 26.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.896 0.379 . . . . 0.0 110.458 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 p -87.21 171.38 10.7 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.46 -38.3 90.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -63.0 -44.53 95.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.643 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.19 -42.72 94.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.704 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.03 -46.57 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -34.52 77.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.674 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.57 -37.68 87.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.558 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 11' ' ' LEU . 82.8 mt -63.4 -33.46 75.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.578 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.491 -177.552 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' ILE . 3.6 mm? . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 121.471 0.653 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.761 ' NH1' ' HA ' ' A' ' 36' ' ' ALA . 4.9 tpp180 -57.57 -37.17 72.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.112 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -69.73 -44.47 70.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.011 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -37.77 76.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.645 HD13 HG13 ' A' ' 26' ' ' ILE . 35.2 mm -65.17 -51.63 63.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 110.098 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.18 -40.61 90.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.093 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -68.32 -28.32 67.05 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.307 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.56 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -81.04 -26.41 36.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.118 0.485 . . . . 0.0 110.193 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.45 -26.99 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.754 0.788 . . . . 0.0 109.471 171.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.92 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -100.41 -40.53 7.43 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.43 55.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.724 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER 70.25 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER 173.01 164.84 0.27 Allowed Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 124.18 0.992 . . . . 0.0 108.805 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 19' ' ' THR . 64.7 Cg_endo -90.07 175.21 21.27 Favored 'Cis proline' 0 N--CA 1.462 -0.378 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.823 -3.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.11 137.18 28.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -85.27 170.26 12.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.438 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 6.8 pm0 -59.4 -37.16 77.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.055 0.455 . . . . 0.0 110.797 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t-20 -65.18 -30.94 71.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.047 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.35 -49.76 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.645 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.62 -35.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.105 -176.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.86 30.85 2.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.273 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 32.1 m -130.6 169.17 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 32' ' ' GLN . 23.6 p -85.16 169.32 13.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.785 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 2.4 mt-10 -48.65 -52.58 22.48 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.787 0.68 . . . . 0.0 110.832 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.43 -37.44 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.844 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 18.1 mm-40 -79.02 -32.85 45.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -72.24 -36.39 69.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.511 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.89 -46.41 90.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.596 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -52.11 -49.65 63.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.514 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . . . -59.69 -58.52 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.819 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.51 -47.09 94.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.588 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.55 -39.32 93.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.61 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.619 ' HD2' ' HD2' ' A' ' 7' ' ' ARG . 77.1 t80 -67.22 -41.04 86.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.322 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.1 mt -64.44 -44.77 90.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -70.53 -37.25 74.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.889 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -58.89 -55.97 28.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 73.4 mm-40 -82.78 -3.22 56.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.62 -174.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.75 44.84 9.9 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.106 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 68.5 m-85 -79.28 -34.14 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.183 0.516 . . . . 0.0 109.743 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 49' ' ' VAL . 1.8 pp -140.1 157.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.473 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 46.1 pt -132.26 165.65 31.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.48 -1.95 73.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.915 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.422 HG21 HD13 ' A' ' 46' ' ' ILE . 57.4 t -76.67 126.96 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.802 0.334 . . . . 0.0 110.53 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -98.56 147.2 25.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.457 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 56' ' ' PRO . 19.1 m-85 . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 13.3 ttm180 . . . . . 0 C--O 1.235 0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 28.9 Cg_exo -61.19 147.77 94.71 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.448 2.098 . . . . 0.0 111.073 169.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -118.8 115.61 24.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.402 0.62 . . . . 0.0 111.389 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.39 144.98 26.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.346 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.97 168.99 18.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' THR . 29.8 mtpp -55.98 -56.43 20.83 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.724 0.64 . . . . 0.0 112.232 -168.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.06 90.14 3.21 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.936 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.1 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.021 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 Cg_exo -66.07 109.07 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.146 2.564 . . . . 0.0 113.316 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -108.44 155.79 20.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.164 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.56 148.21 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.065 0.459 . . . . 0.0 111.051 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.0 p -104.55 -179.81 4.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.088 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -54.32 -43.91 71.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.079 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -57.12 -51.36 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -38.67 93.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.269 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.53 -46.93 87.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -61.53 -41.24 97.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.02 -40.18 92.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.97 -42.83 90.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.179 0.514 . . . . 0.0 110.484 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.92 -178.495 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.669 0.271 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 36' ' ' ALA . 59.1 mmt-85 -54.3 -33.31 58.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.179 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -68.1 -54.25 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.901 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.03 -48.57 75.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -62.07 -43.77 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD21 ' A' ' 73' ' ' LEU . 12.1 tp -65.64 -35.48 80.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.2 ttpp -70.84 -39.95 72.66 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 9.4 mm-40 -62.26 -39.79 94.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.457 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -32.17 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.383 0.611 . . . . 0.0 110.135 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -75.43 -40.13 58.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 8.9 mt-10 -80.85 -40.31 25.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.34 50.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.919 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 19' ' ' THR . 5.9 t30 68.89 -90.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.453 0.701 . . . . 0.0 109.52 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER 177.19 159.33 0.5 Allowed Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.998 0.919 . . . . 0.0 109.345 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.826 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 Cg_endo -82.09 167.78 67.79 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.321 -1.116 . . . . 0.0 112.199 0.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -150.17 129.51 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.18 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.99 -38.26 72.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.504 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -68.91 -35.8 77.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.947 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.72 -45.21 87.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.187 0.518 . . . . 0.0 110.629 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 28' ' ' VAL . 14.9 tt -79.56 -24.72 12.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.936 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.47 11.99 52.39 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.533 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 26' ' ' ILE . 26.3 m -123.15 167.22 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.979 0.389 . . . . 0.0 110.455 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -78.68 166.7 22.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.819 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 19.9 mt-10 -57.99 -40.59 81.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.97 -48.62 77.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.732 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.7 -35.12 67.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.29 -47.65 81.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.81 -53.52 57.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.644 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.44 -53.36 52.49 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.239 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . . . -67.1 -53.53 29.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.291 -174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.18 -40.16 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.78 -39.64 94.74 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.83 0.348 . . . . 0.0 110.513 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -65.89 -46.62 77.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 46' ' ' ILE . 68.5 mt -59.58 -42.06 91.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.227 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -66.58 -36.58 82.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -66.79 -43.01 85.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.033 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -78.26 -20.82 50.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.647 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.01 38.7 5.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.29 -30.65 20.72 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.63 -0.336 . . . . 0.0 111.038 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -140.82 159.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.05 158.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.97 29.04 19.2 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.202 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.53 109.91 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -91.03 130.94 36.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.979 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.363 175.212 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.63 122.56 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.8 2.333 . . . . 0.0 112.176 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -137.25 105.91 5.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB3' HG21 ' A' ' 19' ' ' THR . 70.9 mt -79.74 122.96 27.23 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.031 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.826 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 75.5 m-85 -107.1 -173.41 2.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -57.07 -52.39 65.47 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.52 0.512 . . . . 0.0 112.001 -171.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.62 135.27 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.755 0.312 . . . . 0.0 110.632 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.48 -70.77 0.5 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.519 ' HG2' HG21 ' A' ' 19' ' ' THR . 25.6 Cg_exo -63.9 119.63 6.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.304 2.669 . . . . 0.0 113.439 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.09 156.26 48.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.809 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.432 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.4 mp -95.03 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -93.13 169.9 10.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -24.68 64.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -59.3 -47.01 87.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.91 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.38 -34.39 50.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.909 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.41 -43.6 93.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.33 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 1.2 m-80 -70.05 -30.3 67.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -62.75 -36.56 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.784 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.517 HD21 HD23 ' A' ' 11' ' ' LEU . 82.8 mt -62.9 -19.75 64.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.094 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 47.5 tttp . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.622 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.237 0.42 0 CA-C-O 121.168 0.509 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HB3' HD21 ' A' ' 40' ' ' LEU . 22.6 mmt180 -67.24 -34.89 78.41 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -57.73 -41.02 80.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.153 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -61.53 -35.11 76.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.454 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 19.6 mt -73.99 -30.34 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.438 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.22 -36.16 82.32 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.455 -0.778 . . . . 0.0 109.322 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 13.3 tmtt? -61.93 -52.67 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 10' ' ' ILE . 12.8 pt-20 -60.4 -39.08 86.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.029 0.442 . . . . 0.0 111.411 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.462 HG13 ' HG3' ' A' ' 13' ' ' GLU . 88.6 mt -74.38 -43.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.67 -46.2 89.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.442 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 10.4 pt-20 -92.83 -26.5 17.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.398 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -74.46 -24.29 73.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.116 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 29.3 t-20 76.66 -20.2 0.38 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 111.755 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.809 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 70.9 p 61.95 163.41 0.11 Allowed Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 124.413 1.085 . . . . 0.0 112.67 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.809 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 72.1 Cg_endo -79.51 150.68 84.61 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.522 -2.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -132.63 145.74 51.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.487 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 15.4 m -85.82 165.24 17.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.819 0.342 . . . . 0.0 110.585 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -62.72 -28.43 69.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.986 178.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.549 HD22 ' N ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -70.81 -10.12 58.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.781 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.549 ' N ' HD22 ' A' ' 24' ' ' ASN . 8.8 m-20 -85.28 -50.02 7.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.715 0.293 . . . . 0.0 110.509 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -78.89 -38.52 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.432 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.78 -13.41 10.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.678 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.555 ' H ' HG23 ' A' ' 26' ' ' ILE . 27.2 m -86.22 157.21 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 117.426 0.613 . . . . 0.0 110.197 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 t -85.13 162.21 19.34 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.571 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 10.0 mt-10 -51.04 -50.48 58.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.18 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.09 -41.65 71.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.084 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -79.66 -32.16 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 111.046 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.1 t80 -67.41 -52.85 34.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.22 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' OD2' ' HD2' ' A' ' 56' ' ' PRO . 0.9 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 178.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.95 -42.29 75.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.49 ' CB ' HD12 ' A' ' 10' ' ' ILE . . . -64.51 -50.85 65.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 33' ' ' PHE . 65.8 t -58.41 -44.47 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.691 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 95.5 m-20 -61.33 -48.78 79.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -56.02 -45.65 79.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 7' ' ' ARG . 89.9 mt -65.98 -40.08 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.256 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 41' ' ' LYS . 0.7 OUTLIER -69.57 -31.34 69.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.153 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 99.6 mtt180 -61.76 -58.55 7.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.75 -24.24 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.349 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.93 52.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.716 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 81.8 m-85 -93.5 -34.76 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.064 0.459 . . . . 0.0 110.081 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 pp -137.38 148.49 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.476 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -132.93 176.76 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.009 178.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 86.37 5.18 82.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.475 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.22 135.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -106.79 119.98 40.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 121.02 0.438 . . . . 0.0 111.276 -178.415 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.571 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 74.1 mtp180 . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.689 0.28 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 58.4 Cg_endo -72.45 139.91 32.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.939 2.426 . . . . 0.0 111.726 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -129.25 145.58 51.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 93.7 mt -104.19 145.59 29.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.928 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -130.3 174.35 9.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.818 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.08 -40.38 75.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.38 0.61 . . . . 0.0 109.783 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tt -106.74 105.26 15.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.146 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.495 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 170.68 -70.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.167 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.09 109.56 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.009 2.473 . . . . 0.0 113.454 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.49 148.85 43.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.678 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.7 133.43 43.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.6 p -79.96 178.82 7.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.65 -39.9 91.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.36 -44.16 92.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.01 -36.0 64.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.287 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.97 -45.23 93.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.831 0.348 . . . . 0.0 110.666 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.28 -31.24 70.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 110.56 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.54 -34.38 76.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 96.0 mt -58.62 -43.01 89.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.229 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 tttm . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.55 -177.443 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 10' ' ' ILE . 4.3 mm? . . . . . 0 CA--C 1.521 -0.17 0 CA-C-O 120.678 0.275 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.622 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 18.6 mtm180 -65.62 -21.8 66.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.922 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 77.2 t80 -70.17 -46.47 64.59 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.979 172.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.56 76.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.831 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 7' ' ' ARG . 69.6 mt -58.07 -51.99 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.555 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD21 HD22 ' A' ' 40' ' ' LEU . 96.4 mt -58.4 -45.8 87.64 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.165 0.507 . . . . 0.0 110.835 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 26.3 ttpp -62.16 -48.67 79.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.175 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -31.02 71.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.0 mt -68.58 -43.47 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 110.589 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -75.3 -50.25 16.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.324 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.6 -40.16 66.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.819 0.342 . . . . 0.0 110.885 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 -27.45 70.06 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.502 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.93 26.05 11.03 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.089 0.556 . . . . 0.0 110.916 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.703 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 46.1 p 56.84 163.27 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.434 1.094 . . . . 0.0 113.134 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 71.5 Cg_endo -76.3 174.39 53.16 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 124.091 -1.212 . . . . 0.0 112.659 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.826 HD21 HD12 ' A' ' 26' ' ' ILE . 58.2 tp -152.88 118.76 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 18.2 m -86.75 170.68 11.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.93 -30.82 68.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 177.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -75.31 -39.91 59.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 8.9 p-10 -85.65 -1.46 57.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.826 HD12 HD21 ' A' ' 21' ' ' LEU . 11.1 tt -99.95 -37.45 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.734 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.5 -34.38 3.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.698 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.88 122.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -67.89 173.24 4.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 23' ' ' GLU . 4.4 mt-10 -48.96 -51.32 31.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.766 -171.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.55 -57.89 8.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.834 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.48 -32.14 69.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 37' ' ' VAL . 80.0 t80 -65.63 -51.81 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.47 -46.14 89.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.725 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.19 -45.93 89.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.251 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 7' ' ' ARG . . . -60.68 -55.57 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.452 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 33' ' ' PHE . 88.2 t -58.23 -44.13 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.646 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.384 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.46 -38.61 65.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 46' ' ' ILE . 67.8 mt -59.86 -43.93 94.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.088 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.95 -45.35 89.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -57.21 -49.2 76.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.26 -0.16 35.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.287 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.94 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.112 -0.566 . . . . 0.0 113.557 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.57 -43.62 12.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 117.028 0.414 . . . . 0.0 110.773 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.546 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.57 151.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.423 . . . . 0.0 111.126 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.53 166.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.486 176.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.06 65.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.196 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -72.63 117.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.4 110.05 21.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.232 178.87 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.73 117.06 4.94 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.498 2.132 . . . . 0.0 112.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -102.06 105.13 15.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -84.1 92.02 7.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.198 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -82.92 176.91 8.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.598 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 35.5 pttt -74.4 -0.59 17.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.74 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.75 129.53 17.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.73 -71.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.653 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HG2' HG21 ' A' ' 19' ' ' THR . 30.6 Cg_endo -63.71 118.4 5.34 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.67 2.247 . . . . 0.0 113.284 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.03 150.41 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.872 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.6 mp -93.65 144.44 25.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 p -92.8 170.72 9.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.585 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.14 -35.19 71.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -58.92 -50.6 73.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.116 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.44 -35.71 46.58 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.326 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 73' ' ' LEU . 2.7 tm-20 -61.33 -35.2 76.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.439 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -75.07 -34.96 61.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.053 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.51 -32.5 73.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.283 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.922 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.83 -38.25 75.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.816 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.7 mttp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.957 -178.127 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' O ' HG13 ' A' ' 10' ' ' ILE . 4.2 mm? . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.551 0.215 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.714 ' NH2' ' HA ' ' A' ' 36' ' ' ALA . 11.3 ptm180 -64.69 -16.5 62.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.755 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -77.47 -44.57 28.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.99 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.7 63.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.838 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 7' ' ' ARG . 52.6 mt -50.55 -37.83 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.578 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.5 mt -57.59 -34.06 68.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 36.7 ttpt -74.23 -48.06 31.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -38.1 75.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 110.724 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 21' ' ' LEU . 70.6 mt -66.85 -45.64 87.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.454 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.8 -48.31 77.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.787 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 28.7 mt-10 -65.11 -39.2 92.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.908 0.385 . . . . 0.0 110.758 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.95 -27.17 51.14 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.42 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.77 26.21 14.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.956 0.503 . . . . 0.0 110.11 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.737 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 32.2 p 55.09 166.65 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.346 1.058 . . . . 0.0 112.917 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.737 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.8 Cg_endo -87.3 157.31 47.28 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.433 -3.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.53 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -153.08 129.19 10.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -85.11 170.11 13.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -55.43 -38.13 68.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 178.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.52 -38.61 90.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.587 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.6 -39.6 67.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.797 0.332 . . . . 0.0 111.047 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.53 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.5 tt -82.79 -32.05 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.305 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.44 34.86 2.38 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.248 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 26' ' ' ILE . 30.9 m -130.29 169.93 20.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -85.34 167.67 15.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.082 0.468 . . . . 0.0 111.322 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 1.5 mp0 -51.7 -60.32 3.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.046 0.927 . . . . 0.0 111.189 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.4 -19.99 59.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.9 -169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.53 -36.79 37.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.998 0.428 . . . . 0.0 110.068 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 63.8 t80 -65.28 -44.82 86.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.881 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.68 -49.4 77.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.43 -40.56 74.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HA ' ' NH2' ' A' ' 7' ' ' ARG . . . -61.79 -57.43 11.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.399 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PHE . 69.3 t -57.48 -47.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.359 0.412 . . . . 0.0 111.734 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.05 -38.99 84.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB3' HH21 ' A' ' 7' ' ' ARG . 33.1 t80 -71.85 -41.62 67.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.821 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -67.29 -38.21 84.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.84 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 41' ' ' LYS . 11.6 tmtt? -69.74 -38.26 76.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HD3' HH11 ' A' ' 42' ' ' ARG . 8.0 ttm180 -56.82 -60.5 3.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.432 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -30.43 65.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.381 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.35 56.8 0.57 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.332 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.72 -26.01 13.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.733 0.301 . . . . 0.0 110.406 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 65' ' ' LEU . 1.6 pp -142.65 142.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.851 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.25 164.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.57 22.29 40.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.672 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.22 134.72 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -89.15 109.71 20.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 . . . . . 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.505 . . . . 0.0 110.19 175.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 17.6 mtp180 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 34.3 Cg_endo -66.14 138.34 51.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.629 2.219 . . . . 0.0 112.121 175.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -132.94 148.32 52.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.09 121.62 45.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.362 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.06 -166.44 1.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.771 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 27.2 mtpp -61.81 -51.61 67.59 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.607 0.567 . . . . 0.0 111.432 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.81 133.93 55.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.125 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.46 -69.74 0.37 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.13 107.67 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.889 2.393 . . . . 0.0 112.999 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 47' ' ' ILE . 67.2 mm-40 -115.81 139.97 49.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.227 175.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -75.59 144.17 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -83.46 168.57 16.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.742 0.306 . . . . 0.0 110.48 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.42 -34.68 77.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 23.8 ttmm -60.34 -47.65 85.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.853 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -64.93 -37.7 94.6 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.06 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -58.28 -53.44 58.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.429 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.33 -29.01 65.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 6.2 t80 -66.85 -30.18 70.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 11' ' ' LEU . 21.2 mt -75.65 -19.05 59.44 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.437 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 111.809 -177.528 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.43 0.157 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 40' ' ' LEU . 7.7 ptp180 -60.89 -45.75 93.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.108 -174.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.46 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -60.98 -42.37 98.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.415 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.75 68.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.18 -40.91 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.673 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 84.3 mt -58.09 -51.27 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.648 0.261 . . . . 0.0 110.938 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 5.6 ttpm? -67.34 -41.86 84.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.773 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -29.49 69.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 19' ' ' THR . 53.5 mt -73.46 -47.21 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.96 -47.0 87.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.29 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.21 -33.84 49.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.71 -22.51 57.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.105 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.42 1.46 3.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 0.0 111.237 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.1 p 55.48 164.42 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.263 1.025 . . . . 0.0 113.293 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 73.5 Cg_endo -90.32 118.35 3.41 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.182 -1.174 . . . . 0.0 111.969 -1.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.7 pt? -90.22 134.77 34.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.761 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -80.75 164.84 22.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.164 0.507 . . . . 0.0 110.948 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -51.0 64.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.011 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.27 -14.6 62.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.331 0.586 . . . . 0.0 110.525 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.45 -39.36 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.608 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.505 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.2 tt -76.97 -35.11 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.1 -31.05 3.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.001 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.06 152.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.887 -0.184 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.2 t -68.51 173.31 5.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.368 0.604 . . . . 0.0 110.524 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.37 -41.26 98.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.472 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.92 -40.5 95.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.274 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -73.99 -39.83 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 110.641 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.24 -49.03 78.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.669 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -62.17 -46.33 89.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.279 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.04 -50.56 70.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.445 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.85 72.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.822 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.47 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.557 0.218 . . . . 0.0 111.483 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -65.26 -35.69 81.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.93 -43.4 75.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.2 mt -63.22 -34.23 77.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.053 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -35.09 77.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -67.24 -42.91 83.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.35 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.168 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.75 39.77 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.19 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.05 -30.73 18.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 0.0 110.217 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.8 pp -142.45 152.02 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.46 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 pt -134.84 177.46 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.867 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.33 16.71 79.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.82 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.05 113.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.231 0.538 . . . . 0.0 109.57 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -80.34 113.09 18.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.794 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 79.5 m-85 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.611 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.474 0.178 . . . . 0.0 110.739 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 38.8 Cg_endo -69.93 143.43 50.0 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.312 2.008 . . . . 0.0 111.022 170.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 49.5 m-70 -104.03 -44.46 5.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 79.8 mt 68.2 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.438 0.637 . . . . 0.0 110.641 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -141.19 173.25 11.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 87.7 mttt -75.1 1.74 12.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.57 41.84 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.3 -86.55 1.59 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.153 -0.931 . . . . 0.0 114.019 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.47 159.34 14.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.028 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.55 139.99 51.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.585 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.0 mp -91.43 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.784 0.326 . . . . 0.0 110.729 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.8 p -88.44 170.7 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.28 -24.32 67.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.189 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -50.29 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.89 -42.25 53.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.077 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.03 -44.42 96.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.338 . . . . 0.0 110.473 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.419 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 1.2 m-80 -72.87 -20.04 61.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.882 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -75.86 -28.82 58.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 83.1 mt -70.95 -22.65 62.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 70.6 mmtt . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 6' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -64.64 -42.94 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -59.72 -43.4 94.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.948 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.12 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.377 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.72 -43.54 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.71 -52.45 64.92 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -71.13 -22.77 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.026 -176.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 1.9 tp10 -80.13 -23.71 40.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.248 0.547 . . . . 0.0 109.883 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.02 -47.12 49.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.85 -50.02 75.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.66 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -99.62 -6.15 27.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -90.09 -12.44 61.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.449 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.9 t30 75.38 -17.24 0.52 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.005 0.522 . . . . 0.0 111.435 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.0 p 58.62 156.92 0.09 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.563 1.145 . . . . 0.0 113.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.5 Cg_endo -83.72 176.31 33.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.798 -1.334 . . . . 0.0 113.136 0.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.4 pt? -150.58 133.5 15.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 m -85.28 170.43 12.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.97 -37.93 77.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.093 175.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.42 -16.79 64.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.589 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.04 -49.98 7.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 110.821 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.7 -38.61 58.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.93 22.17 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.189 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 26' ' ' ILE . 33.9 m -127.38 173.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 t -85.01 157.97 20.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 110.928 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.7 pm0 -63.29 -30.24 71.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.046 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -48.3 79.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.422 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 9.7 mm100 -82.44 -19.95 37.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.962 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.81 -55.58 16.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.05 -47.97 76.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.222 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.602 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 8.7 t70 -52.34 -49.04 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.315 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -68.06 -51.45 46.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.288 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.01 -42.32 85.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 111.237 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 95.4 m-20 -65.55 -41.48 92.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.526 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.21 -42.94 96.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.39 . . . . 0.0 110.596 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -59.41 -44.74 92.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.2 ttpm? -70.92 -34.62 71.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.369 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 15.4 ttt-85 -66.37 -40.49 89.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.609 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.7 -40.1 61.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.817 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.05 2.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.805 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.526 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 60.2 m-85 -78.3 -41.32 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.571 0.224 . . . . 0.0 111.415 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.535 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -139.94 161.83 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.0 110.961 -177.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -129.24 170.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.204 174.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 90.71 19.87 42.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.699 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.72 114.5 22.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -88.46 141.03 28.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.0 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 . . . . . 0 C--N 1.32 -0.687 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.719 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 120.537 0.208 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.3 134.7 23.3 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.577 2.184 . . . . 0.0 112.739 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -126.47 135.26 51.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.393 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -98.66 152.8 19.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.838 0.352 . . . . 0.0 110.604 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -134.71 -177.94 4.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.09 -29.45 64.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.965 0.412 . . . . 0.0 110.881 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -128.2 126.72 41.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 156.62 -64.82 0.31 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 58' ' ' LEU . 10.8 Cg_exo -70.45 100.69 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.738 2.292 . . . . 0.0 112.866 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -105.69 140.24 39.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.658 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.6 mp -90.96 140.04 30.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.674 0.273 . . . . 0.0 110.395 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.0 p -90.03 177.09 6.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -59.46 -33.11 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.673 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.19 -44.57 95.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.91 -41.83 21.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.714 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.66 -41.08 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.823 0.344 . . . . 0.0 110.975 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -79.12 -20.34 48.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.14 -33.58 76.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 12' ' ' LYS . 77.8 mt -61.02 -25.97 67.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.944 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 120.703 0.287 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.467 ' O ' HD13 ' A' ' 11' ' ' LEU . 98.7 mtt180 -69.52 -11.84 61.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -100.1 -46.03 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.67 171.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.54 81.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.86 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.99 -47.79 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 73' ' ' LEU . 10.5 mp -64.31 -32.67 74.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.948 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -65.14 -44.78 87.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.99 -41.0 97.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.61 -39.14 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.556 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' HD2' HD22 ' A' ' 65' ' ' LEU . 15.8 t80 -68.58 -50.12 54.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.86 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.22 -40.89 26.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.657 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.33 -18.55 58.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.5 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 62.31 24.32 14.47 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 110.497 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.7 p 54.98 171.96 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.987 0.915 . . . . 0.0 113.235 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.1 Cg_endo -85.06 179.7 21.99 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 123.809 -1.33 . . . . 0.0 112.074 -3.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -155.24 124.17 6.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -76.34 163.48 26.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.304 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.435 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.94 -16.48 60.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.75 -42.15 22.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 21' ' ' LEU . 4.2 tt -77.23 -38.71 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.3 35.89 0.98 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.293 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 26' ' ' ILE . 35.9 m -137.06 174.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -84.99 156.46 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.43 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 4.6 mt-10 -55.38 -40.83 71.84 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.65 -60.71 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.598 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.1 -32.42 69.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.947 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.9 t80 -65.08 -59.2 4.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.899 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 55' ' ' ARG . 5.8 m-20 -57.19 -43.89 83.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.714 0.292 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.41 -45.2 94.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.257 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.82 -48.06 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.46 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 33' ' ' PHE . 99.4 t -59.1 -42.32 86.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.245 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.43 -44.85 93.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.429 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.18 -42.52 99.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.797 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.1 mt -59.11 -42.89 91.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.448 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.509 ' HD3' ' HB ' ' A' ' 49' ' ' VAL . 29.8 ttpt -75.6 -38.31 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.359 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -39.93 94.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.439 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -4.33 56.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.227 0.537 . . . . 0.0 110.48 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 37.04 40.69 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.482 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -83.48 -47.45 11.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.281 0.54 . . . . 0.0 110.238 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -134.82 161.53 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 177.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 64' ' ' GLU . 25.6 pt -129.96 177.23 6.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.934 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.69 11.85 65.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.513 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' ' HD3' ' A' ' 41' ' ' LYS . 39.1 t -77.79 121.75 31.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -101.98 129.75 48.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.19 0.519 . . . . 0.0 111.586 -173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.789 177.205 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 11.2 ptm180 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -66.15 126.08 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.273 1.982 . . . . 0.0 112.059 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -116.91 130.69 56.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.404 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.02 140.27 35.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.611 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.04 178.13 7.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.535 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 68.6 mttm -79.77 -18.03 52.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.61 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.59 104.06 14.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.949 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.58 -67.71 0.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.613 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.15 119.01 3.15 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.534 2.822 . . . . 0.0 114.504 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 47' ' ' ILE . 41.9 mt-10 -130.92 142.41 50.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.032 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD22 ' HD2' ' A' ' 15' ' ' PHE . 6.3 mp -96.76 140.98 30.54 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.11 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 p -100.7 171.73 7.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.07 -33.02 73.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.359 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -60.99 -52.04 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.44 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.75 73.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.114 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.14 -45.5 91.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.738 0.304 . . . . 0.0 110.465 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -73.4 -20.27 60.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.465 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -70.05 -47.16 63.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 11' ' ' LEU . 96.2 mt -60.27 -32.44 71.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.002 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.713 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 mm? . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.4 ptt180 -51.09 -34.28 29.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 111.417 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.491 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 20.3 t80 -71.34 -43.49 66.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.147 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.57 60.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 7' ' ' ARG . 82.4 mt -59.38 -33.66 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.748 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -52.43 -40.97 62.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 24.9 ttpp -69.95 -44.37 69.68 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.071 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.56 -33.83 75.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.94 0.4 . . . . 0.0 110.504 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 19' ' ' THR . 82.4 mt -57.7 -46.48 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.988 172.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -67.28 -44.53 79.05 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.148 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 8.1 mm-40 -62.4 -40.53 96.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.431 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.11 -13.43 52.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.267 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.51 25.54 11.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.145 0.498 . . . . 0.0 110.176 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.534 HG23 HG23 ' A' ' 14' ' ' ILE . 20.6 p 57.76 154.14 0.08 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.428 1.091 . . . . 0.0 113.226 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -91.35 -165.96 2.41 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.693 -0.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.78 125.21 6.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.212 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -84.91 170.02 13.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 111.197 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.76 -41.08 96.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.372 -178.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.49 -24.74 65.62 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.454 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.4 -46.23 28.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.639 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.608 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -80.4 -38.74 18.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.459 -177.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.7 -14.8 12.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.673 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.608 ' H ' HG23 ' A' ' 26' ' ' ILE . 35.1 m -101.0 144.95 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.986 0.393 . . . . 0.0 111.127 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -66.53 161.47 22.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 177.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 7.2 mt-10 -58.81 -40.72 84.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.659 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.24 -34.7 78.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.465 HE21 ' HB ' ' A' ' 28' ' ' VAL . 26.1 mt-30 -75.0 -36.15 61.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.5 . . . . 0.0 109.914 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 49.4 t80 -65.6 -52.96 48.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.326 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' ' HD3' ' A' ' 56' ' ' PRO . 9.8 t70 -56.62 -47.59 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.332 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.58 -45.94 90.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 7' ' ' ARG . . . -66.74 -40.46 88.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.357 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' PHE . 59.5 t -61.76 -46.09 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.616 0.246 . . . . 0.0 110.712 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -63.72 -37.35 87.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.827 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -64.99 -48.55 73.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 0.0 110.121 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 7' ' ' ARG . 59.5 mt -60.98 -37.53 82.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -69.9 -31.5 69.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.27 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.91 -38.86 76.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.859 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 45' ' ' TYR . 48.1 mt-10 -79.93 -22.25 42.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.858 0.361 . . . . 0.0 110.793 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 45.51 4.5 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.438 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.456 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 57.0 m-85 -92.0 -34.04 14.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.105 0.453 . . . . 0.0 111.249 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.45 144.94 32.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.087 177.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 pp -129.98 165.3 30.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.338 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.05 60.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.486 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.93 122.81 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.02 110.15 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.04 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.422 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' OD1' ' A' ' 34' ' ' ASP . 71.6 Cg_endo -76.22 120.71 5.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.489 2.126 . . . . 0.0 112.447 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -109.06 112.72 25.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.27 141.18 31.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.007 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.5 -177.97 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.477 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -81.45 15.0 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.752 0.31 . . . . 0.0 110.782 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.4 tp -159.63 120.08 3.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.937 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.51 -71.09 0.41 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.028 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 14.6 Cg_exo -69.24 122.05 8.86 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.855 2.37 . . . . 0.0 113.308 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -125.36 152.38 44.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.019 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -88.09 137.72 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -83.19 173.67 11.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.19 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.42 -41.01 79.55 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -55.83 -54.81 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.748 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -66.55 -41.54 94.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.932 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -58.53 -46.87 85.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.57 -27.3 62.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -70.67 -24.92 62.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 80.4 mt -58.84 -19.28 40.04 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 74' ' ' LYS . 23.9 ttpt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' HG ' HG11 ' A' ' 28' ' ' VAL . 2.3 mm? . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.66 HH11 ' HA ' ' A' ' 36' ' ' ALA . 2.2 ttm-85 -70.58 -41.26 72.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -170.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 63.9 t80 -58.95 -41.66 87.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -58.9 -47.37 85.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 74.5 mt -63.47 -40.94 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.728 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 73' ' ' LEU . 23.7 mt -55.06 -50.17 69.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.722 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -72.38 -29.69 63.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.988 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 5.6 mm-40 -70.55 -29.8 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' ILE . 79.8 mt -69.89 -36.69 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.168 0.508 . . . . 0.0 109.876 173.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -78.33 -50.23 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.673 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -84.4 -38.63 20.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.945 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -20.08 75.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 65.86 20.47 11.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.841 0.456 . . . . 0.0 110.777 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.641 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.7 p 55.96 165.41 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.858 0.863 . . . . 0.0 113.039 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 92.2 Cg_endo -79.56 171.03 65.61 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 124.056 -1.227 . . . . 0.0 112.32 0.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -134.55 118.69 17.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -86.1 169.04 13.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.367 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.79 -40.63 95.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -71.11 -19.14 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.399 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.36 -42.55 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.519 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -87.94 -36.04 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.609 -177.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.71 -17.6 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.272 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 28.7 m -89.53 161.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 O-C-N 122.742 -0.269 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -85.24 179.99 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 10.9 mt-10 -59.45 -44.24 92.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.946 -173.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -53.01 62.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.624 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 44.2 mt-30 -63.7 -46.11 86.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -59.57 -44.72 93.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.162 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.56 -55.53 33.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.084 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.68 -41.58 81.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.64 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.66 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -64.51 -57.57 8.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.2 -42.31 94.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 O-C-N 123.251 0.344 . . . . 0.0 111.782 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -61.07 -46.49 90.43 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.713 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.2 mt -61.36 -46.75 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.546 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HD2' ' O ' ' A' ' 46' ' ' ILE . 23.1 tptp -69.24 -38.55 78.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 110.027 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -61.66 -41.59 97.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.376 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.899 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.79 39.96 0.74 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.625 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.576 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 67.4 m-85 -91.3 -29.4 17.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 49' ' ' VAL . 1.3 pp -143.75 156.75 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.686 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 29.0 pt -133.02 -179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.422 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.11 17.61 79.91 Favored Glycine 0 N--CA 1.454 -0.13 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.611 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 HD13 ' A' ' 46' ' ' ILE . 86.5 t -93.5 119.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.242 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -94.86 110.68 22.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 111.19 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.604 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.5 ptm85 . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.54 144.08 48.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.06 2.507 . . . . 0.0 112.106 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -124.18 121.66 35.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.34 106.78 18.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.275 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 19' ' ' THR . 44.6 m-85 -95.62 -173.88 3.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 41.5 mtpt -63.0 -48.74 77.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.383 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.88 142.58 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.38 -67.07 0.45 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.613 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 51.7 Cg_exo -56.7 125.68 19.81 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.055 2.504 . . . . 0.0 113.821 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 47' ' ' ILE . 53.3 mm-40 -123.52 142.03 51.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.1 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.4 ' HG ' ' CG2' ' A' ' 46' ' ' ILE . 7.0 mp -90.07 138.34 31.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.365 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.4 p -82.5 179.91 7.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.85 -47.55 74.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.62 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.893 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -64.75 -46.12 90.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.778 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.79 -44.7 96.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.543 0.211 . . . . 0.0 111.355 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -73.32 -30.91 63.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.149 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -66.64 -31.53 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 98.4 mt -57.55 -40.1 78.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.794 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.554 179.658 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' O ' HG13 ' A' ' 10' ' ' ILE . 1.3 mm? . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HG2' HD21 ' A' ' 40' ' ' LEU . 79.5 mtt180 -54.8 -46.88 74.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.506 0.594 . . . . 0.0 111.353 -171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.518 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 88.3 t80 -55.44 -57.41 11.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.084 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.26 97.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.486 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.3 mt -59.91 -49.03 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.863 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.4 mp -59.81 -47.25 86.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -75.82 -26.92 57.66 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.582 -0.447 . . . . 0.0 112.063 -176.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -77.08 -28.17 54.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.449 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.53 -48.33 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.92 -50.03 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.13 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.12 -30.36 22.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.431 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.95 -24.88 72.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.134 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.6 -4.28 2.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.0 0.52 . . . . 0.0 111.16 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 53.3 p 57.35 156.42 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.117 0.967 . . . . 0.0 112.957 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 6.2 Cg_exo -76.35 166.88 81.66 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 124.315 -1.119 . . . . 0.0 112.938 0.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -148.2 127.33 12.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -81.91 169.95 16.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.324 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -58.76 -37.33 76.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.795 174.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.53 -27.78 67.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.602 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.99 -49.86 14.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.758 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 28' ' ' VAL . 11.0 tt -75.7 -29.58 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 -175.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.37 32.95 4.08 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.083 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 26' ' ' ILE . 28.4 m -137.64 171.62 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' GLN . 2.3 t -85.39 164.47 17.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 0.0 110.938 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -60.79 -42.05 96.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.94 -53.94 51.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.665 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' H ' HG23 ' A' ' 29' ' ' THR . 30.6 mm-40 -69.57 -24.16 63.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.01 -54.07 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.69 -48.5 72.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.848 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.72 -56.8 12.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.784 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -70.34 -45.96 65.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.868 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.72 -44.31 98.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.598 0.237 . . . . 0.0 111.104 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -66.55 -35.26 79.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.992 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.72 -42.11 78.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.911 0.386 . . . . 0.0 110.227 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 7' ' ' ARG . 89.7 mt -62.1 -37.82 86.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.443 176.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 4.7 ttpm? -70.81 -25.68 62.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.37 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -70.12 -54.33 13.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.803 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 34.8 mt-10 -80.24 -20.14 45.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 110.912 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 58.29 1.37 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.841 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 96.5 m-85 -96.12 -33.43 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.249 0.547 . . . . 0.0 109.59 173.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.441 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -140.07 150.55 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.33 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.71 -179.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 84.91 4.19 87.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.081 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.74 113.2 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 0.0 109.984 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -79.97 110.18 15.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.336 0.588 . . . . 0.0 109.657 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.398 0.142 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.07 136.21 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.264 2.643 . . . . 0.0 111.521 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -129.69 123.63 31.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.279 0.562 . . . . 0.0 110.285 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 90.4 mt -86.61 87.37 7.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.582 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -71.82 167.4 20.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.268 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 23.8 mtpp -61.97 -47.12 86.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.76 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.64 112.72 25.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.358 . . . . 0.0 110.135 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 160.42 -62.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.278 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.85 116.94 3.08 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.01 2.473 . . . . 0.0 113.324 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 62' ' ' GLY . 35.6 mt-10 -129.67 160.26 33.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.488 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.2 147.78 28.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -91.97 170.56 9.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -64.87 -29.64 70.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 4.0 ttmp? -62.89 -46.6 87.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.778 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -73.29 -36.82 55.21 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.566 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.47 -49.39 75.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -70.66 -25.52 63.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 24.9 t80 -62.92 -39.36 94.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.83 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 11' ' ' LEU . 85.5 mt -54.13 -41.57 68.54 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.152 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.69 0.757 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.751 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -62.89 -28.72 70.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.119 174.026 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.981 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 61.6 t80 -69.76 -41.41 75.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.663 175.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.56 -46.45 80.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 26' ' ' ILE . 25.0 mm -54.78 -48.88 72.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.808 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 73' ' ' LEU . 71.9 mt -56.36 -43.74 79.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -65.39 -45.82 82.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.631 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -29.66 69.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.327 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 21' ' ' LEU . 80.6 mt -61.96 -46.59 96.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -67.87 -42.88 80.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.702 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.6 -40.09 73.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.877 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.47 -20.79 57.92 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.006 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.52 20.44 12.15 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.703 0.401 . . . . 0.0 110.16 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 41.6 p 58.38 150.69 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 124.517 1.127 . . . . 0.0 113.255 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -87.25 161.03 49.2 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.208 -0.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 14' ' ' ILE . 1.6 pt? -131.37 120.96 23.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 m -82.59 164.86 20.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.559 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -59.36 -44.73 92.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 176.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.83 -21.39 62.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.047 0.451 . . . . 0.0 111.011 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.04 -46.79 15.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.665 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -71.61 -37.08 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.58 35.96 1.81 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.135 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 26' ' ' ILE . 35.8 m -140.42 170.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 p -76.8 160.54 29.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.46 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 5.6 mt-10 -57.64 -48.97 77.98 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.255 0.55 . . . . 0.0 109.52 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.76 -45.52 19.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.786 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.446 HE21 ' HB ' ' A' ' 28' ' ' VAL . 27.3 mt-30 -74.65 -38.73 62.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.054 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -64.92 -46.95 79.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.631 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -56.66 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.707 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.73 -34.54 77.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.849 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.751 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -60.34 -52.72 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.68 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -41.87 98.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.715 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -64.3 -48.36 75.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.91 -36.07 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.734 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -75.74 -28.6 58.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -77.66 -43.98 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -76.22 -13.01 60.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.362 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.45 51.77 4.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 73.3 m-85 -98.2 -39.2 8.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.058 0.456 . . . . 0.0 109.822 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 ' HG ' ' A' ' 65' ' ' LEU . 2.0 pp -138.78 149.4 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.576 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.96 168.83 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.817 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 24.94 34.14 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.1 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.43 128.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 110.321 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -94.89 126.04 39.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.826 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.269 0.557 . . . . 0.0 111.784 -177.498 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.593 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 75.0 mtp180 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.451 0.167 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 153.33 57.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 143.36 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.24 136.64 51.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' THR . 96.6 m-85 -108.01 -168.63 1.4 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.864 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 49.8 mtpt -75.79 -13.67 60.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.941 0.4 . . . . 0.0 111.119 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -161.54 161.12 29.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.99 -59.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.143 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.95 141.85 72.61 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.471 2.114 . . . . 0.0 113.756 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -120.52 150.95 40.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.766 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -96.96 144.71 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.4 p -83.4 179.59 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.465 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.1 -42.65 99.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.14 -49.03 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.858 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.65 -47.91 65.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.74 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.409 . . . . 0.0 111.169 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -77.35 -35.28 54.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.985 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -58.93 -39.1 80.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.254 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.981 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.7 -46.96 83.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.919 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.6 mttp . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.742 -175.04 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? . . . . . 0 C--O 1.227 -0.092 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 8.8 mmt180 -59.77 -51.89 67.8 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.598 0.714 . . . . 0.0 109.404 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -51.85 -46.14 64.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.167 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.46 62.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 6' ' ' LEU . 73.2 mt -59.37 -30.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.604 0.24 . . . . 0.0 111.266 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -52.75 -38.65 61.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.598 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.553 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.6 ttpp -74.07 -39.15 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.745 -177.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.07 -32.09 73.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.38 . . . . 0.0 110.523 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.58 -43.51 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 110.081 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -64.09 -50.33 68.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.019 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 6.0 mt-10 -77.7 -19.14 55.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 110.677 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.46 -17.11 69.48 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.617 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.98 16.28 9.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.01 0.524 . . . . 0.0 110.436 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.1 p 56.18 151.6 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.521 1.128 . . . . 0.0 112.956 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -78.85 177.69 37.39 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.451 -1.479 . . . . 0.0 112.457 -2.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 26' ' ' ILE . 43.5 tp -149.79 119.31 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.981 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 17.0 m -85.8 164.51 17.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.201 175.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -68.02 -33.78 75.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.55 -36.47 84.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 9.1 m-20 -71.0 -34.55 71.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.396 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -83.95 -35.03 10.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.099 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 26' ' ' ILE . 31.5 m -135.39 173.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 110.326 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 p -85.59 166.76 15.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.681 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 24.3 mt-10 -67.03 -33.22 75.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.708 0.766 . . . . 0.0 108.957 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -49.77 -57.2 7.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.959 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -72.43 -33.79 67.36 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.966 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 47.6 t80 -66.28 -50.71 62.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.3 t70 -62.76 -45.6 91.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.19 -41.89 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.712 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -67.36 -55.9 11.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.837 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.37 -34.97 67.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.159 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.59 -45.59 86.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.607 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.7 t80 -61.68 -41.43 97.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.088 0.47 . . . . 0.0 110.065 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.0 mt -64.66 -39.85 94.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.134 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -34.81 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -60.9 -52.99 62.68 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.626 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 8.3 mm-40 -74.12 -28.42 61.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.958 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.08 40.9 2.54 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.953 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -89.78 -32.77 16.81 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.676 -0.308 . . . . 0.0 111.295 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -137.42 148.41 25.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 27.6 pt -133.8 170.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.251 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.68 90.57 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.256 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG21 HD13 ' A' ' 46' ' ' ILE . 44.2 t -70.22 128.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -94.71 119.14 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.106 0.479 . . . . 0.0 111.143 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.437 178.309 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 50.4 mtp180 . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 26.8 Cg_exo -60.11 119.55 6.81 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 113.724 -165.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -106.59 112.62 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.527 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.86 145.76 25.91 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.608 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.12 171.92 12.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 51.8 mttm -78.17 -18.33 55.68 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.612 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 124.15 42.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.47 -65.59 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.734 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 33.5 Cg_exo -60.7 121.73 10.17 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.81 2.34 . . . . 0.0 112.812 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -128.23 145.19 51.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 129.85 39.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.35 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.9 p -80.02 166.14 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.104 0.252 . . . . 0.0 110.877 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.6 -38.28 69.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.145 0.498 . . . . 0.0 109.991 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -52.26 -55.39 21.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.726 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -76.42 -36.03 40.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.02 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -63.41 -40.92 98.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.703 0.287 . . . . 0.0 110.873 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.66 -29.4 61.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.437 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.03 -27.01 68.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.294 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 91.8 mt -69.31 -19.1 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.34 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttp . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -56.71 -38.22 72.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.692 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -59.96 -43.95 94.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.192 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.02 82.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.762 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.01 -49.49 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.654 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.8 mp -61.34 -37.31 82.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.254 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -24.26 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.982 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.89 -39.18 61.62 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.58 -43.67 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.579 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.52 -50.61 29.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.876 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -83.28 -40.08 20.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.777 0.322 . . . . 0.0 110.842 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 -26.86 59.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.491 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.5 25.9 13.32 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.075 0.55 . . . . 0.0 110.64 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.521 HG21 ' HG2' ' A' ' 63' ' ' PRO . 18.0 p 56.65 156.97 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.39 1.076 . . . . 0.0 113.338 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.2 Cg_endo -83.25 172.8 46.35 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.377 -2.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.52 136.18 21.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -85.16 166.86 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.692 0.282 . . . . 0.0 110.461 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 1.4 mp0 -55.25 -42.61 73.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.443 0.639 . . . . 0.0 110.242 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -69.59 -22.95 63.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.263 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.37 -49.87 44.7 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.66 0.267 . . . . 0.0 110.501 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.4 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -70.19 -38.68 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.907 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.57 -2.52 11.17 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.785 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 26' ' ' ILE . 34.1 m -116.09 160.97 15.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.234 0.517 . . . . 0.0 110.839 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -70.12 159.88 33.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 10.0 pt-20 -60.31 -29.63 68.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.003 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.85 -52.36 66.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.597 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -74.61 -35.12 62.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 74.5 t80 -58.07 -55.77 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.243 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -54.83 -49.71 70.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.778 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -50.27 73.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.804 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -69.86 -44.82 69.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.549 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.65 -37.03 74.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.482 0.182 . . . . 0.0 110.858 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.19 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.564 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.8 -39.13 93.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.996 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 95.1 mt -62.37 -37.59 86.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 0.0 110.903 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 51.9 tttm -77.68 -33.6 53.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.45 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.04 -47.6 70.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.11 8.27 16.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.41 49.01 59.43 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.387 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 64.1 m-85 -95.15 -39.76 9.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -140.47 142.77 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.214 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.32 175.71 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.068 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.65 6.08 73.73 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 49.8 t -76.24 109.92 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -87.69 111.07 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.071 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.639 173.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.95 101.95 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.194 1.929 . . . . 0.0 110.722 169.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -92.17 108.72 20.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.72 109.42 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.946 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.8 -168.11 1.94 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.449 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -75.86 -45.48 35.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.204 0.525 . . . . 0.0 110.22 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.32 132.0 53.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.608 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.01 -63.14 0.39 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.398 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HG2' HG21 ' A' ' 19' ' ' THR . 35.9 Cg_exo -59.01 120.24 7.98 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.792 2.328 . . . . 0.0 112.662 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.85 151.67 46.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.005 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.21 148.45 22.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.23 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -91.72 161.05 15.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -66.35 -26.8 67.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -61.46 -51.75 67.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.256 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.7 71.44 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.37 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -62.67 -41.88 99.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.04 0.447 . . . . 0.0 109.854 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -70.81 -32.04 68.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.9 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.17 -36.64 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 110.083 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 11' ' ' LEU . 89.2 mt -58.41 -33.28 69.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.257 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.5 tttp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.267 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.415 ' HG ' ' CG1' ' A' ' 28' ' ' VAL . 2.1 mm? . . . . . 0 C--O 1.227 -0.111 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 40' ' ' LEU . 39.9 ttm180 -53.31 -41.65 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 0.0 111.233 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.2 -43.72 95.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.56 61.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.957 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.95 -45.73 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.012 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.93 -41.43 91.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.521 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.06 -46.0 72.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.554 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HB3' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -58.84 -39.28 80.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.278 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.05 -50.06 50.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.446 . . . . 0.0 110.414 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -62.76 -50.29 71.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.72 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -82.57 -35.15 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.809 0.338 . . . . 0.0 111.47 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.54 -24.16 75.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.56 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 71.42 5.94 5.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.129 0.572 . . . . 0.0 110.73 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.6 p 55.9 164.51 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 113.334 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 90.0 Cg_endo -83.98 -178.46 19.38 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.623 -1.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 13' ' ' GLU . 2.6 pt? -155.02 143.43 20.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.2 m -85.27 170.23 13.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.717 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.591 ' HG3' HD22 ' A' ' 24' ' ' ASN . 13.9 pt-20 -61.5 -47.43 85.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.786 0.326 . . . . 0.0 111.35 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.591 HD22 ' HG3' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -72.71 -9.22 58.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -176.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.81 -47.38 30.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -75.13 -38.49 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.46 -19.28 5.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.516 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 35.1 m -98.14 162.06 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.666 0.27 . . . . 0.0 110.622 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.7 p -81.02 165.73 21.42 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.09 -31.51 30.86 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.629 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.27 -53.72 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.065 0.46 . . . . 0.0 110.797 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 2.7 mp0 -70.74 -34.49 71.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.01 -52.06 39.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.661 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -57.71 -54.16 49.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.795 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -54.08 -50.72 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.984 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.647 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -62.02 -53.16 59.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.75 -177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.55 -44.89 97.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 111.37 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -65.89 -40.77 91.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.334 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 75.5 t80 -61.58 -47.87 83.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.176 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 7' ' ' ARG . 96.8 mt -56.2 -44.47 79.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.353 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 3.9 ttpm? -67.33 -38.99 85.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -72.72 -39.89 66.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.407 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 14.2 mm-40 -78.24 -27.64 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.95 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.61 32.93 1.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.55 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 95.8 m-85 -90.3 -43.87 10.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 110.673 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.4 pp -141.0 154.84 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -133.54 173.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 91.52 13.32 58.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.799 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.65 119.1 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.652 0.263 . . . . 0.0 110.425 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -90.85 124.77 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.71 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 61.4 m-85 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.042 0.449 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 94.9 Cg_endo -86.12 160.57 10.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.106 2.538 . . . . 0.0 113.863 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -137.48 126.92 24.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.378 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 86.1 mt -88.25 154.67 20.24 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -133.11 -177.21 4.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.108 0.48 . . . . 0.0 111.278 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp -146.69 145.15 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.952 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 134.68 -67.59 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.892 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 28.1 Cg_exo -62.5 123.57 12.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.637 2.225 . . . . 0.0 111.878 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 151.33 46.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.604 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.662 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 mp -91.92 142.2 27.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.599 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.5 p -88.0 179.31 6.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.262 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.53 -39.24 76.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.3 tppt? -65.02 -42.07 94.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.475 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.59 -47.78 88.5 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.52 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.6 -45.08 94.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -73.28 -25.12 60.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 0.0 111.18 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.22 -40.45 77.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.127 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -55.39 -38.32 68.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.765 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.8 tttp . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.248 -177.916 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 10' ' ' ILE . 1.5 mm? . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.507 0.194 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.518 HH11 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -56.56 -40.37 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.45 -42.01 65.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.308 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 26' ' ' ILE . 42.8 mm -60.48 -52.79 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.388 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.92 -43.64 91.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.402 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.19 -44.61 94.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.675 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.123 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ILE . 77.6 mt -65.87 -45.21 91.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 110.339 175.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.96 -50.21 71.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.612 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.72 -17.28 32.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.46 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 -27.71 23.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.685 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.7 t30 68.53 11.46 8.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 28.6 p 55.04 162.65 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 124.345 1.058 . . . . 0.0 113.294 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 95.3 Cg_endo -79.61 156.14 89.29 Favored 'Cis proline' 0 C--N 1.343 0.274 0 C-N-CA 123.717 -1.368 . . . . 0.0 111.88 -3.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.1 pt? -124.55 132.51 53.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -85.0 162.89 19.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.138 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.836 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.28 -32.94 74.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -65.56 -34.42 78.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.35 -43.7 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.68 -27.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.95 33.96 5.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.334 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 26' ' ' ILE . 33.7 m -135.11 175.87 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 p -83.89 156.92 22.17 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.836 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.47 -21.2 64.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.04 -44.8 79.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.056 0.455 . . . . 0.0 109.933 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -68.06 -29.82 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -64.6 -48.79 73.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.562 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.67 -53.58 53.02 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.64 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -49.59 53.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.745 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -61.93 -54.41 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.608 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.96 -38.59 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 O-C-N 123.105 0.253 . . . . 0.0 111.522 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 17.0 m-80 -60.78 -49.41 77.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.647 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.66 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.629 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 97.0 mt -60.98 -37.73 83.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 5.3 tmmm? -71.37 -40.76 70.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 55.8 mtt180 -60.75 -47.29 86.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.926 0.393 . . . . 0.0 111.141 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -82.29 4.77 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.48 46.24 94.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.119 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 29.6 m-85 -87.55 -37.36 16.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.406 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.8 pp -138.68 150.34 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.097 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.29 173.71 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.471 175.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.43 9.34 69.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.084 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.75 124.9 38.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -92.42 111.28 22.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.891 0.377 . . . . 0.0 110.424 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.488 178.298 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.19 99.9 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.446 2.097 . . . . 0.0 111.012 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -82.05 109.78 16.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.068 0.461 . . . . 0.0 110.933 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 85.6 mt -89.17 105.72 17.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.652 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.0 173.1 7.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.03 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -67.92 -26.76 66.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.349 0.595 . . . . 0.0 109.891 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.27 117.8 31.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.641 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.18 -72.33 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.51 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.04 120.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.449 2.766 . . . . 0.0 114.206 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -129.84 144.46 51.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.622 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.66 145.64 26.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.39 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.2 p -96.04 173.85 7.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.27 -37.27 86.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -62.93 -40.45 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.357 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.511 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -70.87 -41.97 61.45 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.467 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.15 -38.63 88.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.776 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -36.77 85.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.353 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.61 -36.14 79.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.642 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.4 -44.53 89.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.51 . . . . 0.0 110.489 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -178.304 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.547 0.213 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -66.68 -37.47 84.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 109.953 -172.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -55.41 -48.3 74.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.111 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.38 -18.54 54.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.613 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 26' ' ' ILE . 66.2 mt -58.65 -39.37 75.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.436 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' CB ' HD21 ' A' ' 73' ' ' LEU . 46.0 mt -62.3 -30.75 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.385 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -62.94 -43.89 97.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 109.992 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 26' ' ' ILE . 7.8 mm-40 -63.37 -42.8 98.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.384 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 65' ' ' LEU . 74.9 mt -65.93 -31.87 55.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.876 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.21 -49.92 57.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.469 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.26 -28.58 21.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.755 0.312 . . . . 0.0 111.822 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.62 -14.76 64.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.599 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 19' ' ' THR . 4.2 t-20 70.51 -81.81 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.596 0.759 . . . . 0.0 109.486 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER 173.16 157.26 0.27 Allowed Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 124.199 0.999 . . . . 0.0 109.012 176.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 66.7 Cg_endo -87.8 -174.82 9.67 Favored 'Cis proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.108 -0.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -157.73 127.8 6.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 m -85.41 170.14 12.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.367 . . . . 0.0 110.63 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.03 -22.12 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.722 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -84.2 -43.93 14.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.498 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 10' ' ' ILE . 5.1 tp -70.02 -38.43 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.92 -20.13 10.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.943 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.24 160.07 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 t -70.38 166.82 19.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.299 0.571 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.44 -29.15 69.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.45 -43.31 90.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.547 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -71.66 -32.25 67.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.873 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.79 -46.7 80.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.86 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -56.71 -53.14 61.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.453 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.9 -37.64 77.07 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.405 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.14 -59.9 3.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.717 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.14 -43.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.296 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.999 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -68.91 -45.74 70.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.792 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 74.7 mt -63.21 -37.18 86.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.944 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -60.77 -42.35 97.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.99 12.97 18.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.356 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.28 38.33 96.04 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.638 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 34.7 m-85 -88.26 -28.72 20.93 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.487 -0.419 . . . . 0.0 110.488 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.9 pp -143.68 149.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -131.84 150.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.63 35.45 6.18 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.518 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.6 115.2 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.944 0.402 . . . . 0.0 110.452 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.436 ' NE2' ' HA3' ' A' ' 62' ' ' GLY . 89.4 m-70 -82.19 135.91 35.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.66 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--N 1.317 -0.809 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.567 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.867 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.378 0 N-CA-C 110.37 -0.234 . . . . 0.0 110.37 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.867 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 52.7 Cg_exo -53.62 136.47 64.71 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.553 2.168 . . . . 0.0 111.835 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.22 105.57 3.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.111 0.482 . . . . 0.0 110.027 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB3' HG21 ' A' ' 19' ' ' THR . 86.8 mt -74.03 134.33 43.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.147 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.824 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.8 m-85 -125.83 -178.34 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -43.15 -55.66 3.81 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.159 0.912 . . . . 0.0 113.289 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 61' ' ' LEU . 3.2 pp -128.1 146.07 50.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.925 0.393 . . . . 0.0 110.955 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 137.19 -64.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.722 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.23 121.57 8.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.537 2.158 . . . . 0.0 113.074 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -114.72 152.37 32.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.621 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.9 mp -101.17 134.43 44.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.1 p -80.23 160.95 25.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 10.7 pt-20 -69.43 -20.0 63.79 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.48 -48.32 82.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 -35.23 50.51 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.862 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 32.9 tt0 -63.11 -43.26 98.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.56 0.219 . . . . 0.0 110.905 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -67.37 -32.87 74.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.26 -35.71 81.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.236 0.541 . . . . 0.0 109.607 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.594 HD21 ' CB ' ' A' ' 11' ' ' LEU . 73.8 mt -74.59 -19.41 60.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.34 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.987 0.422 . . . . 0.0 110.908 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.458 -0.034 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -60.79 -41.95 96.6 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.869 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.695 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 72.5 t80 -66.44 -42.85 87.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.147 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.98 -47.21 81.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 26' ' ' ILE . 54.2 mt -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 40' ' ' LEU . 82.9 mt -56.01 -46.83 78.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.29 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 26.3 ttpp -68.69 -42.45 77.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 -177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG3' HG13 ' A' ' 26' ' ' ILE . 9.1 mm-40 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.016 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 19' ' ' THR . 73.0 mt -65.33 -42.31 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 110.115 173.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.94 -50.1 57.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.402 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 10.7 mt-10 -74.1 -33.28 63.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.023 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.17 -31.28 14.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.249 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 71.99 19.12 4.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.167 0.587 . . . . 0.0 110.614 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.744 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 14.2 p 56.16 169.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.075 0.95 . . . . 0.0 113.156 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.791 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 79.6 Cg_endo -90.77 156.54 27.8 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 124.715 -0.952 . . . . 0.0 112.276 -1.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -149.35 131.46 15.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.118 0.485 . . . . 0.0 110.527 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -85.26 170.32 12.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.987 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.83 -36.71 77.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.765 0.284 . . . . 0.0 111.765 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -68.47 -25.92 65.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.32 -48.78 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.003 0.43 . . . . 0.0 110.509 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 21' ' ' LEU . 9.4 tt -76.56 -34.4 24.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.607 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.25 28.18 3.4 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.245 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 34.5 m -126.92 172.14 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 p -85.16 163.8 18.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.862 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 24.5 mt-10 -55.8 -42.5 75.71 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.61 -62.08 1.62 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.56 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.77 -47.56 80.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.639 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.5 t80 -63.63 -52.1 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.71 -45.77 85.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -62.25 -39.92 94.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -50.53 72.04 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.803 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' PHE . 97.7 t -58.18 -41.77 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.703 0.287 . . . . 0.0 110.956 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -62.53 -45.48 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -64.68 -41.0 96.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.709 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 11' ' ' LEU . 84.1 mt -63.81 -46.08 86.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.204 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.55 -26.65 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -56.57 -53.67 54.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 26.1 mt-10 -89.6 -8.4 52.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.11 53.76 2.9 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.936 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' HD2' ' HA2' ' A' ' 69' ' ' GLY . 73.4 m-85 -85.42 -38.37 18.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.767 0.317 . . . . 0.0 110.681 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -131.92 149.91 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 176.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 pt -126.9 167.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.12 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 9.99 65.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.67 124.96 38.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.789 174.382 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.431 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 2.6 Cg_endo -81.89 146.48 14.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.486 2.791 . . . . 0.0 112.275 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -125.87 116.29 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 63' ' ' PRO . 78.0 mt -89.0 120.6 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.923 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -100.64 -174.36 2.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.791 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 97.0 mttt -69.89 -26.3 64.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.417 0.627 . . . . 0.0 110.394 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.72 101.43 5.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.055 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.42 -79.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.777 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 73.9 Cg_endo -76.87 120.39 5.46 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 114.198 -172.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HB2' HG13 ' A' ' 47' ' ' ILE . 37.4 mt-10 -100.18 142.23 31.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.074 172.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -95.26 134.52 37.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.731 0.301 . . . . 0.0 110.361 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.0 p -93.26 178.43 5.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.351 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.9 -40.31 80.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.014 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.75 -41.0 90.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.88 -41.72 27.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.407 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -65.78 -34.6 78.54 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.979 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.72 -36.06 67.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 0.0 110.942 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.62 -26.35 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.261 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.695 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 97.0 mt -59.92 -41.8 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.721 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 -178.577 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.484 ' HG ' ' CG1' ' A' ' 28' ' ' VAL . 3.6 mm? . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 120.658 0.266 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.18 -50.7 11.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 64.6 t80 -62.15 -46.07 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.959 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.67 -46.42 89.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.332 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.3 mt -55.99 -46.64 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 98.5 mt -56.45 -50.19 72.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.508 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -77.68 -30.32 51.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.836 -175.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.442 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 5.7 mm-40 -73.61 -22.31 60.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.089 0.471 . . . . 0.0 110.074 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 10' ' ' ILE . 58.9 mt -76.41 -50.38 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 170.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -56.12 -41.6 75.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.586 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -97.01 -26.27 15.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.721 0.296 . . . . 0.0 111.694 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -83.49 -16.0 69.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.383 -174.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.3 t30 76.67 -13.52 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.014 0.526 . . . . 0.0 111.546 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 27.5 p 58.93 156.98 0.09 OUTLIER Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.504 1.122 . . . . 0.0 112.648 -174.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 4.4 Cg_exo -75.55 161.85 93.64 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.946 -1.273 . . . . 0.0 111.935 1.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.4 pt? -124.7 119.96 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -72.18 156.09 39.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.315 0.579 . . . . 0.0 111.042 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.625 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -71.17 -40.76 71.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.662 -175.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.55 -45.54 15.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.301 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.55 -36.79 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 33.7 1.52 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.397 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 26' ' ' ILE . 30.6 m -139.01 174.37 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.843 0.322 . . . . 0.0 110.182 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -85.32 154.26 22.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 0.0 110.343 171.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -68.39 -28.55 67.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.131 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.76 -42.62 85.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.197 0.522 . . . . 0.0 110.58 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HB2' HG23 ' A' ' 29' ' ' THR . 1.5 mp0 -79.78 -21.19 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.381 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 37' ' ' VAL . 84.9 t80 -65.82 -55.97 14.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.063 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' HB2' ' HG2' ' A' ' 56' ' ' PRO . 1.5 p30 -68.47 -33.86 74.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.283 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.64 -50.52 73.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -60.83 -44.91 96.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.226 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 33' ' ' PHE . 93.0 t -57.05 -40.88 75.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.933 0.396 . . . . 0.0 110.903 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -68.37 -38.62 81.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.171 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -66.83 -40.17 87.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.4 mt -60.87 -38.22 84.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.011 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -70.66 -37.49 73.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.101 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -57.03 -53.12 61.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.08 -34.44 71.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.193 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.22 46.25 1.6 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.571 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -94.45 -35.99 12.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.1 pp -137.94 154.93 29.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.73 163.37 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.729 177.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.82 28.15 14.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.784 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 56' ' ' PRO . 87.1 t -71.46 117.42 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 4.2 t60 -96.57 121.98 38.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 -176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 . . . . . 0 C--N 1.32 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.456 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 120.411 0.148 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 26.7 Cg_endo -65.47 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.452 2.102 . . . . 0.0 110.799 170.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -105.74 -35.82 7.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.5 mt 69.5 128.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.862 0.726 . . . . 0.0 110.763 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 20' ' ' PRO . 31.6 m-85 -122.06 -175.55 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 44.5 mtmt -70.02 -5.14 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 tp -160.29 119.07 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.03 -67.99 0.19 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.221 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 58' ' ' LEU . 57.7 Cg_endo -71.24 137.8 31.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.364 2.043 . . . . 0.0 113.459 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -130.29 166.11 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.584 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.8 mp -97.75 145.18 26.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.919 0.39 . . . . 0.0 110.461 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.3 p -80.06 169.56 17.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.01 -38.36 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.94 0.4 . . . . 0.0 110.014 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -69.21 -45.64 69.37 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.989 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.22 97.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.27 -40.49 90.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.221 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.071 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.58 -28.61 69.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.669 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 87.3 mt -58.23 -34.48 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.34 175.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.151 0.5 . . . . 0.0 110.051 177.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -100.41 3.1 42.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.429 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.788 HH11 ' HA ' ' A' ' 36' ' ' ALA . 33.9 mmt180 -67.42 -56.07 11.1 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.581 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 13.9 t80 -62.57 -40.79 97.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.751 176.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.02 -44.96 87.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.326 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.27 -39.17 72.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.784 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.633 ' HG ' HD13 ' A' ' 40' ' ' LEU . 8.0 mt -56.28 -45.02 80.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 6.8 ttpp -62.56 -39.59 94.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.54 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HG2' HG12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -64.61 -37.18 86.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.359 178.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.08 -44.13 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.278 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.35 -50.51 73.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.318 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.83 -18.99 19.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.482 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.17 -27.12 66.82 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.332 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 74.2 -1.78 2.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.212 0.605 . . . . 0.0 111.449 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 62.0 p 59.55 153.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.664 1.186 . . . . 0.0 113.33 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.626 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 2.0 Cg_endo -81.74 167.12 70.87 Favored 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.983 -1.257 . . . . 0.0 112.387 0.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 13' ' ' GLU . 1.7 pt? -140.78 149.05 41.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 25' ' ' ASP . 30.3 t -85.2 167.26 15.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.65 0.738 . . . . 0.0 110.938 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -80.63 -48.21 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.545 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -66.6 -27.88 68.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.585 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 11.1 t70 -72.73 -40.63 65.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.564 -177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -74.29 -32.91 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.24 20.37 2.22 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.721 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -130.66 175.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 117.243 0.522 . . . . 0.0 110.786 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.6 p -85.32 172.5 11.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.693 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 10.3 mt-10 -58.27 -53.2 60.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 110.403 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.78 -29.97 70.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.113 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.2 -46.74 66.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.347 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 67.9 t80 -62.87 -45.35 92.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.772 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 55' ' ' ARG . 6.3 t70 -54.75 -53.86 49.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.664 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.9 -40.23 92.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.62 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.788 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -61.06 -52.22 65.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.8 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.08 -44.73 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.993 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.45 -45.0 95.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.239 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.34 -46.78 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.633 HD13 ' HG ' ' A' ' 11' ' ' LEU . 90.7 mt -63.74 -34.84 78.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.742 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.604 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 56.7 tttm -67.31 -41.55 85.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.776 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -67.29 -47.38 70.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.071 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -74.62 -22.95 58.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.06 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.46 46.83 1.92 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.062 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.638 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 86.3 m-85 -98.66 -36.29 9.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.994 0.426 . . . . 0.0 110.356 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.0 pp -142.36 155.6 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.893 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 34.8 pt -131.82 170.82 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.908 178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 14.32 50.36 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.8 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.604 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 96.7 t -78.41 114.14 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.033 0.444 . . . . 0.0 110.31 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -109.64 131.62 54.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.621 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -91.44 142.99 27.08 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.5 t -121.8 -88.51 0.62 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.879 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -52.61 64.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.868 0.842 . . . . 0.0 110.001 172.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -169.17 -33.32 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.546 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.524 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 10.2 mtp180 -105.8 163.97 15.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.933 -173.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 25.2 Cg_endo -62.48 134.48 48.24 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.644 2.229 . . . . 0.0 112.393 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -126.82 132.41 51.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.124 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.505 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -97.64 138.67 34.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.428 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -110.37 -174.07 2.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.578 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.626 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 54.0 mttp -83.59 -5.37 59.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.389 0.614 . . . . 0.0 110.326 -176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -156.79 120.86 4.34 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . . . 157.36 -57.02 0.37 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.896 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HG3' HD22 ' A' ' 58' ' ' LEU . 30.5 Cg_exo -62.3 106.36 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.62 2.213 . . . . 0.0 112.55 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 4.3 mm-40 -110.55 140.07 45.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 46' ' ' ILE . 6.3 mp -88.66 144.22 26.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.896 0.379 . . . . 0.0 110.458 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 p -87.21 171.38 10.7 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.46 -38.3 90.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -63.0 -44.53 95.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.643 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.19 -42.72 94.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.704 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.03 -46.57 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.449 . . . . 0.0 110.585 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -34.52 77.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.674 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -62.57 -37.68 87.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.558 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 11' ' ' LEU . 82.8 mt -63.4 -33.46 75.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.578 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -68.54 -36.3 78.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.491 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -85.25 -45.78 11.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.294 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -89.54 5.48 45.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.328 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -62.77 -15.08 54.03 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.872 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -75.35 67.0 1.87 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.116 0.96 . . . . 0.0 110.584 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -143.31 124.59 14.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.194 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 t -68.9 93.25 0.54 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.003 0.43 . . . . 0.0 110.747 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -154.6 112.5 3.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.999 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 173.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.9 mttp . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' ILE . 3.6 mm? -67.44 -16.71 64.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 109.508 176.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.761 ' NH1' ' HA ' ' A' ' 36' ' ' ALA . 4.9 tpp180 -57.57 -37.17 72.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.112 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -69.73 -44.47 70.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.011 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -37.77 76.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.313 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.645 HD13 HG13 ' A' ' 26' ' ' ILE . 35.2 mm -65.17 -51.63 63.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 0.0 110.098 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -66.18 -40.61 90.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.093 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -68.32 -28.32 67.05 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.307 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.56 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -81.04 -26.41 36.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.118 0.485 . . . . 0.0 110.193 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.6 mt -71.45 -26.99 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.754 0.788 . . . . 0.0 109.471 171.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -84.05 -26.58 28.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.92 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -100.41 -40.53 7.43 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.43 55.22 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.724 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER 70.25 -90.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -177.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER 173.01 164.84 0.27 Allowed Pre-proline 0 N--CA 1.466 0.351 0 C-N-CA 124.18 0.992 . . . . 0.0 108.805 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HA ' HG22 ' A' ' 19' ' ' THR . 64.7 Cg_endo -90.07 175.21 21.27 Favored 'Cis proline' 0 N--CA 1.462 -0.378 0 C-N-CA 124.297 -1.126 . . . . 0.0 112.823 -3.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.11 137.18 28.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.2 m -85.27 170.26 12.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.438 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 6.8 pm0 -59.4 -37.16 77.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.055 0.455 . . . . 0.0 110.797 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 4.2 t-20 -65.18 -30.94 71.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.047 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.35 -49.76 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.067 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.645 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.62 -35.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.105 -176.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.86 30.85 2.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.273 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 32.1 m -130.6 169.17 21.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 32' ' ' GLN . 23.6 p -85.16 169.32 13.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.785 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 2.4 mt-10 -48.65 -52.58 22.48 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.787 0.68 . . . . 0.0 110.832 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.43 -37.44 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.844 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 18.1 mm-40 -79.02 -32.85 45.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -72.24 -36.39 69.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.511 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.89 -46.41 90.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.596 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -52.11 -49.65 63.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.514 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . . . -59.69 -58.52 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.819 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.4 t -60.51 -47.09 94.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.588 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.55 -39.32 93.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.61 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.619 ' HD2' ' HD2' ' A' ' 7' ' ' ARG . 77.1 t80 -67.22 -41.04 86.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.322 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.1 mt -64.44 -44.77 90.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.809 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -70.53 -37.25 74.06 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.889 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -58.89 -55.97 28.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.162 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 73.4 mm-40 -82.78 -3.22 56.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.62 -174.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.75 44.84 9.9 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.106 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 68.5 m-85 -79.28 -34.14 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.183 0.516 . . . . 0.0 109.743 173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 49' ' ' VAL . 1.8 pp -140.1 157.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.473 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 46.1 pt -132.26 165.65 31.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.48 -1.95 73.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.915 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.422 HG21 HD13 ' A' ' 46' ' ' ILE . 57.4 t -76.67 126.96 37.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.802 0.334 . . . . 0.0 110.53 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -98.56 147.2 25.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.457 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 56' ' ' PRO . 19.1 m-85 -119.98 143.41 48.05 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -114.0 164.51 13.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 164.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.37 -29.34 67.63 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -172.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -97.05 -33.65 11.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 13.3 ttm180 -156.04 140.86 12.14 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.986 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' A' ' 51' ' ' TYR . 28.9 Cg_exo -61.19 147.77 94.71 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.448 2.098 . . . . 0.0 111.073 169.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -118.8 115.61 24.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.402 0.62 . . . . 0.0 111.389 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.39 144.98 26.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.346 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.97 168.99 18.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' THR . 29.8 mtpp -55.98 -56.43 20.83 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.724 0.64 . . . . 0.0 112.232 -168.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.06 90.14 3.21 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.936 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.1 -69.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.021 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 19.6 Cg_exo -66.07 109.07 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.146 2.564 . . . . 0.0 113.316 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -108.44 155.79 20.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.164 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.56 148.21 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.065 0.459 . . . . 0.0 111.051 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.0 p -104.55 -179.81 4.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.088 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -54.32 -43.91 71.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.079 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -57.12 -51.36 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -38.67 93.6 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.269 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.53 -46.93 87.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -61.53 -41.24 97.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.16 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -61.02 -40.18 92.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.97 -42.83 90.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.179 0.514 . . . . 0.0 110.484 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.06 -39.57 93.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.92 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -77.12 -39.5 49.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.346 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.81 5.83 48.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.238 -175.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.46 -17.18 4.12 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.936 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.476 ' O ' ' HB3' ' A' ' 79' ' ' TRP . 10.2 t -81.68 -145.04 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 78' ' ' THR . 29.7 t90 79.99 146.83 0.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.456 0.702 . . . . 0.0 110.9 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -79.45 82.78 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.364 0.602 . . . . 0.0 110.87 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -90.42 14.61 12.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.477 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 111.304 -178.653 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.59 -20.43 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.862 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 36' ' ' ALA . 59.1 mmt-85 -54.3 -33.31 58.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.179 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' CE1' ' HA2' ' A' ' 77' ' ' GLY . 85.4 t80 -68.1 -54.25 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.901 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.03 -48.57 75.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 26' ' ' ILE . 54.9 mt -62.07 -43.77 98.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.12 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD23 HD21 ' A' ' 73' ' ' LEU . 12.1 tp -65.64 -35.48 80.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.881 0.372 . . . . 0.0 110.49 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.2 ttpp -70.84 -39.95 72.66 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.013 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 9.4 mm-40 -62.26 -39.79 94.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.457 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.3 mt -68.85 -32.17 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.383 0.611 . . . . 0.0 110.135 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -75.43 -40.13 58.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 8.9 mt-10 -80.85 -40.31 25.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.34 50.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.919 -175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.643 ' O ' HG23 ' A' ' 19' ' ' THR . 5.9 t30 68.89 -90.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.453 0.701 . . . . 0.0 109.52 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER 177.19 159.33 0.5 Allowed Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.998 0.919 . . . . 0.0 109.345 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.826 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 1.6 Cg_endo -82.09 167.78 67.79 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.321 -1.116 . . . . 0.0 112.199 0.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -150.17 129.51 12.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 173.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.6 m -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.18 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -56.99 -38.26 72.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.504 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -68.91 -35.8 77.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.947 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.72 -45.21 87.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.187 0.518 . . . . 0.0 110.629 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 28' ' ' VAL . 14.9 tt -79.56 -24.72 12.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.936 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.47 11.99 52.39 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.533 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 26' ' ' ILE . 26.3 m -123.15 167.22 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.979 0.389 . . . . 0.0 110.455 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -78.68 166.7 22.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.819 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 19.9 mt-10 -57.99 -40.59 81.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.97 -48.62 77.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.732 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.7 -35.12 67.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.918 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.29 -47.65 81.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.116 0.484 . . . . 0.0 109.7 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.81 -53.52 57.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.644 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -53.44 -53.36 52.49 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.239 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . . . -67.1 -53.53 29.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.291 -174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.18 -40.16 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.78 -39.64 94.74 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.83 0.348 . . . . 0.0 110.513 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -65.89 -46.62 77.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.246 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB3' HD12 ' A' ' 46' ' ' ILE . 68.5 mt -59.58 -42.06 91.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.227 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -66.58 -36.58 82.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.499 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -66.79 -43.01 85.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.033 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -78.26 -20.82 50.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.647 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.01 38.7 5.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.29 -30.65 20.72 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.63 -0.336 . . . . 0.0 111.038 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -140.82 159.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.479 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.05 158.78 42.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.97 29.04 19.2 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.202 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.53 109.91 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -91.03 130.94 36.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.979 -175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.92 145.76 30.88 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.363 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -136.69 -52.99 0.71 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 110.211 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 38.5 p-10 -103.19 23.69 12.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.74 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 34.7 t70 82.15 -10.02 1.14 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.794 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -105.32 161.2 23.49 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 170.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.63 122.56 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.8 2.333 . . . . 0.0 112.176 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -137.25 105.91 5.86 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB3' HG21 ' A' ' 19' ' ' THR . 70.9 mt -79.74 122.96 27.23 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.031 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.826 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 75.5 m-85 -107.1 -173.41 2.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -57.07 -52.39 65.47 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.52 0.512 . . . . 0.0 112.001 -171.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.62 135.27 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.755 0.312 . . . . 0.0 110.632 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.48 -70.77 0.5 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.519 ' HG2' HG21 ' A' ' 19' ' ' THR . 25.6 Cg_exo -63.9 119.63 6.74 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.304 2.669 . . . . 0.0 113.439 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -134.09 156.26 48.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.809 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.432 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.4 mp -95.03 145.77 24.72 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -93.13 169.9 10.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -24.68 64.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -59.3 -47.01 87.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.91 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.38 -34.39 50.76 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.909 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -64.41 -43.6 93.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.33 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 1.2 m-80 -70.05 -30.3 67.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.001 0.429 . . . . 0.0 110.398 177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -62.75 -36.56 83.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.784 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.548 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 82.8 mt -62.9 -19.75 64.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.094 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 47.5 tttp -60.71 -40.22 91.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.622 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -85.45 -48.0 9.4 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' OD1' ' HA ' ' A' ' 73' ' ' LEU . 32.4 p-10 -89.03 5.11 45.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.561 -173.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.485 ' HA2' ' CE1' ' A' ' 8' ' ' TYR . . . -57.96 -20.66 42.32 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.082 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 79' ' ' TRP . 1.4 t -70.71 -62.41 1.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.528 0.664 . . . . 0.0 110.497 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.513 ' H ' HG23 ' A' ' 78' ' ' THR . 9.6 t90 44.57 -148.57 0.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.951 0.5 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 28.7 m 51.7 54.35 11.12 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.124 0.57 . . . . 0.0 111.554 174.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.31 79.73 2.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.891 0.853 . . . . 0.0 110.775 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 173.028 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 5' ' ' LYS . 35.1 mtpt . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.2 -20.31 16.0 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.758 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HB3' HD21 ' A' ' 40' ' ' LEU . 22.6 mmt180 -67.24 -34.89 78.41 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.625 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 37.1 t80 -57.73 -41.02 80.97 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.153 172.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -61.53 -35.11 76.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.781 0.324 . . . . 0.0 110.454 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.61 ' HA ' ' HG2' ' A' ' 13' ' ' GLU . 19.6 mt -73.99 -30.34 27.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.438 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -66.22 -36.16 82.32 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.455 -0.778 . . . . 0.0 109.322 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 13.3 tmtt? -61.93 -52.67 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 10' ' ' ILE . 12.8 pt-20 -60.4 -39.08 86.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.029 0.442 . . . . 0.0 111.411 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.462 HG13 ' HG3' ' A' ' 13' ' ' GLU . 88.6 mt -74.38 -43.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.67 -46.2 89.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.442 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 10.4 pt-20 -92.83 -26.5 17.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.398 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -74.46 -24.29 73.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.116 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 29.3 t-20 76.66 -20.2 0.38 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 111.755 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.809 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 70.9 p 61.95 163.41 0.11 Allowed Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 124.413 1.085 . . . . 0.0 112.67 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.809 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 72.1 Cg_endo -79.51 150.68 84.61 Favored 'Cis proline' 0 C--N 1.344 0.319 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.522 -2.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -132.63 145.74 51.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.487 ' HB2' ' ND2' ' A' ' 24' ' ' ASN . 15.4 m -85.82 165.24 17.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.819 0.342 . . . . 0.0 110.585 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -62.72 -28.43 69.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.986 178.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.549 HD22 ' N ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -70.81 -10.12 58.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.781 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.549 ' N ' HD22 ' A' ' 24' ' ' ASN . 8.8 m-20 -85.28 -50.02 7.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.715 0.293 . . . . 0.0 110.509 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -78.89 -38.52 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.432 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.78 -13.41 10.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.678 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.555 ' H ' HG23 ' A' ' 26' ' ' ILE . 27.2 m -86.22 157.21 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 117.426 0.613 . . . . 0.0 110.197 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 t -85.13 162.21 19.34 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.571 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 10.0 mt-10 -51.04 -50.48 58.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.18 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -55.09 -41.65 71.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.084 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -79.66 -32.16 41.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 111.046 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.1 t80 -67.41 -52.85 34.77 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.855 0.36 . . . . 0.0 110.22 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' OD2' ' HD2' ' A' ' 56' ' ' PRO . 0.9 OUTLIER -59.47 -46.3 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 178.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -55.95 -42.29 75.98 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.096 0.474 . . . . 0.0 110.395 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.49 ' CB ' HD12 ' A' ' 10' ' ' ILE . . . -64.51 -50.85 65.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.691 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 33' ' ' PHE . 65.8 t -58.41 -44.47 88.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.691 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 95.5 m-20 -61.33 -48.78 79.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.378 177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -56.02 -45.65 79.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.626 HD21 ' HB3' ' A' ' 7' ' ' ARG . 89.9 mt -65.98 -40.08 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.256 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 41' ' ' LYS . 0.7 OUTLIER -69.57 -31.34 69.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.153 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 99.6 mtt180 -61.76 -58.55 7.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -73.75 -24.24 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.349 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.93 52.63 1.62 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.716 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 81.8 m-85 -93.5 -34.76 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.064 0.459 . . . . 0.0 110.081 174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 pp -137.38 148.49 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.476 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -132.93 176.76 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.009 178.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 86.37 5.18 82.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.475 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.22 135.05 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -106.79 119.98 40.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.61 160.04 15.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.02 0.438 . . . . 0.0 111.276 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.4 m -116.21 51.85 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.452 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 65.03 9.49 5.51 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.354 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -167.07 -69.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.311 . . . . 0.0 110.725 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.571 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 74.1 mtp180 -91.66 140.54 25.18 Favored Pre-proline 0 C--O 1.237 0.419 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.973 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 58.4 Cg_endo -72.45 139.91 32.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.939 2.426 . . . . 0.0 111.726 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -129.25 145.58 51.32 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 93.7 mt -104.19 145.59 29.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.928 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -130.3 174.35 9.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.818 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -70.08 -40.38 75.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.38 0.61 . . . . 0.0 109.783 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 tt -106.74 105.26 15.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.146 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 170.68 -70.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.167 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.09 109.56 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.009 2.473 . . . . 0.0 113.454 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.49 148.85 43.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.678 174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.7 133.43 43.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.6 p -79.96 178.82 7.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.869 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.65 -39.9 91.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -59.36 -44.16 92.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.357 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.01 -36.0 64.56 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.287 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -62.97 -45.23 93.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.831 0.348 . . . . 0.0 110.666 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.28 -31.24 70.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.125 0.488 . . . . 0.0 110.56 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -67.54 -34.38 76.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 96.0 mt -58.62 -43.01 89.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.229 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.8 tttm -65.13 -44.87 87.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.55 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.79 -53.27 42.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.709 -174.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.38 5.56 50.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.155 0.502 . . . . 0.0 110.827 -175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -60.97 -15.04 41.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.281 -0.418 . . . . 0.0 113.751 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 t -91.93 11.94 23.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.457 ' CZ3' ' HA ' ' A' ' 81' ' ' LYS . 59.1 t90 -65.29 139.33 58.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.898 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.5 m -74.41 116.18 14.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.105 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 58.9 mttp -76.57 -150.65 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.163 0.506 . . . . 0.0 111.42 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -175.45 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 121.058 0.456 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD13 ' HH2' ' A' ' 79' ' ' TRP . 4.3 mm? -100.14 -3.27 32.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.05 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.622 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 18.6 mtm180 -65.62 -21.8 66.6 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.922 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 77.2 t80 -70.17 -46.47 64.59 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.979 172.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.56 76.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.831 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.595 HD12 ' HA ' ' A' ' 7' ' ' ARG . 69.6 mt -58.07 -51.99 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.555 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD21 HD22 ' A' ' 40' ' ' LEU . 96.4 mt -58.4 -45.8 87.64 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.165 0.507 . . . . 0.0 110.835 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 26.3 ttpp -62.16 -48.67 79.03 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.175 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -31.02 71.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.345 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 10' ' ' ILE . 80.0 mt -68.58 -43.47 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 110.589 175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -75.3 -50.25 16.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.324 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -72.6 -40.16 66.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.819 0.342 . . . . 0.0 110.885 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 -27.45 70.06 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.502 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.93 26.05 11.03 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.089 0.556 . . . . 0.0 110.916 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.703 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 46.1 p 56.84 163.27 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.434 1.094 . . . . 0.0 113.134 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 71.5 Cg_endo -76.3 174.39 53.16 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 124.091 -1.212 . . . . 0.0 112.659 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.826 HD21 HD12 ' A' ' 26' ' ' ILE . 58.2 tp -152.88 118.76 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.476 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 18.2 m -86.75 170.68 11.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.152 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -69.93 -30.82 68.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 177.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -75.31 -39.91 59.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 8.9 p-10 -85.65 -1.46 57.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.826 HD12 HD21 ' A' ' 21' ' ' LEU . 11.1 tt -99.95 -37.45 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.734 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.5 -34.38 3.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.698 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.0 m -85.88 122.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.9 t -67.89 173.24 4.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 23' ' ' GLU . 4.4 mt-10 -48.96 -51.32 31.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.766 -171.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -52.55 -57.89 8.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.834 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.48 -32.14 69.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.424 ' O ' HG23 ' A' ' 37' ' ' VAL . 80.0 t80 -65.63 -51.81 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.47 -46.14 89.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.725 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -59.19 -45.93 89.75 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.251 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 7' ' ' ARG . . . -60.68 -55.57 31.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.452 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 33' ' ' PHE . 88.2 t -58.23 -44.13 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.646 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -64.75 -38.05 89.67 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.384 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.46 -38.61 65.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.721 0.296 . . . . 0.0 110.682 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 46' ' ' ILE . 67.8 mt -59.86 -43.93 94.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.088 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.95 -45.35 89.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -57.21 -49.2 76.75 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.616 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.26 -0.16 35.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.287 -174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.94 24.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.112 -0.566 . . . . 0.0 113.557 173.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.57 -43.62 12.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 117.028 0.414 . . . . 0.0 110.773 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.546 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.57 151.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.987 0.423 . . . . 0.0 111.126 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.53 166.59 25.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.486 176.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.06 65.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.196 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -72.63 117.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -90.4 110.05 21.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.753 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -95.77 139.92 31.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -93.12 12.76 23.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.94 11.11 6.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.344 -173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -123.32 -54.0 1.8 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.508 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -151.57 150.09 25.71 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.73 117.06 4.94 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.498 2.132 . . . . 0.0 112.091 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -102.06 105.13 15.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -84.1 92.02 7.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.198 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -82.92 176.91 8.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.598 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . 35.5 pttt -74.4 -0.59 17.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.74 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.75 129.53 17.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 133.73 -71.48 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.653 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HG2' HG21 ' A' ' 19' ' ' THR . 30.6 Cg_endo -63.71 118.4 5.34 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.67 2.247 . . . . 0.0 113.284 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.03 150.41 49.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.872 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 46' ' ' ILE . 7.6 mp -93.65 144.44 25.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.789 0.328 . . . . 0.0 110.838 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 p -92.8 170.72 9.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.585 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.14 -35.19 71.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -58.92 -50.6 73.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.116 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.538 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.44 -35.71 46.58 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.326 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 73' ' ' LEU . 2.7 tm-20 -61.33 -35.2 76.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.439 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -75.07 -34.96 61.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.053 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -63.51 -32.5 73.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.919 0.39 . . . . 0.0 110.283 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.922 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.83 -38.25 75.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.816 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.37 -42.79 92.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.957 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.45 -49.24 61.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.255 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -90.31 3.02 54.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.558 -172.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -67.27 0.9 7.42 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.436 -0.411 . . . . 0.0 113.966 -177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.1 t -90.44 12.08 19.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.087 0.47 . . . . 0.0 110.677 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.471 ' HH2' HD13 ' A' ' 6' ' ' LEU . 24.4 t90 -123.69 131.98 53.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.786 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.8 p 53.4 83.28 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.053 0.941 . . . . 0.0 113.131 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -101.81 179.52 4.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.641 -175.424 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.606 ' HG3' HD22 ' A' ' 6' ' ' LEU . 19.8 ptpt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD22 ' HG3' ' A' ' 5' ' ' LYS . 4.2 mm? -70.82 -30.63 67.12 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.832 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.714 ' NH2' ' HA ' ' A' ' 36' ' ' ALA . 11.3 ptm180 -64.69 -16.5 62.97 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.755 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 8.5 t80 -77.47 -44.57 28.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.99 175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.678 ' HA ' HD21 ' A' ' 76' ' ' ASN . . . -71.21 -27.7 63.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.838 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 7' ' ' ARG . 52.6 mt -50.55 -37.83 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.578 178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.5 mt -57.59 -34.06 68.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.612 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 36.7 ttpt -74.23 -48.06 31.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -38.1 75.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 0.0 110.724 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 21' ' ' LEU . 70.6 mt -66.85 -45.64 87.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.454 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.8 -48.31 77.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.787 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 28.7 mt-10 -65.11 -39.2 92.78 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.908 0.385 . . . . 0.0 110.758 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.95 -27.17 51.14 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.42 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.77 26.21 14.35 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.956 0.503 . . . . 0.0 110.11 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.737 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 32.2 p 55.09 166.65 0.05 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.346 1.058 . . . . 0.0 112.917 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.737 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.8 Cg_endo -87.3 157.31 47.28 Favored 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 124.055 -1.227 . . . . 0.0 112.433 -3.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.53 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -153.08 129.19 10.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -85.11 170.11 13.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -55.43 -38.13 68.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 178.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -62.52 -38.61 90.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.587 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.6 -39.6 67.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.797 0.332 . . . . 0.0 111.047 -174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.53 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.5 tt -82.79 -32.05 9.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.305 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.44 34.86 2.38 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.248 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.472 HG22 HG23 ' A' ' 26' ' ' ILE . 30.9 m -130.29 169.93 20.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -85.34 167.67 15.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.082 0.468 . . . . 0.0 111.322 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 1.5 mp0 -51.7 -60.32 3.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.046 0.927 . . . . 0.0 111.189 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.4 -19.99 59.19 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.9 -169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -79.53 -36.79 37.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.998 0.428 . . . . 0.0 110.068 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 63.8 t80 -65.28 -44.82 86.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.881 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -59.68 -49.4 77.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.43 -40.56 74.95 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.714 ' HA ' ' NH2' ' A' ' 7' ' ' ARG . . . -61.79 -57.43 11.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.399 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 33' ' ' PHE . 69.3 t -57.48 -47.76 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.359 0.412 . . . . 0.0 111.734 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.05 -38.99 84.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB3' HH21 ' A' ' 7' ' ' ARG . 33.1 t80 -71.85 -41.62 67.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.821 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -67.29 -38.21 84.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.84 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 41' ' ' LYS . 11.6 tmtt? -69.74 -38.26 76.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HD3' HH11 ' A' ' 42' ' ' ARG . 8.0 ttm180 -56.82 -60.5 3.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.432 -176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.49 -30.43 65.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.381 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.35 56.8 0.57 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.332 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.72 -26.01 13.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.733 0.301 . . . . 0.0 110.406 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' HD12 ' A' ' 65' ' ' LEU . 1.6 pp -142.65 142.44 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.851 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -128.25 164.69 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.57 22.29 40.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.672 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.22 134.72 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.012 0.434 . . . . 0.0 110.408 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -89.15 109.71 20.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.256 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -95.33 120.11 34.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.159 0.505 . . . . 0.0 110.19 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.0 t -98.14 30.36 3.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.893 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 72.0 -46.81 0.65 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.025 0.93 . . . . 0.0 110.999 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -66.05 -75.71 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.304 0.573 . . . . 0.0 110.282 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' HB3' ' HD2' ' A' ' 56' ' ' PRO . 17.6 mtp180 -141.59 164.12 36.8 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.775 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 55' ' ' ARG . 34.3 Cg_endo -66.14 138.34 51.44 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.629 2.219 . . . . 0.0 112.121 175.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -132.94 148.32 52.28 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.82 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.09 121.62 45.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.362 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -116.06 -166.44 1.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.771 -176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 27.2 mtpp -61.81 -51.61 67.59 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.607 0.567 . . . . 0.0 111.432 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.81 133.93 55.42 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.125 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.46 -69.74 0.37 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.71 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.13 107.67 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.889 2.393 . . . . 0.0 112.999 -175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' O ' HD13 ' A' ' 47' ' ' ILE . 67.2 mm-40 -115.81 139.97 49.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.227 175.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD12 ' CG2' ' A' ' 46' ' ' ILE . 0.4 OUTLIER -75.59 144.17 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -83.46 168.57 16.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.742 0.306 . . . . 0.0 110.48 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.42 -34.68 77.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 23.8 ttmm -60.34 -47.65 85.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.853 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -64.93 -37.7 94.6 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.06 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -58.28 -53.44 58.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.429 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.33 -29.01 65.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 6.2 t80 -66.85 -30.18 70.28 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.546 HD22 HD22 ' A' ' 76' ' ' ASN . 21.2 mt -75.65 -19.05 59.44 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.437 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -54.91 -29.05 55.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 111.809 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 6.4 mm-40 -85.28 -27.53 25.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 60.0 t30 -85.4 3.33 40.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.318 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -48.7 -41.38 26.82 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.453 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.712 HG23 ' H ' ' A' ' 79' ' ' TRP . 2.0 t -91.33 -81.96 0.31 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 119.281 -0.39 . . . . 0.0 111.286 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.712 ' H ' HG23 ' A' ' 78' ' ' THR . 33.7 t-105 45.59 80.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.877 0.471 . . . . 0.0 111.024 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 t 70.26 -34.84 0.3 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.459 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 78' ' ' THR . 97.5 mttt -71.38 80.77 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.277 0.56 . . . . 0.0 110.013 175.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.669 176.018 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.312 0.577 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.63 -9.66 46.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.703 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 40' ' ' LEU . 7.7 ptp180 -60.89 -45.75 93.37 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.108 -174.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.478 ' HE2' ' CG ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -60.98 -42.37 98.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.415 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.75 68.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.18 -40.91 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.673 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 84.3 mt -58.09 -51.27 70.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.648 0.261 . . . . 0.0 110.938 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 5.6 ttpm? -67.34 -41.86 84.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.773 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -29.49 69.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.323 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 19' ' ' THR . 53.5 mt -73.46 -47.21 46.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -59.96 -47.0 87.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.29 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -78.21 -33.84 49.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.477 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.71 -22.51 57.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.105 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 t30 71.42 1.46 3.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 0.0 111.237 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.1 p 55.48 164.42 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.263 1.025 . . . . 0.0 113.293 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 73.5 Cg_endo -90.32 118.35 3.41 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.182 -1.174 . . . . 0.0 111.969 -1.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.7 pt? -90.22 134.77 34.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.761 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.0 m -80.75 164.84 22.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.164 0.507 . . . . 0.0 110.948 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -51.0 64.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.011 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -70.27 -14.6 62.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.331 0.586 . . . . 0.0 110.525 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -84.45 -39.36 19.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.608 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.505 ' HB ' HD12 ' A' ' 21' ' ' LEU . 12.2 tt -76.97 -35.11 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.1 -31.05 3.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.001 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.06 152.79 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.887 -0.184 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.2 t -68.51 173.31 5.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.368 0.604 . . . . 0.0 110.524 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.37 -41.26 98.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.472 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.92 -40.5 95.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.274 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -73.99 -39.83 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 110.641 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -61.24 -49.03 78.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.669 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -62.17 -46.33 89.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.279 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.04 -50.56 70.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.445 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.85 72.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.822 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.9 t -61.47 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.557 0.218 . . . . 0.0 111.483 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -65.26 -35.69 81.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.93 -43.4 75.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.2 mt -63.22 -34.23 77.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.053 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -35.09 77.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -67.24 -42.91 83.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.35 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.168 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.75 39.77 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.19 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.05 -30.73 18.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 0.0 110.217 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.8 pp -142.45 152.02 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.46 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.7 pt -134.84 177.46 6.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.867 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.33 16.71 79.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.82 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.05 113.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 121.231 0.538 . . . . 0.0 109.57 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -80.34 113.09 18.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.794 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 79.5 m-85 -101.51 143.28 31.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.226 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.6 m -129.29 93.12 3.5 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.7 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 64.85 -76.03 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.393 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -99.12 -44.04 6.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.034 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.611 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -137.03 148.46 62.9 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.739 -0.209 . . . . 0.0 110.739 -170.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 38.8 Cg_endo -69.93 143.43 50.0 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.312 2.008 . . . . 0.0 111.022 170.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 58' ' ' LEU . 49.5 m-70 -104.03 -44.46 5.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 57' ' ' HIS . 79.8 mt 68.2 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.438 0.637 . . . . 0.0 110.641 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -141.19 173.25 11.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.921 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 87.7 mttt -75.1 1.74 12.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.57 41.84 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.3 -86.55 1.59 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.153 -0.931 . . . . 0.0 114.019 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -83.47 159.34 14.72 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.933 2.422 . . . . 0.0 114.028 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.55 139.99 51.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.585 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.0 mp -91.43 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.784 0.326 . . . . 0.0 110.729 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.8 p -88.44 170.7 10.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -65.28 -24.32 67.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.189 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.16 -50.29 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -71.89 -42.25 53.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.077 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -62.03 -44.42 96.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.811 0.338 . . . . 0.0 110.473 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.419 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 1.2 m-80 -72.87 -20.04 61.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.882 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -75.86 -28.82 58.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 83.1 mt -70.95 -22.65 62.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 70.6 mmtt -51.16 -65.12 0.61 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.74 -30.18 56.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.767 -172.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.43 3.28 55.32 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -173.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -48.85 -26.42 5.69 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -64.96 -84.92 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 117.472 0.636 . . . . 0.0 112.081 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.478 ' CG ' ' HE2' ' A' ' 8' ' ' TYR . 69.9 t-105 66.92 175.2 0.25 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.365 0.602 . . . . 0.0 111.267 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.6 m -146.37 121.24 9.96 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.077 -0.389 . . . . 0.0 110.138 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -8.53 59.25 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.533 0.206 . . . . 0.0 111.504 -176.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.863 ' HG3' HD22 ' A' ' 6' ' ' LEU . 12.1 ptmm? . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.66 0.267 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.863 HD22 ' HG3' ' A' ' 5' ' ' LYS . 3.3 mm? -81.43 -12.11 59.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.825 175.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -64.64 -42.94 95.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 77' ' ' GLY . 43.8 t80 -59.72 -43.4 94.17 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.948 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.12 77.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.377 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -73.72 -43.54 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.142 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.71 -52.45 64.92 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -71.13 -22.77 62.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.026 -176.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 1.9 tp10 -80.13 -23.71 40.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.248 0.547 . . . . 0.0 109.883 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.02 -47.12 49.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.85 -50.02 75.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.66 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -99.62 -6.15 27.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -90.09 -12.44 61.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.449 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.9 t30 75.38 -17.24 0.52 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.005 0.522 . . . . 0.0 111.435 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.0 p 58.62 156.92 0.09 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 124.563 1.145 . . . . 0.0 113.058 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.5 Cg_endo -83.72 176.31 33.64 Favored 'Cis proline' 0 C--N 1.346 0.423 0 C-N-CA 123.798 -1.334 . . . . 0.0 113.136 0.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.4 pt? -150.58 133.5 15.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 m -85.28 170.43 12.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.337 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -58.97 -37.93 77.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.093 175.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -68.42 -16.79 64.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.589 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.04 -49.98 7.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.933 0.396 . . . . 0.0 110.821 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -72.7 -38.61 58.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.887 -176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.93 22.17 4.71 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.189 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 26' ' ' ILE . 33.9 m -127.38 173.92 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 t -85.01 157.97 20.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 110.928 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.7 pm0 -63.29 -30.24 71.42 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.046 -177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.6 -48.3 79.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.422 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 9.7 mm100 -82.44 -19.95 37.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.962 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.81 -55.58 16.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.05 -47.97 76.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.222 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.602 ' HB3' ' HA ' ' A' ' 32' ' ' GLN . 8.7 t70 -52.34 -49.04 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.315 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -68.06 -51.45 46.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.288 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -59.01 -42.32 85.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 111.237 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 95.4 m-20 -65.55 -41.48 92.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.526 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.21 -42.94 96.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.39 . . . . 0.0 110.596 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.7 mt -59.41 -44.74 92.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.2 ttpm? -70.92 -34.62 71.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.369 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 15.4 ttt-85 -66.37 -40.49 89.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.609 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.7 -40.1 61.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.817 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.22 32.05 2.68 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.805 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.526 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 60.2 m-85 -78.3 -41.32 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.571 0.224 . . . . 0.0 111.415 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.535 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -139.94 161.83 25.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.881 0.372 . . . . 0.0 110.961 -177.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -129.24 170.16 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.204 174.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 90.71 19.87 42.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.699 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.72 114.5 22.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -88.46 141.03 28.87 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.0 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -119.99 136.13 54.66 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.0 m -122.33 -80.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.122 0.487 . . . . 0.0 111.295 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -37.96 84.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 t70 164.32 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.535 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -103.88 158.36 32.05 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.833 -175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.3 134.7 23.3 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.577 2.184 . . . . 0.0 112.739 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -126.47 135.26 51.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.393 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.3 mt -98.66 152.8 19.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.838 0.352 . . . . 0.0 110.604 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -134.71 -177.94 4.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.09 -29.45 64.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.965 0.412 . . . . 0.0 110.881 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -128.2 126.72 41.53 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.503 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 156.62 -64.82 0.31 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.637 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.449 ' HG3' HD22 ' A' ' 58' ' ' LEU . 10.8 Cg_exo -70.45 100.69 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.738 2.292 . . . . 0.0 112.866 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -105.69 140.24 39.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.658 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.6 mp -90.96 140.04 30.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.674 0.273 . . . . 0.0 110.395 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.0 p -90.03 177.09 6.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -59.46 -33.11 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.673 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.19 -44.57 95.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.154 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.91 -41.83 21.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.714 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.66 -41.08 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.823 0.344 . . . . 0.0 110.975 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -79.12 -20.34 48.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.685 0.279 . . . . 0.0 110.652 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 72.5 t80 -65.14 -33.58 76.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 109.838 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 12' ' ' LYS . 77.8 mt -61.02 -25.97 67.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.944 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -74.17 -50.01 21.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -73.31 -40.3 64.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.822 -174.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -98.95 5.77 47.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.914 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -57.52 -22.08 44.31 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.391 170.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 t -76.32 -22.78 54.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.252 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 4.6 t90 49.83 62.29 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.219 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 p -174.45 92.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.212 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.25 80.93 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.508 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.311 178.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.607 ' HB3' ' HE1' ' A' ' 79' ' ' TRP . 98.2 mttt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-O 121.052 0.453 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.76 -26.93 61.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.983 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' O ' HD13 ' A' ' 11' ' ' LEU . 98.7 mtt180 -69.52 -11.84 61.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.387 . . . . 0.0 110.669 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.581 ' HB2' HD22 ' A' ' 76' ' ' ASN . 57.1 t80 -100.1 -46.03 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.67 171.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.54 81.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.86 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -62.99 -47.79 91.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.713 0.292 . . . . 0.0 110.822 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 73' ' ' LEU . 10.5 mp -64.31 -32.67 74.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.948 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -65.14 -44.78 87.54 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.99 -41.0 97.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.487 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.61 -39.14 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.049 0.452 . . . . 0.0 110.556 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' HD2' HD22 ' A' ' 65' ' ' LEU . 15.8 t80 -68.58 -50.12 54.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.86 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.22 -40.89 26.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.657 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.33 -18.55 58.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.5 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 62.31 24.32 14.47 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.168 0.508 . . . . 0.0 110.497 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 10.7 p 54.98 171.96 0.04 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.987 0.915 . . . . 0.0 113.235 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 96.1 Cg_endo -85.06 179.7 21.99 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 123.809 -1.33 . . . . 0.0 112.074 -3.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.804 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -155.24 124.17 6.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.5 m -76.34 163.48 26.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.304 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -61.49 -43.68 98.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.435 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.94 -16.48 60.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -80.75 -42.15 22.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.185 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.804 ' HB ' HD12 ' A' ' 21' ' ' LEU . 4.2 tt -77.23 -38.71 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.3 35.89 0.98 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.293 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 26' ' ' ILE . 35.9 m -137.06 174.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -84.99 156.46 21.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.43 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.537 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 4.6 mt-10 -55.38 -40.83 71.84 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -45.65 -60.71 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.598 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.1 -32.42 69.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.947 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.9 t80 -65.08 -59.2 4.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.899 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' A' ' 55' ' ' ARG . 5.8 m-20 -57.19 -43.89 83.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.714 0.292 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.41 -45.2 94.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.257 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.82 -48.06 72.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.46 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 33' ' ' PHE . 99.4 t -59.1 -42.32 86.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.245 -177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.43 -44.85 93.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.429 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.18 -42.52 99.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.797 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.1 mt -59.11 -42.89 91.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.448 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.509 ' HD3' ' HB ' ' A' ' 49' ' ' VAL . 29.8 ttpt -75.6 -38.31 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.359 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -39.93 94.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.439 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -4.33 56.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.227 0.537 . . . . 0.0 110.48 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 37.04 40.69 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.482 174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -83.48 -47.45 11.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 117.281 0.54 . . . . 0.0 110.238 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -134.82 161.53 40.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.18 177.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 64' ' ' GLU . 25.6 pt -129.96 177.23 6.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.934 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.69 11.85 65.27 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.513 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' HB ' ' HD3' ' A' ' 41' ' ' LYS . 39.1 t -77.79 121.75 31.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -101.98 129.75 48.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.19 0.519 . . . . 0.0 111.586 -173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -115.65 132.72 56.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.789 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -102.67 34.8 2.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.422 0.629 . . . . 0.0 109.317 172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.1 t70 51.32 58.45 5.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.961 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -156.78 -46.66 0.07 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.434 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' HB2' ' HD2' ' A' ' 56' ' ' PRO . 11.2 ptm180 -176.6 163.43 1.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -66.15 126.08 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.273 1.982 . . . . 0.0 112.059 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -116.91 130.69 56.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.404 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -101.02 140.27 35.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.611 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.04 178.13 7.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.535 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 68.6 mttm -79.77 -18.03 52.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.61 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.59 104.06 14.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.949 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.58 -67.71 0.46 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.613 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.15 119.01 3.15 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.534 2.822 . . . . 0.0 114.504 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 47' ' ' ILE . 41.9 mt-10 -130.92 142.41 50.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.032 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD22 ' HD2' ' A' ' 15' ' ' PHE . 6.3 mp -96.76 140.98 30.54 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.11 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.9 p -100.7 171.73 7.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.07 -33.02 73.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.359 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -60.99 -52.04 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.44 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.75 73.75 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.114 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.14 -45.5 91.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.738 0.304 . . . . 0.0 110.465 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -73.4 -20.27 60.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.465 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -70.05 -47.16 63.14 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 11' ' ' LEU . 96.2 mt -60.27 -32.44 71.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.002 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.45 -55.83 29.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.713 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.22 -32.45 22.63 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 8' ' ' TYR . 1.7 t30 -79.97 2.85 21.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.465 ' HA2' ' CE1' ' A' ' 8' ' ' TYR . . . -66.02 -18.95 67.38 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.524 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.5 t -67.07 -47.72 70.45 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.607 ' HE1' ' HB3' ' A' ' 5' ' ' LYS . 9.2 t90 64.08 -74.04 0.05 OUTLIER 'General case' 0 C--N 1.344 0.332 0 O-C-N 123.862 0.726 . . . . 0.0 111.591 174.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.1 m -154.15 -54.4 0.1 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 68.44 -77.55 0.05 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.569 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -175.021 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.653 0.263 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 mm? -56.75 -34.4 67.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.095 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.4 ptt180 -51.09 -34.28 29.7 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.189 0.518 . . . . 0.0 111.417 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.55 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 20.3 t80 -71.34 -43.49 66.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.147 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.1 -25.57 60.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.695 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 7' ' ' ARG . 82.4 mt -59.38 -33.66 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.748 175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -52.43 -40.97 62.82 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.244 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 24.9 ttpp -69.95 -44.37 69.68 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.071 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -62.56 -33.83 75.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.94 0.4 . . . . 0.0 110.504 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 HG23 ' A' ' 19' ' ' THR . 82.4 mt -57.7 -46.48 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.988 172.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -67.28 -44.53 79.05 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.148 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 12' ' ' LYS . 8.1 mm-40 -62.4 -40.53 96.8 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.431 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.11 -13.43 52.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.267 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.51 25.54 11.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.145 0.498 . . . . 0.0 110.176 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.534 HG23 HG23 ' A' ' 14' ' ' ILE . 20.6 p 57.76 154.14 0.08 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 124.428 1.091 . . . . 0.0 113.226 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -91.35 -165.96 2.41 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.843 -1.315 . . . . 0.0 112.693 -0.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.78 125.21 6.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.212 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -84.91 170.02 13.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.147 0.498 . . . . 0.0 111.197 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.76 -41.08 96.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.372 -178.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -67.49 -24.74 65.62 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.73 0.3 . . . . 0.0 111.454 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.4 -46.23 28.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.639 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.608 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -80.4 -38.74 18.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.459 -177.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.7 -14.8 12.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.673 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.608 ' H ' HG23 ' A' ' 26' ' ' ILE . 35.1 m -101.0 144.95 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.986 0.393 . . . . 0.0 111.127 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -66.53 161.47 22.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.227 177.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 7.2 mt-10 -58.81 -40.72 84.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.659 -171.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -65.24 -34.7 78.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.465 HE21 ' HB ' ' A' ' 28' ' ' VAL . 26.1 mt-30 -75.0 -36.15 61.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.149 0.5 . . . . 0.0 109.914 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 49.4 t80 -65.6 -52.96 48.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.326 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' OD1' ' HD3' ' A' ' 56' ' ' PRO . 9.8 t70 -56.62 -47.59 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.332 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.58 -45.94 90.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 7' ' ' ARG . . . -66.74 -40.46 88.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.357 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' PHE . 59.5 t -61.76 -46.09 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.616 0.246 . . . . 0.0 110.712 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -63.72 -37.35 87.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.827 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -64.99 -48.55 73.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 0.0 110.121 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 7' ' ' ARG . 59.5 mt -60.98 -37.53 82.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.941 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 0.9 OUTLIER -69.9 -31.5 69.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.27 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.91 -38.86 76.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.859 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 45' ' ' TYR . 48.1 mt-10 -79.93 -22.25 42.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.858 0.361 . . . . 0.0 110.793 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 45.51 4.5 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.438 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.456 ' HE2' ' OE1' ' A' ' 43' ' ' GLU . 57.0 m-85 -92.0 -34.04 14.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.105 0.453 . . . . 0.0 111.249 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.564 HG22 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.45 144.94 32.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.087 177.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 pp -129.98 165.3 30.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.338 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.05 60.14 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.486 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.93 122.81 11.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.02 110.15 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.04 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -93.85 114.52 26.78 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 174.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.8 m -99.06 -75.56 0.56 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.4 0.619 . . . . 0.0 110.388 -172.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 9.9 p-10 -79.42 -32.0 42.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.095 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 53' ' ' ASP . 32.8 t70 163.47 -25.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.334 -173.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -102.81 157.8 33.01 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.049 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HD3' ' OD1' ' A' ' 34' ' ' ASP . 71.6 Cg_endo -76.22 120.71 5.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.489 2.126 . . . . 0.0 112.447 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -109.06 112.72 25.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -98.27 141.18 31.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.007 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -135.5 -177.97 4.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.477 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -81.45 15.0 2.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.752 0.31 . . . . 0.0 110.782 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.4 tp -159.63 120.08 3.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.937 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.51 -71.09 0.41 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.028 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 14.6 Cg_exo -69.24 122.05 8.86 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.855 2.37 . . . . 0.0 113.308 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -125.36 152.38 44.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.019 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -88.09 137.72 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -83.19 173.67 11.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.19 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.42 -41.01 79.55 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -55.83 -54.81 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.748 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -66.55 -41.54 94.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.932 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -58.53 -46.87 85.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 111.306 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.57 -27.3 62.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 110.661 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -70.67 -24.92 62.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.574 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 80.4 mt -58.84 -19.28 40.04 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 74' ' ' LYS . 23.9 ttpt -43.27 -49.3 6.74 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -73.69 -37.1 65.33 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.078 0.466 . . . . 0.0 111.19 -174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 58.9 t30 -61.56 -20.96 63.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.496 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.52 -34.29 75.23 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.882 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.2 t -100.71 -8.33 22.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.257 0.529 . . . . 0.0 110.838 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -80.93 -39.64 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 p -84.71 -34.82 22.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.63 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.9 mttt 66.58 -83.68 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.819 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 121.096 0.474 . . . . 0.0 110.54 -176.654 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.79 ' HB2' HD22 ' A' ' 6' ' ' LEU . 48.0 mttp . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.79 HD22 ' HB2' ' A' ' 5' ' ' LYS . 2.3 mm? -100.32 -7.95 23.94 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -171.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.66 HH11 ' HA ' ' A' ' 36' ' ' ALA . 2.2 ttm-85 -70.58 -41.26 72.6 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -170.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CD1' ' HB3' ' A' ' 76' ' ' ASN . 63.9 t80 -58.95 -41.66 87.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HB2' ' CH2' ' A' ' 79' ' ' TRP . . . -58.9 -47.37 85.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 14' ' ' ILE . 74.5 mt -63.47 -40.94 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.728 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB3' HD21 ' A' ' 73' ' ' LEU . 23.7 mt -55.06 -50.17 69.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.722 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -72.38 -29.69 63.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.988 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' ALA . 5.6 mm-40 -70.55 -29.8 66.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 10' ' ' ILE . 79.8 mt -69.89 -36.69 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.168 0.508 . . . . 0.0 109.876 173.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -78.33 -50.23 12.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.673 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -84.4 -38.63 20.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.0 110.945 -176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.29 -20.08 75.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 65.86 20.47 11.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.841 0.456 . . . . 0.0 110.777 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.641 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 1.7 p 55.96 165.41 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.858 0.863 . . . . 0.0 113.039 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 92.2 Cg_endo -79.56 171.03 65.61 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 124.056 -1.227 . . . . 0.0 112.32 0.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.5 tp -134.55 118.69 17.55 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.1 m -86.1 169.04 13.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.367 174.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -64.79 -40.63 95.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -71.11 -19.14 62.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.399 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.36 -42.55 53.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.519 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -87.94 -36.04 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.609 -177.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.71 -17.6 8.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.272 174.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 28.7 m -89.53 161.12 2.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 O-C-N 122.742 -0.269 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -85.24 179.99 7.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 10.9 mt-10 -59.45 -44.24 92.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.946 -173.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -53.01 62.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.624 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 44.2 mt-30 -63.7 -46.11 86.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.585 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -59.57 -44.72 93.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.162 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -58.56 -55.53 33.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.084 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.68 -41.58 81.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.64 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.66 ' HA ' HH11 ' A' ' 7' ' ' ARG . . . -64.51 -57.57 8.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.825 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.2 -42.31 94.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 O-C-N 123.251 0.344 . . . . 0.0 111.782 -174.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -61.07 -46.49 90.43 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.713 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.117 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 96.2 mt -61.36 -46.75 88.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.915 0.388 . . . . 0.0 110.546 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HD2' ' O ' ' A' ' 46' ' ' ILE . 23.1 tptp -69.24 -38.55 78.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.322 0.582 . . . . 0.0 110.027 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -61.66 -41.59 97.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.376 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.899 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.79 39.96 0.74 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.625 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.576 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 67.4 m-85 -91.3 -29.4 17.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 49' ' ' VAL . 1.3 pp -143.75 156.75 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.686 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 29.0 pt -133.02 -179.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.422 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.11 17.61 79.91 Favored Glycine 0 N--CA 1.454 -0.13 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.611 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 HD13 ' A' ' 46' ' ' ILE . 86.5 t -93.5 119.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.242 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -94.86 110.68 22.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 0.0 111.19 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -79.8 134.98 36.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 170.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.3 m -127.86 -80.09 0.59 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.114 0.483 . . . . 0.0 110.621 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 11.2 p-10 -105.14 82.61 1.87 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.926 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 6.4 t70 72.03 -36.19 0.35 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.588 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 12.5 ptm85 -118.98 153.81 52.9 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -170.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.54 144.08 48.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.06 2.507 . . . . 0.0 112.106 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -124.18 121.66 35.7 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.34 106.78 18.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.275 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' O ' ' HB ' ' A' ' 19' ' ' THR . 44.6 m-85 -95.62 -173.88 3.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.697 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.646 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 41.5 mtpt -63.0 -48.74 77.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.383 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 mp -119.88 142.58 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.38 -67.07 0.45 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.613 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 51.7 Cg_exo -56.7 125.68 19.81 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.055 2.504 . . . . 0.0 113.821 -175.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 47' ' ' ILE . 53.3 mm-40 -123.52 142.03 51.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.1 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.4 ' HG ' ' CG2' ' A' ' 46' ' ' ILE . 7.0 mp -90.07 138.34 31.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.365 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.4 p -82.5 179.91 7.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.159 -176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -54.85 -47.55 74.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -58.62 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.893 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -64.75 -46.12 90.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.778 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.79 -44.7 96.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.543 0.211 . . . . 0.0 111.355 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -73.32 -30.91 63.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 0.0 111.149 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -66.64 -31.53 72.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 98.4 mt -57.55 -40.1 78.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.794 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -66.5 -43.49 85.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.554 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.02 -46.9 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.952 0.406 . . . . 0.0 111.076 -177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -88.71 5.22 44.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.446 -177.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -51.3 -34.19 32.81 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.134 177.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.0 t -82.05 89.17 6.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.822 0.82 . . . . 0.0 109.493 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 9' ' ' ALA . 64.5 t90 -141.41 136.25 31.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.797 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.3 p 55.72 -161.32 0.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.83 0.852 . . . . 0.0 112.013 176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -140.24 -171.39 3.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -173.568 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.8 ' HG3' HD22 ' A' ' 6' ' ' LEU . 49.1 pttt . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 120.713 0.292 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.8 HD22 ' HG3' ' A' ' 5' ' ' LYS . 1.3 mm? -100.58 -13.59 18.53 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.64 ' HG2' HD21 ' A' ' 40' ' ' LEU . 79.5 mtt180 -54.8 -46.88 74.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.506 0.594 . . . . 0.0 111.353 -171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.812 ' HE1' ' HA2' ' A' ' 77' ' ' GLY . 88.3 t80 -55.44 -57.41 11.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.084 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.26 97.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.486 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 6' ' ' LEU . 61.3 mt -59.91 -49.03 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.705 0.288 . . . . 0.0 110.863 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.4 mp -59.81 -47.25 86.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -75.82 -26.92 57.66 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.582 -0.447 . . . . 0.0 112.063 -176.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -77.08 -28.17 54.48 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.449 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.53 -48.33 35.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.92 -50.03 73.82 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.13 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.12 -30.36 22.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.431 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.95 -24.88 72.94 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.134 -175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.6 -4.28 2.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.0 0.52 . . . . 0.0 111.16 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 53.3 p 57.35 156.42 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.117 0.967 . . . . 0.0 112.957 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 6.2 Cg_exo -76.35 166.88 81.66 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 124.315 -1.119 . . . . 0.0 112.938 0.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.6 pt? -148.2 127.33 12.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -81.91 169.95 16.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.324 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -58.76 -37.33 76.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.795 174.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -67.53 -27.78 67.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.602 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.99 -49.86 14.47 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.758 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.564 HG23 HG22 ' A' ' 28' ' ' VAL . 11.0 tt -75.7 -29.58 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 -175.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.37 32.95 4.08 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.682 -0.771 . . . . 0.0 113.083 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.564 HG22 HG23 ' A' ' 26' ' ' ILE . 28.4 m -137.64 171.62 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 32' ' ' GLN . 2.3 t -85.39 164.47 17.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.026 0.441 . . . . 0.0 110.938 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -60.79 -42.05 96.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.94 -53.94 51.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.665 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' H ' HG23 ' A' ' 29' ' ' THR . 30.6 mm-40 -69.57 -24.16 63.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.01 -54.07 25.24 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.69 -48.5 72.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.848 175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.72 -56.8 12.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.784 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -70.34 -45.96 65.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.868 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.72 -44.31 98.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.598 0.237 . . . . 0.0 111.104 -178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -66.55 -35.26 79.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.992 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.72 -42.11 78.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.911 0.386 . . . . 0.0 110.227 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 7' ' ' ARG . 89.7 mt -62.1 -37.82 86.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.443 176.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 4.7 ttpm? -70.81 -25.68 62.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.37 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -70.12 -54.33 13.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.803 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 34.8 mt-10 -80.24 -20.14 45.27 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.137 0.494 . . . . 0.0 110.912 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.53 58.29 1.37 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.841 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.551 ' CE1' ' HB2' ' A' ' 43' ' ' GLU . 96.5 m-85 -96.12 -33.43 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.249 0.547 . . . . 0.0 109.59 173.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.441 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.1 pp -140.07 150.55 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.33 177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -134.71 -179.83 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 84.91 4.19 87.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.081 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -64.74 113.2 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 0.0 109.984 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -79.97 110.18 15.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.336 0.588 . . . . 0.0 109.657 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.37 130.4 39.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.215 -176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 m -97.05 23.35 7.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.7 t70 70.97 -49.55 0.68 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.133 0.973 . . . . 0.0 111.41 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.7 -59.31 3.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.732 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -141.8 164.32 35.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.07 136.21 12.83 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.264 2.643 . . . . 0.0 111.521 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -129.69 123.63 31.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.279 0.562 . . . . 0.0 110.285 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 90.4 mt -86.61 87.37 7.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.582 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -71.82 167.4 20.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.268 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.714 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 23.8 mtpp -61.97 -47.12 86.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.76 -171.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.64 112.72 25.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.853 0.358 . . . . 0.0 110.135 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 160.42 -62.86 0.29 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.251 -0.976 . . . . 0.0 113.278 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -51.85 116.94 3.08 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.01 2.473 . . . . 0.0 113.324 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 62' ' ' GLY . 35.6 mt-10 -129.67 160.26 33.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.488 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.2 147.78 28.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -91.97 170.56 9.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -64.87 -29.64 70.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 4.0 ttmp? -62.89 -46.6 87.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.778 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -73.29 -36.82 55.21 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.566 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -62.47 -49.39 75.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -70.66 -25.52 63.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.756 0.312 . . . . 0.0 110.432 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 68' ' ' LYS . 24.9 t80 -62.92 -39.36 94.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.83 176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 11' ' ' LEU . 85.5 mt -54.13 -41.57 68.54 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.539 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -66.21 -32.19 73.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.152 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -77.02 -62.94 1.48 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.128 0.49 . . . . 0.0 110.998 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.72 5.07 16.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.474 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.812 ' HA2' ' HE1' ' A' ' 8' ' ' TYR . . . -62.5 -7.17 13.44 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.921 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -71.92 -53.48 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.819 0.31 . . . . 0.0 110.634 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 29.88 57.15 0.17 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.4 1.08 . . . . 0.0 112.622 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.0 t 66.65 -86.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.159 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.85 22.59 5.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.144 0.578 . . . . 0.0 112.053 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.172 179.392 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 mttm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.2 -32.97 61.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.69 0.757 . . . . 0.0 109.013 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.751 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 0.5 OUTLIER -62.89 -28.72 70.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.119 174.026 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.981 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 61.6 t80 -69.76 -41.41 75.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.663 175.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.56 -46.45 80.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.377 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.581 HD13 HG13 ' A' ' 26' ' ' ILE . 25.0 mm -54.78 -48.88 72.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.808 177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' HD21 ' A' ' 73' ' ' LEU . 71.9 mt -56.36 -43.74 79.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 111.159 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -65.39 -45.82 82.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.631 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -29.66 69.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.327 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 21' ' ' LEU . 80.6 mt -61.96 -46.59 96.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -67.87 -42.88 80.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.702 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.6 -40.09 73.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.877 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.47 -20.79 57.92 Favored Glycine 0 CA--C 1.517 0.16 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.006 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.52 20.44 12.15 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.703 0.401 . . . . 0.0 110.16 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 41.6 p 58.38 150.69 0.07 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 124.517 1.127 . . . . 0.0 113.255 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD3' ' HA ' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -87.25 161.03 49.2 Favored 'Cis proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.208 -0.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 14' ' ' ILE . 1.6 pt? -131.37 120.96 23.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.7 m -82.59 164.86 20.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.559 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -59.36 -44.73 92.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 176.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.83 -21.39 62.45 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.047 0.451 . . . . 0.0 111.011 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.04 -46.79 15.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.665 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.581 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -71.61 -37.08 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.58 35.96 1.81 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.135 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 26' ' ' ILE . 35.8 m -140.42 170.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.6 p -76.8 160.54 29.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.46 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HB3' ' NH2' ' A' ' 55' ' ' ARG . 5.6 mt-10 -57.64 -48.97 77.98 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.255 0.55 . . . . 0.0 109.52 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.76 -45.52 19.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.786 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.446 HE21 ' HB ' ' A' ' 28' ' ' VAL . 27.3 mt-30 -74.65 -38.73 62.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.054 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -64.92 -46.95 79.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.631 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.96 -56.66 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.707 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.73 -34.54 77.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.849 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.751 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -60.34 -52.72 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.68 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -63.38 -41.87 98.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.715 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -64.3 -48.36 75.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.763 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.91 -36.07 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.208 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.734 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -75.74 -28.6 58.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -77.66 -43.98 29.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -76.22 -13.01 60.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.362 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.45 51.77 4.22 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.68 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD1' ' HA2' ' A' ' 69' ' ' GLY . 73.3 m-85 -98.2 -39.2 8.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.058 0.456 . . . . 0.0 109.822 173.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 ' HG ' ' A' ' 65' ' ' LEU . 2.0 pp -138.78 149.4 23.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.576 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.96 168.83 22.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.817 178.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.65 24.94 34.14 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.1 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -79.43 128.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 110.321 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -94.89 126.04 39.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.826 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.63 145.75 28.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.269 0.557 . . . . 0.0 111.784 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.2 t -96.23 -149.53 0.31 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.673 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -43.08 -57.0 3.1 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.627 0.579 . . . . 0.0 110.695 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -142.36 -18.68 0.71 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.074 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.593 ' NH2' ' HB3' ' A' ' 30' ' ' GLU . 75.0 mtp180 -105.36 148.4 36.22 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 122.33 -0.231 . . . . 0.0 110.599 -172.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 153.33 57.07 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.0 143.36 31.17 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 110.715 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -112.24 136.64 51.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.753 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' THR . 96.6 m-85 -108.01 -168.63 1.4 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.864 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 49.8 mtpt -75.79 -13.67 60.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.941 0.4 . . . . 0.0 111.119 -176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -161.54 161.12 29.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.99 -59.67 0.63 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.026 -1.083 . . . . 0.0 114.143 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.95 141.85 72.61 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.471 2.114 . . . . 0.0 113.756 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -120.52 150.95 40.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.766 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 46' ' ' ILE . 6.1 mp -96.96 144.71 26.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.4 p -83.4 179.59 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.465 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.1 -42.65 99.43 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.14 -49.03 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.858 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -66.65 -47.91 65.47 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.74 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.87 -35.95 82.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.409 . . . . 0.0 111.169 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -77.35 -35.28 54.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.985 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -58.93 -39.1 80.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.254 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.981 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 96.9 mt -57.7 -46.96 83.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.919 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -71.32 -39.89 71.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.742 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -73.48 -39.02 65.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.931 0.396 . . . . 0.0 111.113 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -92.74 5.66 50.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.381 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA2' ' OH ' ' A' ' 8' ' ' TYR . . . -52.94 -12.3 1.7 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.707 0.643 . . . . 0.0 114.707 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.5 -95.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 117.235 0.517 . . . . 0.0 110.154 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.4 ' CG ' ' N ' ' A' ' 80' ' ' SER . 9.7 t90 51.68 -152.27 0.23 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.665 0.386 . . . . 0.0 110.135 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 77.3 p 51.18 23.49 1.63 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.703 0.801 . . . . 0.0 112.408 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -81.38 72.38 8.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.288 0.566 . . . . 0.0 110.702 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.586 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 173.1 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.617 0.246 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? -91.43 -14.38 30.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.778 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 36' ' ' ALA . 8.8 mmt180 -59.77 -51.89 67.8 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.598 0.714 . . . . 0.0 109.404 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 76' ' ' ASN . 18.3 t80 -51.85 -46.14 64.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.167 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.46 62.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 6' ' ' LEU . 73.2 mt -59.37 -30.81 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.604 0.24 . . . . 0.0 111.266 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -52.75 -38.65 61.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.598 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 25.6 ttpp -74.07 -39.15 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.745 -177.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.07 -32.09 73.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.899 0.38 . . . . 0.0 110.523 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.58 -43.51 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 110.081 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -64.09 -50.33 68.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.019 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 6.0 mt-10 -77.7 -19.14 55.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.986 0.422 . . . . 0.0 110.677 -176.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.46 -17.11 69.48 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.617 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.98 16.28 9.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.01 0.524 . . . . 0.0 110.436 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.1 p 56.18 151.6 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.521 1.128 . . . . 0.0 112.956 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 91.2 Cg_endo -78.85 177.69 37.39 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.451 -1.479 . . . . 0.0 112.457 -2.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 26' ' ' ILE . 43.5 tp -149.79 119.31 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.981 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HB2' ' OD1' ' A' ' 25' ' ' ASP . 17.0 m -85.8 164.51 17.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.201 175.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -68.02 -33.78 75.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.25 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -64.55 -36.47 84.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 22' ' ' SER . 9.1 m-20 -71.0 -34.55 71.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.396 -177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -83.95 -35.03 10.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.9 1.97 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.099 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 26' ' ' ILE . 31.5 m -135.39 173.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 110.326 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.2 p -85.59 166.76 15.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.681 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 24.3 mt-10 -67.03 -33.22 75.07 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.708 0.766 . . . . 0.0 108.957 173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -49.77 -57.2 7.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.959 172.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -72.43 -33.79 67.36 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.966 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 47.6 t80 -66.28 -50.71 62.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.071 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 25.3 t70 -62.76 -45.6 91.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.19 -41.89 80.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.712 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HA ' ' HD2' ' A' ' 7' ' ' ARG . . . -67.36 -55.9 11.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.837 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.37 -34.97 67.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.159 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 34' ' ' ASP . 1.7 m-20 -64.59 -45.59 86.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.607 177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.7 t80 -61.68 -41.43 97.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.088 0.47 . . . . 0.0 110.065 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 95.0 mt -64.66 -39.85 94.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.134 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -34.81 70.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -60.9 -52.99 62.68 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.626 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 8.3 mm-40 -74.12 -28.42 61.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.958 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.08 40.9 2.54 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.953 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -89.78 -32.77 16.81 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.676 -0.308 . . . . 0.0 111.295 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.439 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -137.42 148.41 25.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.913 0.387 . . . . 0.0 111.412 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 27.6 pt -133.8 170.63 19.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.251 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.68 90.57 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.256 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG21 HD13 ' A' ' 46' ' ' ILE . 44.2 t -70.22 128.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -94.71 119.14 32.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.106 0.479 . . . . 0.0 111.143 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -109.79 143.96 38.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.437 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -145.01 -85.28 0.13 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 55' ' ' ARG . 15.6 t70 -65.13 111.91 3.14 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 153.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 4.0 m-20 -52.8 64.82 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.657 1.223 . . . . 0.0 113.444 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 50.4 mtp180 -149.05 116.24 3.76 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-N 112.641 -2.072 . . . . 0.0 106.076 169.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 26.8 Cg_exo -60.11 119.55 6.81 Favored 'Trans proline' 0 C--N 1.331 -0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 113.724 -165.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -106.59 112.62 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.527 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.0 mt -87.86 145.76 25.91 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.608 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -130.12 171.92 12.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 51.8 mttm -78.17 -18.33 55.68 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.612 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 124.15 42.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.47 -65.59 0.58 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.734 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 33.5 Cg_exo -60.7 121.73 10.17 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.81 2.34 . . . . 0.0 112.812 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -128.23 145.19 51.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.501 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.72 129.85 39.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.35 176.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.9 p -80.02 166.14 21.86 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.104 0.252 . . . . 0.0 110.877 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.6 -38.28 69.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.145 0.498 . . . . 0.0 109.991 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -52.26 -55.39 21.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.726 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -76.42 -36.03 40.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.835 -0.621 . . . . 0.0 113.02 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -63.41 -40.92 98.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.703 0.287 . . . . 0.0 110.873 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -74.66 -29.4 61.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.014 0.435 . . . . 0.0 110.437 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -65.03 -27.01 68.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.294 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 69' ' ' GLY . 91.8 mt -69.31 -19.1 63.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.34 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -45.87 -47.51 16.09 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -83.15 -19.64 36.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.83 0.348 . . . . 0.0 111.156 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 65.5 t30 -78.85 -9.26 59.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 -175.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.5 -19.28 57.65 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.432 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.0 t -103.31 -7.64 20.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.027 0.442 . . . . 0.0 110.877 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.507 ' HZ3' ' HD2' ' A' ' 8' ' ' TYR . 10.7 t90 -104.8 147.37 27.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.8 p 51.05 31.75 6.82 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.496 0.665 . . . . 0.0 111.07 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 52.2 tttp -152.78 167.69 28.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 120.462 0.172 . . . . 0.0 111.184 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 33.8 mttm . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.459 0.647 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -67.71 -28.43 67.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.897 174.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -56.71 -38.22 72.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.692 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 5' ' ' LYS . 39.3 t80 -59.96 -43.95 94.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.192 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.12 -41.02 82.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.762 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.01 -49.49 62.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.654 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.8 mp -61.34 -37.31 82.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.254 -177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -24.26 62.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.982 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.89 -39.18 61.62 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.5 mt -69.58 -43.67 80.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.579 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -71.52 -50.61 29.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.876 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -83.28 -40.08 20.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.777 0.322 . . . . 0.0 110.842 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.88 -26.86 59.63 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.491 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.5 25.9 13.32 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.075 0.55 . . . . 0.0 110.64 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.521 HG21 ' HG2' ' A' ' 63' ' ' PRO . 18.0 p 56.65 156.97 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 124.39 1.076 . . . . 0.0 113.338 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 83.2 Cg_endo -83.25 172.8 46.35 Favored 'Cis proline' 0 CA--C 1.53 0.289 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.377 -2.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.52 136.18 21.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -85.16 166.86 16.24 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.692 0.282 . . . . 0.0 110.461 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 1.4 mp0 -55.25 -42.61 73.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.443 0.639 . . . . 0.0 110.242 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -69.59 -22.95 63.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.263 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.37 -49.87 44.7 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.66 0.267 . . . . 0.0 110.501 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.4 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -70.19 -38.68 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.907 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.57 -2.52 11.17 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.203 -0.998 . . . . 0.0 113.785 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 26' ' ' ILE . 34.1 m -116.09 160.97 15.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 117.234 0.517 . . . . 0.0 110.839 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -70.12 159.88 33.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 10.0 pt-20 -60.31 -29.63 68.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.003 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -58.85 -52.36 66.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.597 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -74.61 -35.12 62.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.905 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 74.5 t80 -58.07 -55.77 30.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.243 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -54.83 -49.71 70.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.778 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -50.27 73.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.804 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -69.86 -44.82 69.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.549 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.65 -37.03 74.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.482 0.182 . . . . 0.0 110.858 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.19 -50.65 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.564 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -62.8 -39.13 93.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.996 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 95.1 mt -62.37 -37.59 86.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.045 0.45 . . . . 0.0 110.903 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HD2' ' HB ' ' A' ' 49' ' ' VAL . 51.9 tttm -77.68 -33.6 53.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.45 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -67.04 -47.6 70.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.11 8.27 16.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.41 49.01 59.43 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.387 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.654 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 64.1 m-85 -95.15 -39.76 9.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.9 pp -140.47 142.77 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.214 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.32 175.71 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.068 178.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.65 6.08 73.73 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.686 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 49.8 t -76.24 109.92 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -87.69 111.07 20.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.071 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -78.39 135.78 37.51 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.639 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 7.6 t -104.28 32.41 4.03 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.2 t70 74.75 -47.13 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.257 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD1' ' HB3' ' A' ' 52' ' ' SER . 11.5 p-10 -71.29 -54.22 11.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -147.4 164.33 23.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.13 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.95 101.95 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.194 1.929 . . . . 0.0 110.722 169.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -92.17 108.72 20.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.895 0.379 . . . . 0.0 110.805 -175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.4 mt -76.72 109.42 10.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.946 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -91.8 -168.11 1.94 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.449 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -75.86 -45.48 35.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.204 0.525 . . . . 0.0 110.22 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 30.4 tp -124.32 132.0 53.54 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.608 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.01 -63.14 0.39 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.398 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' HG2' HG21 ' A' ' 19' ' ' THR . 35.9 Cg_exo -59.01 120.24 7.98 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.792 2.328 . . . . 0.0 112.662 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.85 151.67 46.53 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.005 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.21 148.45 22.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.23 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.3 p -91.72 161.05 15.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -66.35 -26.8 67.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -61.46 -51.75 67.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.256 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.7 71.44 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.37 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -62.67 -41.88 99.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.04 0.447 . . . . 0.0 109.854 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -70.81 -32.04 68.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.9 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.17 -36.64 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.03 0.443 . . . . 0.0 110.083 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.905 ' HA ' HD21 ' A' ' 76' ' ' ASN . 89.2 mt -58.41 -33.28 69.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.257 177.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -62.01 -34.7 76.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.081 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.57 -43.18 14.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.606 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.905 HD21 ' HA ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -91.1 5.62 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.97 -18.88 4.76 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.262 0.351 . . . . 0.0 113.952 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 79' ' ' TRP . 3.1 t -74.15 -118.16 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.589 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 73.1 t90 72.93 120.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 173.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.8 m 68.86 -65.5 0.28 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HD3' ' O ' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -75.64 80.38 2.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.124 0.964 . . . . 0.0 111.508 -172.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.634 -179.333 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.689 ' HG3' HD22 ' A' ' 6' ' ' LEU . 46.6 pttt . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.689 HD22 ' HG3' ' A' ' 5' ' ' LYS . 2.1 mm? -82.91 -13.03 56.84 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.305 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.671 ' HG3' HD21 ' A' ' 40' ' ' LEU . 39.9 ttm180 -53.31 -41.65 65.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 0.0 111.233 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.616 ' HB2' HD22 ' A' ' 76' ' ' ASN . 91.0 t80 -60.2 -43.72 95.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.616 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.56 61.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.957 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.95 -45.73 91.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.012 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.93 -41.43 91.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.521 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.06 -46.0 72.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.554 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HB3' HD13 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -58.84 -39.28 80.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.278 179.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.5 mt -70.05 -50.06 50.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.036 0.446 . . . . 0.0 110.414 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -62.76 -50.29 71.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.72 -175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -82.57 -35.15 27.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.809 0.338 . . . . 0.0 111.47 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.54 -24.16 75.42 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.56 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 71.42 5.94 5.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.129 0.572 . . . . 0.0 110.73 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 4.6 p 55.9 164.51 0.06 OUTLIER Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.061 0.944 . . . . 0.0 113.334 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 90.0 Cg_endo -83.98 -178.46 19.38 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.623 -1.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 13' ' ' GLU . 2.6 pt? -155.02 143.43 20.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.2 m -85.27 170.23 13.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.717 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.591 ' HG3' HD22 ' A' ' 24' ' ' ASN . 13.9 pt-20 -61.5 -47.43 85.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.786 0.326 . . . . 0.0 111.35 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.591 HD22 ' HG3' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -72.71 -9.22 58.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -176.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.81 -47.38 30.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -75.13 -38.49 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.46 -19.28 5.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.516 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 32' ' ' GLN . 35.1 m -98.14 162.06 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.666 0.27 . . . . 0.0 110.622 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.7 p -81.02 165.73 21.42 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.09 -31.51 30.86 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.629 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.27 -53.72 55.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.065 0.46 . . . . 0.0 110.797 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 28' ' ' VAL . 2.7 mp0 -70.74 -34.49 71.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.67 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.01 -52.06 39.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.661 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -57.71 -54.16 49.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.795 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -54.08 -50.72 66.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.984 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.647 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -62.02 -53.16 59.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.75 -177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.55 -44.89 97.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 111.37 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -65.89 -40.77 91.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.334 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 75.5 t80 -61.58 -47.87 83.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.176 177.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 7' ' ' ARG . 96.8 mt -56.2 -44.47 79.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.353 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 3.9 ttpm? -67.33 -38.99 85.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -72.72 -39.89 66.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.407 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 14.2 mm-40 -78.24 -27.64 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.95 -177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.61 32.93 1.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.55 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 95.8 m-85 -90.3 -43.87 10.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.018 0.437 . . . . 0.0 110.673 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.4 pp -141.0 154.84 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER -133.54 173.91 14.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 177.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 62' ' ' GLY . . . 91.52 13.32 58.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.799 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -79.65 119.1 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.652 0.263 . . . . 0.0 110.425 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -90.85 124.77 35.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.71 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 56' ' ' PRO . 61.4 m-85 -102.66 153.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -88.03 -41.0 13.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.439 0.638 . . . . 0.0 109.589 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 t70 178.62 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.53 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' OD2' ' HG3' ' A' ' 55' ' ' ARG . 5.6 p-10 -135.8 -39.67 0.7 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.125 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' HG3' ' OD2' ' A' ' 54' ' ' ASP . 88.9 mtt180 -118.42 146.79 40.42 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-O 121.042 0.449 . . . . 0.0 111.256 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 51' ' ' TYR . 94.9 Cg_endo -86.12 160.57 10.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.106 2.538 . . . . 0.0 113.863 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -137.48 126.92 24.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.378 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 86.1 mt -88.25 154.67 20.24 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -133.11 -177.21 4.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.055 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.108 0.48 . . . . 0.0 111.278 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp -146.69 145.15 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.952 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . 134.68 -67.59 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.892 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 28.1 Cg_exo -62.5 123.57 12.64 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.637 2.225 . . . . 0.0 111.878 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 151.33 46.95 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.604 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.662 ' HA ' HG22 ' A' ' 46' ' ' ILE . 8.4 mp -91.92 142.2 27.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.599 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.5 p -88.0 179.31 6.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.262 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.53 -39.24 76.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 3.3 tppt? -65.02 -42.07 94.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.475 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.59 -47.78 88.5 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.52 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.6 -45.08 94.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -73.28 -25.12 60.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.751 0.31 . . . . 0.0 111.18 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -69.22 -40.45 77.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.127 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 mt -55.39 -38.32 68.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.765 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -56.23 -48.22 76.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.248 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 78' ' ' THR . 42.3 mt-10 -85.06 -31.87 23.17 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.3 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.616 HD22 ' HB2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -76.26 5.65 6.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.716 0.293 . . . . 0.0 110.75 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.79 -20.28 56.75 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 164.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 75' ' ' GLU . 6.1 t -78.53 -17.81 55.65 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 72.9 -75.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.313 171.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.5 t -145.44 85.55 1.72 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.914 0.388 . . . . 0.0 110.768 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -175.84 34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 109.074 174.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.871 -177.828 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' HB2' HD22 ' A' ' 6' ' ' LEU . 43.5 mttp . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.377 0.608 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 10' ' ' ILE . 1.5 mm? -75.99 -30.35 58.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.736 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.518 HH11 ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -56.56 -40.37 75.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -72.45 -42.01 65.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.308 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 HG13 ' A' ' 26' ' ' ILE . 42.8 mm -60.48 -52.79 57.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.388 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.92 -43.64 91.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.402 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -63.19 -44.61 94.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.675 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -66.51 -30.87 71.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.123 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ILE . 77.6 mt -65.87 -45.21 91.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 110.339 175.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -62.96 -50.21 71.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.612 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.72 -17.28 32.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.46 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 -27.71 23.66 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.685 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.7 t30 68.53 11.46 8.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 28.6 p 55.04 162.65 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.596 0 C-N-CA 124.345 1.058 . . . . 0.0 113.294 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HA ' ' HB ' ' A' ' 19' ' ' THR . 95.3 Cg_endo -79.61 156.14 89.29 Favored 'Cis proline' 0 C--N 1.343 0.274 0 C-N-CA 123.717 -1.368 . . . . 0.0 111.88 -3.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.1 pt? -124.55 132.51 53.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.6 m -85.0 162.89 19.19 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.138 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.836 ' HG2' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -64.28 -32.94 74.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -65.56 -34.42 78.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.35 -43.7 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG13 HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -78.68 -27.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.097 0.475 . . . . 0.0 109.969 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.95 33.96 5.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.334 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 HG23 ' A' ' 26' ' ' ILE . 33.7 m -135.11 175.87 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.1 p -83.89 156.92 22.17 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.836 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.47 -21.2 64.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.04 -44.8 79.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.056 0.455 . . . . 0.0 109.933 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -68.06 -29.82 68.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.158 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -64.6 -48.79 73.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.562 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -54.67 -53.58 53.02 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.64 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -49.59 53.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.745 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -61.93 -54.41 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.608 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.96 -38.59 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 O-C-N 123.105 0.253 . . . . 0.0 111.522 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' ARG . 17.0 m-80 -60.78 -49.41 77.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.775 0.321 . . . . 0.0 110.647 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -64.66 -38.43 90.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.629 ' HA ' ' HD2' ' A' ' 45' ' ' TYR . 97.0 mt -60.98 -37.73 83.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.749 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 5.3 tmmm? -71.37 -40.76 70.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 38' ' ' ASN . 55.8 mtt180 -60.75 -47.29 86.98 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.926 0.393 . . . . 0.0 111.141 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -82.29 4.77 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.48 46.24 94.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.182 -0.533 . . . . 0.0 113.119 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 29.6 m-85 -87.55 -37.36 16.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.406 177.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 46' ' ' ILE . 1.8 pp -138.68 150.34 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.097 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.29 173.71 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.471 175.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.43 9.34 69.62 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.084 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.75 124.9 38.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -92.42 111.28 22.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.891 0.377 . . . . 0.0 110.424 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -89.84 130.54 36.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.488 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -133.12 110.37 10.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.944 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 63.03 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.989 0.806 . . . . 0.0 110.599 -175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 33.4 t70 -151.72 80.03 1.27 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.807 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 13.3 tpt180 173.46 119.09 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.76 -178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.19 99.9 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.446 2.097 . . . . 0.0 111.012 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -82.05 109.78 16.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.068 0.461 . . . . 0.0 110.933 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 20' ' ' PRO . 85.6 mt -89.17 105.72 17.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.652 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -98.0 173.1 7.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.03 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -67.92 -26.76 66.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.349 0.595 . . . . 0.0 109.891 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.27 117.8 31.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.641 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.18 -72.33 0.31 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.51 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.04 120.4 7.62 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.449 2.766 . . . . 0.0 114.206 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -129.84 144.46 51.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.622 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.66 145.64 26.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.39 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.2 p -96.04 173.85 7.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.27 -37.27 86.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -62.93 -40.45 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.357 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.511 ' HA2' ' HD1' ' A' ' 45' ' ' TYR . . . -70.87 -41.97 61.45 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.467 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.15 -38.63 88.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 0.0 110.776 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -36.77 85.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.353 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -61.61 -36.14 79.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.642 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.4 -44.53 89.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.51 . . . . 0.0 110.489 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -71.93 -31.84 66.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.44 -44.66 34.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.075 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.64 3.2 48.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 110.412 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.88 -0.05 12.52 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.352 -0.451 . . . . 0.0 113.102 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -89.8 19.22 4.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.552 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' SER . 30.8 t90 -91.6 143.52 26.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.789 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' TRP . 68.1 m 74.7 153.13 0.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.468 0.707 . . . . 0.0 111.742 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -142.13 -178.67 5.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.876 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.329 0 O-C-N 123.962 0.789 . . . . 0.0 111.409 -179.748 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.5 mttm . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.03 0.443 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.5 mm? -100.05 -28.05 13.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.505 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -66.68 -37.47 84.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.416 0.627 . . . . 0.0 109.953 -172.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -55.41 -48.3 74.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.111 175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.38 -18.54 54.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.613 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 26' ' ' ILE . 66.2 mt -58.65 -39.37 75.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.436 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' CB ' HD21 ' A' ' 73' ' ' LEU . 46.0 mt -62.3 -30.75 71.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.385 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.62 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -62.94 -43.89 97.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.909 0.385 . . . . 0.0 109.992 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HG3' HD12 ' A' ' 26' ' ' ILE . 7.8 mm-40 -63.37 -42.8 98.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.384 178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 65' ' ' LEU . 74.9 mt -65.93 -31.87 55.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.876 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.21 -49.92 57.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.469 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.26 -28.58 21.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.755 0.312 . . . . 0.0 111.822 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.62 -14.76 64.93 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.599 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 19' ' ' THR . 4.2 t-20 70.51 -81.81 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.596 0.759 . . . . 0.0 109.486 -177.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER 173.16 157.26 0.27 Allowed Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 124.199 0.999 . . . . 0.0 109.012 176.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.824 ' HB3' ' HA ' ' A' ' 59' ' ' TYR . 66.7 Cg_endo -87.8 -174.82 9.67 Favored 'Cis proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.108 -0.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -157.73 127.8 6.18 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.8 m -85.41 170.14 12.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.164 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -62.61 -34.3 76.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.367 . . . . 0.0 110.63 -178.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.03 -22.12 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.722 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -84.2 -43.93 14.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.498 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 10' ' ' ILE . 5.1 tp -70.02 -38.43 75.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.92 -20.13 10.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.943 176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.24 160.07 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 t -70.38 166.82 19.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.299 0.571 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -61.44 -29.15 69.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.45 -43.31 90.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.547 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -71.66 -32.25 67.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.873 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -64.79 -46.7 80.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.86 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -56.71 -53.14 61.17 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.453 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.9 -37.64 77.07 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.405 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -65.14 -59.9 3.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.717 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.14 -43.44 85.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.296 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.999 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -68.91 -45.74 70.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.792 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 74.7 mt -63.21 -37.18 86.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.944 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm-85 -60.77 -42.35 97.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.99 12.97 18.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.356 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 62.28 38.33 96.04 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.638 172.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HD2' ' HA ' ' A' ' 40' ' ' LEU . 34.7 m-85 -88.26 -28.72 20.93 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.487 -0.419 . . . . 0.0 110.488 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 65' ' ' LEU . 1.9 pp -143.68 149.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.49 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -131.84 150.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.63 35.45 6.18 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.518 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.6 115.2 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.944 0.402 . . . . 0.0 110.452 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.436 ' NE2' ' HA3' ' A' ' 62' ' ' GLY . 89.4 m-70 -82.19 135.91 35.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.66 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -108.01 135.66 49.0 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 t -67.25 -34.88 78.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.409 0.623 . . . . 0.0 109.853 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 174.22 -36.36 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.686 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -131.98 -43.51 0.97 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.079 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.867 ' HG3' ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -108.18 147.21 35.11 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.37 -173.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.867 ' HD2' ' HG3' ' A' ' 55' ' ' ARG . 52.7 Cg_exo -53.62 136.47 64.71 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.553 2.168 . . . . 0.0 111.835 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.22 105.57 3.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.111 0.482 . . . . 0.0 110.027 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB3' HG21 ' A' ' 19' ' ' THR . 86.8 mt -74.03 134.33 43.01 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.147 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.824 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.8 m-85 -125.83 -178.34 4.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -43.15 -55.66 3.81 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.159 0.912 . . . . 0.0 113.289 -172.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 61' ' ' LEU . 3.2 pp -128.1 146.07 50.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.925 0.393 . . . . 0.0 110.955 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA3' ' NE2' ' A' ' 50' ' ' HIS . . . 137.19 -64.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.722 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.23 121.57 8.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.537 2.158 . . . . 0.0 113.074 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -114.72 152.37 32.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.621 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' A' ' 46' ' ' ILE . 5.9 mp -101.17 134.43 44.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.1 p -80.23 160.95 25.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 70' ' ' GLU . 10.7 pt-20 -69.43 -20.0 63.79 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.48 -48.32 82.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 -35.23 50.51 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.862 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 32.9 tt0 -63.11 -43.26 98.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.56 0.219 . . . . 0.0 110.905 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -67.37 -32.87 74.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.26 -35.71 81.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.236 0.541 . . . . 0.0 109.607 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.594 HD21 ' CB ' ' A' ' 11' ' ' LEU . 73.8 mt -74.59 -19.41 60.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.34 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -53.03 -37.24 61.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.987 0.422 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.08 -19.89 31.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.439 0.638 . . . . 0.0 110.706 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 12' ' ' LYS . 2.7 t-20 -80.01 -9.8 59.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.268 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.33 -20.89 63.72 Favored Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.912 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 t -100.72 21.19 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.31 0.576 . . . . 0.0 110.631 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -105.51 130.76 53.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.7 t -118.76 159.56 23.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.828 0.347 . . . . 0.0 110.348 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -94.63 28.82 2.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.268 0.556 . . . . 0.0 110.112 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.358 172.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 9.9 mptt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.24 -29.73 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 175.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -60.79 -41.95 96.6 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.869 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.695 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 72.5 t80 -66.44 -42.85 87.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.147 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 13' ' ' GLU . . . -56.98 -47.21 81.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG12 HD13 ' A' ' 26' ' ' ILE . 54.2 mt -61.15 -43.54 96.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 40' ' ' LEU . 82.9 mt -56.01 -46.83 78.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.29 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 26.3 ttpp -68.69 -42.45 77.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 -177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.645 ' HG3' HG13 ' A' ' 26' ' ' ILE . 9.1 mm-40 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.016 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 19' ' ' THR . 73.0 mt -65.33 -42.31 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 110.115 173.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.94 -50.1 57.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.402 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 12' ' ' LYS . 10.7 mt-10 -74.1 -33.28 63.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.023 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.17 -31.28 14.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.249 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 71.99 19.12 4.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.167 0.587 . . . . 0.0 110.614 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.744 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 14.2 p 56.16 169.44 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.075 0.95 . . . . 0.0 113.156 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.791 ' HD3' ' HG2' ' A' ' 60' ' ' LYS . 79.6 Cg_endo -90.77 156.54 27.8 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 124.715 -0.952 . . . . 0.0 112.276 -1.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 26' ' ' ILE . 2.7 pt? -149.35 131.46 15.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.118 0.485 . . . . 0.0 110.527 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -85.26 170.32 12.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.987 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -59.83 -36.71 77.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.765 0.284 . . . . 0.0 111.765 -178.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -68.47 -25.92 65.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.32 -48.78 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.003 0.43 . . . . 0.0 110.509 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.682 ' HB ' HD12 ' A' ' 21' ' ' LEU . 9.4 tt -76.56 -34.4 24.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.607 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.25 28.18 3.4 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.245 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 34.5 m -126.92 172.14 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.5 p -85.16 163.8 18.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.844 -0.162 . . . . 0.0 110.862 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 23' ' ' GLU . 24.5 mt-10 -55.8 -42.5 75.71 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.61 -62.08 1.62 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.56 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.77 -47.56 80.49 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.297 -1.319 . . . . 0.0 111.639 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.5 t80 -63.63 -52.1 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 -175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.71 -45.77 85.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -62.25 -39.92 94.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -50.53 72.04 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.803 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 33' ' ' PHE . 97.7 t -58.18 -41.77 81.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.703 0.287 . . . . 0.0 110.956 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -62.53 -45.48 92.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.976 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -64.68 -41.0 96.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.709 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 11' ' ' LEU . 84.1 mt -63.81 -46.08 86.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.204 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -70.55 -26.65 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -56.57 -53.67 54.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.938 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 26.1 mt-10 -89.6 -8.4 52.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.11 53.76 2.9 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.936 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' HD2' ' HA2' ' A' ' 69' ' ' GLY . 73.4 m-85 -85.42 -38.37 18.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.767 0.317 . . . . 0.0 110.681 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -131.92 149.91 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 176.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 pt -126.9 167.0 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.12 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.58 9.99 65.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.549 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.67 124.96 38.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 0.0 110.586 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -98.21 137.98 36.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.789 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.9 m -77.23 -75.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -115.69 -21.83 9.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.328 172.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -173.96 -29.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.768 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -86.86 140.52 33.12 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.431 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 2.6 Cg_endo -81.89 146.48 14.68 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.486 2.791 . . . . 0.0 112.275 177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -125.87 116.29 21.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.472 HD22 ' HG3' ' A' ' 63' ' ' PRO . 78.0 mt -89.0 120.6 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.923 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -100.64 -174.36 2.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.791 ' HG2' ' HD3' ' A' ' 20' ' ' PRO . 97.0 mttt -69.89 -26.3 64.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.417 0.627 . . . . 0.0 110.394 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.72 101.43 5.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.055 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.42 -79.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.777 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 73.9 Cg_endo -76.87 120.39 5.46 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.477 2.118 . . . . 0.0 114.198 -172.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HB2' HG13 ' A' ' 47' ' ' ILE . 37.4 mt-10 -100.18 142.23 31.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.074 172.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mp -95.26 134.52 37.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.731 0.301 . . . . 0.0 110.361 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.0 p -93.26 178.43 5.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.351 -177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.9 -40.31 80.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.014 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -59.75 -41.0 90.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 73' ' ' LEU . . . -75.88 -41.72 27.35 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.407 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -65.78 -34.6 78.54 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 110.979 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.72 -36.06 67.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.874 0.369 . . . . 0.0 110.942 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.62 -26.35 66.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.261 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.695 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 97.0 mt -59.92 -41.8 92.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.721 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -70.15 -43.08 71.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.533 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -69.02 -44.12 73.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.829 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.14 5.06 43.15 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.125 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.98 -9.75 29.6 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.635 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -82.01 -2.87 53.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.838 0.351 . . . . 0.0 110.82 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -70.53 158.08 36.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.076 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.3 p 62.35 168.81 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.225 1.01 . . . . 0.0 111.303 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 71.82 -33.06 0.26 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.287 0.635 . . . . 0.0 112.601 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -172.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.827 ' HG3' HD22 ' A' ' 6' ' ' LEU . 43.3 pttt . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.827 HD22 ' HG3' ' A' ' 5' ' ' LYS . 3.6 mm? -100.22 5.11 44.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.658 0.266 . . . . 0.0 110.662 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.595 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -45.18 -50.7 11.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -176.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.669 ' HE1' ' HA ' ' A' ' 73' ' ' LEU . 64.6 t80 -62.15 -46.07 90.6 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.959 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 79' ' ' TRP . . . -61.67 -46.42 89.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.332 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 14' ' ' ILE . 70.3 mt -55.99 -46.64 80.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.447 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 7' ' ' ARG . 98.5 mt -56.45 -50.19 72.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.508 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -77.68 -30.32 51.91 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.836 -175.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' N ' ' HD3' ' A' ' 12' ' ' LYS . 5.7 mm-40 -73.61 -22.31 60.05 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.089 0.471 . . . . 0.0 110.074 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 10' ' ' ILE . 58.9 mt -76.41 -50.38 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 170.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -56.12 -41.6 75.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.586 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -97.01 -26.27 15.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.721 0.296 . . . . 0.0 111.694 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . -83.49 -16.0 69.81 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.383 -174.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 7.3 t30 76.67 -13.52 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.014 0.526 . . . . 0.0 111.546 176.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 27.5 p 58.93 156.98 0.09 OUTLIER Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.504 1.122 . . . . 0.0 112.648 -174.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 59' ' ' TYR . 4.4 Cg_exo -75.55 161.85 93.64 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.946 -1.273 . . . . 0.0 111.935 1.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 21' ' ' LEU . 2.4 pt? -124.7 119.96 30.47 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.1 m -72.18 156.09 39.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.315 0.579 . . . . 0.0 111.042 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.625 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -71.17 -40.76 71.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.662 -175.159 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -73.14 -19.15 61.19 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.473 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -81.55 -45.54 15.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.301 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.55 -36.79 42.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 33.7 1.52 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.397 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 26' ' ' ILE . 30.6 m -139.01 174.37 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.843 0.322 . . . . 0.0 110.182 178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -85.32 154.26 22.02 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.056 0.455 . . . . 0.0 110.343 171.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -68.39 -28.55 67.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.131 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.76 -42.62 85.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.197 0.522 . . . . 0.0 110.58 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HB2' HG23 ' A' ' 29' ' ' THR . 1.5 mp0 -79.78 -21.19 44.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.381 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.494 ' O ' HG23 ' A' ' 37' ' ' VAL . 84.9 t80 -65.82 -55.97 14.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.063 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' HB2' ' HG2' ' A' ' 56' ' ' PRO . 1.5 p30 -68.47 -33.86 74.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.283 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.64 -50.52 73.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.124 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -60.83 -44.91 96.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.226 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 33' ' ' PHE . 93.0 t -57.05 -40.88 75.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 120.933 0.396 . . . . 0.0 110.903 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -68.37 -38.62 81.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.171 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -66.83 -40.17 87.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 36' ' ' ALA . 94.4 mt -60.87 -38.22 84.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.011 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -70.66 -37.49 73.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.101 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -57.03 -53.12 61.72 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.08 -34.44 71.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.193 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.22 46.25 1.6 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.571 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -94.45 -35.99 12.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 65' ' ' LEU . 2.1 pp -137.94 154.93 29.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.879 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -133.73 163.37 37.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.729 177.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.82 28.15 14.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.784 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 56' ' ' PRO . 87.1 t -71.46 117.42 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.807 0.337 . . . . 0.0 110.48 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' PRO . 4.2 t60 -96.57 121.98 38.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.923 -176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -99.41 121.55 41.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -69.13 -65.73 0.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.163 0.506 . . . . 0.0 110.157 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -123.71 -20.68 5.41 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.992 174.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.05 -34.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.101 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -103.21 142.19 24.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.851 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 26.7 Cg_endo -65.47 117.34 4.51 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.452 2.102 . . . . 0.0 110.799 170.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -105.74 -35.82 7.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD22 ' HG3' ' A' ' 63' ' ' PRO . 89.5 mt 69.5 128.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.862 0.726 . . . . 0.0 110.763 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 20' ' ' PRO . 31.6 m-85 -122.06 -175.55 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.376 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.648 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 44.5 mtmt -70.02 -5.14 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.3 tp -160.29 119.07 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.03 -67.99 0.19 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.332 -0.937 . . . . 0.0 113.221 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 58' ' ' LEU . 57.7 Cg_endo -71.24 137.8 31.93 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.364 2.043 . . . . 0.0 113.459 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -130.29 166.11 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.584 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' HG22 ' A' ' 46' ' ' ILE . 7.8 mp -97.75 145.18 26.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.919 0.39 . . . . 0.0 110.461 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.3 p -80.06 169.56 17.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -58.01 -38.36 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.94 0.4 . . . . 0.0 110.014 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -69.21 -45.64 69.37 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.989 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.22 97.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.337 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.27 -40.49 90.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.81 0.338 . . . . 0.0 111.221 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -81.07 -24.38 37.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.071 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.58 -28.61 69.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.094 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.669 ' HA ' ' HE1' ' A' ' 8' ' ' TYR . 87.3 mt -58.23 -34.48 70.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.34 175.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -68.44 -45.56 72.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.151 0.5 . . . . 0.0 110.051 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -64.78 -48.88 72.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.988 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -91.71 5.28 50.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.696 -175.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.79 -2.34 1.16 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 114.901 0.721 . . . . 0.0 114.901 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -90.54 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 171.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.556 ' CZ2' ' HB2' ' A' ' 9' ' ' ALA . 69.6 t-105 67.11 166.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 165.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.5 m -147.0 121.39 9.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.961 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -71.48 152.84 42.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.962 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.449 . . . . 0.0 111.443 -176.715 . . . . . . . . 0 0 . 1 stop_ save_